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Abstract:!#Alternative# pathway# (AP)# activation# is# under# strict# control# of# regulators# of#complement#activation# (RCA)# to#prevent#unwanted# complement#activation#and#to# protect# host# cells# against# complement# induced# damage.# In# recent# years#numerous#Staphylococcus, aureus#proteins# have# been# discovered# that# facilitate#evasion# of# the# host's# innate# immune# response.# Several# of# these# complement#inhibitors# target# the# central# complement# component# C3# and# act# by# preventing#AP# activation.# Staphylococcal# immunoglobulin# binding# protein# (Sbi)# is# unique#among#all#complement#evasion#proteins#because#it#triggers#AP#activation#causing#local# fluid^phase# consumption#of#C3.#Previous# studies#have# shown# that#Sbi# is# a#prominent# covalent# attachment# target# for# nascent# C3b,# and# in# this# study# we#show# that#C3b#predominantly#deposits#on#domain# IV#of# Sbi,# thereby#extending#the#C3b#serum#half^life,# and# facilitating#C3#consumption.#Previous# studies#have#also#shown#that# in#complex#with#C3#fragments,#Sbi#can#form#a#ternary#complex#with#complement# factor#H#(FH),#however# little# is#known#about# the#mechanistic#aspects# of# this# complex.# This# study# shows# that# Sbi# directly# binds# to# FH# and#complement# factor# H^related# protein# 1# (FHR^1),# and# in# complex# with# C3#fragments# the# resulting# FH# and# FHR^1# ternary# complexes# are# significantly#stronger# in# avidity.# A# strong# preference# for# the# formation# of# a# FHR^1# ternary#complex#was#also#demonstrated.#Using#site^directed#mutagenesis#we#have#been#able# to# determine# the# amino# acids# that# are# critical# for# the# formation# of# both#ternary#complexes#and#their#role#in#Sbi's#complement#consumption#activity.#The#FHR^1#ternary#complex#protects#C3b#from#inactivation,#and#is#essential#for#the#C3#futile# consumption.# Using# ab, initio# structural# prediction,# single# molecule#fluorescence# resonance# energy# transfer,# and# small# angle# X^ray# scattering# data,#two#structural#models#of#these#ternary#complexes#were#proposed.#In#addition#we#show#that#the#Sbi#mediated#ternary#complexes#significantly#inhibit#the#formation#of# the# terminal# complement# complex# (TCC),#which#will# aid# the#development#of#new#complement#inhibitors#for#treatment#of#autoimmune#diseases.#
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1.1.1(Activation(pathways(!As!a!defense!mechanism!against!constant!attacks! from!invading!pathogens,! the!human!body!has!evolved!an!elaborate!immune!system!that!exerts!a!continuous!surveillance! to! protect! against! these! pathogens.! In! one! approach,! the! antibody!mediated! adaptive! immune! system! can! swiftly! contain! and! clear! invading!bacteria! by! specific! immunoglobulin!molecules! that! can! recognize! the! invader!from!a!previous!infection.!Alternatively,!the!unacquainted!pathogens!are!tackled!by!the!humoral!component!of!innate!immunity,!the!complement!system.!!The! complement! system! comprises! over! 30! soluble! plasma! proteins! and! cell!surface! receptors! (Carroll! 2004)! that! interact! with! each! other! via! an! intricate!network! of! interactions.! The! soluble! fraction! of! this! finely! regulated! protein!network! consists! of! a! number! of! proteases! that! are! themselves! activated! by!proteolytic! cleavage.! These! precursor! zymogens! are! widely! distributed!throughout!body! fluids!and! tissues!without!adverse!effect.!However,!at! sites!of!infection,! they!are! locally!activated!and! trigger!a!series!of!potent! inflammatory!events.!In!this!thesis!over!60!complement!components!and!activation!fragments!are!mentioned.!The!nomenclature!of!all!the!complement!component!(Kemper!et!
al.! 2014)!was! dictated! by! their! respective! chronology! of! discovery.! Thus,! nine!central! components! are! arranged! from! C1! to! C9.! Furthermore! there! are!anaphylatoxins!such!as!C3a,!C4a!and!C5a,!opsonins!such!as!C3b,! iC3b,!C3d!and!C4b;!proteases!such!as!factor!B,!factor!D!and!factor!I;!regulators!such!as!factor!H!(FH),! factor!H! related!proteins!1Q5! (FHR!1Q5),!C1q,!properdin!and!complement!receptor! type! 1! (CR1);! assembled! enzymes! such! as! C3! convertase! and! C5!convertases;! and! finally! receptors! such! as! C3a! receptor,! C5a! receptor! and!C1q!
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receptor!(Zipfel!&!Skerka!2009).! !!Complement!activation!can!be!categorized! into! three!pathways! (Fig.1.1),!based!on! the! triggers! of! activation.! Classical! pathway! activation! is! initiated! by!recognition! of! antibodyQantigen! complexes,! polymerization! of! the!immunoglobulin!molecules! (e.g.! IgG! or! IgM)! or! CQreactive! proteins.! The! Lectin!pathway!activates! in! response! to!mannoseQbinding!proteins! (MBL)!and! ficolins!binding! to! the! carbohydrate! ligands! on! the! bacteria! surfaces.! Finally,! the!alternative! pathway! activation! is! initiated! by! the! spontaneous! hydrolysis!property!of!complement!component!C3.!Despite!differences! in! initiation!stages,!all! three!activation!pathways!converge!at! the! formation!of!a!C3!convertase! the!central! step! of! complement! activation!where! the! activation! signal! is! amplified,!eventually!leading!to!the!formation!of!membrane!attack!complex!(MAC).!!The! complement! system! collectively! recognizes,! opsonizes! and! eliminates!pathogens,!apoptotic!cell!debris!and!immune!complexes!within!minutes!after!the!encounter! (Lambris! et& al.! 2008).! The! activation! of! complement! also! elicits!profound! immunological! consequences,! bridging! the! innate! immunity! and!adaptive!immunity!(Isenman!2012).!Complement!activation!products!enhance!T!cell!immunity!by!promoting!T!cell!proliferation!and!diminishing!T!cell!apoptosis!(Kwan! et& al.! 2012),! while! at! the! same! time! sensitizing! antigens! for! B! cell!recognition,! resulting! in! augmented! antibody! response! and! enhanced!immunological!memory!(Walport!2001).! !
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!
1.1.2(Classical(pathway(The!initiation!of!the!classical!pathway!(CP)!is!triggered!by!interactions!between!the! first! complement! component! (C1)! with! antibodyQantigen! complexes! and!immune!aggregates!consisting!of!immunoglobulins!(e.g.IgG1,!IgG2,!IgG3!or!IgM)!or!CQreactive!protein!(Fig.1.2.A).! ! Apart!from!these!components!of!the!adaptive!
Figure(1.1:(Schematic(presentation(of(complement(system(cascade.(
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immune! system,! it! is! known! that! activation! of! the! classical! pathway! can! also!occur! in! an! immunoglobulin! independent! manner! via! direct! interaction! of! C1!with! a! diverse! range! of! activators,! including! GramQpositive! and!GramQnegative!bacteria,! certain! viruses,! infected! cells,! polyQanionic! foreign! materials! and!βQamyloid!fibrils!(Arlaud!&!Thielens!2001).! !
!This! recognition! flexibility! of! the! C1! complex! can! be! attributed! to! its! complex!molecular!design.!C1!is!composed!of!a!C1q!recognition!module!and!two!C1r!and!two!C1s!molecules! forming!the!protease!module,! together!assembled!to! form!a!C1qr2s2!complex.!C1q! is!a!hexameric!protein,!with!each!monomer!consisting!of!three!chains,!with!a!CQterminal!globular!domain!and!a!collagen!triple!helix!region!at! the! NQterminus.! Consequently,! in! C1q! there! are! six! globular! “heads”,! held!together! by! a! “stalk”! structure! that! result! from! oligomerization! of! the! six!NQterminal!collagen!triplets.!C1’s!recognition!capability!is!located!in!the!six!C1q!“heads”! that! bind! the! fragmentQcrystallizable! (Fc)! regions! of! IgG! and! IgM.!Spontaneous! binding! of! more! than! one! C1q! heads! is! needed! to! trigger! a!conformational! activation! event! of! the! zymogen! C1r,! where! the! activated! C1r!serine!protease!then!cleaves!zymogen!C1s!to!its!activated!serine!protease!state.!The! classical! pathway! proteolytic! cascade! (Fig.1.1)! then! proceeds! with! the!cleavage! of! C4! to! anaphylatoxin! C4a! and! opsonin! C4b,! which! opsonize! a!
Figure(1.2:(Schematic(diagrams(of(the(C1(complex(and(the(MBL/FicolinEMASP(complex.!Image!taken!from!(Fujita!2002).!.!
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pathogen!by!the!activation!of!a!highly!reactive!thioester!in!close!proximity!to!the!antigenic! surface.! C4b! then! binds! to! zymogen! C2,! which! became! cleavable! by!activated!C1s;!proteolytic!fragment!C2b!diffuses!away,!resulting!the!formation!of!C4b2a! classical! pathway! C3! convertase.! Local! C3! molecules! are! then! used! as!substrate!and!proteolytically!converted!to!C3a!and!C3b!fragments.!The!increased!local! C3b! concentration! finally! leads! to! the! formation! of! the! C4b2a3b! classical!pathway! C5! convertase! that! activates! the! C5! molecule,! thus! initiating! the!assembly!of!MAC.!!
1.1.3(Lectin(pathway(!In!contrast!with!the!classical!pathway,!antibody!recognition!is!not!necessary!for!activation!of!the!lectin!pathway;!instead!activation!is!triggered!upon!recognition!of! carbohydrates! on! the! surfaces! of! a! broad! spectrum! of! microorganisms.!(Fig.1.2.B)! Carbohydrates!with! 3Q! and! 4Qhydroxyl! groups! in! the! pyranose! ring!(e.g.! mannose! and! NQacetylQglucosamine! (GlcNAc))! are! recognized! by!mannoseQbinding! lectin! (MBL),! together! with! ficolins! that! specifically! bind! to!GlcNAc!(Fujita!2002).! !!MBL! and! its! associated! serine! proteases! MASP1! and! MASP2! represent! the!functional!equivalent!of!C1q! in!the! lectin!pathway.!They!share!a!similar!overall!topology!with!C1q,!consisting!of!a!CQterminal!carbohydrate!binding!domain!and!NQterminal!collagenQlike!domain.!The!oligomeric!state!of!the!native!form!of!MBL!varies!from!a!dimer!to!a!hexamer,!in!contrast!with!native!ficolins!which!adopt!a!tetrameric!form!(Endo!et&al.!2011).!MBL!and!ficolins!each!individually!associate!with! MASP1,! MASP2,! and! activate! MASP2! when! bound! to! microbial!carbohydrates.! Activated! MASP2! then! relays! the! activation! signal! in! a! similar!fashion! to!activated!C1s!during!classical!pathway!activation,!eventually! leading!to!the!formation!of!MAC.!
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1.1.4(Alternative(pathway!!
The!alternative!pathway! (AP)!plays!a!major! role! in! the!elimination!of! invading!microorganisms!via!its!signal!amplification!function!(Lachmann!&!HughesQJones!1984)! for! the! other! two! complement! pathways.! The! first! step! of! alterative!pathway! activation! (Fig.1.3)! is! the! result! of! a! biophysical! property! of!complement! component! C3.! The! conformational! flexibility! of! this! molecule!allows!it!to!undergo!spontaneous!hydrolysis!constantly!at!a!very!low!rate!(0.005%!of!total!C3!per!min)!(Pangburn!et&al.!1981;!MüllerQEberhard!1988),!traditionally!described!as!the!“tickQover”!mechanism!(!Lachmann!1975).!The!hydrolysis!of!the!internal! thioester! located!within! the! thioester!domain!(TED)!of!C3! leads! to! the!formation! of! C3H2O! that! is! trapped! in! a! C3b! like! conformation.! Factor! B! in! the!plasma! then! binds! to! the! newly! exposed! interaction! interface! on! C3H2O! in! the!presence! of! Mg2+! and! becomes! a! cleavable! substrate! for! factor! D.! Factor! B! is!cleaved! by! factor! D! into! two! fragments! Ba! and! Bb,! the! latter! remaining!associated!with!C3H2O!to!form!the!fluid!phase!alterative!pathway!C3!convertase!C3H2OBb.! The! enzymatic! complex! activates! C3! proteolytically,! releasing! the!anaphylatoxin!C3a!fragment!and!a!metastable!C3b!molecule,!which!can!become!covalently!deposited!on!surrounding!self!or!nonQself!surfaces!(MüllerQEberhard!1966;!Dalmasso!&!MüllerQEberhard!1967).!On!host!cell!surfaces,!C3!convertase!
Figure( 1.3:( Schematic( diagram(of( alternative( pathway( activation,( amplification( and(
regulation.(
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activity! is! suppressed! by! the! presence! of! sialic! acid! or! other! polyanionic!molecules!and!complement!regulatory!proteins.!In!contrast,!on!nonQself!surfaces,!uncontrolled! C3! convertase! activity! promotes! the! positiveQfeedback!amplification! loop!of!C3b!amounting!to!the!deposition!of! large!numbers!of!C3b!molecules!within! a! very! short! period! of! time.! The! deposited! C3b!molecules! in!turn!can!function!as!a!new!platform!for!C3!convertase!assembly.!Stabilization!of!this!alternative!pathway!C3!convertase!complex!has!a!halfQlife!of!90!sec,!however!the! binding! of! properdin! stabilizes! the! enzyme! and! extends! the! halfQlife! by!10Qfold! (Fishelson! &! MüllerQEberhard! 1982).! In! the! fluid! phase,! C3b!concentrations! also! increase! which! in! turn! can! associate! with! C3bBb! to! form!C3bBbC3b,! the! alternative! pathway! C5! convertase,! which! is! analogous! to!C4b2a3b!C5!convertase!in!the!classical!pathway.!!
1.1.5(Membrane(attack(complex( (!The!terminal!or!lytic!phase!of!all!complement!pathways!starts!with!the!cleavage!of! C5! by! C5! convertase! into! C5b! and! a! smaller! fragment! C5a,! a! very! potent!anaphylatoxin!that!stimulates!the!chemotaxis!of!inflammatory!cells!to!the!site!of!complement! activation.! C5b! subsequently! binds! with! C6! to! form! the! C5b6!complex,!followed!by!the!association!of!C7,!which!results!in!the!formation!of!the!lipophilic! C5b67! complex.! ! Additional! association! of! the! C5b67! complex! with!the!heterotrimeric!C8!protein,!forming!the!C5b678!complex,!leads!to!association!with! phospholipids! and! subsequent! penetration! into! the! lipid! bilayer.! The!membrane! inserted! C5b678! then! serves! as! a! receptor! for! C9! and! catalyzes! its!oligomerization,! resulting! in! the! formation! of! a! transQmembrane! tubular! pore!called! the! membrane! attack! complex! (MAC).! The! oligomerization! of! ten! to!seventeen! C9! molecules! creates! a! 7Q10nm! pore! that! makes! the! membrane!permeable!to!water!and!electrolytes,!eventually!leading!to!the!lysis!of!cells!due!to!increased!osmotic!pressure.!!
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In! the!event!of! the!MAC!assembly!occuring!distal! from!a!membrane!or!missing!the! targeted! membrane,! it! binds! with! clusterin! and! vitronectin,! producing! a!soluble! complex! called! sMAC!or! sC5b9.!Within!both!membrane! embedded! and!activated! C9,! a! common! neoQepitope! on! C9! becomes! available! for! antibody!recognition.! Based! on! the! antibody! against! this! epitope,! a! commercial!enzymeQlinked!immunosorbent!assay!(ELISA)!was!used!to!quantify!activated!C9!in!serum,!therefore!leading!to!the!evaluation!of!residual!complement!activity!of!all!pathways.!!
1.2(Complement(component(C3(!C3! belongs! to! the! α2Qmacroglubulin! (α2M)! protein! family,! and! has! 26Q30%!sequence! identity! to! complement! components! C4! and! C5,! which! are! also!members!of! this! family! (Reid!&!Porter!1981)! and!are! thought! to!have! evolved!from! C3! via! two! gene! duplication! events.! ! α2M! family! proteins! contribute!significantly!to!host!innate!immunity!(Blandin!2004),!the!proteins!of!this!family!normally!possess! a!highly! reactive! thioester! region! that,! once! solvent! exposed,!can!covalently!attach!to!nearby!hydroxyl!and!primary!amine!groups.!Although!in!C5! it! has! lost! its! function! during! evolution,! in! C3! and! C4! the! thioester! plays! a!fundamental!role! in!their! immunological! function.!The!substrate!specificity!and!reactivity! of! the! thioester! in! C3! and! C4! have! diverged! during! evolution! and!whilst! in! C3! it! is! able! to! form! both! ester! and! amide! linkages! with! antigenic!surfaces! (Law! &! Dodds! 1997),! humans! have! two! C4! variants! (A! and! B)! that!preferentially! form! either! amide! or! ester! linkage,! respectively! (! Isenman! &!Young!1984).!!Complement! component! C3! is! considered! the! central! molecule! for! all!complement!activation!pathways.! It! circulates! in!plasma! in! its! immunologically!inactive! form,! with! concentrations! varying! from! 1Q1.5! mg/ml.! However,!increased!C3! levels! are!often!observed!during! inflammation! and! infection.!The!
! 9!
majority!of!C3! in!circulation! is!constantly!replenished!by!hepatocytes!(Alper!et&
al.,!1969),!however!under!immunological!stresses,!numerous!extraQhepatic!cells!also!produce!C3,!such!as!leukocytes,!fibroblasts,!keratinocytes!(Pasch!et&al.,!2000)!and!endothelial!cells!(Andoh!et&al.,!1993).!Although!indisputably!the!secreted!C3!molecules! are! primarily! involved! in! detecting! and! removal! of! pathogens,! an!increasing! amount! of! evidence! indicates! that! C3! activation! fragments! are! also!essential!for!driving!and!modulating!adaptive!T!cell!immunity.!The!C3!activation!fragments!C3a!and!C3b,!generated!by!T!cell!itself,!are!required!for!the!induction!of!interferonQγ!secretion!through!autocrine!binding!to!their!respective!receptors,!the! C3a! receptor! (C3aR)! and! C3b! receptor! (CD46)! (Liszewski! et& al.,! 2005;! Le!Friec! et& al.,! 2012).! This! molecular! basis! correlates! with! the! facts! that! CD46!deficient!patients!and!C3Qdeficient!patients!suffer!from!recurrent!infections!and!have!severely!reduced!T!helper!1!cell!mediated!responses!(Ghannam!et&al.,!2008).!It!was! traditionally! accepted! that! the!T! cell! secreted!C3!molecules! are! cleaved!extracellularly!via!activation!of!AP!(Kemper!&!Atkinson,!2006).!However,!it!was!recently!reported!that!C3!activation!could!also!take!place!intracellularly!through!cleavage!by!the!protease!cathepsin!L!(CTSL),!providing!a!new!prospective!for!the!role!of!C3!in!maintaining!T!cell!homeostatic!survival!(Liszewski!et&al.,!2013).!!
1.2.1(C3(structure(
(Human! C3! is! a! 185! kDa! glycoprotein! that! encoded! by! a! 41! kb! gene,! which! is!situated!at!the!far!end!of!the!chromosome!19!long!arm.!This!gene!is!composed!of!41!exons.!The!primary!structure!of!C3,!inferred!from!its!cDNA!sequence,!consists!of!1663!amino!acid!residues!with!a!22!amino!acid!signal!peptide.!The!mRNA!of!C3! is! translated! as! a! singleQchain! preQproQmolecule! starting! with! the! β! chain!followed!by!the!α!chain.!The!two!chains!are!joined!by!a!tetraQarginine!sequence,!which! is! removed! by! an! enzyme! during! postQtranslational! modification.! As! a!result,! in! the! correctly! folded! C3! molecule,! αQ! and! βQchains,! with! molecular!weights! of! 110! and! 75! kDa! respectively,! are! linked! by! disulphide! bonds! and!
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nonQcovalent! interactions.! After! translocation! through! the! endoplasmic!reticulum! to! the! Golgi! body,! three! NQlinked! highQmannose! glycans! are!transferred! to! both! αQand! βQchains,! at! position! Asn85! (Zhang! et& al.! 2003),!Asn939! (Bunkenborg& et& al.! 2004)! and! Asn1617! (Liu! et& al.! 2005).! The! glycan!structure! (Miki! et& al.! 1986;! HASE! et& al.! 1985)! on! the! α! chain!mainly! contains!Man8GlcNAc2!or!Man9GlcNAc2,!whilst!in!the!β!chain,!the!glycan!structure!consists!of!Man5GlcNAc2!or!Man6GlcNAc2.!The!glycans! in!C3!represent!about!2.3%!of! its!molecular!weight.!!
!The! threeQdimensional!model!of!human!C3! (Fig.1.4.A)!has!been!determined!by!XQray! crystallography! (Janssen! et& al.! 2005),! showing! that! the! protein! is!composed!of!13!individual!domains.!The!protein!core!consists!of!8!homologous!macroglobulin! (MG)! domains,! surrounded! by! a! thioesterQcontaining! (TED)!
Figure(1.4:(Conformation(changes(of(complement(component(C3.((A)(Crystal!structure!of!native!human!C3.!PDB!code:!2A73! (B)! Crystal! structure!of! activated!C3! conformation,!C3b.!PDB!code:!2I07.!PDB,!Protein!date!bank.!
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1.2.2(Structure(and(function(of(the(C3(activation(product(!The! C3! molecules! circulating! in! the! plasma! constantly! undergo! “tickQover”,!monitoring!the!surrounding!environment.!A!series!of!proteinQprotein!interaction!interfaces,!hidden!inside!the!inactive!C3!structure!conformation!contribute!to!the!regulation,! communication!and!modulation,!not!only!of! components!within! the!complement!system!but!also!the!adaptive!immune!system!(Fig.1.5).! !
The!main!activity!of!C3! is!unleashed!by! the!cleavage!of!C3!convertase,! through!which!the!anaphylatoxin!fragment!C3a!is!released!and!the!remaining!C3!converts!into!C3b!(Fig.1.4.B)!followed!by!a!series!of!dramatic!conformational!changes.!In!its!C3b!conformation! it! is! then!recognized!by!various!complement!components!including!factor!B,!properdin,!FH!and!FHRs,!factor!HQlike!protein!1!(FHLQ1)!and!complement! receptors! (CR).! Some! of! those! binding! events! facilitate! the!recruitment!of!additional!serum!proteases!such!as!factor!I!and!plasmin!to!further!cleave! C3b! into! fragments! iC3b! and! C3dg! that! display! new! protein! binding!interfaces.! This! final! round! of! cleavage! is! essential! for! the! communication!between! complement! system!and!other! components!of! the! immune! system,! as!iC3b! and! C3dg! are! the! ligands! for! complement! receptors! CR2,! CR3! and! CR4,!
Figure(1.5:(Schematic(diagram(of( the(conformational( changes(of(C3(and( its(activation(
products(in(the(complement(cascade.(Image!adapted!from!(Gros!et!al.!2008).!! !
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resulting! in! BQcell! proliferation,! nitro! oxide! synthesis! and! degranulation! and!promoting!of!phagocytosis.! !!How! C3! changes! its! conformation! to! accommodate! a! range! of! immunological!roles! is! a! question! that! has! fascinated! “complementologists”! and! structural!biologists!for!decades.!Recent!crystal!structures!of!C3!fragments!and!complexes!with! their! ligands,! have! been! crucial! for! our! understanding! of! the! molecular!mechanisms!of!the!function!of!C3.!The!most!important!crystal!structures!include:!native!human!C3!(Janssen!et&al.!2005),!the!anaphylatoxin!fragment!C3a!(Huber!et&
al.!1980),!C3b!(Janssen!et&al.!2006),!C3c!(Janssen!et&al.&2005),!C3d!(Nagar!et&al.!1998),!C3b:factor!H!SCRQ1/4!complex!(Wu!et!al.!2009),!C3d:factor!H!SCRQ19/20!complex! (Morgan! et& al.! 2011),! C3d:CR2! SCRQ1/2! complex! (van! den! Elsen! &!Isenman! 2011),! and! the! complexes! of! C3b! and! C3c! with! the! complement!receptor! of! the! immunoglobulin! superfamily! (CRIg)! (Wiesmann! et& al.! 2006).!ElectronQmicroscopy! has! become! an! increasingly! powerful! technique! in! recent!years,! through! which! structural! models! of! C3H2O! (Nishida! et& al.& 2006),! iC3b!(Alcorlo! et& al.! 2011)! and! properdinQC3bBb! complex! (Alcorlo! et& al.! 2013)! have!been!determined.!!By!comparing!crystal!structures!of!C3,!C3b!and!C3c,!a!putative!mechanism!of!C3!activation! has! been! proposed! (Janssen& et& al.! 2005).! The! structural! function! of!ANA!is!of!great!interest,!given!that!its!removal!is!a!prerequisite!for!enzymatic!C3!activation.! It!was!previously!believed! that! the!ANA!domain! is! in!direct! contact!with!the!TED!domain,!however,!the!C3!structure!(Fig.1.4.A)!shows!that!the!ANA!domain!plays!an!indirect!structural!role!and!extensively!interacts!with!the!MG8!domain! on! one! side! and!with!MG3! on! the! other! side.! In! this! arrangement,! the!ANA! domain! may! serve! to! keep! the! MG8! domain! in! the! correct! position! for!interacting! with! TED! domain.! ! In! summary,! the! removal! of! ANA! and! the!resulting! C3b! conformation! weakens! the! interactions! between! MG8! and! TED,!therefore!allowing!the!TED!domain!to!swing!out!from!its!protective!position.! !
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1.3(Complement(regulation(!It!has!long!been!recognized!that!complement!activation!is!a!doubleQedged!sword,!as!both! invading!pathogens!and!host! cells! are! susceptible! to! lysis!mediated!by!MAC.! To! make! matters! even! more! challenging,! the! complement! system! is!designed! to! constantly! monitor! its! surrounding! environment,! with! the!compromise!that!covalent!deposition!of!complement!effectors!(e.g.!C3b!and!C4b)!is!largely!indiscriminate!across!different!surfaces.!Therefore,!the!advancement!of!the! complement! cascade! and! the! activity! of! its! effector! molecules! have! to! be!tightly! controlled! at! every! level! by! numerous! complement! regulators! and!inhibitors! (Fig.1.6).!These! regulators!are!able! to!discriminate!between!self! and!nonQself!surfaces,!protecting!the!host!cells!from!complement!attack.! !!
!During!complement!activation!the!effector!molecules!are!distributed!in!the!fluid!phase! and! on!membrane! surfaces! (Fig.1.6),!where! complement! regulators! also!coexist!in!large!quantities!and!great!diversity.!This!results!in!the!strict!control!of!
Figure(1.6:(Complement(regulators(in(fluid(phase(and(at(the(cell(surface.(The!function!of!listed!molecules!will!be!explained!in!section!1.3.!Image!adapted!from!(Zipfel!&!Skerka!2009).!!
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the! severity,! propagation! and! endpoint! of! the! complement! attack.! In! the! fluid!phase,!C1!esterase!inhibitor!(C1QINH)!(Davis!et&al.!2008),!a!serpin!type!protease!inhibitor! regulates! the! activation! of! C1q! and! MBL! complexes! by! binding! and!irreversibly! inhibiting! C1r,! C1s! and! MASPQ2.! sMAP! and! MAPQ1! (Skjoedt! et& al.!2010),! the! nonQproteolytic! splice! products! of! the!MASP2! and!MASP1/3! genes,!modulate!the!lectin!pathway!activation!specifically!by!competing!with!MASPs!for!binding! to! the! MBL! and! ficolins.! In! comparison! with! the! regulators! for!complement! pathway! initiation,! even! greater! numbers! of! regulators! are!dedicated! to! the! regulation! of! processes! downstream! of! C3! convertase!formation.! !!Factor!H!and!its!alternative!splicing!variant!FHLQ1!are!the!two!major!regulators!for! AP! C3! convertase! (C3bBb)! activity.! C4bQbinding! protein! (C4BP),! the!regulatory! counterpart! of! the! classical! pathway,! inhibits! CP! C3! convertase!(C4b2a)! activity.! Their! regulatory! mechanisms! share! three! common! features!(Whaley!&!Ruddy!1976;!Pangburn!et&al.!1977;!Scharfstein!et&al.!1978;!Gigli!et&al.!1979).!Firstly,!by!competing!for!shared!interaction!interfaces,!they!accelerate!the!dissociation! rate! (i.e.! decay! acceleration)! of! preQexisting! C3! convertases.!Secondly,!they!compete!with!Bb!and!C2a!for!the!binding!of!C3b!and!C4b,!thereby!averting! the! formation! of! fresh! C3! convertases.! Finally,! they! function! as!coQfactors!for!protease!factor!I,!which!cleaves!C3b!and!C4b,!thus!eliminating!the!platform!of!new!C3!convertase!assembly.!Noticeably,!the!regulatory!functions!of!factor!H,!FHLQ1!and!C4BP!are!not!limited!to!the!fluid!phase,!but!also!extended!to!human!cells!surfaces!by!binding!to!hostQspecific!surface!patterns!(such!as!sialic!acid! or! glycosaminoglycans! (GAG)).! This! contributes! significantly! to! the!prevention! of! selfQattack.! At! the! same! time,! most! human! cell! surfaces! are!decorated! with! membrane! bound! convertase! regulators,! whose! extracellular!regulatory! domains! share! high! degree! of! similarity! with! the! fluid! phase!regulatory! proteins.! Therefore,! membrane! bound! regulators! such! as! CR1! and!decayQaccelerating! factor! (DAF)! act! as! decay! accelerators! to! promote! the!
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dissociation! of! the! C3! convertase.! On! the! other! hand,! CR1! and! membrane!cofactor!protein!(MCP)!recruit!factor!I!to!inactivate!membrane!bound!C3b.!!In! contrast! with! the! extremely! intricate! control! of! C3! convertase! activity,! the!regulation! exerted! on! C5! activation! and! MAC! formations! is! relatively!straightforward.!Only!a!few!regulators!targeting!C5!have!been!described.!FHRQ1!has!been!reported! to! inhibit!C5!convertase!activity!by! interacting!directly!with!C5! (Heinen! et& al.! 2009).! CRIg! has! been! shown! to! inhibit! both! AP! C3! and! C5!convertase!activities!by!binding!to!C3b!and!causing!steric!hindrance!(Wiesmann!
et& al.! 2006)! for! the! assembly!of! both! convertases.! ! At! the! level! of!MAC,! so! far!only!one!membrane!bound!regulator!has!been!described.! ! Protectin!(CD59)!acts!on! the! C8! to! inhibit! MAC! assembly! and! formation.! Nevertheless,! soluble!regulators! such! as! vitronectin! and! clusterin! are! used! to! sequester! the!offQtargeted!MAC!in!fluid!phase.!!In!contrast!to!the!downQregulated!complement!activity!on!the!host!cell!surface,!complement!activation!is!facilitated!on!the!surface!of!pathogens!by!complement!positive!regulators.!Properdin!is!considered!to!be!the!only!positive!regulator!of!complement!activation.!It!recognizes!molecular!patterns!(e.g.!negatively!charged!molecules)! displayed! on! microbial! surfaces! and,! once! bound! to! surface,!promotes! AP! complement! activation! by! stabilizing! AP! C3! convertase! (C3bBb)!(Fearon! &! Austen! 1975;! Hourcade! 2008).! Human! plasma! contains! very! low!concentrations!of!properdin! (5μg/ml)! in! the! form!of!oligomeric!molecules! that!comprise! two! to! four!monomers! (Pangburn! 1989c).! Each!monomer! of! this! 53!kDa!glycoprotein!consists!of!seven!thrombospondinQlike!repeat!(TSR)!domains.!More!recently,!several!proteins!from!the!FHR!family!have!also!been!indicated!to!positively! modulate! complement! activation,! by! antagonizing! factor! H! activity.!FHRQ1! and!FHRQ5!homo!or!heteroQdimers! (Goicoechea!de! Jorge!et& al.! 2013)! as!well!as!FHRQ4!(Hebecker!&!Jozsi!2012)!were!shown!to!compete!for!C3b!binding!with!factor!H!and!thereby!to!stabilize!the!AP!C3!convertase.! !
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1.4(Complement(Factor(H(and(FHR(family(
The! factor! H! family! (Fig.1.7)! of! proteins! includes! complement! factor! H,! FHLQ1!and!five!FHR!proteins.!These!proteins!are!highly!similar!in!primary!structure!but!different!in!size,!varying!from!4!to!20!short!consensus!repeats!(SCRs,!also!known!as!complement!control!protein!(CCP)!modules).!The!intertwined!relationships!of!cooperation! and! competition! within! this! group! of! proteins! contribute!significantly! to! the! elevated! complexity! of! complement! regulation.! This!interconnected!relationship! is!demonstrated!again!on! the!genomic! level!by! the!tandem!arrangement!of!the!factor!H!gene!and!five!FHR!genes!in!the!regulators!of!complement!activation!(RCA)!gene!cluster!on!human!chromosome!1q32.!These!proteins! are! constitutively! synthesized! in! hepatocytes! and! secreted! into! the!plasma.! Early! studies! reported! that! plasma! factor! H! concentrations! can! vary!from!116! to! 562!μg/ml,! but! a!more! recent! study! revealed! that!mean!Factor!H!
Figure(1.7:(A(schematic( structure(of( factor(H(and(its( family(members.(The!homologous!domains!are!indicated!by!their!vertical!position.!The!percentage!of!sequence!identity!between!each!domain!and!the!equivalent!FH!domain!is!presented!above!as!a!yellow!number.!
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concentrations! only! vary!between!2Q3μM! (233!μg/ml! in! young! adults! and!260!μg/ml!in!older!individuals)(Hakobyan!et&al.!2008).!The!rest!of!the!factor!H!family!exists! in! much! lower! concentrations! in! plasma,! FHLQ1,! FHRQ1,! are! present! at!concentration!of!30Q50!μg/ml!(Zipfel!&!Skerka!1999)!and!70Q100!μg/ml!(Skerka!&! Zipfel! 2008),! respectively.! Precise! concentration! determination! of! FHR!proteins! remains! a! challenge,! largely! because! these! proteins! are! generally!associated! with! lipoprotein! particles,! and! because! of! the! lack! of! specific!monoclonal!antibodies.!!
1.4.1(Factor(H(
Factor! H! is! a! 150! kDa! multiQmodular! multiQfunctional! glycoprotein! (Fig.1.8.E)!composed!of!20!SCR!domains.!Its!two!major!functional!sites!are!located!at!either!end! of! its! sequence.! Four! NQterminal! SCR! domains! (SCRs! 1Q4)! enforce! AP! C3!
Figure(1.8:(Factor(H(and(its( interactions(with(C3(activation(fragments.((A)(An!example!of!the!SCR!domain,!the!structure!of!FH!domain!1.!(B)(Crystal!structure!of!FH!domain!18Q20.!(PDB!code:!3SW0).!The!crystal!structures!(CQD)!shows!that!FH!binds!at!two!locations!of!C3b.!(C)!Crystal!structure!of!C3b:FH1Q4!complex.!(PDB!code:!2WII)!The!binding!of!FH1Q4!accelerates!C3!convertase!dissociation,!mediates!Factor!I!cleavage.!(D)!Crystal!structure!of!C3d:FH19Q20!complex!(PDB!code:!3OXU).!(E)!Mapping!of!binding!sites!on! the! 20! SCR! domains! for! FH! ligands:! Heparin;! Sucrose! octasulfate;! Sialic! acid,! C3b! binding.! Eight!glycosylation!sites!are!labeled!using!black!forks.!
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convertase!regulation,!by!binding!to!C3b!(Fig.1.8.C),!accelerating!the!dissociation!of! C3! convertase! and! facilitating! factor! I! cleavage! of! C3b.! The! CQterminal! SCR!domains!(SCRs!18Q20,!Fig.1.8.B),!on!the!other!hand,!contribute!to!surface!binding!and!contain!the!ligandQbinding!sites!for!C3b,!C3d,!heparin,!sialylated!glycans!and!cell! surface!glycosaminoglycans.!Their! concerted!activities!are!essential! for! the!effectiveness! and! directionality! of! factor! H! mediated! complement! regulation.!Crystal! structures! (Fig.1.8.C! and!D)! (Morgan! et& al.! 2011;!Wu! et& al.! 2009)! have!demonstrated!that!the!NQ!and!CQterminal!domains!of!factor!H!target!two!different!interaction! interfaces!on!C3b! ,!suggesting!that! factor!H!could!bind!to!these!two!sites!simultaneously!.!Furthermore,!a!recent!crystal!structure!(Blaum&et&al.!2014)!of! the! SCR! 19Q20! domains! in! complex! with! C3d! and! an! analogue! of! a!glycosaminoglycan!provides!a!detailed!explanation!for!the!positive!cooperativity!(Meri!&!Pangburn!1990)!between!SCR!19Q20!C3d!and!heparin!binding!sites.!!In!addition!to!the!two!most!validated!ligandQbinding!sites,! further!binding!sites!for!C3b!and!heparin!have!been!found!distributed!across!the!molecule.!Factor!H!appears! to! possess! a! third! C3b! binding! site,! initially! suggested! to! be! situated!near!SCR!6Q10!(Sharma!&!Pangburn!1996),!later!pinpointed!to!SCR!6Q8!(Schmidt!
et&al.!2008).!Due!the!weak!and!transient!binding!properties,!further!studies!are!required! to!validate!and!explain! the!biological! significance!of! this! site.!Heparin!binding! is! also! mediated! by! multiple! binding! sites,! apart! from! the! CQterminal!binding! site,! factor! H! SCR! 6Q10! domains! were! determined! to! have! heparin!binding!ability!(Sharma!&!Pangburn!1996).!Crystallographic!studies!(Prosser!et&




1.4.2(Complement(factor(H(like(protein(1(!FHLQ1!is!a!42!kDa!glycoprotein!produced!by!alternative!splicing!of!factor!H!gene.!It!is!composed!of!seven!NQterminal!domains!of!factor!H!(Fig.1.7),!with!four!extra!amino!acids!at!the!CQterminal!end.!This!truncated!form!of!factor!H!possesses!C3b!binding!and!C3!convertase!regulatory!functions!and!in!addition!binds!to!heparin!via!its!CQterminal!SCR!7!domain.!Despite!its!similarity!with!factor!H,!FHLQ1!also!functions! as! a! matrix! protein! component! which! mediates! cell! adhesion!(Hellwage!et&al.!1997),!possibly!partially!explaining!the!differences!in!expression!pattern! compared! with! factor! H.! While! the! majority! of! the! cell! lines!constitutionally!express!both!FHLQ1!and!FH,!MRCQ5!lung!fibroblasts!only!express!FHLQ1! mRNA.! The! presence! of! cytokines,! inflammatory! mediators! and!antiQinflammatory! agents! further! diversifies! the! expression! pattern! of! FH! and!FHLQ1!(Friese!et&al.!1999).!
(
1.4.3(Complement(factor(H(related(protein( ( (!
The! five! FHR! proteins! (FHR! 1Q5)! are! encoded! by! five! separate! genes! that! are!situated!immediately!next!to!the!factor!H!gene.!Like!factor!H,!they!are!modular!glycoproteins!constituted!of!multiple!SCR!domains,!varying!in!number!from!4!to!9!(Fig.1.7).!All!FHR!SCR!domains!share!sequence!identity!(between!40!and!100%)!with! their! corresponding! factor! H! SCR! domains,! indicating! the! potential! for!
Figure( 1.9:( Biochemical( properties( of( FHR(
proteins.!(A)!Western!blot!analysis!of!proteins!from! the! FH! family.! Due! to! high! sequence!similarity,! FHR! proteins! cross! react! with!polyclonal! antiQFH! serum.! (Skerka! &! Zipfel!2008)! (B)! Crystal! structure! of! FHR11Q2.! Two!chains!of!FHR11Q2!form!a!headQtoQtail!dimer.!The!two! chains! are! colored! separately.! (PDB! code:!3ZD2)(C)!Schematic!domain!structure!of!FHRQ1!and! FHRQ2.! The! glycosylation! sites! are!indicated!by!black!forks.! !
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differential! functions! and! proteinQbinding! properties.! Some! signature! factor! H!activities!are!conversed.!For!instance,!FHRQ1,!FHRQ3,!FHRQ4!and!FHRQ5!all!bind!to!C3b;!FHRQ1,!FHRQ3!and!FHRQ5!bind!to!heparin,!although!only!FHRQ5!shows!very!weak!factor!I!cofactor!activity!(Mölkänen!et&al.!2002;!McRae!et&al.!2005).!Novel!functions!are!also!emerging,!and!the!first!two!NQterminal!SCR!domains!(Fig.1.9.B)!of!FHRQ1,!FHRQ2!and!FHRQ5!have!now!been!shown!to!mediate!the!formation!of!homoQ!and!heterodimers!between!FHRQ1,!FHRQ2!and!FHRQ5!(Goicoechea!de!Jorge!
et& al.! 2013).! These! FHR! dimers! show! elevated! affinity! to! tissue! deposited!complement! effectors,! and! compete! with! factor! H! binding,! causing! local!relaxation! of! complement! regulation.! Another! novel! biochemical! property! of!FHR!proteins! is! the!existence!of!differentially!glycosylated! forms!(Fig.1.9.A!and!C).!FHRQ1!can!be!singly!or!doubly!glycosylated!(Skerka!et&al.!1991),!while!FHRQ2!contains! only! one! flexibly! glycosylated! site! (Skerka! et& al.! 1992).! Additionally,!nearly! all! FHR! proteins! are! able! to! associate! with! lipoprotein! particles,! apart!from!FHRQ3!(Skerka!&!Zipfel!2008).!The!most!structurally!characterized!protein!among! FHR! protein! family! is! FHRQ1.! Within! the! 5! SCR! domains,! the! crystal!structure! of! first! two! was! solved! showing! a! headQtoQtail! dimer! (Fig.1.9.B)!(Goicoechea! de! Jorge! et& al.! 2013),! the! rest! of! the! SCR! domains! are! believed!structurally!identical!to!the!FH18Q20!(Fig.1.8.B)!due!to!the!98%!sequence!identity!(Skerka!et&al.!2013).!!FHR!protein!deletions!and!variations!have!been!associated!with!susceptibility!to!numerous! diseases.! Individuals! with! FHRQ1/3! deletion! copy! number!polymorphism!are!associated!with!reduced!risk!of!IgA!nephropathy!(Gharavi!et&
al.! 2011),! ageQrelated!macular!degeneration! (Hughes!et&al.! 2006)! and! systemic!lupus! erythematosus! (Zhao! et& al.! 2011).! Duplication! in! FHRQ5! copy! number! is!strongly! linked! with! familial! C3! glomerulopathy! (Gale! et& al.! 2010).! A! recent!report!also!revealed!a!link!between!the!reduced!copy!number!of!FHRQ1!and!the!presence! of! FH! autoQantibody,! which! contributes! strongly! to! the! pathological!mechanism!of!atypical!hemolytic!uremic!syndrome!(aHUS)!(Moore!et&al.!2010).!
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These! studies! show! that! disruption! of! the! delicately! balanced! interaction!network! between! factor! H! and! FHR! proteins! could! have! disastrous!consequences.! !
1.4.4(Factor(H(family(protein(and(immune(evasion(protein(interactions(
(As!the!major!downQregulator!for!AP!activity!on!host!cell!surfaces,!factor!H!is!also!frequently!hijacked!by!microbial!immune!evasion!proteins!to!aid!microbes!in!the!evading! complement! attack.! Streptococcus& pyogenes! M! protein! was! the! first!protein!to!be!associated!with!factor!H!binding!activity!(Horstmann!et&al.!1988),!and!its!role!in!the!evasion!of!complementQmediated!opsonophagocytosis.!!There!are!two!main!microbial!binding!regions!on!factor!H.!One!is!located!within!SCRs! 6Q7,! which! is! mainly! exploited! by! group! A! Streptococci! pyogenes! and!
Candida& albicans! to! recruit! functional! active! factor! H.! CQterminal! SCRs! 19Q20!contain!a! favorable!binding!site! for!Neisseria&gonorrhoeae! complement!evasion!proteins! Por1A,! Por1B! (Ram! et& al.! 1998)! and! ! OspE! (Hellwage! et& al.! 2001;!Alitalo!et&al.! 2004)! from& Borrelia&burgdorferi,! both!of!which!have! convergently!evolved!to!target!this!site!to!mimic!the!glycosaminoglycan!binding!on!FH.!In!fact,!this!site!is!universally!targeted!by!a!range!of!pathological!bacterial!strains!(Meri!
et& al.! 2013).! The! overlapping! of! the! heparin! binding! sites! and! evasion! protein!binding!sites!prompted!the!hypothesis!that!the!surface!bound!factor!H!has!to!be!correctly! positioned! in! order! to! achieve!maximum! activity.! This! assumption! is!confirmed!by!the!observation!that!B.burgdorferi!produces!two!evasion!proteins!targeting!different! factor!H!heparin!binding!sites:!CRASP1!(Kraiczy!et&al.!2004)!which!binds! to! the!SCRQ7!and!OspE! (Hellwage!et&al.! 2001),!which!binds! to! the!SCR!19Q20.!The!heparin!binding! sites! are!highly! conserved!within! the! factor!H!family;! therefore! in! addition! to! acquisition! of! factor!H,! homologous! FHLQ1! and!FHR!1Q5!proteins!are!also!targeted.!!In! contrast! to! the! similarity! in! surface! acquisition!of! factor!H!by!microbes,! the!
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The! gramQpositive! bacterium! Staphylococcus& aureus! (S.& aureus)! is! a! major!opportunistic!human!pathogen.!It!was!first!discovered!in!1880!by!Sir!Alexander!Ogston!in!Aberdeen,!Scotland!and!was!found!within!the!pus!of!an!acute!abscess!(Ogston!1882).!Under!bacterial! taxonomy,! it! is!classified!as!a!member!of!genus!
Staphylococcus! within! the! family! of! Micrococcaceae.! The! name! “aureus”! was!derived! from! the! appearances! of! its! golden! colonies! (aureus! means! golden! in!
Figure( 1.10:( General( features( of, S.aureus.( (A)! Staphylococci! (black! arrow! pointed)! with!polymorphonuclear!Leukocytes!(Gram’s!stain,!X1000)!(B)!Cellular!structure!of!S.aureus.!Image!taken!from!(!Lowy!1998).!
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Latin)!when!cultured!on!sheep!blood!agar.!Under!the!microscope!(Fig.1.10.A),!it!forms! gramQpositive! cocci! in! clusters! and! the! individual! bacterium! with! a!spherical!shape!has!a!size!of!approximately!1!μm!in!diameter.!
1.5.2(The(genome(
(The! majority! of! the! genetic! material! of! S.& aureus! is! stored! in! a! circular!chromosome! assisted! with! additional! prophages,! plasmids! and! transposons!(Lowy!1998).!The!genome!of!S.&aureus!was!sequenced!in!2001,!revealing!the!size!of! the! genome! to! be! 2.8!Mb!with! a! low!GC! content! of! 33%.!About! 85%!of! the!genomic!DNA!constitutes!approximately!2600!open!reading! frames!(Hiramatsu!2001).! Lateral! gene! transfer! processes! provide! great! dynamic! for! the! genetic!content,!which!agrees!with!the!observation!that!most!antibiotic!resistance!genes!and!virulence!factor!gene!are!carried!by!mobile!elements!such!as!plasmids!and!unique!pathogenicity!islands.!!
1.5.3(Cell(wall(structure(!The! exterior! structural! features! and! chemical! characteristics! have! been!demonstrated! as! indispensable! for! the! virulence! of!S.& aureus.! The! bacteria! cell!(Fig.1.10.B)! is! protected! by! an! inner! layer! cell! wall! and! an! exterior! capsule!structure.!Staphylococcal!cell!wall!is!composed!of!primarily!peptidoglycan!(50%!by!weight),! ribitol! teichoic! acid! and! lipoteichoic! acid.! Together!with! structural!peptides,!they!form!a!densely!crossQlinked!matrix!that!covers!the!cell!membrane,!and!provides!a!foundation!for!cell!wall!anchored!proteins.!Immunologically,!the!peptidoglycan!shows!endotoxinQlike!activity,!stimulates!the!release!of!cytokines!by!macrophages,!promotes!platelet! aggregation! (Lowy!1998)!and!activates! the!complement!system!through!both!CP!and!AP!(Verbrugh!1979).!!Most! staphylococci! produce! extracellular! capsular! polysaccharides! (CP*),! the!variations! in! synthetic!pathways!provide!observable!morphological!differences!
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between! different! strains! of! S.& aureus.! Further! studies! based! on! reactivity! to!monospecific! rabbit! and! mouse! antisera! identified! 11! types! of! CP*! serotypes,!within! which! types! 5! and! 8! account! for! 75%! of! human! S.& aureus! isolates!(O'Riordan! &! Lee! 2004).! Encapsulation! has! been! associated! strongly! with!increased! virulence! of! the! bacteria,! protecting! the! bacteria! from! opsonization!and!phagocytosis.! In! the!presence!of! the! capsule! layer,! deposited!C3b! is! found!mostly! on! cell! wall,! buried! under! the! capsule! layer! and! therefore! unable! to!promote!efficient!phagocytosis.!Only!antibody!mediated!complement!activation!can!efficiently!opsonize!throughout!the!capsule!layer!(Verbrugh!et&al.!1982).!!Many! Staphylococcal! proteins! are! located! on! the! surface! of! the! bacteria,!embedded! in! the! cell!wall! through! the! peptidoglycan.! Although! these! proteins!demonstrate!great!structural!diversity,!they!share!common!characteristics!as!cell!wall!anchored!(CWA)!proteins.!The!protein!architecture!starts!with!a!NQterminal!signal! peptide! that! directs! proteins! to! be! translocated! through! the! secretory!apparatus!in!the!membrane,!followed!by!functional!domains.!The!CQterminal!part!of! CWA! protein! typically! contains! a! cell! wallQspanning! domain! and! a!characteristic! sorting! signal! which! facilitates! their! covalent! anchorage! to!peptidoglycan!(Foster!et&al.!2014).!Most!of!the!staphylococcal!CWA!proteins!are!essential! for! invasion! and! survival! of! the! bacteria.! IronQregulated! surface!determinant!extracts!heme!groups!from!hemoglobin!and!transports!them!across!the! cell! membrane! into! the! cytoplasm! (Pilpa! et& al.! 2009;! Grigg! et& al.! 2010).!
Staphylococcal!Protein!A!(SpA)!binds!to!the!Fc!fragment!of!the!IgG!that!inhibits!CP!complement!activation,!and!it!also!acts!as!a!superantigen!for!BQlymphocytes!and! disrupts! the! adaptive! immune! system.! Furthermore,! apart! from! those!interfering!with!the!immune!system,!the!most!abundant!group!of!CWA!proteins!is! the! matrix! molecule! adhesion! (MSCRAMM)! family! proteins,! which!demonstrate!essential!roles!in!the!colonization,!dissemination!and!pathogenesis!stages! of! bacterial! advance.! Recently,!more! and!more! CWA! proteins! are! being!associated! with! previously! unQannotated! functions,! which! elicit! the! idea! that!
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CWA! proteins! carry! redundant! functions! to! provide! advantages! for! bacteria!under!constantly!changing!physiological!condition.!!
1.5.4(Colonization( (!
S.& aureus! is! a! common!human! commensal,! it! colonizes! approximately!30! to!50!percent! of! healthy! adults! and! about! 20! percent! of! the! human! population!becomes!permanently! and!persistently! colonized! (Kluytmans! et& al.! 1997).! It! is!most! commonly! found! colonized! in! the! moist! squamous! epithelium! of! the!anterior!nares,!but!also!colonizes!the!mucous!membrane!of!the!pharynx,!vagina!and!axillae! (Peacock!et& al.! 2001;! Lowy!1998).!The! colonized!bacteria!normally!persist! unnoticed! by! the! host,! reaching! a! state! of! mutual! acceptance! and!tolerance.! But! upon! disintegration! of! this! balanced! condition,! the! previously!localized! and! nonQinvasive! commensal! bacteria! can! quickly! disseminate! and!spread! throughout! the! body.& S.& aureus! infection! can! result! in! a! wide! range! of!diseases.! The! detailed!mechanism! leading! to! S.& auerus! infection! is! still! largely!unknown!but!traditionally!S.&aureus!was!described!as!an!opportunistic!pathogen,!which! preys! on! individuals! with! compromised! immune! systems! or! having!undergone!major!surgery.!Therefore!the!deteriorated!host! immune!system!and!the! breached! epithelial! barrier! could! partially! account! for! the! invasion! of! S.&
aureus.! However,! the! capability! of! S.& aureus& to! cause! disease! in! hosts! without!obvious!predisposing!conditions!is!getting!increasingly!recognized!(van!Belkum!&!Melles!2009).!
(
1.5.5(Staphylococcal(infection(disease( (
(The! persistent! carriers! of! S.& aureus! are! at! higher! risk! of! infection! when!immuneQcompromized,! the! colonized! nasal! epithelium! provides! a! reservoir! of!bacteria! from!which! subsequent! infections! can! develop! (Wenzel!&! Perl! 1995).!Mild! skin! infections,! including! impetigo,! folliculitis! and! furunculosis,! are! the!
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common!symptoms!of!S.aureus! infections! (Darmstadt!&!Lane!1994),!which!are!usually!selfQlimiting!or!can!be!easily!treated!with!topical!applications.!However,!if!left!untreated,!bacteria!could!enter!the!blood!stream!through!the!damaged!skin!and!mucosal!tissue,!leading!to!more!serious!and!even!lifeQthreatening!conditions.! !!Once! the! circulation! system! becomes! bacteraemic,! the! previously! localized!infection!is!able!to!spread!to!other!tissues.!S.&aureus!is!known!to!spread!to!joints,!bones!and!kidneys!and! lungs.!However! the!most! vulnerable! tissue! is! the!heart!(Fowler!et&al.!2005).!Endocarditis! is! the! infection!of! cardiac!valves,!whereby!S.&
aureus&can!adhere!to!and!establish!thrombi!on!healthy!or!damaged!valves.!The!heart! valves!are!a! susceptible! location! for& S.& aureus! infection,! since! they! lack!a!separate!blood!supply,!therefore!they!cannot!directly!be!reached!by!neutrophils.!Clinical!complications!of!endocarditis! include!stroke!and!cardiac!arrest!and!the!mortality!rate!is!over!50%!(Lowy!1998).!





or!those!living!in!crowded!residences!are!subjected!to!a!high!risk!of!community!acquired!S.& aureus! infections.!However,! the!nosocomial! infections! are! acquired!through! three! common! routes:! skinQtoQskin! contact,! compromise! of! the! skin!barrier!and!sharing!contaminated!equipment.!Nevertheless,!it!is!now!clear!that!a!patient’s!own!endogenous!reservoir!is!the!most!prevalent!origin!for!nosocomial!
S.& aureus! infection! (Eiff! et& al.! 2001).! Nasal! carriage! increases! the! risk! for!autoQinfection!by!the!factor!of!three!(Wertheim!et&al.!2004).(
(
1.5.7(History(of(MRSA( (!Over!the!last!hundred!years,!evolving!in!parallel!with!the!episodic!discoveries!of!new!antibiotics,!S.&aureus!has!earned!a!reputation!for!being!versatile!under!the!selective! pressures! from! antibiotics.! Until! the! discovery! of! penicillin,! S.& aureus&infection! was! extremely! lethal! and! the! mortality! rate! was! as! high! as! 80%!(Skinner!1941).!In!1940,!penicillin!was!introduced!to!treat&S.&aureus!infection.!It!functions!as!an!inhibitor!of!the!penicillin!binding!proteins!(PBP),!which!catalyze!the! crossQlinking! reaction! of! peptidoglycan! during! cell! wall! biosynthesis;! the!inhibition! directly! causes! the! lysis! of! bacteria.! However,! only! two! years! after!clinical!usage,!the!first!S.&aureus!strains!resistant!to!this!antibiotic!were!isolated!(Chambers! 2001).! The! resistance! was! established! by! acquisition! of! a! plasmid!that! encoded! penicillinase,! catalyzing! the! hydrolysis! of! penicillin.! By! 1960,!approximately!80%!of!all!S.&aureus!strains!had!become!resistant!to!penicillin.!In!response! to! rising! penicillin! resistance,! in! 1961,! a! penicillinaseQresistant!penicillin!derivative!called!methicillin!was!introduced!to!treat!S.&aureus!infection.!However!only!after!a!year,!S.&aureus!developed!resistance!to!this!antibiotic!and!was! later! named! methicillin! resistant! S.& aureus& (MRSA).! The! methicillin!resistance!(mec)!is!attained!by!the!acquisition!of!the!mecA!gene!that!is!located!on!a! mobile! island! designated! the& staphylococcal! cassette! chromosome! mec!(SCCmec)!(Katayama!et&al.!2000).!The!mecA!gene!encodes!an!unique!PBP,!PBP2a,!which! demonstrates! low! affinity! for! all! βQlactam! antibiotics! (e.g.! penicillin! and!
! 29!
methicillin)!(Hartman!&!Tomasz!1984).!Therefore!even!if!other!types!of!PBPs!are!totally!inhibited,!the!PBP2a!can!still!mediate!normal!cell!wall!biosynthesis.!!Taking!advantage!of!the!resistance!to!the!βQlactam!antibiotic!family,!by!the!1980s!MRSA! had! become! prevalent! in! the! nosocomial! setting,! where! bacteria! can!constantly! replicate! under! fresh! antibiotic! selection! pressures.! Unfortunately!MRSA!has!conquered!nearly!all!antibiotics!discovered!since!1940,!and!so!MRSA!is! now! a! term! often! associated! with! strains! that! carry! multiple! antibiotic!resistances.!According!to!MRSA!statistics!between!2009!and!2013!(Public!Health!England!2014).!In!England,!Wales!and!North!Ireland,!over!80%!of!MRSA!isolates!are! resistant! to! ciprofloxacin,! over! 60%! of! the! isolates! show! resistance! to!erythromycin! and! below! 20%! of! all! isolates! are! resistant! to! fusidic! acid,!gentamicin,! mupirocin! and! rifampicin.! Only! vancomycin,! tigecycline,! linezolid!and! daptomycin! show! minimal! resistant! isolate! counts! and! serve! as! the! last!resort!for!MRSA!treatment.!However!this!last!line!of!defense!is!being!constantly!challenged,! as! MRSA! isolates! that! are! resistant! to! these! antibiotics! are!sporadically!being!reported!globally.!!Until! the! midQ1990s,! MRSA! infections! were! mostly! confined! within! hospitals,!targeting!immune!compromised!patients.!However,!since!the!arrival!of!the!new!millennium,! MRSA! transmission! has! demonstrated! a! new! trend.! Increasing!MRSA! outbreaks! in! the! community! setting! were! reported! (Chambers! 2001),!which! lead! to! the! isolation! of! a! distinct! strain! of! MRSA,! community! acquired!MRSA!(CAQMRAS).!CAQMRSA!demonstrates!high!virulence!and!fitness!(Voyich!et&
al.! 2005),! as! it! not! only! can! spread! continuously! in! immuneQcompromised!population!but!also! cause!disease! in!healthy! individuals.!According! to!genomic!and! biochemical! analysis,! most! CAQMRSA! possess! the! LukF! gene! encoding! the!pantonQvalentine( leuocidin! (PVL)! toxin! and! produce! increased! amounts! of!phenolQsoluble!modulins!(PSMs)!peptides,!both! toxins!contribute! immensely! to!the! neutrophil! killing.! CAQMRSA! has! also! shown! increased! expression! level! of!
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alphaQtoxin,! which! induces! lysis! of! human! macrophages! and! erythrocytes.!Therefore,! in! contrast! to! most! hospital! acquired! MRSA! (HAQMRSA)! and!methicillin! sensitive! staphylococcus& aureus! (MSSA),! CAQMRSA! demonstrates!enhanced!ability!to!resist!and!evade!immunological!effector!cells.!However,!this!aggressive! behavior! also! brings! detrimental! side! effects,! CAQMRSA! is! usually!sensitive! to! most! antibiotics! other! than! the! βQlactam! family! (Otto! 2013)! and!usually!a!lower!concentration!of!the!antibiotic!is!required!to!sufficiently!contain!the!infection!(Cheung!et&al.!2011).! ! Type!IV!and!V!SCCmer!mobile!elements!are!the! universal! genetic! characteristics! of! CAQMRSA! (Daum! et& al.! 2002),! these!shorter! methicillin! resistant! determinant! elements! could! be! attributed! to! the!relaxed! antibiotic! resistance,! therefore! causing! less! fitness! burden! (Lee! et& al.!2007)!which!is!the!prerequisite!condition!for!increased!CAQMRSA!virulence.!!Since! 2005,! in! England,!Wales! and! Northern! Ireland,! due! to! elevated! hospital!hygiene! standards! and! tightened! monitoring! measures,! both! MRSA! related!infections! and! deaths! are! in! a! steadily! decline.! Nevertheless,! the! sporadic!appearances! of! the! multiQdrug! resistant! MRSA! strains! and! the! intermittent!outbreaks! of! the! CAQMRSA! remind! us! the! challenges! we! are! facing! from! this!constantly!evolving!pathogen.!!!!!!!!!!!!
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1.6(S.,aureus(proteins(for(invasion(attachment(and(immune(evasion(
!As!a!commensal!bacterium,!millions!of!years!of!coexistence!and!coevolution!with!humans!has!created!the!S.&aureus&of!today,!a!versatile!pathogen!that!is!capable!of!both!persistent!colonization!and!opportunistic!invasion.&As!introduced!in!Section!1.5.3,!CWA!proteins!and!secreted!proteins!contribute!immensely!to!various!steps!of! staphylococcal! infection.& Virulence! factors! produced! by! S.& aureus! are!summarized!in!Fig.1.11!and!can!be!roughly!categorized!into!proteins!attenuating!complement!activation!(complement!inhibitors)!and!phagocytosis!(phagocytosis!inhibitors),! proteins! mediating! host! environment! adhesion! (adhesion! factors),!proteases!that!degrade!extracellular!matrix!(invasion!factors)!and!leukocyte!lytic!proteins!(cytolytic!toxin).&!!!
Figure(1.11:(S.aureus( expresses(cell(wall(anchored(and(secreted( immune(evasion(factors.!These!factors!are!responsible!for!the!resistance!against!the!complement!system!and!phagocytosis,!targeted! host! cell! adhesion,! efficient! tissue! invasion! and! direct! damage! on! host! cells.! The!inhibitors!of! complement!and!phagocytosis!not!only!suppress!the! innate! immune! response,!but!also!dampen!the!development!of!adaptive!immunity.!Adhesion,!invasion!and!cytolytic!factors!are!part! of! an! invaluable! arsenal,! by! which! S.aureus! thrives! inside! the! host! system.! The! selected!molecules!are!described!in!detail!in!section!1.6,!the!full!name!is!given!in!abbreviation!section.!
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1.6.1,S.,aureus(complement(evasion(
(The!complement!system! functions!partially!as!an!early!warning!system! for! the!host! against! colonizing! and! invading! pathogens;! it! coordinates! concerted!bactericidal! attacks! involving! both! innate! and! adaptive! immune! system!components.! During! the! course! of! evolution,! S.& aureus! has! adapted! numerous!physical! and! biochemical! mechanisms! to! avoid! detection! by! the! complement!system.! Firstly,! the! encapsulated! exterior! is! extremely! futile! for! complement!deposition! and! amplification.! Secondly,! underneath! the! capsule! layer,! the! cell!wall! of! the!S.& aureus! is! embedded!with! a! large! spectrum!of! CWA!proteins! that!deteriorate! complement! activity.! Finally,! to! actively! inhibit! complement!activation! in! close! vicinity,! S.& aureus! expresses! and! secretes! an! arsenal! of!immune!evasion!proteins!that!block!complement!cascades.!!As! introduced! earlier! (Section! 1.1.1),! specific! proteinQprotein! interactions! and!sequential! proteolytic! cleavages! are! essential! for! complement! activation! and!regulation.!This!provides!numerous!stages!of!intervention!that!can!be!exploited!by!staphylococcal!immune!evasion!proteins!to!efficiently!debilitate!this!carefully!regulated! protein! interaction! network.! Staphylococcal! complement! inhibition!strategies! can!be! roughly! categorized! into! three!distinct!mechanisms.!Firstly!S.&
aureus! secretes! small! fluid! phase! proteins! to! the! surrounding! environment!where!they!directly!interfere!with!complement!activation!at!almost!every!level.!Secondly,! S.& aureus! expresses! CWA! proteins! that! are! able! to! recruit! host!complement! regulators!onto! the!bacterial! surface,! avoiding! complement! attack!by! imitating! the! host! cell! surface.! Thirdly,! S.& aureus! produces! proteases! that!specifically!degrade!complement!component!C3.! !!Given!that!all!complement!pathways!converge!on!the!proteolytic!activation!of!C3!by! C3! convertase,! to! exert!most! effective! inhibition! on! complement! activation,!most!secreted!staphylococcal!immune!evasion!proteins!are!designed!to!attenuate!
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C3!convertase!activity.! !!
Staphylococcal! extracellular! fibrinogen! binding! (Efb)! protein! consists! of! two!functional!domains.!The!NQterminal!domain!(EfbQN)!mediates!fibrinogen!binding,!resulting! in! inhibition!of!platelet!activation!(Palma!et&al.!2001).!The!CQterminal!domain! (EfbQC)! inhibits! the! activation! of! both! CP! and! AP! (Lee! et& al.! 2004)!through! strong! interactions! (Hammel! et& al.! 2007b)! with! C3d! containing! C3!activation!products!(e.g.!C3b,!iC3b!and!C3d).!The!strong!binding! ! (Kd!of!0.8!nM)!alters!the!C3b!native!conformation,!causing!impaired!binding!of!factor!B,!thereby!allosterically! preventing! the! assembly! of! AP! C3! convertase! (Chen! et& al.! 2010).!Furthermore,! the! binding! of! C3! could! also! render! the! Efb:C3! complex! an!unsuitable! substrate! for!CP!C3! convertase,! causing! inhibited!CP!activation.!Not!only! does! it! interrupt! complement! activation,! the! EfbQC! binding! to! the! C3d!concave! surface! also! physically! blocks! CR2! binding,! by! which! the! effect! of!complement!mediated!B!cell!activation!is!severely!disrupted.!!In!2007,!a!homolog!of!EfbQC,!(Efb!homologous!protein)!Ehp!or!the!extracellular!complement! binding! protein! (Ecb)! was! identified! (Hammel! et& al.! 2007a).! In!contrast!to!Efb,!Ehp!is!a!slightly!shorter!(105!aa)!secreted!protein,!sharing!44%!identity!with!EfbQC,!binding!to!the!C3d!part!of!C3!molecule!in!similar!fashion!to!EfbQC.! Therefore,! Ehp! largely! demonstrates! similar! complement! inhibition! and!BQcell!activation!inhibition!properties.!However!in!a!recent!study,!Ehp!has!been!shown!to!form!a!tripartite!complex!with!C3b!and!factor!H,!which!contributes!to!the!bacterial!survival!in&vitro!(Amdahl!et&al.!2013).!!In! addition! to! complement! inhibition! by! direct! binding! to! C3,! Staphylococcal!complement! inhibitor,!SCIN,!a!9.8!kDa!secreted!protein,!blocks!both!AP!and!CP!activation! by! trapping! AP! and! CP! C3! convertases! in! an! enzymatically! defunct!dimeric! state! (Rooijakkers! et& al.& 2005a).! Although! the! trapped! C3! convertase!dimers! are! not! able! to! accept! new! C3! substrate! or! to! form! subsequent! C5!
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convertase,!the!SCIN!mediated!complexes!demonstrate!extremely!long!halfQlives!comparing! with! physiological! AP! C3! convertase.! This! property! allows!crystallographic! studies! of! the! SCIN! stabilized! C3! convertase! complex!(Rooijakkers! et& al.! 2009),! which! provided!molecular! details! on! both! the! SCIN!inhibition!mechanism!and!the!AP!C3!convertase!architecture.!!To! counteract! the! already! deposited! complement! effector! molecules! (e.g.! C3b!and! C4b),! S.& aureus! acquires! host! complement! regulatory! proteins! through!numerous! membrane! anchored! CWA! proteins! on! its! surface.! SerineQaspartate!acid! repeat! protein! (SdrE)! was! first! hypothesized! as! an! adhesive! molecules!(Corrigan!et&al.! 2009).!However,! recent! functional! investigations!demonstrated!that! SdrE! not! only! acquires! serum! factor! H! (Sharp! et& al.! 2012)! but! also! C4BP!(Hair!et&al.!2013).!The!presence!of!surface!bound!factor!H!and!C4BP!inhibits!C3!convertases!activity,!but!they!have!to!work!with!protease!factor!I!to!cleave!C3b!or!C4b!into!their!inactivated!forms.!S.&aureus&expresses!Clumping!factor!A!(ClfA)!on! the! cell! surface! to! recruit! active! factor! I,! leading! to! increased! local!concentration!of!factor!I!by!which!C3b!and!C4b!inactivation!can!be!accelerated.!!The! severity! and! efficiency! of! the! complement! attack! is! directly! related! to! the!local!C3!level.!To!diminish!the!high!concentration!of!local!C3!with!low!bacterial!burden,!S.&aureus!has!learned!to!kidnap!host!proteolytic!pathways,!among!which!the! plasminogen! activation! pathway! is! frequently! exploited.! S.& aureus& secretes!staphylokinase!(SAK)!that!proteolytically!activates!the!zymogen!plasminogen!to!plasmin! (Mölkänen! et& al.! 2002).! Subsequently,! activated! plasmin! in! the! fluid!phase!can!cleave!C3!into!its!activation!products!(Gorham!et&al.&2014;!Barthel!et&al.!2012).!Numerous&staphylococcal!immune!evasion!proteins!(e.g.!Efb!and!Sbi)!have!been! described! that! accelerate! this! process! by!mediating! plasminogen! and! C3!binding,! leading! to! consumption! of! local! C3,! but! they! do! not! directly! trigger!plasminogen! activation! (Koch! et& al.! 2012).! SAK! activated! plasmin! also!contributes! significantly! to! the! removal! of! bacterial! surface! opsonin! by!
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proteolytically!degradation!of!C3b!and!IgG!molecules!(Rooijakkers,!et&al.!2005b).!So! far,! staphylococcal! zincQdependent! protease! aureolysin! is! the! only! protease!that!has!been!shown!to!directly!degrade!C3!molecules.! ! It!cleaves!C3!near!the!C3!convertase! cleavage! site,! producing! C3a! and! C3b.! C3b! is! then! subsequently!degraded!by!factor!H!and!factor!I!(Laarman!et!al.!2011).!!It! is! evident! that! S.& aureus! is! equipped! with! a! bounteous! arsenal! of! immune!evasion! proteins! to! avoid! complement! attack,! and! the! central! complement!component! C3! is! heavily! targeted.! This! reflects! the! complicated! and!everQchanging! relationship! between! the! host! and! invading! bacteria.! By!combining!factors!such!as!the!expression!level,!cellular!location,!interQmolecular!synergy! and! expression! timing! of! these! immune! evasion! proteins,! a! variety! of!complement!evasion!tactics!can!be!employed!to!suit!different!stages!of!S.&aureus&infection.!
1.7,Staphylococcal(binder(of(immunoglobulin((Sbi)(
Staphylococcal!binder!of!immunoglobulin!(Sbi)!is!the!second!IgG!binding!protein!identified! from! S.& aureus! (Zhang! et& al.! 1998).! It! was! discovered! in! a! shotgun!phage! display! experiment! utilizing! S.& aureus& strain! 8325Q4! chromosomal! DNA,!but!later!shown!to!be!expressed!in!numerous!clinical!strains!of&S.&aureus!(Jones!
et&al.!2008).!The!Sbi!gene!encodes!a!protein!of!436!amino!acids.!Structural!and!
Figure( 1.12:( Domain( structure( of( full( length( Sbi.! (Burman!et& al.! 2008)( The! predicted! cell!wallQspanning!prolineQrepeat! region! (Wr)! (Zhang!et&al.!1998).!CQterminal! tyrosineQrich! region!(Y),!which!has!been!implicated!in!IgGQmediated!signal!transduction.!(Zhang!et&al.!2000).(!
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bioinformatical! analyses! revealed! that! it! comprise! four! NQterminal! functional!domains! (Fig.1.12),! a! proline! rich! domain! and! a! tyrosine! rich! domain,! but!without!the!typical!GramQpositive!cell!wall!anchoring!sequence!LPXTG!(Burman!
et&al.!2008).!!Most! of! the! immuneQmodulating! activities! of! Sbi! are! located! at! the!NQterminal!end!of! the!molecule.!The!IgG!binding!domains!IQII!share!high!sequence! identity!with! the! IgG!binding!domain!of!SpA,!however! they!bind!to! the!Fc!region!of! the!IgG!molecule!in!a!unique!way!that!causes!the!formation!of!crossQlinked!insoluble!IgG! immuneQcomplexes! (Atkins! et& al.! 2008).! In! contrast! to! the! clear! functional!annotation! of! domain! IQII! (SbiQIQII),! Sbi! domain! IIIQIV! (SbiQIIIQIV)! has! been!associated! with! a! range! of! activities.! Initially,! the! phage! display! experiments!demonstrated! that! peptides! from! domain! IV! (SbiQIV)! bind! to! β2Qglycoprotein! I!(β2QGPI),!a!protein!involved!in!blood!coagulation!(Zhang!et&al.!1999).!However,!in!subsequent! pullQdown! studies! using! recombinant! proteins,! domain! IV! was!associated!with!C3! fragments!binding!activity.!When!domain!IIIQIV!was!used,! it!was! found! to! bind! to! C3! fragments! together!with! factor!H! to! form! a! tripartite!complex!(Burman!et&al.!2008;!Haupt!et&al.!2008).!The!crystal!structure!(Clark!et&
al.! 2011)of! SbiQIV! in! complex!with!C3d! shows! that! SbiQIV!binds! to! the! concave!surface!of!C3d,!sharing!the!interaction!interface!with!EfbQC!and!Ehp.!In!addition,!SbiQIV! also! binds! to! the! convex! surface! of! the! C3d! fragment,! providing! an!unprecedented!alternative!binding!mode.!Although!the!binding!strength!on! the!convex! side! has! been! shown! to! be! extremely! weak! (Upadhyay! et& al.! 2008),!interaction!interface!analysis!and&in&silico!binding!simulation!studies!support!this!binding!mode!being!physiologically!genuine!(Gorham!et&al.!2014).!!Among! staphylococcal! C3d! binding! proteins,! Sbi! demonstrates! the! weakest!binding! strength.! However,! the! complement! modulation! function! of! Sbi! is! the!most! intriguing.!By!binding!to!C3,!SbiQIV!alone! inhibits! the!alternative!pathway!activation! in!a!dose!dependent!manner.!Like!EfbQC!and!Ehp,!SbiQIV!antagonizes!
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C3d! binding! to! CR2,! inhibiting! B! cell! activation.! Together! with! domain! III,!SbiQIIIQIV! inhibits!all! complement!pathways!by! inducing! the! futile!consumption!of!C3!through!AP!activation.!It!was!hypothesized!that!Sbi!triggers!C3!activation!distally!and!limits!the!deposition!of!the!metastable!C3b!molecule!to!nearby!IgG!and! Sbi! itself,! through!which! it! safely! depletes! local! C3! and! protects! S.& aureus&from!opsonization.!Noticeably,!during!this!process,!Sbi!itself!becomes!deposited!with!C3!fragments,!however!the!functional!roles!of!SbiQC3b!adducts!still!remain!to! be! elucidated! (Burman! et& al.! 2008).! Finally,! as!mentioned! earlier,! SbiQIIIQIV!facilitates!the!plasminQmediated!degradation!of!C3!(!Koch!et&al.!2012).!!
!Given! the! counterQintuitive! role! of! Sbi! as! a! C3! activator,! its! cellular! location,!expression!pattern!and!immune!evasion!mechanism!are!scrutinized! in!detail! in!order! to! make! sense! of! how! this! protein! is! utilized! to! consume! C3! without!causing! damage! to! the! bacteria.! Sbi! gene! deletion! severely! compromises! the!survival!rate!of&S.&aureus!Newman!strain!in!a!wholeQblood!based!survival!assay.!The!deletion!of!Sbi!has!a!slightly!weaker! impact!on! the!survival! rate!reduction!compared! with! the! deletions! of! other! wellQknown! staphylococcal! immune!
Figure(1.13:(Putative(model(of(Sbi( cellular( localization.(Sbi!is!tethered!on!the!S.aureus!surface! through! interactions! with! lipoteichoic! acid! and! a! putative! second! membrane!component!X.!The!IgG!binding!domain!I!and!II!are!biologically!active!even!associated!with!cell! membrane.! On! the! contrary,! SbiQIIIQIV! becomes! activated! after! dissociation.! The!dissociation!mechanism! remains! to! be! investigated.! CWA! proteins! Spa! and! ClfA! are! also!shown!on!the!image.!Image!taken!from!(Smith!et!al.!2012).!.!
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evasion! factors! (e.g.! SpA,! ClfA! and! Isd).! Therefore,! Sbi! is! an! immune! evasion!factor! that! contributes! to! the! avoidance! of! opsonophagocytosis.!Moreover,! the!secreted! Sbi! containing! NQterminal! domains! III! and! IV! is! the! minimal!requirement!for!Sbi!mediated!protection!(Smith!et&al.!2011).!!The! sophisticated!domain!arrangement! confers!upon!Sbi! a!unique! flexibility! in!cellular!location.!It!can!be!secreted!abundantly!to!the!surrounding!environment!(Zhang!et&al.!1999;!Burman!et&al.!2008).!It!is!also!found!tethered!on!the!cell!wall!using!CQterminal!proline!rich!and!tyrosine!rich!domains!through!lipoteichoic!acid!(LTA),!in!this!way!(Fig.1.13),!the!NQterminal!domains!of!SbiQIIIQIV!are!buried!by!the! capsule! layer,! with! only! SbiQIQII! in! contact! with! ambient! environment.!Although,!the!molecular!detail!about!the!release!of!the!cell!wall!bound!Sbi!is!still!unknown,!but!it!has!been!shown!that!both!cell!wall!bound!and!secreted!forms!of!Sbi!contribute!to!immune!evasion!by!the!bacterium!(Smith!et&al.!2012).!!The! expression! of! Sbi! is! strictly! regulated! by! at! least! three! independent!regulatory! mechanisms.! The! presence! of! IgG! in! the! surrounding! environment!induces! Sbi! expression! (Zhang! et& al.! 2000),! but! both! accessory! gene! regulator!(agr)!and!small!pathogenicity!island!rNAs!D!(SprD)!are!the!negative!regulators!of!Sbi! expression! (Chabelskaya! et& al.! 2010).! Both! regulatory! elements! have! been!shown!to!contribute!significantly!to!the!virulence!of!S.aureus!in!animal!models.! !
(
1.8(Aims:(
(Among!the!four!Sbi!NQterminal!domains,!Sbi!domain!III!and!IV!have!been!shown!to!be!the!minimal!domain!requirement!to!trigger!futile!consumption!of!C3.!Based!on!the!SbiQIIIQIV!construct,!a!systematic!siteQdirected!mutagenesis!study!will!be!performed,! and! the! resulting! Sbi! mutants! will! be! examined! for! their! C3!consumption!activity.!Using!the!functionally!defective!mutants!of!Sbi,!a!series!of!comparative!structural!and!functional!experiments!will!be!performed!to!discover!
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2.1.1(DNA(plasmids(for(use(as(PCR(templates(!pQE30SbiQIIIQIV!The!DNA!sequence!of!Sbi!NQterminal!domain!IIIQIV!(150Q266!aa)!was!cloned!into!pQE30!vector!by!Dr!Elizabeth!Clark.!This!vector!contains!an!ampicillin!resistance!gene! and! the! inserted! sequence! is! under! control! of! the! T5! promoter.! The!expressed! SbiQIIIQIV! protein! contains! a! NQterminal! 6×His! tag.! (Appendix!Fig.9.1.1.1)!!pQE30SbiQIIIQIVQcys!A!derivative! construct!of!pQE30SbiQIIIQIV!made!by!Dr!Sylvain!Royer.!A!CQterminal!cysteine!residue!was!inserted!for!the!convenience!of!sulfhydrylQspecific!labeling!investigations.!(Appendix!Fig.9.1.1.2)!!pET15bQC3d17A! !Prof! David! E.! Isenman! (University! of! Toronto)! kindly! provided! the! expression!vector!for!human!complement!component!C3!fragment!C3d.!The!DNA!sequence!of!the!C3d!fragment!(D996QR1303)!was!cloned!into!pET15b.!A!single!point!mutation,!C1010A,!was!inserted!to!prevent!the!formation!of!interQmolecular!disulfide!bond.!This! vector! contains! an! ampicillin! resistance! gene! and! the! expression! of! the!inserted!gene!is!under!control!of!a!T7!promoter.!During!cloning,!the!NQterminal!HisQtag! sequence! was! deleted! to! produce! tagQfree! C3d17A! protein.! ! (Appendix!Fig.9.1.1.3)!!pMAQTQC3a! !The!codon!optimized!C3a!gene!suited!for!Escherichia&coli!(E.coli)!expression!was!
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commercially! synthesized! by! the! GeneArt! service! provided! by! Invitrogen.!According! to! the! protein! sequence! of! human! complement! component! C3!(Swissprot! accession!No.P01024.3),! the! coding! region! from! amino! acid! 672! to!749!was! inserted! into!the!pMAQT!vector!carrying!an!ampicillin!resistance!gene.!(Appendix!Fig.9.1.1.4!and!Fig.9.11)!!
2.1.2.(Expression(plasmids(pQE30! !This! plasmid! contains! a! nonQcleavable! NQterminal! 6×HisQtag! and! an! ampicillin!resistance! gene.! The! expression! is! under! control! of! a! T5! promoter.! (Appendix!Fig.9.1)!!pET28a! !This!plasmid!contains!a!NQterminal!thrombin!cleavable!6×HisQtag,!a!T7!tag!and!a!CQterminal!6×HisQtag,!a!kanamycin!resistance!gene!and!is!under!the!control!of!a!T7!promoter.!(Appendix!Fig.9.3)!!pGEXQhtb! !This! plasmid! is! a! derivative! vector! of! pProexQhtb! (Appendix! Fig.9.2),! which!contains! a!TEV!protease! cleavable!NQterminal!GSTQtag,! an!ampicillin! resistance!gene!and!is!under!the!control!of!a!tac!promoter.!!
2.1.3(Cell(strains(The& E.coli! strain! DH5α! (NEB)! chemically! competent! cells! were! used! for!molecular!cloning!experiments!in!this!study.!For!mutagenesis!experiments,!E.coli!strains! XLQGold! Ultra! and! XLQBlue! (Agilent)! chemically! competent! cells! were!used.! E.coli! strains.! BL21! (DE3)! (BIOLINE)! and! Origami! (DE3)! (Agilent)!chemically!competent!cells!were!used!for!protein!expression.! !!!
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2.1.4(Microbial(media(
E.coli! cells! were! cultured! in! autoclave! sterilized! luriaBbertani! broth! (LB,! 1%!tryptone,!0.5%!yeast! extract,! 1%!NaCl)! liquid!medium!or!LBQagar! (LB!medium!supplemented!with!2%!agar).!Antibiotic! stock!solutions! (100!mg/ml!ampicillin!or!50!mg/ml!kanamycin)!were!added!to! the!medium!at!a!dilution!of!1! in!1000!prior! to! the! culturing! of! cells.! The! LBQagar!was! allowed! to! cool! down! to! near!body!temperature!before!the!antibiotic!was!added!and!the!medium!was!poured!into!90mm!Petri!dishes.!The!LB!agar!plates!were!sealed!and!stored!in!a!4°C!cold!room.! !!




(Phusion! HighQFidelity! DNA! polymerase! (ThermoFisher)! was! used! to! amplify!DNA!fragments! for!subsequent!cloning!procedures.!PCR!reactions!were!carried!out! using! an! MJ! Research! PTCQ200! thermocycler.! The! final! volume! for! each!reaction!was!maintained! between! 20Q25! μl,! by!making! aliquots! from! a!master!mix.! Lyophilized! synthesized! DNA! was! resuspended! with! water! to! a! final!concentration!of!100!ng/μl;!another!1:50!dilution!with!sterile!water!was!made!
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for! the! usage! as! DNA! template.! MiniQprep! purified! plasmids! being! used! as!template!DNA!were!diluted!1:20! in! sterile!water.!After! the!PCR!products!were!digested!by!restriction!enzymes,!purified!and!ligated!with!linearized!plasmid,!the!insertQcontaining! plasmids! were! transformed! into! competent! cells.! Individual!clones!were! then!screened! for! the!correct! insert!by!OneTaq!polymerase! (NEB)!colony!PCR.!!Phusion!HighQFidelity!DNA!polymerase!was!used! to!amplify!all!DNA! fragments!for!standard!cloning!experiments!described!in!this!study.!The!recipe!for!a!typical!reaction!master!mix!is!shown!in!table!2.1,!the!corresponding!temperature!cycle!program!is!in!table2.2.! !!Table!2.1:!Phusion!DNA!polymerase!PCR!reaction!mix! !
Volume(μl)( Component(10! 5×Phusion!HF!Buffer!1! 10!mM!dNTPs!1! Forward!Primer!(25!μM!working!stock)!1! Reverse!Primer!(25!μM!working!stock)! !1! Template!DNA!0.5! Phusion!DNA!Polymerase!(2!U/μl)!40.5! Autoclaved!Water!!Table!2.2:!Phusion!DNA!polymerase!PCR!program!
Step( Temperature( Duration(1.!Initial!denaturation! ! 98°C! 30!sec!2.!Denaturation! 98°C! 10!sec!3.!Annealing! 72°C! 30!sec!4.!Elongation! 72°C! 1!min!Go!to!step!2!for!35!cycles!5.!Final!elongation! 72°C! 10!min!6.!End! 4°C! Q!!OneTaq! polymerase! was! used! to! screen! transformed! cells! for! the! plasmid!containing!the!DNA!insert!of!interest.!For!each!clone,!small!amount!of!cells!were!transferred! to! the!PCR! tube!using!a! sterile!pipette! tip.!A!prolonged! initial!heat!lysis! step!was! added! to! ensure! complete! cell! lysis! by!which! the!DNA! template!
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becomes! accessible! to! the! polymerase.! Table! 2.3! shows! a! recipe! for! a! typical!reaction,!Table!2.4!shows!the!corresponding!temperature!cycle!program.!!Table!2.3:!OneTaq!DNA!polymerase!PCR!reaction!mix!
Master(mix((8×25μl(reactions)( Component(1μl! OneTaq!polymerase!8μl! Forward!Primer! !8μl! Reverse!Primer! !40μl! Standard!Reaction!Buffer×5!4μl! 10!mM!dNTP!139μl! Sterile!Water!!Table!2.4:!OneTaq!DNA!polymerase!PCR!program!
Step( Temperature( Duration(1.!Initial!denaturation! ! 95°C! 5!min!2.!Denaturation! 95°C! 30!sec!3.!Annealing! 55°C! 30!sec!4.!Elongation! 68°C! 1!min!Go!to!step!2!for!35!cycles!5.!Final!elongation! 68°C! 10!min!6.!End! 4°C! Q!!
2.2.2(SiteEdirected(Mutagenesis(methods( (
(In! this! study,! mutations! were! inserted! by! mutagenic! PCR! reactions! utilizing!synthesized! DNA! primers! incorporating! the! altered! genetic! code.! For! each!mutagenesis!experiment,!a!50!μl!PCR!master!mix!(Table!2.5)!was!set!up!and!then!divided! into! five! 10! μl! aliquots,! through! which! five! different! extension!temperatures!(72°C,!72.5°C,!73.3°C,!74.3°C!and!75°C)!were!tested!for!the!optimal!amplification!conditions.!A!typical!mutagenic!PCR!program!is!shown!in!Table!2.6.!During! the! extension! step,! different! temperatures! are! achieved! by! creating! a!temperature!gradient!using!a!thermocycler.!!After! amplification,! the! PCR! products! were! analyzed! on! a! 1%! agarose! gel! to!evaluate! the! result! of! the! mutagenesis! reaction.! The! successfully! amplified!plasmids! were! then! digested! by! methylation! sensitive! DpnI! fast! digest!
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(ThermoFisher)!restriction!enzyme!for!30min!at!37°C.!The!Pfu!DNA!polymerase!that! was! utilized! in! the! PCR! reaction! yields! mutated,! unmethylated! double!stranded!circular!plasmids,!which!were!incompatible!as!substrates!for!the!DpnI!restriction!enzyme!and! thus!survive! the!digestion.!The!mutated!plasmids!were!then!purified!from!the!digestion!mixture!by!MiniElute!PCR!reaction!cleanQup!kit!(Qiagen).! 5μl! of! the! purified!mutant! plasmids!were! added! to! 10! μl! of! XLQGold!ultraQcompetent! cells.! After! transformation,! several! successful! colonies! were!selected! and! cultured! in! 15!ml! of! LB! broth! at! 37°C! overnight.! Cells!were! then!recovered!by!centrifugation!(8000g,!10!min)!and!resuspended!in!1!ml!of!water,!from!which!plasmids!were!then!extracted!using!GeneJet!miniprep!kit!and!stored!at! Q20°C.! The! purified! plasmid! was! sequenced! to! confirm! the! success! of! the!mutagenesis! experiment.! For! double,! triple! and! quadruple! mutants,! the!mutations!were!inserted!stepQwise!based!on!verified!mutated!plasmid.!!Table!2.5:!Pfu!DNA!polymerase!mutagenic!PCR!reaction!mix!
Volume((μl)( Component(10! 10×Pfu!Buffer!with!MgSO4!1! 10mM!dNTPs!1! Forward!Primer!(125!ng/μl)!1! Reverse!Primer!(125!ng/μl)! !1! Template!DNA!(2!ng/μl)!1! Pfu&DNA!Polymerase!(2!U/μl)!40! Autoclaved!Water!!Table!2.6:!Pfu!DNA!polymerase!mutagenic!PCR!program!





(DNA!electrophoresis!Agarose! gels! (30!ml! or! 50!ml)!were!made! by! dissolving! 1%! (w/v)! agarose! in!1×TAE!buffer!(40!mM!TrisQacetate,!1!mM!EDTA,!pH!8.0)!and!a!1:20000!dilution!of!a!10!mg/ml!ethidium!bromide!solution!was!added!for!visualization!of!DNA.!5!μl!of!the!PCR!product!was!added!to!1!μl!of!6×DNA!loading!buffer!(0.25%!(w/v)!bromphenol! blue,! 0.25%!xylene! cyanol! FF,! 30%(v/v)! glycerol! in! sterile!water)!and! electrophoresed! using! horizontal! flatbed! chambers! (BioRad)! at! a! constant!current! of! 80!mA.! For! DNA! size! estimation,! the! DNA! ladders! (NEB)! shown! in!Fig.2.1!were!utilized.!Gels!were!imaged!using!a!ChemidocQit2!UV!transilluminator!(UVP).!
DNA!purification!A!MinElute!PCR!purification!kit!(Qiagen)!was!used!to!purify!nucleic!acid!samples!(e.g.!PCR!products!and!single!restriction!enzyme!digested!DNA)! through!which!protein!contaminants!in!the!sample!were!removed!and!DNA!was!eluted!with!10!μl!of!sterile!water.!In!cases!where!PCR!reactions!amplified!more!than!one!band,!the!whole!PCR!reaction!mixture!was!electrophoresed,!and!the!desired!band!was!excised!for!DNA!extraction.!In!this!study,!the!double!restriction!enzyme!digested!DNA! insert! and! plasmid! pending! ligation! reaction! were! always! purified! by!electrophoresis! and! then! extracted! from! the! gel.! QIAquick! gel! extraction! kit!
Figure(2.1:(Markers(used(for(DNA(
fragment( size( estimation.! NEB!1Kb!DNA!ladder! ! !
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(Qiagen)!was!used! in!all! gel! extraction!procedures.!The! resulting!purified!DNA!was!eluted!with!50!μl!of!sterile!water.!!
2.2.4(Insertion(of(DNA(fragments(into(plasmids( (
(PCR! products! and! vectors! were! sequentially! digested! with! restriction!endonucleases! according! to! the! manufacturers! instruction.! After! the! first!digestion!cycle,!the!DNA!fragment!was!purified!with!MiniElute!PCR!purification!kit.!After! the! second! restriction!digest,! the!DNA! fragment!was! electrophoresed!and! extracted! from! the! gel! using! a! QIAquick! gel! extraction! kit.! Restrictive!enzyme!digestion!details!of!DNA!fragments!are!summarized!in!Table!2.7.!Before!the! stickQend! ligation! reaction,! concentrations! of! all! double! digested! DNA!fragments!were!measured.!Ligation!reactions!were!setQup!according!to!equation!2.1.!Two! insert:vector! ratios! (3:1! and!1:1)!were!normally! tested! for! successful!ligation! conditions,! at! least! 100! ng! of! DNA! was! added! for! each! reaction.! The!ligation!reaction!was!catalyzed!by!T4!DNA!ligase!at!room!temperature!for!1!hour,!a!typical!T4!ligation!reaction!setQup!is!shown!in!Table!2.8.!!Table!2.7:!DNA!insert!
!!! !"!!"!!"#$%&!×!!"#$!!"!!"#$%&!(!")!"#$!!"!!"#$%&!(!") !× ! !"#$%&!"#$%& ! "#$%!!"#$% = !"!!"!!"#$%&!!![Equation!2.1]!! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! !!Table!2.8:!Typical!recipe!for!DNA!ligation!reaction!
Volume((μl)( Component(XV! Vector! !XI! Insert!1.5! 10×T4!Ligase!Buffer!0.75! T4!DNA!Ligase!To!final!volume!15μl! Sterile!Water!
PCR!products! Plasmid! Restriction!Enzymes!C3a! pGEXQhtb! BamHI/HindIII!SbiQIIIQIV! ! pET28a! BamHI/HindIII!
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2.2.5(Transformation(of(E.coli(cells(!To! insert! the! plasmid! into! cloning! cell! lines,! 3Q5! μl! of! the! ligation! mixture! or!mutated!plasmid!were!added!to!10!μl!of!chilled!cells!on!ice!and!left!for!30!min.!The!cells!were!heatQshocked!at!42°C!for!45!sec!and!returned!to!ice!for!5!min.!200!μl! of! SOC!medium!was! added! to! the! cells!which!were! then! incubated! at! 37°C,!shaking!at!220!rpm!for!2!hours.!100!μl!of!the!transformation!mixture!was!spread!onto!an!LB!plate!containing!the!appropriate!antibiotic.! !When!miniQprepped! plasmid!was! used! for! transformation! into! expression! cell!lines,!1!μl!of!plasmid!was!added!to!10!μl!of!chemically!competent!cells.!The!rest!of! the!procedure!was!performed!as!described!above.!HeatQshock!duration!may!vary! depending! on! the! cell! strains;! so! corresponding! adjustments! were! made!according!to!the!manufacturer’s!instructions.!!
2.2.6(DNA(sequencing(of(plasmids(
( Table!2.9:!DNA!sequencing!primer!selections!




2.3.1(SDSEPAGE(and(Gradient(gel(In! this! study! sodium! dodecyl! sulphate! polyacrylamide! gel! electrophoresis!(SDSQPAGE)!was! done! using! the!Novex!Mini! gel! system! (Invitrogen)! using! 4%!polyacrylamide! stacking! gels! (Table 8.2)! and! 8%,! 12%! 15%! polyacrylamide!resolving! gels! (Table! 8.1),! 4Q20%! gradient! gel! (Table! 8.3)! was! made! by! a!
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gradient!maker!and!used!in!some!circumstances.!Protein!samples!to!be!analyzed!were! mixed! with! 2×loading! buffer! and! boiled! for! 10! min.! Reducing! and!nonQreducing!loading!buffers!(Table!8.4)!were!prepared!to!suit!the!requirements!of!different!experiments.!Generally!5Q15!μl!samples!(approximately!less!than!25!μg! of! protein)! were! loaded! in! each! lane,! electrophoresed! in! 1×TriQGlycine!running!buffer!(Table!8.5),!using!a!constant!current!setting!of!60Q80!mA!until!the!bromophenol!blue!dye!ran!off!the!gel.!Gels!were!extracted!from!the!cassette!then!subjected! to! downstream! immunoblotting! or! protein! extraction! procedures,!however!most!commonly!gels!were!stained!with!Coomassie!Blue!(Table!8.6)!for!1!hour!after!being!heated!in!a!microwave!for!40!sec.!Gels!were!then!deQstained!(Table! 8.7)! and! dried! in! cellophane! membrane! (Invitrogen).! Pierce! Unstained!Protein! MW! Marker! (Invitrogen),! Pierce! Prestained! Protein! MW! Marker!(Invitrogen)! and! Amersham! Rainbow! Marker! (GE! Healthcare)! (Fig2.2)! were!used!to!estimate!the!size!of!proteins.! !!
Figure( 2.2:( Protein(markers( for( protein( size( estimation.!(A)! Pierce!Unstained!Protein!MW!Marker!(B)(Pierce!Prestained!Protein!MW!Marker!(C)!Amersham!Rainbow!Marker.!5!μl!marker!was!loaded!on!the!gel.!Images!taken!from!manufactures!website.!!
(
2.3.2(Protein(expression(The!general! technique! for!recombinant!protein!expression! is!described! in! later!
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sections.! After! an! expression! vector! was! transformed! into! an! E.coli! strain,! a!single!colony!was!picked!and!grown!at!37°C!overnight!in!a!15!ml!of!LB!medium!with!addition!of! the!appropriate! antibiotic.!The!overnight!primary! culture!was!then! used! to! inoculate! a! scaledQup! secondary! LB! culture! (500Q1000! ml)! with!appropriate! antibiotic! added.! Cells! were! grown! in! a! temperatureQcontrolled!incubator! with! shaking! at! 180! rpm.! The! expression! of! protein! was! generally!induced!during!the!exponential!phase!of!bacterial!growth!(OD600≥0.7)!by!adding!isopropyl! thiogalactoside! (IPTG)! to! the! culture.! IPTG!concentration,! expression!temperature! and! duration! of! expression! were! factors! requiring! unique!optimization! for! specific! expression! constructs.! Table! 2.10! summarizes! the!expression!conditions!for!proteins!included!in!this!study.!!Table!2.10:!Summary!of!protein!expression!conditions! !
!
2.3.3(Harvest(&(Lysis(of(cells, ,
E.coli! cells!were!harvested!by! centrifugation! (8000!g,! 25!min,!4°C).!Cell!pellets!were! suspended! in! 20!ml! of! protein! dependent! buffer.! The! resuspended! cells!were! sonicated! (Branson! digital! sonicator)! on! ice! for! 6! cycles! of! an! 80%!amplitude!burst!for!a!total!of!10!sec;!each!cycle!was!separated!by!10!min!interval!to! prevent! overQheating! of! the! sample.! The! resulting! extract! was! clarified! by!centrifugation!(60,000!g,!30!min,!4°C).! !!!
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2.3.5(Buffer(exchange,Three!buffer!exchanging!methods!were!used!in!the!study.!When!using!Vivaspin!centrifugal! concentrators! to! enrich! purified! protein,! a! series! of! dilutions! and!enrichment! cycles! were! repeated! utilizing! the! replacement! buffer,! until! an!equivalent! of! 625×!dilution! (4! cycles! of! 5×! dilution)! of! the! original! buffer!was!achieved.! Alternatively,! protein! samples!were! also! buffer! exchanged! by! PDQ10!gravitational! desalting! column.! Essentially,! to! a! PDQ10! column! that! had! been!preQequilibrated!with!25!ml!of!replacement!buffer,!2.5!ml!of!protein!sample!was!added.! After! the! protein! sample! was! totally! absorbed,! 3.5! ml! of! replacement!buffer!was!added!to!elute!3.5!ml!of!protein!solution!in!desired!buffer.!!Finally,! for! small! volumes!and!concentrated!protein! samples,!Protein!Desalting!Spinning!Columns!(7!kDa!cutQoff,!Thermo!Scientific)!were!used.!Briefly,!the!spin!column! was! first! equilibrated! with! replacement! buffer! through! 3! wash! cycles!(400!μl!each!time).!The!column!was!centrifuged!at!1500!g! for!1!min!to!remove!excess!liquid.!After!placing!in!a!new!collection!tube,!30Q120!μl!of!protein!sample!was!spotted!on!the!center!of!the!dry!resin!bed,!after!which!the!column!was!spun!at!1500!g!for!2!min!to!recover!the!buffer!exchanged!protein!sample.!!
2.3.6(Concentrator(and(Concentration(measurement(Vivaspin! centrifugal! concentrators! were! used! to! concentrate! protein! samples;!samples!were! spun! at! 3500!g! until! concentrated! to! the! desired! concentration.!The! protein! concentrations!were! determined! by!measuring! absorbance! at! 280!nm!using!a!NanoVue!spectrophotometer!(GE!Healthcare).! !!
2.3.7(Antibodies(&(antisera( (!The!following!primary!antibodies!were!used!in!this!study:!rabbit!antiQSbi!serum,!polyclonal! goat! antiQC3! (CompTech),! polyclonal! rabbit! antiQC3d! (Dako),!polyclonal! rabbit! antiQC3a! (CompTech),! polyclonal! goat! antiQfactorQB!
! 53!














Dilution'Sbi! Polyclonal! 1.5/5000! Q! 15/5000!C3! Polyclonal! 1/10000! 1.5/50000! Q!C3a! Polyclonal! 1/20000! ! 15/5000!C3d! Monoclonal! 1.5/5000! Q! 15/5000!Factor!B! Polyclonal! 1/10000! 1.5/50000! Q!Factor!H! Polyclonal! 6/5000! 1.5/50000! Q!6×Histidine!tag! Monoclonal! 1/20000! Q! Q!Biotin! StreptavidinQHRP! 1/20000! Q! Q!!After! protein! samples! had! been! separated! by! SDSQPAGE! electrophoresis,!SDSQPAGE!gel!and!methanolQactivated!polyvinylidene!fluoride!(PVDF)!membrane!were! soaked! for! 15! min! in! Pierce! Fast! semiQdry! transfer! buffer! (Thermo!Scientific).!Immunoblotting!was!performed!using!pierce!G2!semiQdry!fast!blotter!(Thermo!Scientific).!Blotting!was!performed!at!a!constant!25!V!for!15!min.!The!
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(ComplementQactive! lyophilized! human! serum! standard! (HSS)! was! purchased!from!EuroQdiagnostica,!Sweden.!Citrated!human!plasma!was!purchased!from!TCS!bioscience,!UK!and!stored!at!Q80°C.!Factor!B,!factor!D,!factor!H,!factor!I!and!factor!P!depleted!sera!were!purchased!from!CompTech,!USA.!!










(The!goat!antiQFH/FHRQ1!antiQserum!was!acquired!from!Merck!Millipore.!100!μl!of! the!goat!serum!was!diluted! to!1!ml!with!PBS!buffer!and! loaded!on!a!gravity!column! packed! with! 500! μl! of! protein! G! Sepharose! resin! (SigmaAldrich).! The!flowQthrough!fraction!was!reloaded!twice!for!maximum!capture!of!the!antibody.!After! intensive! washing! (10! column! volumes! of! PBS),! the! bound! goat! IgG!molecules!were!eluted!with!elution!buffer! (the!compositions!of!buffers!used! in!
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3.2.1.2(Purification(of(FH(and(FHRE1(!FH! and! FHRQ1! were! prepared! from! citrated! human! plasma! (TCS! bioscience),!using!a!newly!developed!affinity!purification!protocol.!Firstly!the!citrated!plasma!was!allowed!to!clot!by!adding!CaCl2! to! final!concentration!of!15!mM.!After!one!hour’s! incubation!at!37°C,! the!clot!was!removed!by!centrifugation!(5000!g)! for!20!min.!EDTA!stock!was!added!to!the!serum!to!a!final!concentration!of!25!mM!to!prevent! unwanted! complement! activation.! 5!ml! filtered!EDTAQserum!was! then!loaded! on! two! 1! ml! antiQFH/FHRQ1! IgG! coupled! Sepharose! columns!(antiQFH/FHRQ1! column)! using! a! ÄKTA! purifier.! During! loading! of! the! serum,!flowQrate!was!set!for!0.4!ml/min,!the!slow!flowQrate!enhances!the!capture!of!FH!and!FHRQ1!from!serum.!After!loading,!the!flowQrate!was!raised!to!1!ml/min,!the!column!was!washed!by!10!ml!of!PBS!buffer!and! the!bound!protein!was!eluted!with!an!8!ml!wash!of!elution!buffer.!100!μl!of!1!M!Tris!pH!8.0!buffer!was!added!to!
Figure(3.1:(Generation(of(antiEFH/FHRE1(antibody(column.!(A)!SDSQPAGE!analysis! summarizing! protein! G! affinity! purification! of! IgG! from! goat!antiQFH/CFHR1!serum.!Lanes:!1!Goat!serum!before!purification,!2!Goat!serum!after! purification,! 3!Wash! I,! 4!Wash! II,! 5! Elution! I,! 6! Elution! II,! 7! Goat! IgG!positive! control.! (B)! SDSQPAGE! evaluation! of! goat! IgG! coupling! to!NHSQactivated!column.!Lanes:!1,!IgG!before!coupling!reaction,!2!Flow!through!fraction!1,!3!Flow!through!fraction!2.! !
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each!fraction!collecting!tubes!beforehand.!Therefore!the!pH!environment!of!the!eluted!protein!was!neutralized!immediately!after!the!elution!step.!According!to!the!chromatogram,!elution! fractions!were!collected,!concentrated!and!analyzed!by!SDSQPAGE.!!As!the!antibody!column!was!coupled!with!polyclonal!antiQFH!antibodies,!not!only!FH! and! FHRQ1! will! be! enriched! from! serum,! but! also! FHLQ1! and! other! FHR!proteins.! Thus,! the! sample! was! then! subjected! to! anion! exchange!chromatography.! Under! anion! exchange! conditions,! at! a! given! pH! the! net!positively! charged! protein! surface!will! bind! to! the! anionic! column!matrix,! the!retained! proteins! are! then! sequentially! eluted! with! a! gradient! of! increasing!positive! ion!concentration! in! the!elution!buffer.!Firstly,! the!protein!sample!was!buffer!exchanged!to!BufferQ2A!using!PD10!column.!Then!the!sample!was!loaded!on! a! 1!ml! Q! Sepharose!HP! column,!with! the! flow! rate! set! for! 1!ml/min.! After!loading,! the! column!was!washed! by! 8! column! volume! of! BufferQ2A,! the! bound!protein! was! subsequently! eluted! by! a! 50! column! volume! 0Q100%! gradient! of!BufferQ2B.! Each! peak! was! analyzed! by! SDSQPAGE! to! identify! FH! or! FHRQ1!containing!fractions.!!At! the! final!polishing!step,!FH!or!FHRQ1!containing! fractions!were!subjected! to!heparin!affinity!chromatography!separately.!Protein!fractions!were!firstly!buffer!exchanged! to! BufferQ3A,! subsequently! loaded! on! 1ml! HiTrap! Heparin! High!Performance!column!using!the!ÄKTA!purifier.!The!bound!protein!was!washed!by!8! column! volumes! of! BufferQ3A,! and! eluted!with! a! 25! column! volume! 0Q100%!gradient!of!BufferQ3B.!Elution!fractions!were!then!examined!for!the!presence!of!purified!FH!or!FHRQ1!protein.!
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!!Utilizing! the! antiQFH/FHRQ1! antibody! column,! affinity! chromatography! was!performed!to!purify!FH!and!FHRQ1!from!human!serum.!Fig.3.2.A!shows!that!after!passing! through! EDTAQserum,! proteins! were! retained! on! the! antiQFH/FHRQ1!column.!Using!100!mM!glycine!pH!2.7!as!eluting!buffer,! the!immune!complexes!were! successfully! dissociated,! resulting! in! a! 500! mAU! elution! peak.! The!
Figure(3.2:(Purification(of(
FH( and( FHRE1( from(
human( serum( (A)(Chromatogram! of! affinity!purification! using!antiQFH/FHRQ1! antibody!column.! Elution! fraction!“E1”! was! collected! and!prepared! for! secondary!purification.! !
(B)! Chromatogram! for! the!secondary! anion! exchange!chromatography.! The!immuneQaffinity! purified!protein! sample! was!separated! again! according!to! their! charge! at! pH8.5.!Elution! fractions! of!different! peaks!were!mixed!and! concentrated! as!indicated.! (C)! SDSQPAGE!analysis! of! the! affinity! and!anion!exchange!purification!fractions.! Labeled!chromatographic! sections!were! examined! for! their!protein! composition.!Putative! bands! of! FH! and!FHR1! were! pointed! using!black!arrows.! (
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Heparin&affinity&polishing&step&of&FHRB1&As! shown! in! Fig.3.3.A,! a! considerable! amount! of! serum! protein! contamination!was! removed! during! the! loading! stage.! In! the! following! elution! process,! one!major!peak!was!observed!by!elevating!the!NaCl!concentration!to!175!mM,!and!a!subsequent!increase!of!the!NaCl!concentration!yielded!a!series!of!smaller!peaks.!As!indicated!by!the!curly!bracket!in!Fig.3.3.A,!fractions!were!mixed,!concentrated!and! subjected! to! SDSQPAGE! analysis.! Fig.3.3.C! demonstrates! that! while! the!
Figure( 3.3:( Heparin( affinity(
purification( of( FH( and(
FHRE1( proteins! (A)! Heparin!affinity! chromatography! of!FHRQ1! containing! fraction.!Fractions! confined! by! the!curly! bracket! were! mixed,!concentrated!and!analyzed!by!SDSQPAGE! electrophoresis.!
(B)! Heparin! affinity!chromatography! of! FH!containing! fraction.! Fractions!confined!by! the! curly! bracket!were!mixed,!concentrated!and!analyzed! by! SDSQPAGE!electrophoresis.! (C)(SDSQPAGE!analysis!of!heparin!affinity! purification! of! FHRQ1!and!FH.!According!to! figure!A!and! B,! labeled! elution!fractions! were! examined! for!their! protein! composition.!“BP”! is! an! abbreviation! of!before! purification.! (DEE)(AntiQFH! Western! blots! of!purified! FHRQ1! and! FH.!Labeled! elution! fractions!were!examined.!
! 62!
majority! of! the! serum!protein! contaminations!were! found! in! the! flowQthrough!fraction!and!peak! fraction!1,!putative!FHR1!was!eluted!at! the! later!stage!of! the!purification!and!located!in!peak!fraction!2.!The!series!of!small!peaks!may!be!the!result! of! FHR1! in! different! dimerization! states! (Section! 1.4.3).! Estimated! from!the!gel,!FHR1!purity!in!peak!fraction!2!was!about!60%.!The!purity!and!identity!of!purified!FHR1!were!verified!by!the!polyclonal!antiQFH!Western!blot!(Fig.3.3.D).! !!
&




,!Human!C3!was!purified! from!EDTA! treated!human!serum!based!essentially!on!previous!published!method!(Alsenz!et&al.!1992)!with!considerable!modifications!(Fig.3.4).!PEG!4000!was!added!to!10!ml!of!freshly!prepared!human!serum!to!the!final!weight/volume!ratio!of!4%.!The!mixture!was!stirred!for!30!min!at!4!°C,!and!then! was! clarified! by! centrifugation! (10,000! g,! 30! min,! 4°C).! The! PEG!concentration!of!the!supernatant!was!then!adjusted!to!16%,!after!another!round!of!the!stirring!and!centrifugation,!the!final!C3!containing!pellet!was!resuspended!with!20!ml!of!BufferQQA!.!10!ml!of!the!filtered!suspension!sample!was!loaded!on!
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a!5!ml!QQSepharose! fast! flow!anion!exchange!column! (Amersham! Biosciences,! GE!healthcare,! Uppsala.! Sweden)! using! a! ÄKTA!purifier.!After!washing!the!column!with!75!ml!of! BufferQQA,! the! NaCl! concentration! was!increased! to! 150! mM! by! elevating! the!BufferQQB! concentration! to! 30%.! After! an!additional! 50! ml! washing! step,! bound! C3!molecules! were! eluted! by! raising! the! NaCl!concentration! to! 265! mM! (53%! BufferQQB).!The!53%!BufferQQB!elution!step!was!held! for!5! column! volumes! (total! of! 25! ml)! to!completely! elute! the! targeted! protein! and! to!avoid!contamination!with!unwanted!proteins.!The!C3!fractions,!roughly!25!ml,!were!then!pooled!and!concentrated!to!5!ml.!! !To!perform!the!subsequent!cation!exchange!chromatography,! the!concentrated!C3! fractions! were! buffer! exchanged! to! BufferQSA.! 10! ml! buffer! exchanged! C3!sample!was!then!loaded!on!a!1!ml!SPQSepharose!High!Performance!column.!After!washing!the!column!with!BufferQSA!to!remove!unbound!proteins,!a!washing!step!(15!column!volumes)!with!45%!BufferQSB!was!used! to!elute! the! loosely!bound!protein! contaminations.! Then! in! the! following! step,! purified! C3!was! eluted! by!increasing! the! BufferQSB! percentage! from! 45%! to! 100%! over! 20! column!volumes.!!
Figure( 3.4:( Summary( of( C3(
purification(
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!A! protocol! for! purifying! functional! active! C3! using! an! inexpensive!chromatographic!setQup!from!EDTA!human!serum!has!been!described.!Fig.3.5.A!
Figure(3.5:(Primary(purification(of(C3.!(A)!Anion!exchange!chromatography!of!enriched!C3!sample.!After!the!initial!loading!stage,!the!elution!process!was!divided!into!three!stages.!Firstly,! Buffer! B! concentration! was! elevated! to! 30%,! after! intensive! wash,! Buffer! B!concentration!was! increased!to!53%,!after!which!a!major!peak!was!produced.!The!buffer!concentration!was!then!elevated!to!100%!in!a!sharp!gradient.!Fractions!for!analysis!were!indicated! using! curly! brackets! and! arrows.! (B)! SDSQPAGE! analysis! of! anion! exchange!chromatography! purification! of! C3.! The! fractions! labeled! in! chromatogram! A! were!analyzed.!“BP”!is!an!abbreviation!of!before!purification.!“C3”!sample!contain!purified!C3!as!positive!control.!C3!αQchain:!120!kDa,!C3!βQchain:!70!kDa.!!
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shows! that! an! optimized! stepQwise! elution! strategy!was! used! to!maximize! the!purity! of! C3! containing! fractions.! In! the! first! stage! of! elution,! the! BufferQQB!concentration! was! increased! to! 30%! and! held! at! this! concentration! for! 15!column! volumes.! The! SDSQPAGE! analysis! (Fig.3.5.B)! of! elution! fractions! 1Q4!shows! that! during! this! prolonged! elution! step,! a! major! serum! protein!contamination! (approximately! 66! kDa)! was! completely! eluted.! At! the! second!stage! of! elution,! the! column! was! washed! by! 53%! of! BufferQQB! for! 5! column!volumes.! A! sharp! BufferQQB! gradient!was! utilized! to! elute! proteins! as! a! single!major! peak.! SDSQPAGE! analysis! of! peak! fractions! 5Q10! demonstrates! that! the!major!constituents!of!this!peak!were!complement!C3!and!a!25!kDa!serum!protein.!In!the!final!elution!step,!BufferQQB!concentration!was!adjusted!to!100%!within!5!column! volumes,! which! elutes! the! proteins! as! a! slightly! skewed! peak.! The!SDSQPAGE!analysis!of!the!corresponding!peak!fractions!(11Q13)!shows!that!this!peak!consists!of!nearly!equal!proportion!of!complement!C3,!serum!protein!1!(25!kDa)!and!serum!protein!2!(15!kDa).!Given!that!this!peak!proportionally!contains!much!more!unwanted!protein!contamination!than!C3,!this!peak!was!not!included!in!the!subsequent!secondary!purification!process.!!To!further!increase!the!purity!of!C3,!the!C3!containing!fractions!from!the!primary!purification! (Fig.3.5.A! fraction!5Q10)!were! concentrated,! buffer! exchanged,! and!separated!by! cation! exchange! chromatography.! In! the! secondary!purification! a!slightly! easier! stepQwise! elution! strategy! was! utilized! to! achieve! maximal!separation! of! C3! from! unwanted! serum! proteins.! It! is! clear! from! the!chromatogram!(Fig.3.6.A)!that!during!the! loading!stage!a!reasonable!amount!of!protein!was!removed.!In!the!first!stage!of!the!elution!the!BufferQSB!concentration!was! elevated! to! 45%! and! held! at! this! concentration! for! 15! column! volumes.!During! this! stage! the! absorbance! at! 280! nm! suggested! that! a! considerable!amount! of! less! charged! serum! proteins! were! eluted.! The! prolonged! 45%!BufferQSB! washing! ensures! that! unwanted! proteins! were! completely! removed!before!the!next!elution!step.!In!the!second!elution!step,!BufferQSB!concentration!
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was! increased! to! 100%! in! 20! column! volumes,! during! this! step! a! symmetrical!elution!peak!was!observed.! SDSQPAGE!analysis! (Fig.3.6.B)!of! the!peak! fractions!suggests!that!the!main!constituent!of!this!peak!is!complement!C3.!Based!on!the!SDSQPAGE! profile! of! secondary! purification! C3! fractions,! the! purest! fractions!were! pooled,! concentrated! and! buffer! exchanged! to! PBS! for! further! usage.!Following!this!protocol,!normally!3!mg!of!C3!molecule!can!be!purified!from!5!ml!EDTA!normal!human!serum.!! !
Figure( 3.6:( Secondary( Purification( of( C3.! (A)! Secondary! cation! exchange!chromatography!purification!of!C3.!C3!containing!fractions!from!primary!purification!were!separated!again!using!cation!exchange!chromatography!at!pH5.5.!Fractions!to!be!analyzed!were! indicated!using! a! curly!bracket.! (B)! SDSQPAGE! analysis!of! selected! cation! exchange!fractions.! The! analyzed! fractions! represent! the! elution! peak! of! C3! molecule,! C3! αQchain!(120! kDa)! and! βQchain! (70! kDa)! were! the! two! major! protein! bands! on! this! gel.! (C)!SDSQPAGE!profile!of!purified!C3!molecule.!
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3.2.2.2(Purification(of(C3b(
( (During! the! preparation! of! the! SbiQC3b! adduct! through! the! reconstituted! AP!pathway,! a! large! amount! of! free! C3b! molecules! was! produced.! As! shown! in!Fig.5.3.4.A,! after! Ni2+! affinity! purification,! free! C3b! molecules! were! separated!from!HisQtagged!molecules!and!collected!in!the!flowQthrough!fraction.!Given!that!other! AP! components! could! also! exist! in! the! flowQthrough! fraction,! an! extra!anion!exchange!chromatography!step!was!utilized!to!polish!the!purity!of!the!C3b!sample.!The!C3bQcontaining! flowQthrough! fraction!was! firstly!buffer! exchanged!to!BufferQQA.!10!ml!of!diluted!C3b!was!then!loaded!on!a!1!ml!QQSepharose!High!Performance! anion! exchange! column!using! a!ÄKTA!purifier.! After!washing! the!column!with!10!ml!of!BufferQQA,!the!bound!proteins!were!eluted!by!a!40!column!volume! gradient! of! BufferQQB.! Chromatographic! peaks! were! analyzed! by!SDSQPAGE!to!identify!the!C3b!containing!elution!fractions.!
The! chromatogram! (Fig.3.7.A)! shows! continuous! low! UV! 280nm! absorbance!until!the!middle!of!the!elution!stage,!two!peaks!were!observed!indicated!by!the!curly! bracket! on! the! chromatogram! as! peak! fraction! 1! and! 2.! The! SDSQPAGE!
Figure( 3.7:( Polishing( of( C3b( molecule.( (A)!Anion!exchange! chromatography!of! C3b.!C3b!molecules!were!eluted!as! the!major!peak,! labeled!using! curly!bracket! as! “2”.! (B)!SDSQPAGE!profile!of!purified!C3b.(
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&The! codon! optimized! C3a! gene! suited! for! E.coli! expression! was! commercially!synthesized! by! the! GeneArt! service! provided! by! Invitrogen.! According! to! the!sequence! of! human! complement! component! C3! (Swissprot! accession!No.P01024.2),!the!coding!region!from!amino!acid!672!to!749!was!inserted!in!the!pMAQT!vector!carrying!ampicillin!resistance.!The!coding!sequence!was!amplified!by! PCR! using! the! pMAQTQC3a! vector! as! a! template! (Primers,! forward! 5’Q! CTC!GGATCCATGAGCGTTCAGQ3’,! reverse! 5’Q! GCTCCAGGTACCCCCGGGQ3’).! PCR!reactions!were!carried!out!using!the!recipe!and!program!given!in!Section!2.2.1.! !!
The!resulting!PCR!(Fig.3.8.A)!products!were!sequentially!digested!by!restriction!enzymes!BamHI!and!KpnI.!The!digested!C3a!coding!DNA!fragment!was!purified!using! a! gel! extraction! kit! (QIAGEN)! and! ligated! with! double! digested! GSTQtag!fusion! vector! pGEXQhtb! (Fig.3.8.B).! Colony! PCR! (Fig.3.8.C)! was! performed! to!screen!for!a!positive!clone,!and!the!sequence!of!the!positive!clone!was!confirmed!by!DNA!sequencing!(Appendix!9.1.1.5).!!
Figure(3.8:(Cloning(of(C3a(gene.!(A)!BamHI!and!KpnI!double!digested!C3a!PCR!product.!(B)!BamHI!and!KpnI!double! digested!pGEXQhtb!vector.! (C)!After! ligation,!Colony!PCR! for!0.2Kb!C3a!DNA!insert.!
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3.2.3.2(GSTEC3a(purification(and(cleavage&
&The&E.coli!Origami!(DE3)!strain!was!used!for!GSTQC3a!fusion!protein!expression.!Bacteria!containing!the!pGEXQhtbC3a!plasmid!(Appendix!Fig.9.1.1.5)!were!grown!overnight!in!LB!medium!supplemented!with!100!μg/ml!ampicillin!and!20!μg/ml!tetracycline! at! 37.! The! 15! ml! primary! culture! was! incubated! with! 1! L! LB!medium!containing!100!μg/ml!ampicillin!and!20!μg/ml!tetracycline.!Cells!were!grown!at!37°Cwith!shaking!at!180!rpm.!The!expression!of! the!GSTQC3a!fusion!protein! was! induced! during! the! exponential! growth! phase! (OD600=0.8Q1.0)! by!adding! 0.05!mM! isopropyl! thiogalactoside! (IPTG)! to! the! culture! at! 12.!E.coli!cells!were!collected!by!centrifugation!(8000!g,!20!min)!16!hours!after!induction.!The!cell!pellet!was!suspended!in!20!ml!of!PBS!buffer!supplemented!with!EDTA!free! protease! inhibitor! cocktail! (Roche).! Lysis! of! the! cells! was! performed! as!described! in!2.3.3.!The! supernatant! sample!was! then! loaded!on!a!5!ml!GSTrap!column!(GE!healthcare)!using!an!ÄKTA!purifier!with!a!flow!rate!of!1!ml/min.!The!loaded!column!was!washed!with!6!column!volumes!of!PBS!buffer!and!the!bound!GSTQC3a!fusion!protein!was!eluted!with!GST!elution!buffer.!Prior!to!the!cleavage,!GSTQC3a!protein!was!concentrated!using!a!10!kDa!cutQoff!spinQconcentrator!and!buffer! exchanged! into! cleavage! buffer.! The! C3a! protein! was! cleaved! from! the!GSTQC3a! fusion! protein! with! AcTEV! protease! (Invitrogen).! 20! U! of! AcTEV!protease!was!added!to!2.5!ml!of!GSTQC3a!fusion!protein!sample!(10!mg/ml)!and!the!cleavage!reaction!was!carried!out!at!4for!48!hours.!!GSTQC3a! fusion! protein! was! solubilized! in! PBS! buffer! and! purified! using!glutathione! affinity! chromatography! (Fig.3.9.A).! Analyzing! the! purification!fraction! by! SDSQPAGE! and! coomassie! staining! revealed! that! at! least! 70%! of!protein!purified!was!GST!rather!that!the!GSTQC3a!fusion!protein!(Fig.3.9.B,!lane!1!and! 2).! The! yield! of! GSTQC3a! was! about! 5! mg! fusion! protein! per! liter! of! LB!medium.! GSTQC3a! fusion! protein! was! digested! by! AcTEV! protease! to! produce!GST!and!C3a!proteins.!The!progress!of!the!digestion!was!evaluated!by!SDSQPAGE!
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(Fig.3.9.B),! totally! digested! protein! sample! was! then! subjected! to! cation!exchange!chromatography.! !!
3.2.3.3(C3a(tag(removal&!Removal! of! the! GST! tag! was! achieved! by! cation! exchange! chromatography!utilizing!a!1!ml!SP!sepharose!High!Performance!column!on!a!ÄKTA!purifier!(GE!Healthcare).! The! column!was! initially! equilibrated!with! 10! column! volumes! of!BufferQ3A,! then!2.5!ml!of! the!cleaved!protein!mixture!was!subsequently! loaded!on!the!column!with!a!flow!rate!of!0.5!ml/min.!The!loading!step!was!followed!by!a!10!columnQvolume!washing!step.!Next!the!bound!C3a!molecule!was!eluted!by!a!gradient!of!BufferQ3B.!Finally,!the!purity!of!the!purified!C3a!was!accessed!on!a!15%!TrisQGlycine! SDSQPAGE! gel,! the! purest! fractions!were!mixed! and! concentrated.!Fig.3.10.A!shows!that!the!majority!of!the!protein!(GST!tag)!was!not!retained!by!the!column.!Elution! fractions!1!and!2!were!analyzed!by!SDSQPAGE!(Fig.3.10.B).!Approximately!0.5mg!of!C3a!protein!was!produced!from!1!liter!of!LB!medium.!





3.2.4.1(Expression(of(C3d17A(!In!the!pET15bQC3d17A!expression!vector!(Section!2.1.1!and!Appendix!9.1.1.3),!the!NQterminal!6×Histidine! tag!was!deleted! for! the!expression!of! the!untagged!C3d!molecule.!The!E.coli&BL21!(DE3)!strain!was!used!for!protein!expression,!a!freshly!transformed! bacterial! colony! was! incubated! in! LB! medium! with! 100! μg/ml!ampicillin!and!grown!overnight!at!37.!15!ml!of!the!overnight!primary!culture!was!incubated!with!1!L!LBQ5052!medium.!Recombinant!protein!expression!was!induced!by!the!bacterial!consumption!of! lactose!for!20h!at!25.!The!cell!pellet!was!harvested!by!centrifugation!(8000!g,!20!min)!from!1!L!culture!medium!and!reQsuspended! in! 40!ml! of!MESQ1A!buffer! and! lysed! as! described! above! (2.3.3).!The! cell! lysate! was! centrifuged! at! 60,000! g! for! 30! min! at! 4.! The! bacterial!culture! after! induction,! the! supernatant! and! insoluble! protein! fractions! were!





Primary&purification&C3d17A! protein! was! purified! from! the! soluble! fraction! by! a! twoQstep! cation!exchange! chromatography! method! using! SP! Sepharose! column! on! a! ÄKTA!purifier! (GE! Healthcare).! After! the! lysate! was! clarified,! the! supernatant! was!equally!split!(roughly!20!ml!for!each!sample)!and!applied!on!a!SPQSepharose!Fast!Flow!5!ml!column!sequentially!with!a!flow!rate!of!1!ml/min.!Before!the!elution!step,!the!nonQspecifically!bound!proteins!were!removed!by!washing!the!column!with!10! column!volumes!of!MESQ1A!buffer.! The! elution!of! bound!proteins!was!achieved! by! washing! with! gradient! of! MESQ1B! buffer,! the! recombinant! C3d17A!protein!was!eluted!by!ion!strength!corresponded!to!an!electrical!conductivity!of!20!mS/cm.!After! the! first!purification!step,! the!peak! fractions!and!column! flow!through!were!examined!by!SDSQPAGE!gel!(Fig.3.11.B).!!!
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Secondary&purification&of&C3d&The! confirmed! C3d17A! peak! fractions! were! mixed! and! concentrated! using! a!Vivaspin!10!kDa!cutQoff!spin!concentrator!and!desalted!with!a!PDQ10!column!(GE!healthcare)!with!the!sample!eluted!in!MESQ2A!buffer!complemented!with!0.25%!of!NaCl.!The!secondary!purification!involved!a!1ml!SP!Sepharose!HP!column!on!a!ÄKTA! purifier.! After! loading! and! extensive!washing,! the! bound! C3d17A! protein!was!eluted!by!a!gradient!of!MESQ2B!buffer.!The!purity!of!the!purified!C3d17A!was!accessed! by! SDSQPAGE! gel,! and! the! purest! fractions! were! concentrated! and!buffer!exchanged!for!future!usage.!!!
Figure( 3.11:( Primary(
purification( of( C3d! (A)! Cation!exchange! chromatography!purification! of! C3d.! FlowQthrough!(FT)! fraction! and! 8! elution!fractions!(1Q8)!were!collected!and!analyzed! by! SDSQPAGE.! (B)!SDSQPAGE! analysis! of! C3d!expression! and! primary!purification.! Samples! analyzed:!whole! cell! lysate! (L),! soluble!fraction!(S),!cell!debris!(D),!elution!fractions! 1Q8,! and! purification!flowQthrough!(FT).!
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The! chromatogram! for! the! secondary! purification! is! shown! in! Fig.3.12.A.! The!bound!proteins!were!eluted!by!a!prolonged!gradient!of!MESQ2B!buffer!by!which!proteins!emerged!as!distinct!peaks.!The!C3d!peak!was!eluted!in!the!middle!of!the!BufferQ2B! gradient;! peak! fractions! were! collected! and! examined! by! SDSQPAGE!(Fig.3.12.B).!Utilizing!these!strategies!C3d!with!over!90%!purity!was!produced;!normally! 6! mg! of! recombinant! C3d! protein! was! purified! from! 1! L! of! the!LBQautoQinduction!medium.!!!!!!!!!!!!






(As!described!in!this!section!protocols!have!been!established!for!the!purification!of! FHRQ1! and! FH.! ImmuneQaffinity! purification! protocols! for! FH! have! been!described!elsewhere,! in!some!cases!monoclonal!antibodies!were!used! to! target!specifically!particular!diseaseQassociated! isoforms!of!FH! (Alsenz!et&al.! 1985).!A!relatively! decent! yield! of! FH! can!be!derived! from! serum,! as! the!normal! serum!concentration!of!FH!is!500!μg/ml.!However,!the!estimated!serum!concentration!of!FHRQ1! is!only!70!μg/ml,! this!poses!a!great!challenge! for! the!efficiency!of! the!current!purification!protocol.!The!protocols!described!in!this!study!deliberately!exploit!the!crossQreactivity!of!polyclonal!antiQFH!antibody!in!order!to!enrich!FH!and! FHRQ1! at! the! same! time.! Following! this! threeQstep! protocol! described! in!Section! 3.2.2,! FH! and! FHRQ1! were! successfully! separated,! 90%! purity! was!achieved! for! FH,! but! only! 60%!purity!was! achieved! for! FHRQ1.!Heterogeneous!natural! dimerization! states! are! the! major! handicap! to! further! increasing! the!purity! of! FHRQ1.!As! introduced! in! Section!1.4.3,! FHRQ1! forms!homodimers! and!heterodimers!with!itself!and!FHRQ2!and!FHRQ5!in!the!serum.!These!dimerization!states! of! FHRQ1! are! held! together! by! strong! hydrophobic!interactions(Goicoechea!de!Jorge!et&al.!2013).!Therefore!it!is!unlikely!that!these!FHRQ1!dimers!will!disassemble!and!only!FHRQ1!monomer!will!be!purified!under!conventional! chromatographical! conditions.! The! dimerization! states! of! FHRQ1!were!vividly!demonstrated!by!the!series!of!small!peaks!observed!during!heparin!chromatograph! polishing! step! (Fig.3.3.A! curly! bracket! 2),! according! to! the!previously! published! study(Goicoechea! de! Jorge! et& al.! 2013),! these! series! of!peaks!represent!different!dimerization!states!of!FHRQ1.!However,!as!indicated!by!the!280nm!absorbance!reading!(Fig.3.3.A),!the!protein!content!of!individual!peak!was!extremely!low,!therefore!all!these!peaks!are!mixed!and!concentrated!for!the!sake! of! FHRQ1! recovery! percentage.! As! shown! by! Fig.3.3.C! lane! 2,! despite! the!
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majority! of! this! sample!being!made!up!by!FHRQ1,! there! are! two!protein!bands!between!35!kDa!and!25!kDa!molecular!weight!markers!that!could!represent!two!differently! glycosylated! FHRQ2.! Despite! the! contamination! from! other! FHR!protein,! the! purified! FHRQ1! sample! is! free! from! FH! contamination! (Fig.3.3.D);!therefore!it!is!usable!in!the!in&vitro!assays.! !!!There!are!several!attempts!that!could!be!made!in!the!future!to!increase!the!yield!and! purity! of! the! serum! derived! FHRQ1.! Firstly,! during! the! capturing! step,! a!FHRQ1!monoclonal!antibody!coupled!column!could!be!used.!In!current!protocol,!although! FHRQ1! was! captured,! the! huge! concentration! excess! of! FH! often!saturates!all!the!antibody!bindingQsites,!therefore!the!initial!enrichment!of!FHRQ1!was!frequently!inefficient.!Secondly,!the!heparin!chromatograph!polishing!could!be!performed!again.!But!instead!of!mixing!all!the!peaks,!individual!peaks!should!be! analyzed! for! the! presence! of! FHRQ1! homoQdimer.! Based! on! an! efficiently!enriched! FHRQ1! sample,! a! sufficient! amount! of! pure! FHRQ1! sample! could! be!derived! from! an! individual! heparinQpolished! peak! (Goicoechea! de! Jorge! et& al.!2013).!
(
3.3.2(GSTEC3a(production(
(The!codon!optimized!C3a!gene!has!been!cloned!into!pGEXQhtb!expression!vector.!The!expression!of!GSTQC3a!fusion!protein!is!under!the!control!of!a!TrcQpromoter;!analyzing!the!purified!GSTQC3a!protein!fraction!by!SDSQPAGE!revealed!that!only!30%!of!the!recombinantly!expressed!protein!is!GSTQC3a!fusion!protein!whilst!70%!is! the!GST!protein! tag.!Given! that! the!DNA!sequencing!of! the!plasmid! revealed!the!gene!has!been!correctly!cloned!into!the!vector,!the!possibility!of!production!of! GST! due! to! cloning! problems! is! ruled! out.! Plasmid! contamination! may! be!another! explanation! for! the! coQexpression.! However,! the! 4! DNA! sequence!verified! clones! screened! for! GSTQC3a! expression! all! showed! similar!
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et&al.!2008),!when!it!was!demonstrated!that!Sbi!domain!IIIQIV!induces!fluid!phase!futile!consumption!of!C3.! In! the!same!paper,! it!was!also!demonstrated! that!Sbi!triggered! C3! consumption! is! compatible! with! the! addition! of! EGTA.! This!observation! indicated! that! the! nature! of! Sbi! triggered! C3! consumption! is! the!exploitation!of! complement!alternative!pathway.!Based!on! these!results,! it!was!proposed!that!SbiQIIIQIV!binds!to!the!intact!C3!in!serum,!this!binding!then!induces!C3!to!adopt!a!conformation!that!is!primed!for!factor!B!binding!through!which!the!regulation!of!complement!is!subverted.!This!controlled!depletion!of!C3!is!in!turn!advantageous!toward!the!survival!of!invading!pathogen.!!Later!the!same!year,!(Haupt!et&al.!2008)!reported!a!new!molecular!characteristic!of! SbiQIIIQIV,! that! it! can! bind! C3dQcontaining! C3! isoforms! in! combination! with!complement! regulatory! protein! factor! H! to! form! tripartite! complexes.! The!authors!suggest!that!in!combination!with!C3!activation!fragments,!Sbi!could!bind!to!factor!H!in!a!more!stable!form!as!tripartite!complexes,!thereby!increasing!the!amount! of! host! inhibitory! regulator! at! the! site! of! infection,! consequently!protecting! the! pathogen! from! complement! attack! and! improving! bacterial!survival!rate.!!In! the! context! of! these! two! previous! works,! the! first! aim! of! this! thesis! is! to!elucidate! the! detailed! molecular! mechanism! by! which! Sbi! triggers! C3!consumption.!In!this!study,!SbiQIIIQIV!was!subjected!to!a!systematic!mutagenesis!procedure!to!generate!mutant!proteins!with!defective!functionality.!By!designing!various!comparative!studies!utilizing!mutant!and!wild!type!proteins,!we!hope!a!credible!mechanism!of!Sbi!triggered!C3!consumption!can!be!proposed.!
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To! guide! the! design! of! experiments,! based! on! fundamental! understanding! of!alternative!pathway!activation!and!regulation,!three!hypotheses!were!proposed!to!explore!the!role!of!SbiQIIIQIV!in!the!activation!of!C3.!!!
Figure( 4.1.1:( Hypotheses( for( SbiEIIIEIV( triggered( C3( consumption.( The! diagram!confined! by( black( edges! summarizes! the! structural! conversion! of! C3! to! the! C3b!conformation.!C3!molecules!undergo!conformation!change!to!the!C3b!conformation!via!the!C3!convertase!cleavage!and!“tickQover”!mechanism.!The!stabilized!C3b!molecule! is!able! to! form! a! new! alternative! pathway! C3! convertase,! therefore! causes! positive!feedback!for!the!activation!of!C3!(blue!dashed!line),!leading!to!the!local!activation!of!C3!molecule.! However,! in! most! cases,! C3b! molecules! are! immediately! recognized! and!broken! down! by! complement! regulators,! by! which! the! activation! of! complement!alternative! pathway! is! constantly! under! strict! control.! In! the! presence! of! SbQIIIQIV!(diagram!confined!by!red(edges),!the!assembly!of!C3!convertase!and!depletion!of!local!C3!molecule! are! strongly!promoted.!This!phenomenon! leads!us! to! the! following! three!hypotheses:! (1)! SbiQIIIQIV! binding! to! C3! molecule! could! accelerate! the! structure!conversion!from!C3!to!C3b.!Increased!local!C3b!concentration!could!in!turn!overwhelm!the!complement!regulation.!(2)!SbiQIIIQIV!could!increase!the!halfQlife!of!C3b!molecule.!(3)!SbiQIIIQIV!is!known!to!form!a!covalent!adduct!with!the!C3b!molecule,!this!unique!species!of!C3b!may!be!more!resistant!toward!serum!C3b!degrading!enzymes.!!!!!
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4.1.1.(Hypotheses(for(Sbi(triggered(C3(activation( (The!current!model!of!AP!activation!describes!the!“tickQover”!of!C3!as!the!source!of!the!initial!C3bQlike!species.!Relying!on!the!intrinsic!structural!flexibility!of!C3,!the! “tickQover”! process! happens! constantly! in! serum,! providing! potential! new!platforms!for!the!assembly!of! initial!fluid!phase!AP!C3!convertase.!This!process!normally!occurs!at!a!very!low!rate!reaching!an!equilibrium!status!with!the!serum!complement! regulatory! activity.! Previous! binding! studies! suggested! that! apart!from! the! TED! domain! part! of! C3! molecule,! SbQIIIQIV! also! demonstrates! weak!interaction! with! the! C3a! fragment! (Burman! et& al.! 2008).! Other! than! the!most!wellQknown! function! as! an! anaphylatoxin,! C3a! also! functions! as! a! crucial!structural! component! within! the! C3! molecule.! The! cleavage! of! C3a! triggers! a!series! of! structural! rearrangements,! resulting! in! the! formation! of! C3b!conformation.! Therefore,! the! first! hypothesis! states! that! by! interacting! with!these!two!regions!of!the!C3!molecule,!SbiQIIIQIV!could!accelerate!C3!conversion!to!C3b! conformation! in! a! mechanism! that! based! on! protein! interactions.! The!resulting!increase!in!local!C3b!concentration!in!turn!overwhelms!the!regulation!of!AP!activation.! !!It! is! evident! that! modulation! of! the! nascent! C3b! stability! is! the! essence! of!multiple! complement! activation! regulatory! mechanisms.! AP! activation! is!inhibited! if! the!C3b!molecule! is! swiftly!degraded.!On! the! contrary,! a! longQlived!C3b! molecule! could! develop! into! nascent! AP! C3! convertase! leading! to!complement! AP! activation.! As! introduced! in! Section! 1.3,! the! stability! of! the!nascent! C3b! molecule! is! mainly! dependent! on! three! factors:! the! local!concentration!of!complement!regulators!(e.g.! factor!H,!factor!I),!the!presence!of!complement! positive! regulators! (e.g.! properdin),! and! the! biochemical!characteristics!of!the!surface!where!C3b!molecule!is!deposited.! !!Hypothesis!2!proposes!that!in!addition!to!binding!of!C3/C3b,!SbiQIIIQIV!binds!to!other!serum!proteins!simultaneously,! thereby!recruiting!complement!regulator!
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antagonists! and!AP!C3! convertase! stabilizers,! leading! to! consumption!of!C3.! In!addition,! under! the! same! consideration! of! C3b! stability,! an! alternative!hypothesis!(hypothesis!3)!was!also!investigated.!In!this!hypothesis,!we!proposed!that! the!covalent!adduct! formed!between!SbiQIIIQIV!and!C3b! is!essential! for! the!C3!consumption!process.!SbiQC3b!covalent!adducts!could!became!less!accessible!for! complement! regulator! binding.! Therefore,! the! SbiQC3b! adduct! helps! to!overcome!the!regulation!of!AP,!leading!to!the!consumption!of!C3.! !!
4.2(Materials(&(Methods(!
4.2.1(Expression(and(Purification(of(SbiEIIIEIV(!The!expression!vectors!of!pQE30SbiQIIIQIV!WT!or!mutant!were!transformed!into!the!
E.coli!strain!BL21!(DE3).!In!each!case,!a!single!colony!was!picked!and!grown!at!37°C!overnight! in!15!ml!of! LB!medium!containing!ampicillin! (100!μg/ml).!The!overnight! primary! culture! was! then! used! to! inoculate! 500! ml! of! LB! medium!containing! ampicillin.! Cells!were! grown! at! 37°C!with! shaking! at! 180! rpm.! The!expression! of! SbiQIIIQIV! protein! was! induced! during! the! exponential! phase! of!bacterial! growth! (OD600=0.7)! by! adding! isopropyl! thiogalactoside! (IPTG)! to! a!final! concentration! of! 0.5!mM! in! the! culture.! The!E.coli& cells!were! collected! by!centrifugation,!3!hours!postQinduction.!Cell!pellets!were! suspended! in!20!ml!of!HisA! buffer! (Table! 2.11)! supplemented! with! EDTA! free! protease! inhibitor!cocktail!mini!tablets!(Roche).!The!resuspended!cells!were!lysed!by!sonification.!The!resulting!lysate!was!clarified!by!centrifugation!(60,000!g,!30!min,!4°C).!!The! supernatant! was! collected! and! purified! through! metal! affinity!chromatography,! typically! 15!ml! of! supernatant! sample!was! loaded! on! a! 1!ml!HisTrap!column!(GE!healthcare)!using!an!ÄKTA!purifier.!The!loaded!column!was!washed!with!15!column!volumes!of!HisA!buffer!and!the!bound!SbiQIIIQIV!protein!was!eluted!with!a!0Q100%!gradient!of!HisB!(Table!2.11)!buffer!over!12!column!
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volumes.! Based! on! the! chromatogram,! the! SbiQIIIQIV! containing! fractions!were!collected!accordingly!and!evaluated!by!SDSQPAGE!analysis.!The!purest!fractions!were! then! selected,! pooled,! concentrated! and! finally! buffer! exchanged! using! a!PD10! column! into! phosphate! buffer! saline! (PBS)! buffer! according! to! the!manufacturer’s!instructions.!!For! assays! requiring! high! protein! purity,! Sbi! containing! fractions! from! the!primary!purification!were!collected,!concentrated!and!buffer!exchanged!back!to!HisA!buffer.!The!prepared!sample!was! loaded!on!a!1ml!Histrap!HP!column! for!secondary!purification.!The!bound!proteins!were!eluted!with!an!extended!HisB!gradient! (20! column!volumes).!Based!on! the! chromatogram! the!peak! fractions!were!collected!and!analyzed!by!SDSQPAGE.!The!purest!fractions!were!then!mixed,!concentrated! and! buffer! exchanged! into! PBS! buffer.! Protein! concentrations!(Section!2.3.6)!were!determined!using!a!NanoVue!(GE!life!Science).!!!
4.2.2.(Complement(activation(in(serum(
(One! vial! of! complement! active! lyophilized! human! serum! standard! (HSS)! was!dissolved! in! 100!μl! preQchilled! sterile!water! to! 2×HSS.! For! a! typical! Sbi! serum!incubation! experiment,! 10! μl! of! 2×HSS! was! mixed! with! equal! volume! of! Sbi!solution! in! a! PCR! tube.!After! thorough!mixing,! the!mixture!was! incubated! in! a!thermocycler!at!37°C!for!30min.!Treated!serum!samples!were!collected!regularly!(e.g.,! 5,! 10,! 15! and!30!min),! normally! 1! μl! of! treated! serum!was! retrieved! and!added! to! 20! μl! of! 1×SDS! loading! buffer.! To! collect! treated! serum! samples! for!ELISA!analysis!or!other!experiments,!at!least!2.5!μl!of!treated!serum!sample!was!retrieved!and! immediately! frozen!on!dry! ice,!unless! the!treated!serum!samples!were!subjected!to!downstream!measurement!immediately.!!Factor!B,!factor!D,!factor!H,!factor!I!and!factor!P!depleted!sera!were!also!used!to!
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perform! incubation! experiments! with! Sbi.! For! a! typical! Sbi! depleted! sera!incubation!experiment,!equal!volumes!of!depleted!serum!and!Sbi!solution!were!mixed!at!a!final!volume!of!at!least!10!μl,!1!μl!of!MgCl2QPBS!stock!solution!was!also!added! to! adjust! the! final! MgCl2! concentration! to! 0.5! mM.! Sample! collection!procedure!and!storage!methods!were!as!described!above.!!
4.2.3.(Complement(assay(
,In! this! study,! residual! serum! complement! activity! was! determined! using! a!Wieslab! complement! system! assay! kit! (Euro! Diagnostica)! that! measures! the!formation!of! terminal!pathway! component!C5bQ9!by!an!ELISA!approach.!Using!ELISA! strips! coated! separately! with! activators! for! the! classical,! MBL! and!alternative! pathways,! residual! complement! activities! are! determined!correspondingly.! Residual! complement! activity! of! Sbi! treated! serum! was!normally!determined!by!both!classical!and!alternative!pathway!assays.! !!Briefly,!to!determine!residual!classical!pathway!activity,!Sbi!was!incubated!with!2×! HSS! as! described! in! section! 4.2.2.! Typically,! 2.5! μl! of! treated! serum! was!immediately! added! to! 250! μl! of! classical! pathway! diluent.! After! all! serum!samples!had!been!prepared,!100!μl!of!diluted!serum!was! transferred! into!each!well.!Each!sample!was!measured!in!duplicate!together!with!positive!and!negative!controls!and!buffer!blank!samples.!The!loaded!plate!was!incubated!at!37°C!for!1!hour.! After! incubation,! the! plate! was! washed! 3! times! with! 300! μl! of! washing!solution;!100!μl!of!antibody!alkaline!phosphatase!conjugate!was!added.!After!30!min! of! incubation! at! room! temperature,! and! a! further!washing! step,! 100! μl! of!nQnitrophenyl! phosphate! substrate! solution! was! added.! After! 30! min,! the!absorbance!of! the!wells!was! read!using!a!plate! reader!at!Abs405nm.!Absorbance!values!were! converted! to! percentage! of! residual! complement! pathway! activity!following!manufacturer’s!instructions.!!
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!A!similar!protocol!was!used!to!determine!alternative!pathway!residual!activity,!with!minor! changes.! Essentially,! to!prepare! the!ELISA! sample,! 15!μl! of! treated!serum!sample!was!retrieved!and!mixed!with!240!μl!alternative!pathway!diluent.!100!μl!of!diluted!sample!was!then!transferred!to!LPS!coated!wells.!!!!
4.2.4.,SbiEIIIEIV(mutagenesis, ,
,Systematic! mutagenesis! studies! were! carried! out! on! SbiQIIIQIV.! Based! on! a!previously!cloned!pQE30SbiQIIIQIV!construct,!the!mutagenesis!protocol!described!in!2.2.2! was! used! to! generate! SbiQIIIQIV! single! mutants.! Customized! primers! !(Table! 4.2.1! &! 4.2.2)! were! obtained! from! Invitrogen! (Life! Technologies).!pQE30SbiQIIIQIV! plasmid,! the! template! DNA,!was! purified! from! a! 10!ml! overnight!





























4.2.5(SbiEIIIEIV(mutant(serum(activation(assay(SbiQIIIQIV!treatment!of!HSS!was!performed!as!described!in!section!4.2.2.!For!each!Sbi!mutant,! treated!serum!samples!at!5,!10,!15!and!30!min!were!collected.!The!resulting! SbiQC3b! adduct! formation! and! C3! activation! were! detected! by! both!polyclonal!antiQSbi!and!antiQC3d!Western!blots!(Section!2.3.8).!!
4.2.6,In,vitro(SbiEC3H2O(adduct(formation( (1.5!mg/ml!of!purified!C3!molecule!(3.3.1)!was!incubated!with!10!μM!of!SbiQIIIQIV!WT!or!K173A!respectively.!The!incubation!mix!was!collected!at!2!hour!intervals!for!16!hours.!SDSQPAGE!and!antiQSbi!Western!blot!analyses!were!performed! to!detect!the!formation!of!SbiQC3(H2O)!adduct.!!









(A! SwitchSENSE! DRX! 2400! instrument! (Dynamic! Biosensors)! was! used! to!characterize! the! binding! kinetics! and! protein! size! changes! based! on!SwitchSENSE!technology!(Langer!et&al.&2013;!Knezevic!et&al.!2012).! !
Figure(4.2.1:(Principle(of(SwitchSENSE( technology!(A)! Immobilization!of!protein!and!the!electrically! switchable!nanolevers( (B)! Increasing! in!protein! size! reduces!dynamic! response!
(C)! Dynamic! response! changes! during! increasing! hydrodynamic! diameter! (D)! Dynamic!response! changes! over! a! protein! binding! event.! Figures! adapted! from! Dynamic! Biosensor!website!www.dynamicQbiosensors.com.!
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was!added!to!reduce!the!cysteine!residue!at!the!CQterminus!of!the!protein.!After!1! hour! incubation! at! room! temperature,! the! protein! sample! was! buffer!exchanged!to!the!appropriate!labeling!buffer!and!the!labeling!reagent!was!added!immediately.! Protein! samples! were! labeled! with! two! types! of! biotin! label! to!satisfy!the!requirements!of!different!experiments.! !! !
! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! Figure!4.2.2:!EZQlink!HPDP!biotin!EZQlink! NQ[6-(Biotinamido) hexyl]-3’-(2’-pyridyldithio)Propionamide (HPDP)!biotin! label! (Thermo!Scientific)!was!used! to! label!proteins! that! required!biotin!tag! removal! afterward.! After! protein! samples! were! reduced,! they! were! buffer!exchanged!into!reaction!buffer!(PBS!containing!2!mM!EDTA).!4!mM!HPDPQbiotin!stock! dissolved! with! dimethylformamide! was! added! to! the! buffer! exchanged!protein! sample! to! a! final! concentration! of! 0.4!mM.! The! labeling! reaction! took!place!at!room!temperature!for!2!hours.!Afterwards,!the!labeled!protein!samples!were! concentrated! and! buffer! exchanged! back! to! PBS! buffer,! stored! at! Q80°C!pending!usage.!
! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! Figure!4.2.3:!IodoacetylQPEG2Qbiotin 
NonQcleavable! and! reduction! resistance! iodoacetylQPEG2Qbiotin! tag! (Thermo!Scientific)!was!also!utilized!to! label!protein!samples.!After!reduction!of!protein!samples,!they!were!buffer!exchanged!into!reaction!buffer!(50!mM!TrisQHCl,!5!mM!
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EDTA! pH! 8.0).! 4! mM! iodoQPEG2Qbiotin! stock! dissolved! in! reaction! buffer! was!added!to!a!final!concentration!of!200!μM.!The!labeling!reaction!was!kept!in!the!dark! for! 90!min! at! room! temperature,! then! the! labeled! protein! samples!were!concentrated!and!buffer!exchanged!to!PBS!buffer,!stored!at!Q80°C!pending!usage.!
!
4.2.11.,PullEdown(experiment(
(HPDP!biotin!labeled!SbiQIIIQIV!WT!and!mutants!(K173A,!S199A!and!R231A)!were!immobilized!on!100!μl!of!neutravidin!agarose!beads.!The!loaded!beads!were!then!washed!extensively!with!PBS!buffer!by!which!excess!nonQimmobilized!proteins!were!removed.!After!washing!with!PBS,!2!ml!of!human!serum!(TCS!bioscience)!supplemented! with! 20! mM! EDTA! was! incubated! with! Sbi! loaded! neutravidin!agarose!beads!for!30!min!with!rotation.!The!incubated!agarose!beads!were!then!recovered!by!centrifugation!(1000!g)!and!washed!extensively!with!PBS!with!0.1%!tween20! (PBST)! buffer! to! reduce! nonQspecific! binding.! The! binding! of! serum!proteins!to!bait!proteins!SbiQIIIQIV!WT,!K173A,!S199A!and!R231A!was!analyzed!using! SDSQPAGE! and! stained! with! Coomassie! blue! RQ250,! utilizing! uncharged!neutravidin!agarose!beads!as!negative!control.! !
(
4.2.12.,InEgel(Trypsin(digestion(
(For! protein! identification,! protein! bands! of! interest! were! excised! from! the!SDSQPAGE! gel.! An! inQgel! tryptic! digestion! kit! (Thermo! Scientific)! was! used! to!prepare! trypsinized! protein! fragments! according! to! the! manufacturer’s!instruction.! Briefly,! the! excised! gel! slices! (2×2!mm)! were! repetitively! washed!with! deQstain! buffer! (25! mM! NH4HCO3,! 50%! acetonitrile)! until! the! gel! slices!became! transparent.!Gel! slices!were! then! reduced!by! adding!30!μl! of! reducing!buffer! (50! mM! TCEP! in! deQstain! buffer),! after! which! an! alkylation! step! was!performed!by!adding!30!μl!of!alkylation!buffer!(100!mM!Iodoacetamide!and!25!
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mM!NH4HCO3)!and!incubated!for!1!hour!in!the!dark.!After!reQequilibration!with!deQstain!buffer,!100%!acetonitrile!(50!μl)!was!added!to!shrink!the!gel!slice,!until!the!gel!slice!became!white!in!color!and!decreased!in!size.!The!excess!acetonitrile!was! then! removed! and! allowed! to! thoroughly! evaporate! (15! min,! room!temperature).! Finally,! 35! μl! of! 100! ng! of! trypsin! in! digestion! buffer! (25! mM!NH4HCO3)!was!used!to!swell! the!airQdried!gel!slice.!The!digestion!reaction!took!place! at! 30°C! overnight! with! shaking;! afterward! the! digestion! mixture! was!removed!and!placed!in!a!clean!tube!ready!for!mass!spectrometry!analysis.! !!
4.2.13,Mass(spectrometry(protein(identification(
(After! inQgel! protein! digestion,! the! resulting! peptide! samples! were! sent! to!Chemical!Characterization!and!Analysis!facility!(CCAF,!University!of!Bath)!where!Electrospray! ionization! (ESI)Qquadrupole! (Q)QTime! of! Flight! (TOF)! mass!spectrometry! (MS)! analysis! was! performed.! Briefly,! between! 0.1Q0.5! μl! of!peptide! sample!was! spotted! on! C8! or! C18! column! integrated!HPLCQChip,! after!separation! (Buffer! A:! 0.1%! Formic! acid;! Buffer! B:! 0.1%! Formic! acid! and! 90%!Acetonitrile;! Flow! rate:! 0.6! μl/min)! the! resulting! peptides! were! ionized! by!HPLCQChip! Cube! MS! interface! (Agilent),! and! subsequently! analyzed! by! 6520!series! AccurateQMass! Quadrupole! Time! of! Flight! mass! spectrometer! (Agilent).!Utilizing! the! peptide! fragment! pattern! generated,! SwissProt! searches! were!carried!out!using!Mascot!program!to!discover!the!identity!of!the!protein.!!
4.2.14.,BLItz(ternary(complex(reconstruction(
(
In&vitro!reconstruction!of!Sbi:C3d:FH!and!Sbi:C3d:FHRQ1!ternary!complexes!were!performed!using!bioQlayer!interferometry!on!a!BLItz!system!(Fortebio)!following!manufacturer’s!instruction.!Briefly,!a!NiQNTA!coated!biosensor!tip!was!hydrated!for!30!min! in!assay!buffer! (PBS).!HisQtag!protein!(SbiQIIIQIV)!was! loaded!on! the!biosensor!tip!for!120!sec!with!orbital!shacking!at!2200!rpm.!The!loaded!sensor!
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!SbiQIIIQIV!mediates!binding!of!factor!H!or!FHRQ1!in!combination!with!C3!isoforms!(C3,!C3b!and!C3d),!resulting!in!the!formation!of!the!ternary!complexes.!An!ELISA!based! binding! assay! was! designed! to! measure! SbiQIIIQIV! mediated! tripartite!complex!formation.!Typically!1!μg/well!of!SbiQIIIQIV!WT!or!mutants!were!coated!on!a!Nunc!MaxiSorp! flatQbottom!96!well!polystryrene!plate! in!a!predetermined!pattern! using! sodium! carbonate! buffer! pH! 9.5.! Coating! of! the! plate! took! place!overnight! at! 4°C.! Once! the! coating! buffer! was! removed! the! plate! was! then!blocked!with! 300!μl/well! of! PBST! supplemented!with! 5%! skimmed!milk! for! 1!hour!and!washed!once!with!300!μl/well!of!PBST.!The!complex!components!were!then! added! to! the!well! in! PBSTQ1.25%!milk! and! left! for! 1! hour.! The!plate!was!then! thoroughly! washed! with! PBST! (4! times! with! 5! min! intervals)! before!
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applying!polyclonal!goat!antiQFH!antibody!(recognizing!both!human!factor!H!and!FHRQ1)! diluted! in! PBSTQ1.25%! milk! (1:4000! dilution)! for! 1! hour! at! room!temperature.!Again!the!plate!was!thoroughly!washed!before!the!addition!of!the!secondary! antiQgoat! IgG! antiserum! (1:18,000! dilution)! for! 1! hour! at! room!temperature.! After! the! final! wash! cycle,! 100! μl/well! of! the! 1Qstep! Ultra! TMB!ELISA! substrate! solution!was! added.! 20!min! later! the! absorbance! of! the!wells!was!read!using!a!plate!reader!at!Abs650nm.!!
4.2.16.,FH/FHRE1(Competition(assay(
(Based!on!the!existing!ELISA!assay!for!tripartite!complex!formation,!considerable!modifications!were!made,!by!which!the!competitive!relationship!between!FH!and!FHRQ1! for!binding!of!C3! isoforms!was!elucidated.!Firstly!1!μg/well!of!SbiQIIIQIV!WT!were! coated! on! a! Nunc! MaxiSorp! plate! in! a! predetermined! pattern! using!sodium! carbonate! buffer! pH! 9.5.! After! coating! at! 4°C! overnight,! the! plate!was!emptied.!Then,!PBS!supplemented!with!2%!BSA!was!added!(300!μl/well)!to!each!wells!to!block!the!uncoated!surface!for!1!hour!at!37°C!and!then!washed!with!PBS!buffer.!The!complex!components! (FH,!FHRQ1!and!C3! isoforms;! in!PBSQ2%!BSA)!were!then!added!in!such!a!way!that!a!decreasing!FHRQ1:FH!molar!ratio!(from!4!to!0)!was! created!within! each! column!of! the!ELISA!plate.!At! the! same! time!C3!isoforms’! concentration! remained! the! same! as! an! invariable.! After! 1! hour!incubation! at! room! temperature,! the! plate! was! thoroughly! washed! with! PBS!before!monoclonal!antiQFH!antibody!OXQ24!(biotinylated,!ThermoPierce)!diluted!with!PBSQ2%!BSA!(1!in!2000)!was!added!for!1!hour.!OXQ24!binds!to!a!FH!specific!epitope! on! SCR! domain! 5.! Following! a! thorough! wash! of! the! plate,!StreptavidinQHRP! conjugate! solution! (1! in! 5000!dilution!with! PBSQ2%!BSA,! GE!Healthcare)!was!utilized!to!bind!the!biotinylated!primary!antibody!for!1!hour!at!room! temperature.! Finally! after! final! washing! steps,! 1Qstep! Ultra! TMB! ELISA!substrate!solution!was!added,!20!min!later!the!absorbance!of!the!wells!was!read!using!a!plate!reader!at!Abs650nm.!
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4.2.17.,C3H2O,preparation,C3! with! hydrolyzed! thioester! was! prepared! by! supplementing! purified! C3!solution!(2!mg/ml,!PBS)!with!50!mM!methylamine.!The!hydrolysis!reaction!was!kept!in!a!37°C!water!bath!for!2!hours.!!
4.2.18.,C3H2O(cleavage(assay(C3H2O!(400!μg/ml)!was!incubated!with!factor!H!(160!μg/ml),!rFHRQ1!(50!μg/ml)!and! factor! I! (4! μg/ml).! Incubation! reactions! were! divided! into! two! groups!according!to!whether!SbiQIIIQIV!WT!(80!μg/ml)!or!K173A!(80!μg/ml)!was!added,!the!final!reaction!volume!was!adjusted!to!12!μl.!Cleavage!reactions!were!kept!at!37°C! using! a! thermocycler,! samples! (2! μl)!were! retrieved! regularly! and!mixed!with!reducing!SDS!sample!buffer,!boiled!at!96°C! for!10!min,! then!separated!by!SDSQPAGE!electrophoresis.! !
(
4.2.19.,Double(depletion(serum(validation(
(Firstly,! EDTAQserum! pullQdown! experiment! was! performed! using! factor! H!depleted!serum!(1!ml)!with!neutravidin!resin!immobilized!SbiQIIIQIVWT,!based!on!Section!4.2.15.!Secondly,!serum!albumin!and!IgG!were!depleted!from!the!factor!H!depleted! serum! (10! μl)! using! Pierce! Top2! abundant! protein! depletion! spin!column! (Thermo!Scientific),! and!concentrated! to!20!μl!by!Vivaspin!500! (3!kDa!cutQoff)! centrifugal! concentrator.! 5! μl! of! the! sample! was! then! separated! by!SDSQPAGE.!Both!pullQdown!sample!and!triple!depleted!serum!were!analyzed!by!antiQFh/FHRQ1!Western!blot.!
(
4.2.20.(Double(depleted(serum(recovery(experiment(
(PBS! buffer,! SbiQIIIQIV! WT! or! K173A! mutants! were! incubated! with! double!depleted!serum!supplemented!with!rFHRQ1!or!factor!H!or!both.!In!each!reaction,!the! final! concentration!of! the!double!depleted!serum!was!diluted! to!40%,!with!
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other! assay! components.! All! protein! components! of! this! assay! were! buffer!exchanged! to! PBS! buffer! to! avoid! fluctuation! of! salt! concentration.! To!reconstitute! the!double!depleted!serum,!2!μl!of! factor!H!(1!mg/ml)!and!1!μl!of!rFHRQ1!(0.25!mg/ml)!were!added!to!4!μl!of!serum.!When!added!together!a!1:1!molar!ratio!of!factor!H!and!rFHRQ1!was!achieved.!After!incubation!at!37°C!for!1!hour!in!the!thermocycler,!C3!consumption!was!evaluated!by!antiQC3a!and!antiQC3!Western!blot!(Section!2.3.8).!Reaction!compositions!are!shown!in!Table!4.2.5.! !
(
Table(4.2.5:!Recipes!of!double!depleted!serum!recovery!experiments!
Group! Double!depleted!sera! SbiQIIIQIV!WT! SbiQIIIQIV!K173A! Factor!H!(1mg/ml)! rFHRQ1!(0.25mg/ml)! 5mM!MgCl2! PBS!Serum!only! 4! Q! Q! Q! Q! 1! 5!4! 1! Q! Q! Q! 1! 4!4! Q! 1! Q! Q! 1! 4!
FHRQ1! ! 4! Q! Q! Q! 1! 1! 4!4! 1! Q! Q! 1! 1! 3!4! Q! 1! Q! 1! 1! 3!











(Sbi! NQterminal! domain! IIIQIV! inhibits! all! complement! pathways! by! mediating!futile! consumption! of! C3.! Previous! studies! indicated! that! the! consumption!process! involves! manipulation! of! the! alternative! pathway! to! achieve! local!depletion! of! C3! molecules.! However,! the! molecular! details! remain! elusive!(Burman!et&al.!2008).!In!this!section,!the!biochemical!changes!during!Sbi!induced!consumption!of!C3!were!characterized.! !






purification.! (A)( Chromatogram! of! primary! purification,! volume! (ml)! and! fractions! are!shown!on!XQaxis.!(B)!Coomassie!stained!gel!of!SbiQIIIQIV!primary!purification,!Lane!1!soluble!fraction! before! purification,! 2! purification! flowQthrough,! 3B5! purified! fractions.! SbiQIIIQIV!(black!arrow),!with!an!expected! size!of!14.9!kDa!is! located!between!18.4!kDa!and!14.4!kDa!molecular!weight!markers.! Lane!3!and!4!demonstrate! that! two! thirds!of! the!purified! Sbi! is!slightly! contaminated.( (C)! Chromatogram! of! secondary! purification.! (D)! The! purity! of!SbiQIIIQIV!containing!fractions!are!verified!by!SDSQPAGE!and!Coomassies!blue!staining.!Lanes!1Q7! represent! the! corresponding! fractions! on! the! chromatogram! indicated! by! blue! arrows.!Fractions!4Q7!show!the!minimum!level!of!contamination!and!were!mixed!for!future!usage.!!
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4.3.2(Sbi(induces(futile(consumption(of(C3(!To!investigate!the!molecular!detail!of!the!complement!consumption!induced!by!Sbi,!SbiQIIIQIV!treated!human!serum!standard!(HSS)!samples!(Section!4.2.2)!were!analyzed!by!immunoQblotting!with!various!polyclonal!antibodies!to!monitor!the!deposition!of!activated!C3,!formation!of!SbiQC3b!adducts,!cleavage!of!factor!B!and!release! of! C3a.! Proteolytic! activation! of! C3! releases! anaphylatoxin! C3a! and!produces! metastable! C3b! molecules! that! subsequently! become! covalently!deposited!on!surrounding!protein!targets!among!which!SbiQIIIQIV!itself!has!been!shown!as!a!primary!transacylation!target!(Burman!et&al.!2008).!To!assemble!the!AP!C3! convertase,! the!C3H2O!bound! factor!B!molecule! is! cleaved!by! factor!D! to!larger! enzymatic! fragment! Bb! and! smaller! fragment! Ba.! The! cleavage! process!occurs! simultaneously! with! the! activation! of! AP,! therefore! it! makes! an! ideal!marker! for! AP! activation! detection.! HSS! incubation! with! SbiQIIIQIV! (10! μM)! at!37°C!for!30!min!demonstrated!that!5!min!laggingQtime!was!required!before!the!initiation! of! C3! activation.! Once! activated,! the! C3b! molecules! deposit! on!surrounding!serum!proteins,!causing!the!formation!of!high!molecular!weight!C3b!covalent!adduct!species!(Fig.4.3.2.A).!The!activation!of!C3!was!also!captured!by!polyclonal!antiQC3a!immunoQblotting.!As!shown!in!Fig.4.3.2.D,!over!time!the!C3a!epitope!disappears! from! the! intact!C3!αQchain! (120!kDa)! and! reappears! in! the!form!of! free! C3a!molecules! (9! kDa).! Synchronized! factor!B! activation!was! also!detected,! which! suggests! that! AP! C3! convertase! is! involved! in! the! C3!consumption! process! (Fig.4.3.2.C).! Finally,! the! polyclonal! antiQSbi! Western!blotting!demonstrated!that!a!small!fraction!of!free!SbiQIIIQIV!molecule!increases!in! their! molecular! weight! significantly! during! the! C3! activation! process,! by!forming!covalent!adducts!with!C3d!containing!C3! isoforms!(e.g.!C3b!and! iC3b).!The! C3b! component! within! the! SbiQC3b! adduct! (approximately! 140! kDa)! is!subject! to! proteolytic! cleavage! by! serum! proteases,! thereby! gradually! being!converted!to!a!smaller!SbiQiC3b!adduct!(120!kDa).!(Fig.4.3.2.B)!
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Figure( 4.3.2:! SbiEIIIEIV( induces( C3( futile( consumption.! Immunoblots! of! Sbi! treated! serum!detected! by! polyclonal! antiQC3d! (A),! antiQSbi! (B),! antiQFactor! B! (C)! and! antiQC3a! (D).! (A)! C3!activation! and! deposition! in! serum! after! incubation! with! 10! μM! SbiQIIIQIV! for! 30! min.! (B)!Detection! of! SbiQC3b! adduct! formation! and! free! SbiQIIIQIV! used! in! the! incubation! reaction.! (C)(Detection!of! factor!B!cleavage!products! in!serum.( (D)!Synchronized!disappearance!of! intact!C3!αQchain!and!the!release!of!anaphylatoxin!C3a!during!SbiQIIIQIV!mediated!C3!futile!consumption.!!
4.3.3(Sbi(triggers(C3(consumption(via(alternative(pathway(!The!activation!of!different!complement!activation!pathways!has!been!shown!to!be! highly! dependent! on! divalent! ions.! Classical! and! lectin! pathway! activations!are! mediated! by! calcium! ions,! and! magnesium! ions! play! essential! roles! in!alternative! pathway! activation.! Using! this! property,! ion! chelation! by! EDTA! is!used!to!inhibit!all!complement!pathways;!on!the!contrary!the!classical!and!lectin!pathways! can! be! selectively! inhibited! by! adding! preferential! calcium! ion!ionQchelating! reagent,!EGTA.!Previous! studies! indicated! that! in! the!presence!of!
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EDTA,!Sbi! triggered!C3!consumption!was! inhibited.!However,!with!the!addition!of!EGTAQMg2+,!SbiQIIIQIV!was!still!able! to! trigger!C3!consumption.!These!results!implied! that! the! Sbi! triggered! C3! consumption! process! is! in! essence! the!activation!of!the!complement!system,!perhaps!by!hijacking!solely!the!alternative!pathway.! To! verify! this! hypothesis,! human! sera! with! depleted! alternative!pathway!components!(e.g.!factor!I,!factor!H,!factor!P,!factor!D!and!factor!B)!were!incubated!with!SbiQIIIQIV.!C3!consumption!and!SbiQC3b!adduct! formations!were!then! analyzed! by! Western! blots! (Fig.4.3.3.A! &! B).! Given! that! only! serum!components! required! for! the! alternative! pathway!were! depleted,! the! depleted!sera!should!still!demonstrate!normal!CP!activity;!therefore!the!CP!activity!of!all!depleted!sera!were!determined!(Fig.4.3.3.C)!and!compared!with!HSS.! !
Figure( 4.3.3:! Alternative( pathway( components( are( essential( for( the( Sbi( triggered( C3(
consumption.! (A)! AntiQC3d! Western! blot! detects! Sbi! triggered! C3! activation! in! human! sera!depleted!of!complement! factor! I,! factor!H,! factor!P,! factor!B!and! factor!D.!(B)!AntiQSbi!Western!blot! detects! the! formation! of! SbiQC3b! covalent! adduct.! (C)! Measurement! of! classical! pathway!complement! activity! using! HSS! and! depleted! sera.! FI! for! factor! I,! FH! for! Factor! H,! FP! for!properdin,!FB!for!factor!B!and!FD!for!factor!D.(
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With! the! complement! regulators! factor! I! and! H! depleted,! incubation! of! the!depleted! sera! with! SbiQIIIQIV! results! in! the! spontaneous! activation! of! C3.!Fig.4.3.3.A! shows! that! C3! consumption! in! factor! H! depleted! serum! shares! a!similar!Western!blot!profile!with!consumption!of!C3!in!normal!serum.!As!shown!in!Fig.4.3.2.A,!missing!of!C3!αQ120!kDa!chain,!C3b!deposition!and!the!appearance!of!iC3b!α’Q68!chain!all!signify!the!consumption!of!C3.!However,!when!using!factor!I! depleted! serum,! due! to! the! absence! of! protease! factor! I,! C3b! molecules!accumulate!in!the!solution!and!presence!as!the!C3b!α’Q110!chain!in!the!Western!blot! (Fig.4.3.3.A).! The! deposited! C3b! molecules! are! also! free! from! proteolytic!cleavage!and!therefore!appear!as!the!very!high!molecular!weight!covalent!adduct!species.! With! the! absence! of! essential! alternative! pathway! components! (e.g.!properdin,!factor!B!and!factor!D),!SbiQIIIQIV!is!unable!to!trigger!C3!consumption.!After!prolonged!incubation,!the!majority!of!the!C3!remains!as!the!unreacted!form!of!120!kDa!C3!αQchain.!Although!factor!H!is!regarded!as!the!cofactor!for!factor!I!mediated! C3b! cleavage,! our! results! show! that! in! the! absence! of! factor! H,! C3b!molecules!in!the!serum!are!also!subjected!to!proteolytic!processing,!which!could!be!a!result!of!the!presence!of!other!factor!I!cofactors!(e.g.!C4BP!and!sCR1)!in!the!serum.!!The! same! C3! consumption! pattern! was! reproduced! when! the! samples! were!analyzed! by! antiQSbi! polyclonal! antisera.! Sbi! adduct! formations!were! observed!only! after! incubation! with! factor! H! and! I! depleted! sera! (Fig! 4.3.3.B).! Without!factor!I!cleavage,!intact!SbiQC3b!adduct!was!observed!(approximately!140!kDa).!However,! in! factor! H! depleted! serum,! the!majority! of! the! SbiQC3b! adduct! was!converted! to! the! SbiQiC3b! adduct! (120! kDa).! Finally,! all! depleted! sera! possess!roughly! 70%! classical! pathway! activity! comparing! with! positive! control! HSS!(Fig.4.3.3.C).!The!discrepancies!could!be!the!results!of!differences! in!C3!and!C5!concentration,!since!sera!were!acquired!from!different!sources.!Nevertheless,!the!results!show!all!depleted!sera!demonstrate!normal!C3!activity.!!
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4.3.4(Sbi(triggered(C3(consumption(can(also(be(captured(by(CP(ELISA(assay(
(As!Sbi! is!an!activator!of!AP,!an!AP! inhibition!experiment!might!not!be!an! ideal!way!to!characterize!the!speed!of!the!C3!futile!consumption!process.!Here,!the!Sbi!mediated!inhibition!of!AP!and!CP!were!compared.! !
Figure( 4.3.4:!PreEincubation( dependent( SbiEIIIEIV( inhibitions( of( classical( and( alternative(
pathway( activities.! (A)! Schematic! diagram! of! the! experiment! design,! HSS! was! first!preQincubated!with!SbiQIIIQIV!at!37°C!for!different!length!of!time!(0,!15!and!30!min).!Two!sets!of!treated!sample!were!collected;!their!residual!classical!or!alternative!pathway!activities!were!then!measured.!(B)!Residual!classical!and( (C)!alternative!pathway!complement!activities!of!SbiQIIIQIV!treated! sera! samples.!Percentage! activity!was! calculated!using! absorbance! readings! at!405!nm!with!the!equation!activity&=[(sampleBnegative&control)/positive&control&(PC)]×100.!Each!condition!was! assayed! in! duplicate! and! the! error! bars! represent! the! upper! and! lower! result.! PC! is! a!abbreviation!of!positive!control.!!As! shown! in! Fig.4.3.2.A,! after! the! initial! lag! time,! the! C3! consumption! process!occurs! at! a! steady! pace.! To! quantify! the! speed! of! C3! consumption,! HSS! was!incubated!with!SbiQIIIQIV!(Fig.4.3.4.A),!samples!were!taken!at!various!time!points!and!the!residual!AP!and!CP!activities!were!determined!separately!(Section!4.2.3).!Fig.4.3.4.B! shows! that!without!preQincubation,! the!presence!of!10!μM!SbiQIIIQIV!inhibits!CP!activity! to!60%.!After!15!min!of! incubation! the! residual!CP!activity!
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was! reduced! to! 40%! and! finally! after! another! 15! min! incubation! only! 12%!residual! CP! activity! was! detected.! In! contrast! to! the! time! dependent! steadily!decline! in! CP! activities,! the! inhibition! of! AP! activity! (Fig.4.3.4.C)! hardly! shows!any!correlation!with! incubation!duration.!At!0min,! the!residual!AP!activity!was!reduced!to!10%,!after!15min!incubation!the!AP!activity!was!reduced!to!minimum.!The! reason! for! the!preQincubation! independent! inhibition!of!AP!activity! is! that!after! the! samples!were! collected,! they!were! incubated! for! an! extra! hour! in!AP!diluent! on! the! ELISA! plate,! during! which! SbiQIIIQIV! could! still! trigger! the!consumption! of! C3.! Therefore,! determination! of! residual! CP! activity! offers! a!more!subjective!measurement!of!C3!consumption!process.!!The!results!of!the!CP!inhibition!experiment!suggest!that!the!complete!inhibition!of! CP! activity! by! SbiQIIIQIV! is! the! result! of! two! separate! mechanisms.! One!inhibition! mechanism! is! independent! from! incubation,! likely! to! be! a! result! of!proteinQprotein! interactions.! The! secondary! mechanism! is! dependent! on! the!length! of! incubation,! which! agrees! with! the! gradual! C3! consumption!Western!blotting!profile!shown!in!Fig.4.3.2.A.!Thus,!binding!of!SbiQIIIQIV!to!CP!component!and! futile! C3! consumption! together! contribute! to! the! effective! inhibition!of! CP!activity.!
4.3.5(SbiEIIIEIV(interferes(with(AP(driven(C5bE9(formation(!The!results!presented!here!expose!another!molecular!feature!of!the!Sbi!mediated!C3! futile! consumption! process.! To!measure! AP! activity,! a!Wieslab! ELISA! plate!was! coated! with! AP! activator! lipopolysaccharide! (LPS)! that! triggers! the!activation!of!C3,!leading!to!the!formation!of!quantifiable!C5bQ9!membrane!attack!complex.! However,! when! SbiQIIIQIV! was! added,! severe! inhibition! of! C5bQ9!formation!was!observed!which!contradicts!with!the!C3!activating!function!of!Sbi.!(Fig.4.3.4.C,0min).! In! contrast! to! the! effective! inhibition!of!AP!C5bQ9! formation!(Fig.4.3.4.C,0min),! SbiQIIIQIV! is! less! potent! in! the! inhibition! of! C5bQ9! formation!from!CP.!(Fig.4.3.4.B,0min)! !
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In! conclusion,! SbiQIIIQIV! mediates! C3! futile! consumption! exclusively! via! the!alternative!pathway,!and!the!C3!futile!consumption!differs!from!AP!activation!as!the!terminal!pathway!is!strongly!inhibited.!!
4.3.6(SbiEIIIEIV(mutagenesis(studies(!
4.3.6.1(Creation(of(SbiEIIIEIV(mutants(It!was!demonstrated!previously! that! the!Sbi!NQterminal!domains! III! and! IV!are!the!minimal!domain!requirement!for!Sbi!induced!C3!consumption!(Burman!et&al.!2008).!Whilst!Sbi!domain! IV!was!characterized!as!a! threeQhelix!bundle!C3/C3d!binding! domain! (Upadhyay! et& al.! 2008;! Clark! et& al.! 2011),! very! little! is! known!about! the! structural! and! functional! aspects! of! Sbi! domain! III.! Given! that! Sbi!domain! III! was! reported! as! intrinsically! unfolded! (Upadhyay! et& al.! 2008)! we!adopted!a!systematic!mutagenesis!approach!aiming!to!elucidate!the!function!of!Sbi! domain! III! by! biochemical! assays.! At! the! same! time,! based! on! information!from!a!previous!publication!(Clark!et&al.!2011),!selected!residues!on!Sbi!domain!IV!were!also!mutated.!The!impacts!on!activity!of!SbiQIIIQIV!were!then!evaluated!by!C3!activation!assay.! !!Aiming! to!generate!a! systematic!Sbi!domain! IIIQIV!mutant! library,! siteQdirected!mutagenesis! primers! were! designed! to! mutate! Sbi! domain! III! residues! by!following! three! criteria! (Fig.4.3.5.A).! Firstly,! Sbi! is! known! to! form! covalent!adducts!with!metastable! C3b!molecules,! and! hydroxyl! group! containing! amino!acids!(serine!(S),!threonine!(T)!and!tyrosine!(Y))!are!the!primary!target!for!C3b!deposition.! At! the! same! time! the! hydroxyl! side! chain! could! also! contribute!immensely! to! proteinQprotein! interactions! and! protein! tertiary! structure.!Therefore,! hydroxyl! group! containing! residues! were! also! included! in! this!mutagenesis! study.! Secondly,! similar! to! hydroxyl! side! chain! residues,! amino!acids! with! amine! containing! side! chains! could! also! take! significant! structural!functions.! Thus,! arginine! (R),! asparagine! (N)! and! lysine! (K)! residues! in! Sbi!
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domain!III!were!substituted!with!alanine!residue!respectively.!Finally,!analysis!of!the! Sbi! primary! sequence! revealed! that! domain! III! contains! a! large! number! of!lysine! residues! existing! in! combination! with! adjacent! aspartate! (D)! residues,!forming! acidQbase! residue! pairs! (“DK”! pair).! Therefore! the! lysine! residues!participating!in!the!“DK”!pairs!were!included!in!the!mutagenesis!study.!Overall,!38%! of! domain! III! residues! were! studied! in! this! systematic! mutagenesis!experiment!(Fig.4.3.5.B).!
Figure(4.3.5:(Schematic(diagrams(summarizing(the(systematic(mutagenesis(experiment(of(
SbiEIIIEIV.!(A)!Color!coded!Sbi!domain!III!primary!sequences.!Within!domain!III! five!“DK”!pairs!are! identified,! labeled! in! orange.! Amine! containing! residues! are! labeled! in! blue;!hydroxylQcontaining! residues! are! labeled! in! green.! RedQcolor! labeled! residues! represent! the!residues! involved! in! the! mutagenesis! study.! (B)! An! overview! of! the! single! amino! acid!substitution!mutant!distribution!across!the!Sbi!domain! III.!(C)!Selection!and!distribution!of!Sbi!domain!IV!mutants.!
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Figure( 4.3.6:( Agarose( gel( analysis( of( mutation( incorporated( pQE30SbiEIIIEIV(
vectors.( All! mutations! were! based! on! the! pQE30SbiQIIIQIV! construct.! Using!siteQdirected!mutagenesis,! single! amino!acid! substitutions!were! inserted!at! the!selected!amino!acid!position.!Mutagenic!PCR!reactions!were!carried!out!at! five!extension!temperatures!(72°C,!72.5°C,!73.3°C,!74.3°C!and!75°C).!The!outcomes!of!mutation! insertion! and!PCR! amplification!were! represented! as! the! intensity! of!the!DNA!band!at!4.0!kb.! (!After! the! successful! incorporation! of! a! single! mutation! into! the! pQE30SbiQIIIQIV!plasmid,! the!mutated!plasmids!were!purified!and!transformed!into!E.coli!strain!BL21!(DE30).!Given!that!all!SbiQIIIQIV!mutants!are!single!amino!acid!substitution!mutants,! the!expression!and!purification!protocol!used! for!all! the!mutants!was!identical! to! the! protocol! used! for! SbiQIIIQIV! wild! type! protein! (Section! 4.2.1).!
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After!IPTGQinduced!overQexpression,!E.coli!cells!were!lysed;!the!mutant!proteins!were! then! purified! from! the! soluble! fraction! of! the! cells! using! Ni2+! affinity!chromatography.! Under! the! same! purification! parameters,! the! majority! of!SbiQIIIQIV! mutants! demonstrated! a! similar! chromatogram! to! that! shown! in!Fig.4.3.7.A.!After!the!initial! loading!and!washing!of!the!1!ml!Histrap!FF!column,!the!HisQtagged!protein!was!eluted!with!a!12!columnQvolume!gradient!of!0!to!100%!HisB! buffer.! At! the! early! stage! of! the! elution,! a! 280! nm! absorption! peak! was!observed! and! normally! consisted! of! three! peak! fractions! (Fig.4.3.7.A! Black!arrow).!The!peak!fractions!for!each!SbiQIIIQIV!mutant!were!collected.!The!purity!of!the!purified!protein!was!then!accessed!by!SDSQPAGE!electrophoresis!analysis!(Fig.4.3.8! and! 4.3.9).! Although! the! majority! of! the! SbiQIIIQIV! mutants! reach! a!consensus! in! their! chromatographic! profile,! the! SbiQIIIQIVY177F! mutant!demonstrated! an! abnormal! chromatographic! profile! (Fig.4.3.7.B).! On! the!chromatogram,!no!significant!protein!peak!was!detected,!but! the!putative!peak!fractions! (Fig.4.3.7.B! Black! arrow)! were! collected! and! analyzed! by! SDSQPAGE!(Fig.4.3.8).!!Fig.4.3.8! and! Fig.4.3.9! demonstrate! that! the! peak! fractions! of! every! SbiQIIIQIV!mutant! purification! contain! purified! SbiQIIIQIV! mutant! protein! of! the! expected!size!(14.9!kDa).!Although!some!of!the!peak!fractions!were!slightly!contaminated!by! E.coli! endogenous! proteins,! every! Sbi! mutant! contained! at! least! one!peakQfraction,! which! was! free! from! contamination! (Fig.4.3.8! and! 4.3.9! black!arrow).! The! corresponding! fraction! was! then! used! for! subsequent! SbiQIIIQIV!functional!characterizations.!!Although! the! SbiQIIIQIVY177F! mutant! failed! to! produce! an! elution! peak! in! its!chromatogram!(Fig.4.3.7.B),!the!SDSQPAGE!analysis!of!the!putative!peak!fractions!detected! the! presence! of! purified! SbiQIIIQIVY177F! protein! in! the! fractions.!Therefore!the!absence!of!the!280!nm!absorption!peak!is!a!result!of!poor!280!nm!absorption! property! of! the! Y177F! mutation.! By! mutating! the! only! 280! nm!
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absorptive! residue! (tyrosine! 177! to! a! phenylalanine),! the! Y177A! mutant! of!SbiQIIIQIV!has!become!nearly!transparent!to!280!nm!UV!light.!
!!!!!!!!
Figure( 4.3.7:( Chromatograms( of(
SbiEIIIEIV( mutant( protein(





Figure( 4.3.8:( SDSEPAGE( profiles( of( purified( SbiEIIIEIV( domain( III( single(




4.3.6.2(SbiEIIIEIV(mutants(serum(activation(assay(!This! study! utilized! a! library! of! SbiQIIIQIV! mutants! to! evaluate! the! functional!impacts!of! these! substitutions.! SbiQIIIQIV!mutants!were! incubated!with! the!HSS!(Section!4.2.2),!the!C3!consumption!process!was!then!followed!by!antiQC3d!and!antiQSbi!Western!blots!(Section!4.2.5),!over!a!30!min!period!(Fig.4.3.10).! It!was!demonstrated! in! Section! 4.3.2! that! the! formation! of! SbiQC3b! adduct! and! the!consumption!of!C3!αQchain!are!two!indications!of!Sbi’s!C3!consumption!process.!As!demonstrated!by!Fig.4.3.11!and!4.3.12,!the!systematic!screening!of!SbiQIIIQIV!single!mutants!shows!that!majority!of!the!SbiQIIIQIV!single!mutants!is!still!able!to!induce!timeQdependent!consumption!of!C3!αQchain!and!to!form!SbiQC3b!adduct.!However,! several! SbiQIIIQIV! mutants! with! aberrant! phenotypes! (highlighted! in!red,!Fig.4.3.11!and!4.3.12)!were!also!identified.!!R231! in! domain! IV! had! previously! been! implicated! as! a! crucial! residue! that!mediates! Sbi! binding! on! the! C3d! concave! surface.! As! expected,! the! activity!screens! demonstrate! that! the! mutation! of! this! residue! causes! a! significant!
Figure( 4.3.9:( SDSEPAGE( profiles( of( purified( SbiEIIIEIV( domain( IV( single( amino( acid(
substitution( mutants.( Each!mutant! was! purified! by!Ni2+! affinity! chromatography!with! a! 1!ml!Histrap!FF!column.!Three!peak!fractions!(1,!2!and!3)!were!analyzed!by!SDSQPAGE!and!shown!as!a!single!gel!segment.!All!SbiQIIIQIV!mutants!display!expected!size!of!14.9!kDa,! located!between!18!kDa!and!14.4!kDa!molecular!weight!marker.!According!to! the!gel,! the!most!pure! fractions!were!taken!for!subsequent!studies,!indicated!by!a!black!arrow.!
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decrease! in! Sbi’s! activity.! At! very! high! concentration,! 30! min! incubation! was!needed!to!initiate!the!activation!of!C3!(Fig.4.3.11).!Based!on!the!antiQSbi!Western!blot! (Fig.4.3.12),! R231A! also! demonstrated! decreased! adduct! formation! level,!which!could!be!a!result!of!the!reduced!C3!avidity.!
Figure( 4.3.10:( Functional( screen( of( SbiEIIIEIV( mutants.( The! C3! consumption! activity! of(SbiQIIIQIV! mutants! and! truncation! variants! was! assayed! individually.! Treated! serum! samples!were!collected!in!various!time!points!and!analyzed!by!both!antiQSbi!and!antiQC3d!Western!blots.!!According!to!the!antiQC3d!Western!blot!screening!(Fig.4.3.11),!the!substitution!of!lysine!173!in!the!middle!of! the!Sbi!domain!III! to!alanine!(K173A)!produces!the!most!dramatic!decrease!in!Sbi’s!activity,!since!no!C3!consumption!was!observed!during! the!30!min! incubation!period.!The! corresponding! antiQSbi!Western!blot!shows!this!mutant!lacks!the!ability!to!form!SbiQC3b!adducts.!Serine!199!(S199)!is!located!at! the!NQterminal! end!of! Sbi!domain! IV! in! the! junction! region!between!domain!III!and!IV.!The!substitution!of!S199!also!causes!significant!reduction! in!C3!consumption!activity,!and!shows!a!15!min!lagQtime!on!C3!activation.!!Three!mutations!(D208N,!K212A,!S213A)!were!designed!to!evaluate!the!role!of!Sbi!domain!IV!convex!surface!binding! in!the!C3!consumption!process.!All! three!SbiQIIIQIV! mutants! demonstrate! comparable! C3! consumption! activity! to! the!SbiQIIIQIV!wild!type.!However,!the!mutation!of!a!nearby!amino!acid!residue!serine!226! (S226)! produces! the! most! unexpected! C3! consumption! profiles.! The!antiQC3d!Western!blot!demonstrates!that!S226A!is!an!activator!of!C3,!and!at!very!high! concentration! no! significant! delay! in! C3! activation! was! detected.! But,!uniquely,! this! mutant! shows! no! detectable! SbiQC3b! formation.! These!observations!suggest!that!S226!could!be!a!covalent!attachment!site!of!C3b.!This!
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possibility!will!be!explored!in!detail!in!chapter!5.!!











(In!this!study,!via!systematic!mutagenesis!and!ensuing!functional!defect!screening,!amino!acid!residues!that!contribute!significantly!to!Sbi!induced!C3!consumption!were! located,! among! which! three! SbiQIIIQIV! mutation! representatives! were!selected! and! utilized! in! a! series! of! subsequent! comparative! studies! aiming! to!challenge!different!hypotheses!about!Sbi!triggered!C3!consumption!mechanisms.!As! shown! in! Fig.4.3.13,! the! three! chosen! mutations! were! evenly! distributed!along!SbiQIIIQIV!molecule.!K173A!is!located!in!the!middle!of!domain!III,!S199A!is!found! in! the! junction! region! and! the! R231A!mutation! is! located! in! domain! IV.!Among! these! three!mutations,! only! the!negative! impact! of!R231A! is! explicable!with!previous!data.!The!reasons!of! the!compromised!C3!consumption!activities!caused! by! K173A! and! S199A! mutations! remain! to! be! investigated.! In! the!following! sections! the! structural! aspects! of! the! SbiQIIIQIV! mutants! will! be!investigated!first,!then!functional!assays!will!be!performed.!!
4.3.8(Structural(analyses(of(SbiEIIIEIV(defective(mutants(
(
4.3.8.1(CD(spectrometry(studies(of(SbiEIIIEIV(WT(and(mutants( (!It! is!generally!accepted! that! the!structure!of!a!protein! is!closely! linked!with! its!function!and! the!primary!sequence!of!a!protein! is!essential! for! the! folding!of!a!protein! to! its!correct!secondary!structure.! It! is!evident! in!our!SbiQIIIQIV!mutant!functional! screen! (Section! 4.3.6.1)! that! the! substitution! of! charged! sideQchain!amino! acid! residues! with! alanine! can! greatly! affect! the! activity! of! SbiQIIIQIV.!Therefore,! it! is! reasonable! to! speculate! that! these! substitution! mutations! are!
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structurally! different! from! the!wild! type! SbiQIIIQIV! and! the! resulting! structural!defects!could!be!the!underlying!reason!for!their!impaired!activity.! !!
In! this! study,! SbiQIIIQIV! WT,! S199A! and! K173A! were! analyzed! by! circular!dichorism! (CD)! spectroscopy! to! estimate! their! secondary! structure! content.!As!described! in! Section! 4.2.1,! different! SbQIIIQIV! proteins! were! expressed! and!purified! twice!with!Ni2+! affinity! chromatography,! finally! buffer! exchanged! into!10! mM! sodium! phosphate! buffer! pH! 7.4! before! CD! analysis.! To! improve! the!signal!to!noise!ratio,!for!each!SbiQIIIQIV!protein!ten!repetitive!CD!spectra!between!
Figure( 4.3.14:( Circular( dichroism( (CD)( analysis( of( SbiEIIIEIV(WT( and(mutants.( (A)! CD!spectra! of! SbiQIIIQIV! WT,! S199A! and! K173A,! with! background! absorbance! subtracted! and!expressed! in!mean!residue!ellipticity!θ.!The!positive!peak!at!190!nm!and!negative!peaks!at!205!and!215!nm!are!indicative!of!alphaQhelicity.!A!decreased!200!nm!reading!is!indicative!of!increased! random! coil! content.( (B)( Idealized! CD! spectra! of! defined! protein! secondary!structure.!The!spectrum!of!αQHelix! in!yellow!shows! two!negative!peaks!at!222!nm!and!208!nm!and!a!positive!one!at!190!nm.!The!spectrum!of!βQsheet! in!blue!demonstrates!a!negative!peak! at! 219! nm! and! a! positive! one! at! 196! nm.! The! spectrum! of! random! coil! in! red! has! a!positive! band! at! 212! nm! and! a! negative! one! around! 195! nm.! (C)( Secondary! structure!composition!estimation!by!CDNN.!!
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190! and! 280! nm! were! acquired! (Appendix! 9.4.1),! and! then! averaged! to! one!representative! spectrum.( Compared! with! the! characteristic! CD! spectra! of!different!secondary!structures!(Fig.4.3.14.B),!the!CD!spectra!of!all!three!types!of!SbiQIIIQIV!(Fig.4.3.14.A)!resemble!the!CD!spectrum!of!protein!composed!mainly!of!αQhelix! secondary! structure.! Overlay! of! all! three! representative! spectra! shows!that! there! are!no! significant!CD!differences!between!200!nm! to!280!nm!of! the!spectrum.! However,! between! 190! nm! and! 200! nm! of! the! spectrum,! the! CD!reading!of!SbiQIIIQIV!mutants!(K173A!and!S199A)!are!noticeably!higher!than!the!WT! CD! reading.! By! deconvoluting! the! representative! spectra! using! CDNN!software!(Section!4.2.7),!the!secondary!structure!composition!of!different!types!of!SbiQIIIQIV!was!interpreted.!Fig.4.3.14.C!shows!that!all!three!types!of!SbiQIIIQIV!demonstrate! comparable! secondary! structure! compositions! with! limited!differences.! The! two! types! of! SbiQIIIQIV!mutants! show! subtly! increased! αQhelix!content.! The! WT! protein! contains! the! highest! percentage! of! random! coil!secondary!structure.! !!!!
4.3.8.2(Analysis(of(SbiEIIIEIV(and(Sbi:C3d(hydrodynamic(diameter(
(In!addition!to!the!traditional!structural!analysis! like!CD!spectroscopy,!SbiQIIIQIV!WT! and! mutants! were! also! analyzed! by! switchSENSE! technology,! which!determines!the!hydrodynamic!diameter!of!a!protein!or!a!protein!complex.!In!this!study,! the! hydrodynamic! diameter! of! SbiQIIIQIV! WT! and! its! mutants! were!measured!and!the!hydrodynamic!diameters!of!their!C3d!bound!forms!were!also!determined.!The!experiments!were!performed!as!described!in!Section!4.2.9.!!
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Figure( 4.3.15:( Hydrodynamic( diameter(measurements( of( various( types( of( SbiEIIIEIV( and(
their( C3d( bound( complex( forms.( (A)( Time! resolved! normalized! fluorescence! of! a! 48! bp!Cy3Qlabeled!DNA! reference! (blue),! after! immobilization!of! SbiQIIIQIV!WT! (pink)! and!addition!of!C3d!(black!dash!line).( (B)!Time!resolved!normalized!fluorescence!of!DNA!reference!(blue),!after!immobilization! of! SbiQIIIQIV! S199A!mutant! (yellow)! and! addition! of! C3d! (black! dash! line).! (C)!Time! resolved! normalized! fluorescence! of! DNA! reference! (blue),! after! immobilization! of!SbiQIIIQIV! K173A! mutant! (green)! and! addition! of! C3d! (black! dash! line).( (D)! Time! resolved!normalized! fluorescence! of! DNA! reference! (blue),! after! immobilization! of! SbiQIIIQIV! R231A!mutant!(purple).!(E)!Table!summarizes!the!hydrodynamic!diameters!of!various!types!of!SbiQIIIQIV!and!their!C3d!bound!form.!!Hydrodynamic! diameter! analysis! (Fig.4.3.15.E)! shows! that! among! unliganded!SbiQIIIQIV! variants,! the! K173A! mutant! adopts! the! most! compact! conformation!(3.8! nm),! R231A! exhibits! most! extended! conformation! (4.7! nm)! and!WT! and!S199A!share!a!similar!hydrodynamic!diameter!(4.3!nm).!When!bound!with!C3d,!the!K173A!complex!is!the!most!compact!(5!nm).!WT!and!S199A!complexes!show!similar! hydrodynamic! diameters,! 6.6! nm! and!6.3! nm! respectively.! Because! the!SbiQIIIQIV! R231A!mutant! does! not! bind! C3d,! no! R231A:C3b! complex! diameter!
! 119!
data! could! be! acquired.! These! results! demonstrate! that! the! SbiQIIIQIV! variants!with!opposed!functional!characteristics!also!show!discrepancies!structurally.!To!be!specific,!the!unliganded!SbiQIIIQIV!WT!is!0.5!nm!larger!than!the!K173A!mutant,!and! in! the! C3d! bound! form! the!WT! complex! is! 1.6! nm! larger! than! the! K173A!complex.! The! differences! in! diameter! are! augmented! by! the! binding! of! C3d,!assuming!that!in!both!types!of!complexes!C3d!contributes!equally!to!the!overall!diameter,! SbiQIIIQIV!WT!must! be! able! to! switch! into! an! extended! conformation!that! consumes!more! space! and! the!K173A!mutant! fails! to! reach! this! extended!conformation.!
4.3.9(Functional(analyses(of(SbiEIIIEIV(WT(and(mutants(
(
4.3.9.1(C3d(binding(kinetics(of(SbiEIIIEIV(WT(and(mutants( (!Comparison!of!the!SbiQIIIQIV!WT!and!R231A’s!C3!consumption!profiles!indicates!that! the! ability! to! trigger! C3! consumption! is! related! to! the! binding! strength!between!SbiQIIIQIV!and!C3.!Although!K173!and!S199!were!not! indicated!as!C3d!binding! residues! by! previous! crystallography! studies,! they! could! lead! to!unexpected! structural! defects! that! in! turn! effect! C3! binding.! Therefore,! in! this!study!the!binding!affinities!between!four!types!of!SbiQIIIQIV!(WT,!S199A,!K173A!and! R231A)! and! C3d! were! determined! by! “SwitchSENSE”! real! time! binding!kinetic!analysis.!The!C3!proteolytic!fragment!C3d!was!used!as!the!ligand!due!to!its!smaller!size!and!the!close!mimicry!of!C3QSbi!interaction!interface.!To!measure!the! binding! kinetics,! the! upward! dynamic! responses! of! immobilized! SbiQDNA!conjugate!were!monitored! at! four! C3d! concentrations! (40!nM,! 70!nM,! 100!nM!and!130!nM)! in! real! time! (Fig.! 3.3.16.AQG).! A! decrease! in! the! upward!dynamic!response!signifies!the!binding!of!C3d!to!Sbi,!an!increase!in!the!upward!dynamic!response! represents! the! dissociation! of! Sbi:C3d! complex.! As! summarized! in!Fig.3.3.16.H,! for! each! complex! three! parameters! were! acquired,! dissociation!constant!(Kd),!“onQrate”!(kon)!and!“offQrate”!(koff).!
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Figure(4.3.16:(SwitchSENSE(binding(kinetic(measurements(of(C3d(fragment(binding(to(various(types(
of( SbiEIIIEIV.( (AEB)(Time!resolved!dynamic!response!of! immobilized!SbiQIIIQIV!WT(during!C3d!association!and! dissociation.! (CED)! Time! resolved! dynamic! response! of! immobilized! SbiQIIIQIV! S199A! during! C3d!association!and!dissociation.!(EEF)!Time!resolved!dynamic!response!of!immbolized!SbiQIIIQIV!K173A(during!C3d! association! and! dissociation.! (G)! Time! resolved! dynamic! response! of! immobilized! SbiQIIIQIV! R231A!during! C3d! association! (H)! Table! summarizes! the! three! binding! kinetic! measurements! (i.e.! dissociation!constant! (Kd),! “onQrate”(kon)! and! “offQrate”(koff))! for! every! type! of! SbiQIIIQIV:C3d! interaction.! Upward!dynamic! response! readings! were! recorded! every! 5! s.! The! association! and! dissociation! curves! were!determined!by!global!fitting!and!used!to!calculate!the!kinetic!parameters.!!This! binding! kinetic! analysis! (Fig.4.3.16)! agrees! with! previous! data! that! the!R231A!mutation!significantly!impairs!C3d!binding.!In!this!study,!no!measurable!
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binding! was! observed! between! SbiQIIIQIV! R231A! and! C3d.! Apart! from! the!mutation!on!domain!IV,!the!rest!of!the!functionQcompromising!mutations!do!not!have! a!negative! impact! on! the!C3d!binding!property.! SbiQIIIQIV!WT!and!K173A!share!a!set!of!nearly!identical!binding!constants!to!C3d.!S199A!demonstrates!an!unexpected! increased! binding! affinity! to! C3d,! the! “onQrate”! of! S199A! to! C3d! is!almost! three! times!higher! than!the!corresponding!WT!“onQrate”.!Therefore,! the!C3!binding!strength!does!affect!SbiQIIIQIV’s!ability!to!consume!C3!but!it!does!not!proportionally! correlate! with! Sbi’s! power! to! trigger! C3! consumption.! As!described!by!this!study,!SbiQIIIQIV!mutants!with!higher,!lower!and!the!same!C3d!binding!strength!as!WT!all!demonstrate!severe!functional!defects.!Consequently,!additional! factors!must! also! play! a! role! facilitating! SbiQIIIQIV! to! consume!C3! in!serum.!!The!kinetic!parameters!of!SbiQIIIQIV!binding!to!C3d!had!been!determined!in!two!previous!reports!(Burman!et&al.,!2008;!Upadhyay!et&al.,!2008).!The!Kd!measured!by!surface!plasmon!resonance!(SPR)!is!1.4!μM,!which!is!significantly!higher!than!0.17!μM!that!was!determined!using!isothermal!titration!calorimetry!(ITC).!In!this!study,! the!WT!SbiQIIIQIV:C3d!affinity!(5.0!nM)!measured!by!SwitchSENSE!is!one!order! of! magnitude! lower! than! the! previously! reported! values.! The! similar!discrepancy!was!observed!previously!in!a!study!of!antibody!antigen!interaction!using!both!SwitchSENSE!and!SPR! (Villa!2012).!This! could!be!attributed! to! two!reasons,! 1)! the!higher!detection! sensitivity! of! the! switchSENSE!method!and!2)!the! superimposed! surface! effects! of! SPR! due! to! the! requirement! to! chemically!couple!one!of!the!binding!partners!to!the!biosensor!surface.!!
4.3.9.2(Do(defective(SbiEIIIEIV(mutants(show(a(lack(of(adduct(formation?(
(As!was!revealed!in!our!functional!screening,!the!SbiQIIIQIVK173A!mutant!shows!no!C3!activation!nor!SbiQC3b!adduct!formation.!One!possible!explanation!for!this!is!that! the! substitution! of! a! lysine! residue! for! an! alanine! residue! eliminates! this!
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location! as! a! potential! C3b! deposition! site.! Hypothesis! three! (Section! 4.1)!proposes! that! the! formation! of! the! SbiQC3b! adduct! is! the! central! step! of! C3!consumption.!Therefore,!whether!the!K173A!mutant!could!still!form!the!SbiQC3b!adduct!was!examined.! !
Based!on!the!C3!“tickQover”!mechanism,!formation!of!the!SbiQC3(H2O)!adduct!was!expected! after! prolonged! incubation! between! C3! and! SbiQIIIQIV.! Fig.4.3.17.B!shows!the!SDSQPAGE!analysis!of!the!incubation!samples,!which!were!also!probed!by! antiQSbi!Western! blot! shown! in! Fig.4.3.17.A.! Although! the! formation! of! the!SbiQC3(H2O)!adduct!was!not!readily!observable!on!the!SDSQPAGE!gel,!the!Western!blot!analysis!shows!that!both!types!of!SbiQIIIQIV!are!able!to!form!covalent!adducts!with! C3(H2O).! The! SbiWTQC3(H2O)! adduct! becomes! detectable! after! 6! hours! of!incubation,!but!interestingly!the!SbiK173A!QC3(H2O)!adduct!is!detectable!from!hour!2!of!incubation.!Since!in!the!SbiQC3(H2O)!covalent!adduct!the!C3a!fragment!is!not!proteolytically! removed,! it! is! slightly! larger! than! the!SbiQC3b!adduct! formed! in!the!serum.!
Figure( 4.3.17:( In, vitro( SbiEC3( adduct( formation( assay.( (A)( AntiQSbi! western! blot! analysis.! (B)(SDSQPAGE!4Q20%!gradient!gel!analysis.!1.5!mg/ml!of!purified!C3!molecule!was!incubated!with!10!μM!of!SbiQIIIQIV!WT! or! K173A! respectively.! Each! condition! was! incubated! at! 37°C! for! a! total! of! 16! hours;!samples!were! collected!every!2Qhour.!SbiQC3(H2O)!adduct! is! indicated!by!pink! arrow,!SbiQC3b! adduct! is!indicated!by!green!arrow.!C3!α!and!β!chains!and!free!SbiQIIIQIV!molecules!are!indicated!by!black!arrow.!Individual!incubation!conditions!were!separated!by!black!dashed!lines.(
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4.3.9.3(Do(Sbi(mutants(affect(the(binding(of(other(serum(proteins?(
(To! search! for! the! serum! components! that! are! essential! for! Sbi! induced! C3!consumption,! comparative! serum! pullQdown! experiments! (Fig.4.3.18)! were!performed! using! CQterminal! biotinylated! SbiQIIIQIV! WT,! K173A,! S199A! and!R231A! as! bait! proteins.! A! SDSQPAGE! analysis! of! serum! proteins! that! were!retained!on!neutravidin!agarose!beads!charged!with!SbiQIIIQIVWT!and!mutants!is!shown!in!Fig.4.3.19.A.( !!
Comparing!SbiQIIIQIVWT!and!mutant!SDSQPAGE!profiles,!significant!band!intensity!variations! are! observed! at!molecular!weight! of! 150!kDa,! 120!kDa! and!45! kDa.!Protein!bands! labeled!a,&b&and& c!on!Fig.4.3.19.A!were! identified!respectively!as!complement!factor!H,!complement!C3!alpha!chain!and!FHRQ1!by!NanoLC!coupled!ESIQTOF!mass!spectrometry.!In!addition,!the!identical!samples!were!analyzed!by!Western! blotting! (Fig.4.3.19.BQC)! to! further! evaluate! the! interaction! profiles! of!SbiQIIIQIV! mutants.! Having! demonstrated! the! variation! in! C3! consumption!activity!between!SbiQIIIQIV!WT!and!mutants,! the!analysis!of! interaction!profiles!appears! to! show! that! functionally! intact! SbiQIIIQIV! WT! interacts! strongly! with!factor!H!and!FHRQ1,!while!functionally!compromised!SbiQIIIQIV!S199A!and!R231A!mutants! demonstrate! weaker! interaction! patterns! and! the! functionally! null!SbiQIIIQIV! K173A! mutant! shows! the! weakest! interaction! strength.! It! was!
Figure( 4.3.18:( Serum( pullEdown(
experiment( using( biotin( labeled(
SbiEIIIEIVs.( Different! types! of( biotin!labeled!SbiQIIIQIV!were!immobilized!on!neutravidin! agarose! beads.! The!pullQdown! was! performed! in! human!serum! supplemented! with! 10mM!EDTA.! After! incubation! and! intensive!washing! of! the! neutravidin! beads,!pullQdown! samples! were! then!subjected! to! analysis! including!SDSQPAGE,! MS! protein! identification!and!western!blotting.!!
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previously!demonstrated! that!SbiQIIIQIV!binds!C3! isoforms! in! combination!with!FH!to!form!a!ternary!complex,!but!the!pullQdown!result!presented!here!suggests!that!FHRQ1!also!could!be!a!constituent!of!the!ternary!complex.!It!is!surprising!to!discover!that!the!R231A!pullQdown!sample!demonstrated!comparable!C3!binding!level!as!other!types!of!SbiQIIIQIV!(Fig.4.3.19.C).!This!suggests!that!the!binding!of!FH!and!FHRQ1!could!enhance!C3!binding.!
Figure(4.3.19:(SDSEPAGE(and(Western(blot(analysis(of(SbiEIIIEIV(serum(pull(down(
sample.(Numbers! are!designated! to!different! samples.( 1!Neutravidin!beads! control,! 2!WT! pullQdown,! 3! K173A! pullQdown,! 4! S199A! pullQdown,! 5! R231A! pullQdown.! Samples!were! first! analyzed! by! SDSQPAGE! (A),! polyclonal! antiQfactor! H!Western! blot! (B),! and!polyclonal!antiQC3d!Western!blot!(C).!Protein!bands!showing!intensity!variation!across!different!SbiQIIIQIV!pullQdown!samples!are!labeled!a,!b!and!c.!!
4.3.9.4(Mutation’s(effect(on(complement(activation(!SbiQIIIQIV!WT! and!mutants! in! this! assay! were! adjusted! to! 10! μM.! The! sample!collection!procedure!is!summarized!by!Fig.4.3.4.A.!The!treated!serum!samples!at!different!time!points!were!added!to!either!CP!or!AP!assay!diluent,!their!residual!complement! activities!were!measured! by! assessing! C5bQ9! formation! using! the!Welisa!lab!complement!activity!kit!(Section!4.2.3).! !
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!
!Residual! CP! activity! measurements! (Fig.4.3.20.A)! agree! with! the! results! of!Western!blot!based!SbiQIIIQIV!activity!screens.!SbiQIIIQIV!WT!inhibits!CP!activity!in!a! timely! manner,! but! all! three! mutants’! inhibition! activities! were! greatly!compromised.! The! residual! CP! activities! of! K173A! at! all! three! timeQpoints!fluctuate! around! 80%.! Similar! results! were! observed! for! the! S199A! mutant.!Similarly!to!the!antiQC3d!Western!blot!(Fig.4.3.11),!with!the!addition!of!R231A,!a!weak! time! dependent! inhibition! of! CP! activity! was! observed,! the! residual! CP!activity! drops! from! 98%! to! 92%! then! to! 72%.! Another! intriguing! observation!was! that! without! preQincubation! (0! min),! only! the! C3! binding! mutant! R231A!shows!almost!no!inhibition!(residual!activity!of!98%).!!In! contrast! to! the! CP! measurements,! AP! measurements! (Fig.4.3.20.B)! do! not!totally!correlate!with!the!results!from!Western!blot!based!C3!activation!assay.!As!mentioned! earlier,! SbiQIIIQIVWT! inhibition! of! AP! activity! does! not! show! any!correlation!with!preQincubation!time.!Without!incubation,!WT!protein!can!reduce!the! residual! AP! activity! to! 10%,! with! incubation! no! measurable! residual! AP!
Figure(4.3.20:!Classical(and(alternative(pathway( residual( activities(of( SbiEIIIEIV(mutantEtreated(
human(serum.!HSS!was!incubated!with!SbiQIIIQIV!WT,!K173A,!S199A!and!R231A.!For!each!incubation!reaction,! treated! serum!samples!were!collected!at! three! time!points! 0,! 15! and!30!min.!Their!residual!classical! (A)! or! alternative! (B)! pathway! residual! complement! activities! were! then! determined.!Percentage!activity!was! calculated!using!an!absorbance! reading!at! 405!nm!with! the! equation!activity&
=[(sampleBnegative& control)/positive& control]×100.! Each! condition! was! assayed! in! duplicate! and! the!error!bars!represent!the!upper!and!lower!result.!
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activity! was! detected! at! all.! The! inhibition! provided! by! K173A! also! shows! no!dependency!on!preQincubation!time.!The!residual!AP!activity!remains!above!60%!after! 30! min! inhibition.! Measurements! of! AP! inhibition! from! R231A! mutant!shows! the! most! interesting! results,! after! 15! min! preQincubation! only! limited!inhibition! was! measured,! but! with! an! additional! 15! min! incubation,! complete!inhibition!of!AP!activity!was!observed.!!
4.3.10(Reconstructions(of(Sbi(mediated(ternary(complexes(
(Having!demonstrated!that!Sbi!mutants!show!differences!in!their!ability!to!form!ternary! complexes! in! serum,! further! in& vitro! analyses! were! carried! out! to!investigate!the!extent!to!which!mutated!side!chains!contribute!to!the!formation!of!the!stabilized!ternary!complexes.(
(
4.3.10.1(Reconstruction(of(FH(containing(ternary(complex(by(BLItz!!SbiQIIIQIV! WT,! K173A! and! S199A! constructs! were! immobilized! on! NiQNTA!biosensors! and! subjected! to! BioLayer! Interferometry! (BLI)! measurements.!Complex! formation!was! followed! in!real! time!by!stepQwise!addition!of!C3d!and!FH!as!analytes.!All!three!SbiQIIIQIV!constructs!were!successfully!immobilized!and!excess!Sbi!molecules!were!removed!by!an!immediate!washing!step!(Fig.4.3.21.A).!Upon! addition! of! C3d,! the! formation! of! Sbi:C3d! complexes!was! detected! in! all!three! Sbi! constructs! as! an! increase! in! BLI! signal.! Upon! addition! of! the! FH,! a!significant! secondary! binding! event! was! observed! based! on! SbiQIIIQIVWT:C3d!complex,!followed!by!rapid!dissociation!of!the!ternary!complexes!in!PBS!buffer.!In! contrast,!no! strong!FH!association!was!detected!based!on! the!S199A:C3d!or!K173A:C3d! complexes,! slow! Sbi:C3d! complex! dissociation! starts! immediately!after! the! addition! of! FH! and! protein! complexes! dissociate! considerably! in! PBS!buffer!washing!step.!Similar!binding!characteristics!were!observed!when!ternary!complexes! were! reconstituted! using! C3! as! an! intermediate! analyte.! NiQNTA!
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immobilized! SbiQIIIQIV! WT! and! K173A! constructs! showed! similar! level! of! C3!binding! (Fig.4.3.21.B).! However,! upon! addition! of! FH,! only! the! SbiQIIIQIVWT:C3!complex! forms! ternary! complexes! with! FH! in! comparison! with! the! impaired!association!of!K173A!mediated!complex.! !
!




interferometry.! (A)! SbiQIIIQIV! WT,!S199A! and! K173A! were!immobilized! and! C3d! and! factor! H!were! applied! in! fluid! phase!sequentially.! The! NiQNTA! surface!was! loaded! with! saturated! amount!of! all! three! types! of! SbiQIIIQIV.! After!the! application! of! C3d,! similar!binding! level! was! observed.! Upon!application! of! factor! H! a! secondary!binding! event! was! detected! based!on! Sbi! WT:C3d! complex.! No!significant! secondary! factor! H!binding! event! was! detected! in!S199A! and! K173A! mutants.! (B)(SbiQIIIQIV! WT! and! K173A! were!immobilized! and! C3! and! factor! H!were! applied! in! fluid! phase!sequentially.! An! additional!secondary! binding! event! was!detected! based! on! Sbi! WT:C3!complex,! but! not! when! C3! was!bound! with! Sbi! K173A.! Due! to! the!large! size! of! C3! molecule,! a! large!binding!signal!was!produced.!!
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activation! fragments! C3b! and! C3d! were! added,! followed! by! the! addition! of!increasing! amount! of! purified! FH! or! FHRQ1.! After! washing,! the! amount! of! the!ternary! complex! formation! was! quantified! using! a! polyclonal! antiQfactor! H!antiserum.! !!SbiQIIIQIVWT!binds!FH! in!combination!with! intact!C3!and! its!activation!products!(C3b! and!C3d)! (Fig.4.3.22.A).! The!highest! affinity! is! achieved!when!C3! (Kd=6.8!nM)!and!C3d! ! (Kd=15.1!nM)!were!used!as!secondary!ligands,!the!binding!levels!reach! saturation! after! factor! H! concentration! of! 120! nM.! However,! in!combination!with!C3b! ! (Kd=181.0!nM),!a!higher!concentration!of!factor!H!(250!nM)! was! needed! to! reach! binding! saturation.! Compared! with!WT,! the! K173A!mutant! (Fig.4.3.22.B)! shows! impaired! FH! binding.! Weak! concentration!dependent!FH!binding!was!observed!in!combination!with!C3!or!C3d,!however!in!combination! with! C3b! no! FH! binding! was! detected.! When! SbiQIIIQIVR231A! was!coated!(Fig.4.3.22.C),!FH!binding!was!reduced!to!a!minimal!level!independent!of!the!type!of!C3!isoforms.! !!SbiQIIIQIVWT! also! binds! FHRQ1! in! combination! with! C3! isoforms.! Using! C3! !(Kd=3.5! nM)! and! C3d! (Kd=1.6! nM)! as! secondary! ligand! a! similar! saturated!binding!level!(25!nM)!was!observed.!However,!higher!concentration!(≈100!nM)!of!FHRQ1!was!needed!to!reach!saturated!binding!level! in!combination!with!C3b!(Kd=10.0!nM)((Fig.4.3.22.D).!Similar!to!FH!binding!profile,!K173A!mutant!shows!impaired! FHRQ1! binding! kinetic! and! binding! level.! Again,! in! combination!with!C3b,!no!concentration!dependent!FHRQ1!binding!was!detected.!The!assembly!of!FHRQ1! ternary! complex! is! most! affected! by! the! C3! binding! mutant! R231A.!Regardless!of!the!C3!isoform,!no!increasing!trend!of!FHRQ1!binding!was!detected.!!The! SbiQIIIQIVWT! ternary! complex! binding! kinetics! suggest! that! independent! of!the! type! of! C3! isoforms,! SbiQIIIQIVWT! preferentially! recruits! FHRQ1! over! FH.! In!combination! with! C3,! C3d! and! C3b,! 2Q,! 9Q! and! 18Qfold! decreases! in! Kd! were!
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observed!for!FHRQ1!containing!ternary!complexes.! !
Due!to!the!poor!FH!binding!profiles,!the!accuracy!of!estimated!Kd!for!K173A!and!R231A! is! not! satisfactory;! therefore! these! values! are! not! provided.! More!sensitive!methods!might! be! used! in! the! further! for! the! determination! of! these!values.!Slightly!contradictory!to!the!pullQdown!results!(Fig.4.3.18),!which!suggest!
Figure(4.3.22:(In,vitro(factor(H(and(CFHR1(ternary(complex(formation(is(affected(by(C3(
isoforms( and( mutations( in( SbiEIIIEIV.( (AEC)( SbiQIIIQIV! WT,! K173A! and! R231A! were!immobilized!and!for!each!type!of!Sbi!the!concentration!dependent!binding!of!factor!H!(0Q500!nM)! in!combination!with!C3!(0.11!μM),!C3b!(0.11!μM)!and!C3d!(0.28!μM)!was!measured!by!polyclonal!Factor!H!antiserum.!(DEE)!SbiQIIIQIV!WT,!K173A!and!R231A!were!immobilized!and!for! each! type! of! Sbi! the! concentration! dependent! binding! of! CFHR1! (0Q400! nM)! in!combination! with! C3,! C3b! and! C3d! was! measured! by! polyclonal! factor! H! antiserum.!Measurements!were!done!in!duplicate.!The!Kd!values!were!determined!from!the!fitted!curve!using!GraphPad!Prism.!
(
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that!K173A!mutant!is!more!impaired!than!the!R231A!mutant,!in!this!section,!the!ELISA!reconstruction!of!ternary!complexes!shows!the!opposite.!This!could!be!a!consequence!of!the!differences!in!the!serum!C3!concentration!(5.4Q8!μM)!and!the!experimental! C3! concentration! (0.11! μM).! In! serum,! R231A!might! still! able! to!bind!C3,!this!binding!then!enhanced!by!the!binding!of!FH/FHRQ1.!
(
4.3.10.3(Binary(binding(of(SbiEIIIEIV(to(FH(or(FHRE1( (!Previously,! Sbi! had! been! described! to! only! bind! FH! in! combination! with! C3d!containing!C3!isoforms!(Haupt!et&al.!2008).!Given!the!discovery!of!the!previously!uncharacterized!FHRQ1!ternary!complex!in!this!study,!the!possibility!of!the!direct!binding!of!SbiQIIIQIV!to!FH!or!FHRQ1!was!examined.!
Based! on! Section! 4.2.15,! SbiQIIIQIVWT!was! coated! on! ELISA! plate,! and! then! the!concentration!dependent!binding!of!FH!or!FHRQ1!was!determined.!Surprisingly,!the!binding!experiments!(Fig.4.3.23)!indicated!SbiQIIIQIVWT!could!bind!directly!to!both!FH!and!FHRQ1.!Compared!with!the!Kd!of!ternary!complex!formation!(Section!4.3.16),!both!binary!complexes!(Sbi:FH!Kd=106.0!nM!and!Sbi:FHRQ1!Kd≈603.0!nM)!are! considerably!weaker! in! avidity.! Noticeably,! the! FH! binary! interaction!with!
Figure( 4.3.23:( SbiEIIIEIVWT( forms( binary( complex( with( factor( H( and( FHRE1.( (A)(SbiQIIIQIVWT!was! immobilized! and! the! concentration! dependent! binding! of! factor!H! (0Q1000!nM)!was!measured!by!polyclonal!Factor!H!antiserum.!(B)! SbiQIIIQIV!WT!was! immobilized!and!the! concentration! dependent! binding! of! FHRQ1! (0Q1500! nM)! was! measured! by! polyclonal!factor!H! antiserum.!Measurements!were!done! in!duplicate.!The!Kd!values!were!determined!from!the!fitted!curve!using!GraphPad!Prism.!
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SbiQIIIQIVWT!is!stronger!than!the!FH!binding!to!Sbi:C3b!complex.!This!suggests!a!possibility! that! SbiQIIIQIV! discourages! the! binding! of! FH! to! C3b,! which!antagonizes!the!factor!I!mediated!C3b!degradation.!!
4.3.11(Factor(H(and(FHRE1(compete(for(C3(isoforms(binding(in(combination(
with(SbiEIIIEIVWT(!An! ELISA! procedure! (Section! 4.2.16)!was! developed! to! determine!whether! FH!and! FHRQ1! compete! for! the! formation! of! SbiQIIIQIVWT! mediated! ternary!complexes.!
!SbiQIIIQIVWT! was! coated! on! the! ELISA! plate! then! a! constant! concentration! of!factor! H! and! three! C3! isoforms! (C3,! C3b! and! C3d)! were! added! together! with!increasing! amounts! of! FHRQ1,! the! factor! H! binding! was! detected! by! the!monoclonal! antibody! OXQ24.! This! assay! (Fig.4.3.24)! demonstrated! that! the!formation! of! Sbi:C3! isoforms:! FH! ternary! complexes! were! inhibited! in! a!doseQdependent! fashion! by! increasing! concentration! of! purified! FHRQ1.! The!inhibition!effects!are!common!over!different!C3!activation!fragments,!but!when!C3b! is! used! the! most! pronounced! effect! is! observed.! At! equal! FH! and! FHRQ1!molar! ratio,! regardless! of! the! type! of! C3! isoforms,! less! than! 50%! of! ternary!
Figure( 4.3.24:( FH( and( FHRE1( compete( for( the( formation( of( ternary( complex( with( C3(
isoforms( and( SbiEIIIEIV.( (A)! Proposed!competitive! binding!mechanism!between! factor!H! and!FHRQ1.!(B)!The!formation!of!factor!H!ternary!complex! is!inhibited!by!the! increasing!amount!of!FHRQ1.!ELISA!wells!were!coated!with!1!μg!of!SbiQIIIQIV,!as!secondary!ligand!0.4!μM!of!C3,!0.14!μM!of!C3b!and!0.3!μM!of!C3d!were!added!respectively,! finally!0.014!μM!of! factor!H!was! incubated!with!increasing!amount!of!purified!FHRQ1!(0Q0.055!μM).!Measurements!were!done!in!duplicate.!
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complexes! are! FH! bound,! which! suggests! preferential! binding! of! FHRQ1.!Interestingly,! at! the! physiological! FHRQ1:FH!molar! ratio! of! 0.5:1! (Skerka! et& al.!2013),!FH!binding!was!reduced!by!40%!(!secondary!ligand:!C3!or!C3d!)!or!by!60%!(!Secondary!ligand:!C3b).!
4.3.12(Functional(role(of(FHRE1(containing(ternary(complex(
(
4.3.12.1( Sbi( mediated( ternary( complexes( are( protective( for( C3b(
conformation(
Because!of!the!competitive!nature!between!the!FH!and!FHRQ1!containing!ternary!complexes,!this!competition!could!affect!the!in&vitro!factor!I!cleavage!rate!of!C3b!conformations! such! as! C3H2O.! As! the! vital! component! of! the! initial! AP! C3!convertase,! the! longevity! of! C3H2O! is! one! of! the! determinants! of! AP! pathway!activation.! The! assay! components! (Section! 4.2.18)! were! mixed! with! either!SbiQIIIQIVWT!or!SbiQIIIQIVK173A!at!37°C.!This!assay!(Fig.4.3.25)!demonstrated!that!in!the!presence!of!SbiQIIIQIVWT!the!cleavage!rate!of!C3H2O!was!reduced,!after!2!min!of!cleavage!reaction!an!extra!20%!of!residual!C3H2O!αQchain!was!observed.!Due!to!the! similar!molecular!weight!of!C3H2O!α’Qchain! (77!kDa)! and!C3H2O!βQchain! (75!kDa),! these! two! chains! appear! as! a! single! band! in! SDSQPAGE! analysis!(Fig.4.3.25.A),!slightly!higher!than!the!66.2!kDa!molecular!weight!marker.!
Figure(4.3.25:(Sbi(mediated(ternary(complexes(extend(C3b(conformation(halfElife.((A)( In&
vitro!cleavage!of!C3H2O,!C3H2O!(2.2!μM)!was!incubated!with!either!SbiQIIIQIV!WT!(5!μM)!or!K173A!(5!μM)!mutant!together!with!factor!H!(1.2!μM),!FHRQ1!(1.2!μM)!and!Factor!I!(4!ng/μl)!at!37!°C,!the! cleavage! process! was! analyzed! at! different! time! points! by! SDSQPAGE.! (B)! A! gel!densitometric!analysis!of!C3!α!chain!degradation!in!the!present!of!different!SbiQIIIQIV.! !
! 133!
4.3.12.2( FHRE1( containing( complex( is( essential( for( Sbi( induced( C3(
consumption.(
(Having! established! that! SbiQIIIQIV’s! C3! consumption! activity! is! related! to! the!formation! of! Sbi:C3:FH! and! Sbi:C3:FHRQ1! ternary! complexes,! further!experiments!were!required!to!determine!individual!roles!of!those!complexes!in!the! mechanism! of! C3! consumption.! During! the! course! of! the! research,! it! was!observed!that!SbiQIIIQIV!failed!to!trigger!C3!consumption!in!FH!reconstituted!FH!depleted! serum,! therefore! it!was! suspected! that! the! immuneQaffinity! depletion!method! used! during! the! manufacturing! process! could! deplete! both! FH! and!FHRQ1! molecules,! due! to! high! degree! of! protein! identity! shared! between! two!molecules.! !!
Figure(4.3.26:(rFHRE1(plays(decisive(role(in(Sbi(triggered(C3(consumption.((A)(Polyclonal!antiQFactor!western!blot,!1!Purified!factor!H,!2!FHRQ1,!3!Neutravidin!resin!pullQdown!control,!4!Normal!human!serum!SbiQIIIQIV!pullQdown,!5!Factor!H!depleted!serum!SbiQIIIQIV!pullQdown!and!6!Albumin/IgG!depleted!Factor!H!depleted!serum.!(B)!Detection!of!C3!αQchain!variation!using!antiQC3a!antibody.!C3!activation!was!induced!by!the!addition!of!PBS,!WT!and!K173A!SbiQIIIQIV!in!stepQwisely! reconstituted! factor! H! and! FHRQ1! double! depleted! sera.! (C)! Detection! of! C3a!release.!One!representative!experiment!from!a!total!of!three!repeats!was!presented.!
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To! test! this! theory,! SbiQIIIQIV! affinity! pullQdown! experiments! were! performed!using! factor! H! depleted! serum! (Section! 4.2.19),! Fig.4.3.26.A! lane! 5( shows! that!neither!factor!H!nor!FHRQ1!were!retained!on!SbiQIIIQIV!immobilized!neutravidin!resin,!whereas!the!formation!of!Sbi:C3!complex!was!observed!(Appendix!Fig.9.7).!To! complement! the! pullQdown! result,! an! excess! amount! of! HSA/IgG! double!depleted!factor!H!depleted!serum!sample!was!also!analyzed!(Fig.4.3.26.A!lane!6).!Based!on! the!results!of!both!analyses,!we!concluded! that! the! factor!H!depleted!serum!is!in!fact!FH/FHRQ1!double!depleted!serum.! !!The!double!depleted!serum!offers!a!unique!opportunity! to!study!the! individual!function! of! those! two! types! of! tripartite! complexes! in! relation! to! the! C3!consumption!activity!of!Sbi!molecule!(Section!4.2.20).!PBSQMg2+!buffer,!SbiQIIIQIV!WT! or! K173A! mutant! were! incubated! with! the! double! depleted! serum!supplemented! with! FHRQ1! or! FH! or! both,! C3! consumption! was! detected! by!monitoring! C3! αQchain! (Fig.4.3.26.B)! and! release! of! anaphylatoxin! C3a!(Fig.4.3.26.C).! Incubation!of!double!depleted! serum!with!PBSQMg2+,! SbiQIIIQIVWT!or!K173A!results!in!depletion!of!the!intact!C3!molecule,!and!similar!results!were!also! observed! when! FHRQ1! supplemented! double! depleted! serum! was! used.!However,! when! incubations! were! performed! using! factor! H! supplemented!double! depleted! serum,! C3! levels! were! maintained! over! one! hour! incubation!period! in! all! three! conditions.! Finally,! the! double! depleted! serum! was!reconstituted!by!addition!of!an!equal!molar!ratio!of!FHRQ1!and!factor!H.!Under!this! condition,! very! limited! amount! of! C3! consumption! and! C3a! release! were!detected! in! the! present! of! PBSQMg2+! buffer! or! K173A! mutant,! but! with! the!addition!of!SbiQIIIQIVWT!significant!C3!consumption!was!achieved.!These!results!suggest! that! fluid! phase! complement! regulator! FH! prevents! spontaneous!complement! activation.! The! sequestering! of! factor! H! in! the! form! of! Sbi:C3:FH!tripartite!complexes!is!insufficient!to!suppress!complement!regulation,!however!with!the!coQexistence!of!the!Sbi:C3:FHRQ1!complex,!complement!regulations!are!subverted.!
! 135!
4.4.(Discussion(!In! this! chapter,! the!expression!and!purification!protocols! for!SbiQIIIQIV!WT!and!mutants!were!presented.!We!showed!that!Sbi!exploits!complement!AP!to!deplete!intact!C3!molecules!in!serum.!Interestingly,!the!activation!of!AP!is!controlled!to!prevent! the! activation! of! C5.! The!mutagenesis! studies! of! SbiQIIIQIV! successfully!pinpointed!the!residues!affecting!Sbi’s!activity.!Analyses!of!the!mutants!suggest!that!the!impaired!FHRQ1!ternary!complex!formation!could!be!the!reason!for!their!defective!phenotypes.!
(
4.4.1(Analysis(of(SbiEIIIEIV(triggered(C3(futile(consumption(
(At! the! beginning! of! this! chapter,! results! for! expression! and! purification! of!SbiQIIIQIVWT! protein! were! presented.! High! purity! SbiQIIIQIVWT! molecule! was!prepared! for! downstream! assays.! By! analyzing! the! SbiQIIIQIVWT! treated! HSS!sample,!it!was!demonstrated!that!SbiQIIIQIVWT!triggered!C3!consumption!process!is!a!time!dependent!phenomenon.!The!activation!of!C3!coincides!with!formation!of! the!SbiQC3b!adduct,!proteolytic!activation!of! factor!B!and!release!of!C3a.!A!5!min! lag! time!was! observed,! until! the! explosive! activation! of! C3!molecule,! this!suggests!that!even!in!the!presence!of!excessive!amounts!of!SbiQIIIQIV!(10!μM),!C3!consumption! does! not! occur! immediately,! implying! that! a! timeQdependent!process! in! the! serum! could! be! an! essential! part! of! the! Sbi! triggered! C3!consumption! mechanism.! It! is! known! that! the! spontaneous! hydrolysis! of! C3!molecule,! the! “tickQover”! of! C3,! takes! places! at! a! slow! but! steadily! rate,!approximately!0.005%/min!(Pangburn!et&al.!1981).!This!process!could!account!for! the! lag! time!observed,!as!a!putative! threshold!of!protected!C3H2O!molecules!has!to!be!reached!in!order!to!overwhelm!regulation!of!AP!activation.! !!It!has!been!shown!before!that!futile!C3!consumption!by!Sbi!involves!activation!of!AP.!By!analyzing!the!outcome!of!Sbi! induced!C3!consumption!in!AP!component!
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depleted!sera,!we!concluded!that!all!AP!essential!components!(factor!B,!D!and!P)!are! irreplaceable.! This! suggests! that! apart! from! the! initiation! step,! the!downstream! activation! cascade! is! probably! shared! between! C3! futile!consumption!and!AP.!However,! incubation!with!depleted!sera!did!offer!several!interesting!observations.!Firstly,!although!factor!H! is!described!as! the!coQfactor!for!factor!I!that!facilitates!the!cleavage!of!C3b!molecule,!using!FH!depleted!serum!after! 30! min! incubation! no! residual! C3b! α’Qchain! was! detected! (Fig.4.3.3.A).!Secondly,!after!incubation!with!factor!B,!D!and!P!depleted!sera,!no!C3!activation!was!detected,!but!degradations!of!intact!C3!αQchain!were!observed!(Fig.4.3.3.A).!This! agrees! with! the! report! that! accredited! SbiQIIIQIV! with! the! activity! of!recruiting!C3/C3b!cleaving!proprotease!plasminogen!(Koch!et&al.!2012).!
(
4.4.2( Functional( screens( of( SbiEIIIEIV(mutants( provide(molecular( insights(
into(C3(futile(consumption( (
(In! this! study,! systematic! mutagenesis! was! performed! in! combination! with!structural!and!functional!analyses!to!unravel!the!molecular!details!of!Sbi!induced!complement! consumption.! A!Western! blot! approach! was! designed! to! perform!the! primary! functional! screening! of! Sbi! mutation! library.! This! method! was!employed!because!it!can!directly!report!molecular!weight!changes!of!the!C3!and!SbiQIIIQIV! molecules! during! the! C3! consumption! process.! However,! it! is! not! a!quantitative!assay,!thus!it!can!only!serve!as!an!estimation!method!for!the!amount!and! the! speed! of! C3! consumption.! Despite! the! limitations! of! this! method,! the!results! clearly! demonstrated! that! the! mutations,! K173A,! S199A! and! R231A!greatly! reduced! the! amount! of! SbiQC3b! adduct! formation! and! the! speed! of! C3!consumption.! !!To!determine!the!underlying!molecular!explanations!for!these!defective!mutants!and!to!challenge!the!hypothesis!of!the!C3!futile!consumption!mechanism,!a!range!of!comparative!assays!were!designed!and!performed!using!the!selected!mutants.!
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In!many!aspects,!these!mutants!behave!in!very!similar!ways!to!the!WT!protein.!Both!WT!and!K173A!offer!covalent!deposition!sites!for!C3(H20)!molecule,!and!CD!spectra!reveal!limited!secondary!structural!differences.!In!terms!of!C3d!binding!affinity,! WT! and! K173A! demonstrate! comparable! binding! affinity,! the! S199A!mutation! increases! the!binding!affinity,!and! the!R231A!mutation!abolishes!C3d!binding!completely!as!previously!reported.!The!measurement!of!hydrodynamic!diameter!suggests!that! the!K173A!mutant! is!more!compact! in! length!compared!to! WT! and! other! Sbi! mutant! proteins,! offering! the! first! clue! for! its! defective!phenotype.!!Comparative!pullQdown!experiments!were!also!conducted!to!study!the!potential!differences! in! Sbi!mediated! protein! complex! formation! in! serum.! Previously! a!pullQdown!experiment!demonstrated!that!Sbi!interacts!with!various!C3!isoforms,!during! which! SbiQIIIQIV! was! immobilized! through! its! lysine! residues! on! a!NHSQcolumn,!and!then!serum!components!retained!on!the!charged!column!were!analyzed.!However!as!shown! in!Section!4.3.6.2,! the! lysine!173!has!a!significant!functional! impact,! therefore! to! preserve! this! residue,! in! this! study,! a! specially!engineered!CQterminal!cysteine!residue!was!used!to!immobilize!various!SbiQIIIQIV!constructs! on! the! solid! phase.! The! new! pullQdown! experiment! revealed! that!SbiQIIIQIV!WT! binds! to! C3,! FH! and! FHRQ1.! But!WT,! R231A,! S199A! and! K173A!mutants! of! SbiQIIIQIV!demonstrate! increasingly!weak!binding! to!FH!and!FHRQ1,!while! C3! binding! level! remains! less! affected.! In! comparison,! no! binding! of!properdin!was!detected,!which!is!considered!the!most!established!upQregulator!of! complement! activation! (Hourcade! 2006),! and! previously! shown! as! an!essential!component!of!C3!futile!consumption!(Fig.4.3.3).!We!proposed!that!Sbi!forms! ternary! complexes! in! combination! with! C3! isoforms! and! FH/FHRQ1,!impaired! ternary! complex! formation! could! lead! to! the! defective! complement!consumption!activity.!!!
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The! Sbi! mutant! library! functional! screening! (Section! 4.3.6.2)! also! indicated! a!putative! C3b! deposition! residue,! S226.! As! this! residues! does! not! fit! with! the!previous!beliefs!regarding!to!the!C3b!deposition!site!on!Sbi!(Burman!et&al.!2008),!in! chapter! 4! not! only! the! authenticity! of! the! covalent! attachment! site! will! be!verified! but! also! the! SbiQC3b! adduct! formation!mechanism! as! a! whole! will! be!securitized.!!
4.4.3(Ternary(complexes(!In! this! study! the! results! confirm! the! previous! findings! (Haupt! et& al.! 2008)! of!stepwise! ternary! complex! formation! between! SbiQIIIQIV,! FH! and! various! C3!isoforms.! In! the! same! study! it!was! also! shown! that! all! TED!domain! containing!fragments!of!C3!are!eligible!constituents!for!ternary!complex!formation,!and!the!minimal!binding!domains!of!FH!were! located!to!domain!19Q20,!despite!domain!15Q20!demonstrated!enhanced!binding!level.!However,!the!new!data!provided!in!this!thesis!lead!to!the!development!of!an!additional!scenario!that!SbiQIIIQIV!could!also!bind!FHRQ1! in!combination!with!various!C3! isoforms.!As!mentioned! in! the!introduction! in! Section! 1.4.4,! the! domain! 18Q20! of! FH! is! almost! identical! in!primary!sequence!to!the!domain!3Q5!of!FHRQ1.!Therefore,!it!is!possible!for!FHRQ1!to! substitute! for! FH! as! an! alternative! tertiary! ligand! of! the! ternary! complex,!which!explains!the!observation!in!the!pullQdown!study!(Section!4.3.9.3).! !!The! formation! of! Sbi:C3! isoform:FHRQ1! ternary! complexes! were! subsequently!verified! by! an! ELISA! approach.! It! was! noticed! that,! for! SbiQIIIQIVWT,! when! C3b!was! used! as! secondary! ligand,! higher! concentrations! of! FH! or! FHRQ1! were!needed!to!reach!binding!saturation,!which!could!be!related!to!the!poor!binding!strength!between!SbiQIIIQIV!and!C3b!(Burman!et&al.!2008).!Moreover!the!ability!to!assemble!FH!or!FHRQ1!containing!ternary!complexes!were!compared!between!the! WT! and! mutant! SbiQIIIQIV.! It! was! found! that! the! mutations! (K173A! and!R231A)! inserted! in! SbiQIIIQIV! impair! the! formation! of! both! types! of! ternary!
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complexes,!regardless!of!the!type!of!C3!isoforms!used.! !Primary! sequence! mapping! of! identified! mutants! reveals! further! insights! into!SbiQIIIQIV! mediated! ternary! complex! assembly.! R231! is! located! within! SbiQIV,!(Upadhyay! et& al.! 2008)! reported! that! the! alanine! substitution!mutation! of! this!residue! abolishes! C3d! concave! surface! binding,! therefore! this! C3! binding!property! is! essential! for! ternary! complex! formation.! K173! is! located! in! the!middle!of!SbiQIII,!the!mutation!of!this!residue!severely!impairs!the!Sbi’s!ability!to!assemble! the! ternary! complex.! Thereby! for! the! first! time! a! defined! functional!role! of! Sbi! domain! III! is! discovered.! Finally,! within! SbiQIIIQIV! S199! is! located!between! SbiQIII! and! SbiQIV,! the! functional! significance! of! this! residue! suggests!that! ternary! complex! formation! requires! synergy! from! both! SbiQIII! and! SbiQIV.!Previously,!SbiQIV!homologue!staphylococcal!proteins!Ecb!and!Efb!were!reported!that!are!able!to!form!ternary!complex!with!FH!in!combination!with!C3b!(Amdahl!
et& al.! 2013).! However,! unlike! Sbi,! Ecb! and! Efb! do! not! contain! any! SbiQIII! like!domains,! therefore! this! suggests! that! the! SbiQIII! domain! is! a! unique!molecular!adaption!specialized!in!mediating!ternary!complex!formation.!!In! order! to! deepen! the! understanding! concerning! the! impact! of! ternary!complexes! on! complement! activation! and! regulation,! using! the! present!structural! biology! data,! models! of! ternary! complexes! are! extrapolated! and!presented!in!Fig.4.4.1.!Initially,!based!on!crystal!structures!of!SbiQIV:C3d!complex!(Clark! et& al.! 2011)! and! FH19Q20:C3d! complex! (Morgan! et& al.! 2011),! a! putative!structural! model! of! ternary! complex! SbiQIV:C3d:FH19Q20! was! constructed!(Fig.4.4.1.A).!Subsequently,!the!FH19Q20!component!of!this!model!was!replaced!by!the!crystal!structure!of!FH!domain!18Q20!(Morgan!et&al.!2012)(Fig.3.4.1.B).!The!location! of! SbiQIII! is! at! the! NQterminal! end! of! SbiQIV,! therefore! based! on! this!model!the!putative!binding!sites!of!SbiQIII!could!be!on!both!FH!domain!18!and!19.!The!putative!ternary!complex!models!of!Sbi,!FH18Q20!in!combination!of!C3!or!C3b!are!also!constructed!(Fig.4.4.1.C!and!D).!Although!in!the!modeling!process!FH18Q20!is!utilized,! given! the!high! sequence! identity!between!FH18Q20! and!FHRQ13Q5,! it! is!
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reasonable!to!assume!they!share!an! identical!3D!structure.! In! fact!apart! from!a!loop! region! in! FH! domain! 20! and! FHRQ1! domain! 5,! the! crystal! structures! of!FHRQ14Q5!and!FH19Q20!are!largely!superimposable(Bhattacharjee!et&al.!2015).!
!In! the! pull! down! study!we! found! Sbi! preferentially! favours! the! formation! of! a!FHRQ1! ternary! complex! over! a! FHQcontaining! complex,! this! suspicion! was!subsequently! confirmed! by! the! ELISA! measurement.! However,! given! the! high!sequence! identity! between!FH18Q20! and!FHRQ13Q5,! the! binding! selectivity! is! very!hard! to! explain.!We!propose! an! explanation!based!on! the!observation! that! the!FHRQ5! that! forms! the! correct! dimeric! state! binds! to! renalQbound! mouse! C3!significantly!better!than!FHRQ5!dimerization!mutant!(Goicoechea!de!Jorge!et&al.!
Figure( 4.4.1:( Structural( models( of( ternary( complex.! (A)! Putative! structural! model! of!SbiQIV:C3d:FH19Q20! ternary! complex.! (B)( Putative! structural! model! of! SbiQIV:C3d:FH18Q20!ternary! complex.(C)( Putative! structural! model! of! SbiQIV:C3:FH18Q20! ternary! complex.(D)!Putative! structural!model!of! SbiQIV:C3b:FH18Q20! ternary! complex.!Putative!SbiQIII! location! is!indicated! by! the! black! dashed! oval.! Protein! data! bank! association! code:! 2WY8! (Sbi:C3d),!3OXU(FH19Q20:C3d),!3SWO!(FH!18Q20),!2A73!(C3),2I07(C3b)!.!
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2013).!A!similar!scenario!could!apply!to!the!formation!of!Sbi:C3:FHRQ1!tripartite!complex.!The!preferential!binding!might!not!be!a!result!of!ligand!selectivity!of!Sbi!but! due! to! the! physiological! dimerization! state! of! FHRQ1.! Differential!glycosylation!of!FHRQ1!could!also!be!a!likely!cause!as!discussed!in!Section!5.5.4.!
(
4.4.4(Binary(complexes(
(In!contradiction!to!previous!findings!(Haupt!et&al.!2008)!that!C3!isoform!binding!is!a!essential! step! for!Sbi! to!bind!FH,! in! this!study,! it!was!shown!that!SbiQIIIQIV!could! directly! bind! to! FH! or! FHRQ1! in! a! concentration! dependent! manner.! As!shown! in! Section! 4.3.10,! it! was! determined! that! when! bound! to! C3! isoforms,!SbiQIIIQIV!demonstrates!significantly!increased!binding!affinities!to!both!FH!and!FHRQ1.!Although!the!structural!basis!of!this!change!in!binding!kinetic!properties!is!elusive,!it!seems!that!binding!of!C3!isoform!is!a!prerequisite!step!for!SbiQIIIQIV!to!achieve!high!affinity!FH/FHRQ1!binding.!!
4.4.5(Functional(significance(of(Sbi(containing(ternary(complexes(!Here,! for! the! first! time! a! functional! connection! between! ternary! complex!formation! and! C3! consumption! is! established.! It! has! been! shown! in! previous!publications!(Goicoechea!de!Jorge!et&al.!2013)!that!FHRQ1!acts!as!an!antagonist!of!FH!to!deregulate!complement!activation,!and!the!deregulatory!activity!is!further!enhanced!by!the!formation!of!homo/heterodimers!of!FHRQ1!with!either!itself!or!other!FHRs!(FHRQ2!&!5).!The!proposed!complement!deregulation!mechanism!is!that!FHRQ1!competes!with!FH!for!C3b!binding,!which!results!in!protection!of!C3b!against!FH!mediated!FI!cleavage.!!!It! was! discovered! that! within! the! ternary! complexes,! SbiQIIIQIV! mediates! the!competitive!binding!between!FH!and!FHRQ1!to!various!C3!isoforms!(e.g.!C3,!C3b!
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and! C3d).! Without! SbiQIIIQIV,! a! 28! times! molar! excess! of! FHRQ1! is! needed! to!replace! 60%! of! C3b! bound! FH! (Goicoechea! de! Jorge! et& al.! 2013),! but! in! the!presence!of!SbiQIIIQIV!at!equal!molar!ratio!(FH:FHRQ1=1:1)!a!similar!reduction!in!FH!binding!is!achieved!regardless!of!the!type!of!C3!isoforms.!This!demonstrates!again!that!Sbi!preferentially!utilizes!FHRQ1!to!form!ternary!complexes,!which!fits!with! the! observation! that! the! Sbi! mediated! FHRQ1! binding! is! 2,9! and! 18! fold!lower! in!Kd! than!the!corresponding!FH!binding!profiles!(Section!4.3.10).!At! the!same! time,! the! positive! relationship! between! ternary! complex! formation! and!protection!of!C3H20!against!FI!cleavage!was!also!demonstrated!(Section!4.3.12.1).! !!One! unique! experiment! presented! in! this! study! involves! the! application! of!FH/FHRQ1! double! depleted! serum.! The! serum! was! purchased! from!Comptech,USA!as!FH!single!depleted!serum,!however!during!downstream!usages,!suspicions!were!raised!that!the!serum!could!be!FH/FHRQ1!double!depleted.!The!pullQdown! experiment! shown! in! Fig.4.3.26.A! confirmed! this! suspicion.! The!verification!of!FH/FHRQ1!doubleQdepleted!status!is!advantageous!for!this!study.!As! shown! in! Fig.4.3.26.B! &! C,! the! individual! and! combined! effects! of! FH! and!FHRQ1! containing! ternary! complexes!were!examined,! the! results! indicated! that!only! the! FHRQ1! containing! ternary! complex! is! required! for! Sbi! triggered! C3!consumption.!!
4.4.6(Complement(inhibitory(activities(of(SbiEIIIEIV(
(The! mutagenesis! studies! of! SbiQIIIQIV! created! several! SbiQIIIQIV! mutants! with!specific!defective!phenotypes.!S199A!and!K173A!demonstrate!impaired!ability!to!form! ternary! complexes,! but! have! normal! C3! binding! activity.! In! comparison,!R231A!lacks!both!abilities.!As!shown!in!Section!4.3.9.4,!the!AP!and!CP!inhibition!profiles!of!these!mutants!vary!considerably.!In!the!following!discussion!section,!the!putative!molecular!mechanisms!are!proposed.!!
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4.4.6.1( CP( complement( assay( demonstrates( inhibition( caused( by(
C3:SbiEIIIEIV(binding(
(
(As!shown!by!Fig.4.3.20,!the!degree!of!CP!activity!inhibition!is!proportional!to!the!preQincubation! time.! But! at! the! same! time,! without! any! preQincubation,! CP!activities!were! differentially! suppressed! by! the! presence! of! SbiQIIIQIV!mutants.!Because! Sbi! triggered! C3! consumption! does! not! take! place! under! CP!experimental! conditions! without! preQincubation,! the! CP! measurement!demonstrates!the!extent!of!Sbi!mediated!inhibition!that!is!not!a!consequence!of!C3!consumption.!The!percentages!of!inhibition!caused!by!SbiQIIIQIV!mutants!with!different! molecular! features! demonstrate! that! the! molecular! basis! consists! of!both!C3!binding!and!ternary!complex!formation.!At!0!min!(Fig.4.3.20.A),!R231A!(no!C3!binding,!no!ternary!complex)!demonstrates!no!CP!inhibition.!K173A!and!S199A!(impaired!ternary!complex!formation)!demonstrate!20%!reduction!in!CP!activity.!Finally,!WT!protein!shows!a!40%!inhibition!in!CP!activity.!As!shown!in!Fig.4.4.2,!apart!from!using!C3!as!substrate,!CP!only!uses!C3b!as!the!component!of!C5! convertase.! Therefore,! by! direct! interactions! and! formation! of! ternary!




al.! 2008),! but! the! ternary! complex! stabilizes! this! interaction,! therefore! K173A!and! S199A! mutants! are! less! potent! as! inhibitors! of! CP! activity! than! the! WT!protein.!
&
4.4.6.2(Sbi(ternary(complexes’(impact(on(AP(C3/C5(convertases(.(!So!far!SbiQIIIQIV!has!been!firmly!established!as!an!activator!of!AP,!therefore!any!inhibition! of! AP! residual! activity! without! preQincubation! (Fig.4.3.20.B)! seems!rather! counterQintuitive.! Given! that! the! assay! plate! surface! has! already! been!universally!coated!with!AP!pathway!complement!activators,! the!presence!of!C3!activator!SbiQIIIQIV!should!not!cause!inhibition!to!a!great!extent.!But!the!opposite!was! observed.! At! 0!min! SbiQIIIQIV!WT! inhibits! AP! activity! by! 90%.! To! explain!these!results!a!new!hypothesis!is!proposed!where!the!SbiQIIIQIV!weakly!inhibits!AP!C3!convertase!activity,!but!heavily!inhibits!AP!C5!convertase!activity.!The!C3!convertase! inhibition! is! shared! among! numerous! Staphylococcal! C3! binding!proteins! (Chen!et& al.! 2010),!which!bind! a! common!binding! surface! on! the!C3b!TED!domain!but! vary! in! their! binding! strength,! Sbi! has! the!weakest! affinity! to!C3b,!this!expands!the!modest!inhibition!of!AP!C3!convertase.! !!The! severe! AP! C5! convertase! inhibition! is! rather! hard! to! explain,! as! AP! C5!convertase! comprises! two! C3b! molecules.! One! possibility! is! that! SbiQIIIQIV!simultaneously! binding! on! two! C3b! molecules! jeopardizes! the! C5! convertase!activity;! another! possibility! is! that! the! inhibition! is! a! result! of! FH/FHRQ1!
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recruitment! via! formation! of! ternary! complexes.! These! two! possibilities! are!evaluated! by! analyzing! C5! convertase! inhibition! activities! of& staphylococcal! C3!binding!proteins,!including!EfbQC,!Ecb!and!SbiQIV.!These!three!proteins!target!the!same!surface!on!TED!domain,!potentially!causing!inhibition!of!both!AP!C3!and!C5!convertases.! Among! these! proteins,! EfbQC! demonstrates! the! strongest! C3b!affinity,!although!it!completely!inhibits!AP!C3!convertase,!it!only!mildly!inhibits!AP!C5!convertase!activity!by!30%!(Jongerius!et&al.!2007).!In!contrast!to!Efb,!Ecb!demonstrates!similar!C3b!affinity!and!similar!C3!convertase!inhibition,!but!it!is!a!better!C5!convertase!inhibitor!(70%!reduction).!This!enhancement!could!be!the!consequence! of! the! recent! discovery! that! Ecb! forms! tighter! ternary! complexes!with!C3b!and!FH!than!EfbQC!(Amdahl!et&al.!2013).!Since!Sbi!has!a!weaker!binding!strength!than!Efb!and!Ecb!to!C3b,!it!is!not!likely!that!the!significant!inhibition!on!AP!C5!convertase!caused!by!Sbi!is!due!to!binary!Sbi:C3b!interaction.!Considering!with! the! example! of! Ecb,! I! conclude! that! SbiQIIIQIV’s! C5! convertase! inhibition!activity! is! largely! due! to! the! formation! of! ternary! complexes.! This! conclusion!correlates!well!with! the!K173A!AP! inhibition!profile,!which!only! shows!a!30%!reduction!in!AP!activity.! !!According! to! the! above! discussion! sections,! Fig.4.4.2! was! constructed! that!summarizes! the! current! theories! about! the! relationships! between! ternary!complexes!and!inhibition!on!CP/AP!activity.!Given!that!SbiQIIIQIV!is!able!to!bind!FH!or!FHRQ1!in!combination!with!various!C3!isoforms,!therefore!in!the!presence!of!SbiQIIIQIV!the!majority!of!the!C3!substrate!presented!to!C3!convertase!is!in!the!form!of! two! types!of! ternary! complexes! (Sbi:C3:FH!or! Sbi:C3:FHRQ1).!After! the!intraQcomplex! conversion! to! C3b,! the! C3b! embedded! in! the! FHRQ1Qcontaining!complex!is!protected!from!proteolytic!inactivation,!but!the!C3b!embedded!in!FH!containing! complex! undergoes! immediate! FI! mediated! cleavage.! Thus! it! is!unlikely! to! participate! in! the! modulation! of! C3/C5! convertase! activity.!Consequently,!by!forming!the!Sbi:C3:FHRQ1!ternary!complex,!Sbi!slightly!inhibits!CP! C5! convertase,! but! strongly! inhibits! AP! C5! convertase.! The! bound! FHRQ1!
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could! be! responsible! for! the! inhibition! of! C5! convertase,! as! demonstrated! by!(Heinen! et& al.! 2009)! that! FHRQ1! inhibits! C5! activation! in! a! doseQdependent!manner.!!
4.4.7(Hypothesis(evaluation( (






! ! !Covalent!deposition!was!one!of!the!first!molecular!features!discovered!about!the!complement!component!C3!molecule.!Following!the!proteolytic!activation!of!C3,!the!nascent!C3b!molecule!utilizes!its!internal!thioester!motif!to!covalently!target!hydroxyl! and! amine! chemical! groups! in! the! surrounding! environment! (Law!&!Dodds! 1997).! Based! on! early! biochemical! experiments,! the! primary! structure!and! covalent! attachment! mechanism! of! the! thioester! motif! were! established,!however! the! complete! working! mechanism! was! not! fully! revealed! until! the!publication!of!the!C3!and!C3b!crystal!structures!(Janssen!et&al.!2005;!Janssen!et&al.!
Figure(5.1.1:(C3(thioester.((A)!Domain!structure!of!C3!(B)!Domain!structure!of!C3b!
(C)!Thiolactone!ring!composed!of!QCysQGlyQGluQGlnQ.!The!polypeptide!backbone!is! in!black.!The!sideQchains!are! in!blue,!and! the! thioester! in! red.!(D)! Simplified!covalent!binding!mechanism!of!C3.!CQD!taken!from!(Law!&!Dodds!1997).!1!
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2006).! The! C3! thioester! motif! consists! of! four! residues,! QCysQGlyQGluQGlnQ!(Nonaka!et&al.!1985;!de!Bruijn!&!Fey!1985),!forming!a!thiolactone!ring!structure,!in! the! immunological! inert! C3! molecule.! This! motif! is! facing! inward! and! the!thioester! bond! is! protected! by! a! hydrophobic! pocket! formed! by! the!MG7! and!MG8!domains!of!C3!(Fig.5.1.1.A).!However!in!the!C3b!molecule!(Fig.5.1.1.B),!the!dramatic! conformational! changes! expose! this! motif! to! the! surrounding!environment.! Catalyzed! by! a! nearby! histidine! residue! (H1106),! the! exposed!thioester! bond! is! highly! susceptible! to! nucleophilic! attacks! from! hydroxyl! or!amine!groups,!resulting!in!the!formation!of!ester!or!amide!linkages!(Fig.5.1.1.D).!The!thioester!motif!is!highly!conserved!within!the!macroglobulin!protein!family!including! C3! and! C4! molecules! from! various! animal! species! (Blandin! 2004).!However,!the!subtle!amino!acid!differences!within!these!molecules!diversify!the!kinetic!properties!and!covalent! linkage!preference!of! their!embedded! thioester!motif.! It! is! known! that!human!C3! thioester!prefers! to! form!ester! linkages!over!amide!linkages!(Law!et&al.!1979).!! !The!C3b!deposition!process!plays!a!crucial!role!in!fighting!infections,!as!the!C3b!molecules! deposited! on! the! pathogen! surface! signal! a! range! of! innate! and!adaptive! immune! responses.! In! addition! to! the! immunological! signaling!functions,! as! part! of! the! complement! activation! cascade,! the! deposited! C3b!molecule! is!also! involved! in!determining! the! fate!of! the!complement!activation!cascade.! ! It! has! become! increasingly! clear! that! the! proteolytic! stability! of! the!surface!deposited!C3b!molecule!is!the!key!property!utilized!by!the!complement!system!to!differentiate!self!and!nonQself!surfaces!(Morgan!et&al.!2011;!Kajander!
et& al.! 2011).! Targeted! by! serum! complement! regulators,! C3b! molecules! are!degraded! rapidly! to! iC3b! and! C3d! on! selfQsurface,! but! when! deposited! on! a!nonQself!surface,!the!halfQlife!of!deposited!C3b!can!be!dramatically!prolonged!at!most! 10Qfold! (Meri! &! Pangburn! 1990),! which! increases! the! probability! of!complement!activation!and!amplification!on!the!particular!surface.! !!
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The!current!theory!for!the!molecular!basis!of!this!mechanism!is!that!the!chemical!property! of! a! particular! biological! surface! could! either! attract! or! repel! the!recruitment!of!C3b!binding!complement!regulators! (e.g.!FH).! In!addition! to! the!detailed! characterization! of! the! biological! surface! (e.g.! host! cell! membrane),!which! actively! downQregulates! surface! complement! activity,! various! biological!surfaces! have! also! been! shown! to! be! able! to! extend! the! halfQlife! of! the! C3b!molecule,! thereby! facilitating! complement! activation.! LongQchain!polysaccharides! (Pangburn! 1989a;! Meri! &! Pangburn! 1990)! as! the! main!component! of! bacterial! cell!walls!were! demonstrated! to! be! able! to! extend! the!halfQlife! of! the! deposited! C3b! molecule.! Meanwhile,! it! was! also! shown! that!forming! adducts! with! serum! proteins! can! be! a! mechanism! for! increasing! C3b!serum!halfQlife!(Pangburn!1989b).!Given!the!almost!nonQdiscriminative!nature!of!the!C3!thioester!reactivity,!C3b!can!be!covalently!attached!on!almost!any!kind!of!biological!target.!However,!C3b!preference!for!deposition!targets!is!documented.!Complement!component!C3b,!C4b!are!heavily!targeted!by!nascent!C3b!molecules!(Jelezarova! &! Lutz! 1999),! but! IgG! is! accredited! as! the! most! prominent! C3b!deposition! target! in! the! serum.! Several! inQdepth! investigations! on! IgGQC3b!adduct!formation!revealed!that!C3b!can!weakly!interact!nonQcovalently!with!IgG!molecule!(Kulics!et&al.!1983)!and!serineQ132!on!the!IgG!surface!is!responsible!for!the!majority! of! C3b! deposition! (Vidarte! et& al.! 2001;! Shohet! et& al.! 1993).!More!importantly,!a!concentration!dependent!relationship!was!demonstrated!between!purified!IgGQC3b!adduct!and!the!extent!of!AP!C3!consumption!(Fries!et&al.!1984);!thereby! suggesting! that! the! C3b! adduct! can! function! both! as! facilitator! and!initiator!of!C3!activation!through!complement!AP.!!Normally! C3b! deposition! on! bacterial! proteins! is! considered! a! form! of!antigenQopsonin!interaction,!however!in!this!study,!the!complement!modulatory!function!of! Sbi!prompts!us! to! reQevaluate! the!purpose!and! the! ramifications!of!SbiQC3b! adduct! formation.! Although! in! chapter! 4,! it! was! demonstrated! that!Sbi:C3:FHRQ1!ternary!complexes!play!an!irreplaceable!role!in!the!mechanism!of!
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C3! futile! consumption,! the! complement!modulating! impact! of! SbiQC3b! adducts!should!not!be!underestimated!or!ignored.!Thus,!in!this!chapter,!I!aim!to!establish!protocols! for! the!production!of!SbiQC3b!adducts,! to! identify! the!C3b!deposition!site/s!on!SbiQIIIQIV,!and!finally!to!elucidate!the!potential!complement!modulatory!function!of!SbiQC3b!adduct.!!
5.2(Materials(&(Methods:(!
5.2.1(SbiEIIIEIV(recloning(into(pET28a(vector(
(Using!pQE30SbiQIIIQIV!plasmid!as!the!PCR!template,!a!gene!fragment!corresponding!to!Sbi!domain!III!and!IV!(from!I154!to!V266)!was!amplified!by!PCR!reaction!using!primers!(Forward:!5’Q!CGCGGATCC!ATTGAAAATGCGGATAAAGCAATTAAAGATTT!CQ3’! Reverse:! 5’Q! CCCAAGCTTCGCCACTTTCTTTTCAGCATCTTTTTGQ3’).! The! PCR!product!flanked!by!BamHI!and!HindIII!restriction!sites!was!then!double!digested,!purified!and!ligated!with!double!digested!pET28a!plasmid.!After!transformation!of! the! ligation!mixture! into!E.coli!DH5α!cell! line,! colony!PCR!was!performed! to!screen!for! insert!containing!clones.!The! integrity!of! the!DNA!insert!was! further!verified! by! DNA! sequencing.! Sequence! verified! pET28aSbiQIIIQIV! vectors! were!transformed!into!E.coli!BL21(DE3).!Following!the!standard!expression!protocol!their! expression! profiles! were! analyzed! by! SDSQPAGE.! Finally,! for! experiment!described! in! Section! 5.2.2! one! pET28aSbiQIIIQIV!clone!was! selected! for! largeQscale!production!of!SbiQIIIQIV28a!following!the!method!described!in!Section!2.3.2.!!
5.2.2(LargeEscale(preparation(&(labeling(of(SbiEC3b(adduct(
(Alternative!pathway!activation!was!reconstituted& in&vitro! to!achieve! largeQscale!production!of!the!SbiQC3b!adduct.!For!a!typical!reaction!300!μg!of!purified!C3,!50!μg!of!SbiQIIIQIV28a,!6!μg!of!factor!B,!50!ng!of!factor!D!and!25!ng!of!factor!P!were!mixed!to!final!volume!of!120!μl.!All!components!were!buffer!exchanged!into!PBS!pH7.2!buffer!in!advance.!The!reaction!was!kept!at!37°C!for!1!hour.!
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!In! order! to! produce! biotinylated! SbiQC3b,! in! addition! to! the! components!described!above,!200!μM!of!iodoacetylQPEG2QBiotin!(Fig.3.2.2)!was!also!added.!A!lightly! alkine! pH! environment! maintained! by! PBS! buffer! pH! 8.2! was! used! to!ensure!the!labeling!of!nascent!SbiQC3b.! !!
5.2.3(SbiEC3b(adduct(purification(
(Purification!of!SbiQC3b!adducts!was!achieved!by!using!a!spinQcolumn!loaded!with!metal!affinity!chromatography!resin.!Following!in&vitro!SbiQC3b!adduct!formation!described! by! Section! 5.2.2,! the! reaction!mixture!was! loaded! on! 300! μl! of! Ni2+!sepharose! resin,! washed! intensively! with! HisA! buffer! and! highQsalt! stringent!washing!buffer! (50!mM!TrisQHCl,!1!M!NaCl!and!pH!7.5)!and! finally!eluted!with!300!μl!of!HisB!buffer.!Mild!centrifugation!speed!(1000!g)!was!used!in!all!buffer!exchange! and! washing! steps! to! avoid! damage! to! the! spinQcolumn.! Protein!samples! were! collected! during! each! step! of! the! preparation! of! biotinlyated!SbiQC3b! adducts.! Afterwards! protein! samples! were! analyzed! by! SDSQPAGE,!antiQBiotin!and!antiQSbi!Western!blots.!!
5.2.4(Hydroxylamine(sensitivity(assay( (
(TwoQdimensional! SDSQPAGE! analysis! (reducing! condition,! 8%! or! 12%!acrylamide! gel! in! both! dimensions),! after! the! Sbi! treated! human! serum! was!separated!by!the!1st!dimension!gel,!the!protein!containing!gel!strip!was!excised!and!soaked!in!1!M!hydroxylamine!solution!(pH!10)!for!1!hour!at!37°C.!Then!the!gel!strip!was!recharged!with!1×!SDS!loading!buffer,!rotated!90!degree!and!loaded!on! a! 2nd! dimension! gel.! An! antiQSbi!Western! blot! was! then! used! to! study! the!location! of! SbiQC3b,! SbiQiC3b! adducts! and! the! potentially! dissociated! SbiQIIIQIV!molecule.!antiQC3d!Western!blot!was!also!carried!out!to!confirm!the!effectiveness!of!hydroxylamine!treatment.!
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!An!alternative!version!of!the!2D!gel!based!hydroxylamine!sensitivity!assay!was!designed!based!on!purified!SbiQC3b!adduct.!After!separating!the!purified!SbiQC3b!adduct! using! a! 12%! acrylamide! gel,! guided! by! preQstained! protein! molecular!weight!markers,!the!gel!segment!located!above!120!kDa!was!excised!and!treated!with!hydroxylamine!solution!(pH!10)!for!1!hour!at!37°C.!After!treatment,!the!gel!segment! was! reQcharged! with! SDS! sample! buffer! and! loaded! on! a! 15%!acrylamide! 2nd! dimension! gel.! The! location! of! Sbi! was! then! revealed! by!polyclonal!antiQSbi!Western!blot.!
(
(







(In! this! chapter,! SbiQIIIQIVpQE30! mutant! proteins! were! expressed! and! purified!based!on!the!method!described!in!Section!3.2.1.!!




(To!100!μl!of!1!mg/ml!of!SbiQC3b!adduct,!the!trichloroacetic!acid!(TCA)!solution!precipitation! procedure! was! carried! out! according! to! Section! 5.2.9.! 30! μl! of!reducing!and!denaturation!buffer!(50!mM!Tris!pH!7.4,!6!M!guanidine!HCl,!and!5!mM!DTT)!was!added!to!dissolve!the!precipitated!protein!pellet,!and!boiled!for!15!min.! Next,! 270! μl! of! 50!mM! ammonium! carbonate! buffer! pH8.0!was! added! to!dilute!the!guanidine!HCl!concentration!to!0.6!M.!For!each!digestion!reaction,!3!μg!of!Trypsin!Gold!protease!(Promega)!was!added,!and!left!in!a!37°C!incubator!with!shaking!(200!rpm)!for!at!least!20!hours.! !!Following!the!digestion!reaction,!10!μg!of!soybean!trypsin!inhibitor!was!added;!the!trypic!peptide!digest!was!then!mixed!with!100!μl!of!preQwashed!neutravidin!resin! in! 50! mM! ammonium! bicarbonate.! After! 15! min! incubation,! the! bound!neutravidin!agarose!beads!were!pelleted!by!centrifugation!(1000!g)!and!washed!extensively!with!PBS!buffer!and!with!sterile!water.!To!elute!the!bound!peptides!from!the!neutravidin!resin,!200!μl!of!elution!buffer!(8!M!guanidine!HCl!pH!1.0)!was! added,! after! 5! min! of! room! temperature! incubation.! Neutravidin! agarose!was! pelleted,! and! peptideQcontaining! supernatant! was! collected.! Finally! to!remove! guanidine! HCl! from! mass! spectrometry! (MS)! samples,! the! eluted!peptides! was! desalted! using! C18! MS! sample! cleanup! column! as! described! in!Section!5.2.10.!
,
5.2.9(TCA(precipitation(
(100%! (w/v)! TCA!was!made! by! adding! 5! g! TCA! to! 3.5!ml! of! sterile!water,! the!solution!was! stored!at! room! temperature.!To!precipitate!proteins,!1!volume!of!
! 155!
TCA!stock!was!added!to!4!volume!of!protein!solution.!The!precipitation!reaction!was! held! for! 10!min! on! ice,! and! then! the! precipitated! protein!was! pelleted! by!centrifugation!at!(13000!g).!Supernatant!was!removed!and!discarded;!the!pellet!was! then! washed! with! several! cycles! of! iceQcold! acetone! solution! (200! μl! per!cycle).!Finally!the!protein!pellet!was!dried!at!95°C!for!5!min.! ,
,
5.2.10(C18(peptide(cleanEup(
(To! prepare! protein! or! peptide! samples! for!mass! spectrometry! analysis,! Pierce!C18! Spin! Columns! (Thermo! Scientific)! were! used! to! desalt! and! concentrate!samples!at!once.!Briefly,!2!cycles!of!200!μl!of!50%!(v/v%)!methanol!washing!step!were!performed!to!activate!the!C18!resin.!Then!the!resin!was!washed!twice!with!200! μl! of! equilibration! buffer! (5%! acetonitrile! (ACN),! 0.5%! formic! acid).! A!maximum!of!150!μl!of!sample!could!be!loaded!at!a!time,!so!if!the!sample!volume!was!larger!than!150!μl,! the!sample!was!divided!into!aliquots!of! less!than!150μl!and!these!applied!to!the!column!sequentially.!After!sample! loading,! the!column!was!washed!repetitively!with!equilibration!buffer.!For!desalting!8!M!guanidine!HCl,!4!cycles!of!200μl!washes!were!performed.!Finally!the!two!20!μl!100%!ACN!elution! steps! were! utilized! to! yield! protein/peptide! samples! that! were!compatible!with!ESIQToF!mass!spectrometry!analysis.!
,
5.2.11(Peptide(mass(determination(!Peptide! mass! spectra! were! acquired! using! the! method! described! in! Section!3.2.17!with!slight!modifications.!For!each!mass!spectrum,! the!multiple!charged!mass! peak! was! deconvoluted,! and! the! peptide! mass! was! assigned! using! the!Masshunter!program!(Agilent).!
,
5.2.12(SbiEIIIEIV(trypin(digestion(simulation(SbiQIIIQIV! trypic! fragments! were! generated! using! the! “PeptideMass”! program!
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available! on! the! ExPAsy! bioinformatics! resource! portal!(http://web.expasy.org/peptide_mass/).! The! primary! sequence! of! SbiQIIIQIV28a!was! submitted! and! trypicQdigest! peptide! masses! were! calculated! using! the!assumptions! that! peptide! carries! +1! positive! charge! and! is! monoisotopic.!Considering! the! ! ! possible! insufficient! digestion! of! the! SbiQC3b! adduct,! trypic!peptides! containing! up! to! 5!missed! cleavage! events!were! included! in! the! final!simulation!report.!The!digestion!simulation!was!shown!in!appendix!Fig.9.8.!!!
5.2.13(ELISAEC3(binding(assay(
(For! the! C3! binding! ELISA,! 1μg/well! of! SbiQIIIQIV! or! SbiQIIIQIV! mutants! were!coated! on! a! Nunc! MaxiSorp! plate.! After! blocking! (5%! Skimmed! milkQPBST),!purified!C3!was!added!for!1!hour!at!room!temperature.!The!concentration!of!the!analyte!can!be!either!a!fixed!value!or!a!variable!depending!on!the!specific!assay.!After!the!C3!capturing!step,!polyclonal!goat!anti!C3!antibody!(1:100,000!dilution,!Complementech,! USA)! was! applied.! After! incubation! and! thorough!washing! of!the!plate,!secondary!antibody!HRP!conjugate!against!goat!IgG!(1:18,000!dilution)!was! added.! Finally,! 1Qstep! Ultra! TMB! ELISA! substrate! solution! was! used! to!quantify!C3/C3b!binding.!!
5.2.14(Complement(assay(






(The! C3! activation! assay! was! carried! out! based! on! a! previously! described!protocol!(Section!3.2.7).!
(
5.2.16(Analysis(of(C3(consumption(property(of(C3b(and(SbiEC3b(The!assay!was!inspired!by!the!C3!consumption!experiment!described!in!(Fries!et&
al.!1984),!with!necessary!modifications.!To!compare!the!C3!consumption!activity!of! C3b! and! SbiQC3b,! the! first! challenge!was! to! eliminate! free! SbiQIIIQIV28a! (17.9!kDa)! contamination! from! the! SbiQC3b! sample.! To! overcome! this! handicap,!SbiQC3b! (190! kDa)! was! repetitively! concentrated! and! diluted! using! a! 30! kDa!cutQoff!Vivaspin!concentrator.!PBS!supplemented!with!1!M!NaCl!buffer!was!used!during!this!process,!until!an!equivalent!of!3125×!dilution!(5!cycles!of!5×!dilution)!was! achieved.! Then! the! SbiQC3b! sample! was! buffer! exchanged! to! normal! PBS!buffer!by!the!standard!method.!Table!5.2.3!Composition!of!samples!used!to!compare!C3!consumption!by!C3b!and!SbiQC3b!
!Prior! to! the! experiment,! the! protein! concentrations! of! C3b! and! SbiQC3b! were!determined,!and!adjusted!to!5.2!μM!(equivalent!of!0.92!mg/ml!of!C3b,!1!mg/ml!of! SbiQC3b).! 2×HSS!was! reconstituted!with! 100! μl! of! water! containing! 10!mM!MgCl2!and!20!mM!EGTA.!To!set!up!the!C3!consumption!reactions!(Table!5.2.3),!2×MgEGTAQHSS!was!diluted!once!by!adding!various!amount!of!C3b!or!SbiQC3b!
Group! C3b/SbiQC3b!added!(μl)! PBS!(μl)! 2×MgEGTAQHSS!(μl)! C3b/SbiQC3b!concentration!(μM)!
C3b! 6! 0! 6! 2.6!4! 2! 6! 1.7!2! 4! 6! 0.88!1! 6! 6! 0.44!
SbiQC3b! 6! 0! 6! 2.6!4! 2! 6! 1.7!2! 4! 6! 0.88!1! 5! 6! 0.44!No! 0! 6! 6! 0!
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together! with! filtered! PBS.! Care! was! taken! to! mix! the! reaction! mixture!thoroughly! and! to! start! all! the! consumption!experiments! simultaneously.!After!incubation!at!37°C!for!1!hour!in!a!thermocycler,!C3!consumption!was!evaluated!using!the!AP!complement!assay!kit.!At!the!same!time,!treated!serum!(1!μl)!was!added! to! 20μl! of! 1×SDSQPAGE! loading! buffer,! 10μl! of! the! sample! was! then!analyzed!by!antiQSbi,!antiQC3a!and!antiQfactor!B!Western!blots.! !!
5.2.17(Factor(I(depleted(serum(cleavage(assay(
(The!active!C3!in!factor!I!depleted!serum!was!firstly!consumed!by!incubating!the!serum!with!0.5!mM!MgCl2! at!37°C! for!1!hour.!Afterward,! SbiQC3b!adduct! (0.24!μg/μl)! or! free! C3b! (0.24! μg/μl)!molecule!was! added! to! C3! exhausted! Factor! I!depleted! serum.! The! incubation! was! divided! into! two! groups! according! to!whether!SbiQIIIQIV!WT!(3!μM)!was!added!or!not.!Cleavage!reaction!was!carried!out!at!50%!v/v!serum!concentration,!dilution!was!made!by!PBSQMg2+(PBS!with!1!mM!MgCl2).!At!0!min!purified!factor!I!was!added!to!the!final!concentration!of!4!ng/μl.! Serum! samples! were! retrieved! at! 0,! 5,! 10,! 15,! 30! and! 60! min.! An!equivalent! of! 0.5! μl! of! 100%! serum! was! analyzed! using! antiQSbi! or! antiQC3d!Western!blots.!!
5.3(Results:(
(Previous!studies!have!demonstrated!that!SbiQIIIQIV!is!a!prominent!transacylation!target! of!metastable! C3b!molecules.! The! SbiQC3b! adduct!was! also! proposed! to!behave! like! an! IgGQC3b! adduct! (Burman! et& al.! 2008),! by! offering! resistance! to!factor! I! mediated! cleavage! and! facilitating! the! activation! of! the! alternative!pathway.!The!work!described!here!also!shows!that!the!process!of!SbiQC3b!adduct!formation! synchronizes! with! the! progression! of! C3! consumption! (Fig.4.3.2).!However,!using!our!Western!blot!based!C3!activation!assay!(Section!4.3.6.2),! it!would!be!premature!to!conclude!whether!the!SbiQC3b!adduct!is!the!prerequisite!
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condition!of!C3!consumption!or!the!consequence!of!C3!consumption.!Therefore!purified! SbiQC3b! adduct! would! be! ideal! for! the! performance! of! detailed!biochemical!analyzes.! !!Purification!of! the!SbiQC3b!adduct! from!serum! is!hampered!by! the!existence!of!other!prominent!transacylation!target!such!as!IgG!and!serum!albumin,!affecting!the!quantity!and! the!purity!of!SbiQC3b!adduct!derived!by! this!method.!We!also!experienced!difficulties!with!the!affinity!of!the!SbiQC3b!adduct!for!the!Ni2+!resin,!and!decided!to!introduce!an!additional!(CQterminal)!hisQtag.!The!first!part!of!this!chapter!describes!the!results!of!the!reQcloning!of!SbiQIIIQIV!into!a!pET28a!vector!with! a! second! hisQtag.! In! addition,! a! protocol! for! making! SbiQC3b! using! a!reconstituted!alternative!pathway!was!also!provided.!!
5.3.1(SbiEIIIEIV(recloning(to(the(pET28a(vector(
(
Figure(5.3.1:!Cloning(of(the(SbiEIIIEIV(gene(into(the(pET28a(vector.!(A)!Schematic!diagram!shows! SbiQIIIQIV! constructs! in! two! different! vectors.( (B)! Agarose! gel! showing! BamHI! and!HindIII! double! digested! pET28a! vector! and! the! PCR! product! of! SbiQIIIQIV! gene! fragment.( (C)!Agarose!gel!analysis!of! colony!PCR!screening! for!SbiQinsertQcontaining! colonies.!The!expected!size!of!the!PCR!product!is!around!0.4!Kb.!!
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Utilizing!pQE30SbiQIIIQIV!as!a!template,!the!SbiQIIIQIV!gene!fragment!from!I154!to!V265!was! amplified! by! PCR! reaction! using! primers! containing! BamHI! and! HindIII!restriction!sites.!An!agarose!gel!electrophoresis!analysis!of! the!doubleQdigested!Sbi! gene! insert! and!pET28a!vector! is! shown! in!Fig.5.3.1.B.!After! a! standard!T4!ligase!reaction,!the!ligated!pET28aSbiQIIIQIV!construct!was!then!transformed!into!an!
E.coli&DH5α!cell!line.!The!efficiency!of!the!ligation!reaction!was!then!checked!by!colony!PCR!reaction.!A!total!of!5!colonies!were!selected,!which!all!contained!the!SbiQIIIQIV!gene!insert!(Fig.5.3.1.C).!Clones!1,!2!and!3!were!cultured!overnight! in!LB!medium! and! the! expression! vectors!were! purified! by! a! standard!miniprep!protocol.! The! incorporation! of! the! correct! Sbi! insert! was! verified! by! DNA!sequencing! (Appendix! 9.1.1.6).! Individual! expression! vectors! were! then!transformed! into! E.coli! strain! BL21(DE3)! and! screened! for! the! expression! of!SbiQIIIQIV28a.! Fig.5.3.2! shows! that! after! IPTG! induction! all! three! clones! show!overQexpression! of! a! recombinant! protein! corresponding! to! the! size! of!SbiQIIIQIV28a.!
!Clone! 1!was! utilized! for! the! largeQscale! production! of! SbiQIIIQIV28a.! The! soluble!fraction! of! a! 1! Liter! induced! culture! was! loaded! on! a! 1ml! Histrap! FF! column!using! a! ÄKTA! purifier.! The! bound! protein!was! eluted!with! a! gradient! of! HisB!
Figure( 5.3.2:( SDSEPAGE( screening(
of( SbiEIIIEIV28a( expression(
conditions.! After! induction! with! 1!mM! IPTG! at! 37°C.! For! every! clone,!2Qhour! and! 4Qhour! postQinduction!samples! were! analyzed.! Before!induction! sample! is! labeled! “BI”.!SbiQIIIQIV28a,!with!an!expected!size!of!17.9! kDa! is! located! slightly! higher!than!the18.4!kDa!weight!marker.!
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5.3.2.1(Generation(and(purification(of(SbiEC3b(adduct!!The! difficulty! of! purifying! the! SbiQC3b! adduct! from! serum! prompted! the!development! of! an! alternative! route! to! prepare! the! SbiQC3b! adduct.! There! are!several! obstacles! that! are! difficult! to! overcome! when! attempting! to! purify!SbiQC3b!from!serum.!Firstly,! large!amounts!of!SbiQIIIQIV!are!required,!given!that!C3!serum!concentration!is!not!easily!changeable.!Secondly,!due!to!the!existence!of! C3b! processing! enzymes! (e.g.! factor! I),! SbiQC3b! rarely! remains! intact! after!
Figure( 5.3.3:! Ni2+( affinity( chromatography( and( SDSEPAGE( profile( of( SbiEIIIEIV28a(
purification.! (A)!A! chromatogram! of! the!Ni2+! affinity!purification,! volume! (ml)! and! fractions!are!shown!on!XQaxis.!Peak!fractions!are! labeled!2Q4!and!flowQthrough!is!labeled!5.!Absorbance!at!280!nm,!solvent!conductivity!and!percentage!of!buffer!B!are!colour!coded!as!shown!on!the!graph.!The!protein!was!purified!using!a!1!ml!Histrap!FF!column,!eluted!with!12!column!volumes!of!HisB!gradient.!(B)!Coomassie!stained!gel!of!SbiQIIIQIV28a!purification,!Lane!1!soluble!fraction!before! purification,! 2Q4! purified! peak! fractions! and! 5! flowQthrough.! pET28aSbiQIIIQIV,! with! an!expected!size!of!17.9!kDa!is!located!slightly!higher!than!18.4!kDa!weight!marker.! !
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prolonged! incubation.! Thirdly,! various! metal! binding! serum! proteins! usually!coQpurify! with! the! SbiQC3b! adduct.! Finally,! the! presence! of! other! prominent!transacylation! targets! usually! compete! with! SbiQIIIQIV! for! C3b! deposition,!therefore!only!a!fraction!of!the!metastable!C3b!is!actually!deposited!on!SbiQIIIQIV.!!To! overcome! this! inefficient! and! timeQconsuming! procedure,! SbiQIIIQIV28a! was!added!to!purified!C3!in!combination!with!other!alternative!pathway!components!(e.g.! factor! B,! D! and! P).! Using! this! reconstituted!AP! system,! a! large! amount! of!unprocessed! SbiQC3b! adduct! was! generated! in! a! considerably! short! period! of!time! (Fig.5.3.4.A).! The! SbiQC3b! adduct! was! then! purified! using! a! N2+! affinity!sepharose! resin! loaded! in! a! spinQcolumn! (Fig.5.3.4.B).! The! purified! SbiQC3b!adduct!was! also! analyzed! by! antiQSbi!Western! blot! (Fig.5.3.4.C)! to! confirm! the!deposition!of!Sbi!on!C3b!α’!chain.!
Figure( 5.3.4:( Generation( and( purification( of( SbiEC3b( adduct.! (A)! SDSQPAGE! analysis! of! AP!activation! and! C3b! deposition! processes.! Lane! 1,! before! AP! activation.! C3! αQchain! appears! as! a!single!band.!Lane!2,!after!AP!activation.!C3!αQchain!converts! to!α’Qchain!and!SbiQC3bQα’Qchain.!(B)(SDSQPAGE! analysis! of! purified! SbiQC3b! adduct.! Lane! 1Q2,! two! elution! fractions! of! N2+! affinity!purification.!SbiQC3b!adduct!comprises!of!SbiQC3bQα’Qchain!and!C3!β!chain.!Small!amount!of!C3b!is!indicated! by! the! faint! C3! α’Qchain! band.! These! two! samples! also! contain! nonQdeposited! SbiQIIIQIV!protein,!but!this!is!not!retained!on!the!8%!acrylamide!gel.!(C)!An!antiQSbi!Western!blot!confirms!the!putative!SbiQC3bQα’Qchain!band!contains!Sbi.!
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5.3.2.2(Chemical( properties( of( the( covalent( linkage( between( Sbi( and( C3b(
molecule!




SbiEC3b( adduct.!(A)! After! hydroxylamine! treatment! the! locations!of! the!SbiQC3b!adduct! were! determined! by! antiQSbi! western! blot.! (B)! After! hydroxylamine!treatment! the! locations! of! C3b/iC3b! fragments! were! determined! by! antiQC3d!Western!blot.!“SPQiC3b”!is!an!abbreviation!of!serum!protein!iC3b!adduct.!(C)!After!hydroxylamine! treatment! the! locations! of! SbiQC3b! adduct! were! determined! by!antiQSbi!western!blot.!The!2nd!dimension!was!a!12%!acrylamide!gel! that!captures!small!molecular!weight!SbiQIIIQIV.!Lane!1!in!all!blots!was!Sbi!treated!serum!sample!without! hydroxylamine! treatment.! OnQdiagonal! spots! are! highlighted! by! pink!dashed!square.!OffQdiagonal!spots!are!highlighted!by!yellow!dashed!square.!
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Figure( 5.3.6:( Hydroxylamine( sensitivity( assay( using( purified( SbiEC3b(
adduct.!(A)!SDSQPAGE!profile!of!purified!SbiQC3b!adduct.!Before!staining,!the!band! highlighted! by! red! dashedQline! square! was! excised! and! treated! with!hydroxylamine.! (B)! 2nd! dimension! SDSQPAGE! analysis! of! hydroxylamine!treated!SbiQC3b!α’Qchain.!(C)(2nd!dimension!antiQSbi!Western!blot!analysis!of!hydroxylamine!treated!SbiQC3b!α’Qchain.! !
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5.3.2.3(The(potential(adduct(formation(sites(on(SbiEIIIEIV(!
!The!exact!adduct!formation!site(s)!on!SbiQIIIQIV!have!been!a!subject!of!conjecture!for!years!based!on!various!circumstantial!evidence.!Initially,!(Burman!et&al.!2008)!proposed! that! the! transacylation! targets! are! the! hydroxyl! group! containing!residues!located!within!Sbi!domain!III.!This!assumption!was!made!based!on!the!fact!that!neither!C3!consumption!nor!covalent!adduct!formation!occurred!in!the!absence!of!SbiQIII.!However,!two!years!later,!the!crystal!structure!between!SbiQIV!
Figure( 5.3.7:( Crystal( structure( of( the( Sbi( domain( IV( binding( on( the(
convex(surface(of(C3d.!(A)!SbiQIV!(light!blue)!binding!to!the!convex!surface!of!C3d! (green),! the! image!was! created!using! PDB! file!2WY7.( (B)! A! closeQup!image!of! the! SbiQIV:C3d! interaction.!Q1013! in! the! thioester! region! of! C3d! is!able!to!form!ester!or!amide!linkages!with!hydroxyl!or!primary!amine!groups.!On!Sbi!domain!IV,!K212!and!S213!are!the!closest!potential!deposition!targets.!Other! possible! deposition! targets! in! the! vicinity! are! S199,! S219,! K220! and!S226.!In!this!structure,!D208!is!the!closest!residue!to!Q1013.!
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and! the!C3d! fragment!prompted! the!emergence!of!an!alternative!possibility.! In!the!crystal!structure,!two!antiQparallel!SbiQIV!molecules!bind!to!both!concave!and!convex! surfaces! of! C3d,! this! dual! binding! model! was! supported! by! a! NMR!analysis! (Clark! et& al.! 2011)! and! an! in& silico&protein! binding! dynamic!modeling!study! (Gorham! et& al.! 2014).! The! convex! surface! binding! model( (Fig.5.3.7)(revealed!SbiQIV!making!a!close!contact!with!the!thioester!region!of!C3d,!placing!Sbi!residues!K212!and!S213! in!close!proximity!to! the!thiolactone!ring!component!Q1013!in!C3d.! !!
!Using! the! previous! information! and! our! recent! finding! that! C3b! deposition! on!SbiQIIIQIV!can!occur!on!both!hydroxyl!and!amine!containing!residues,!one!clear!conclusion! that! emerges! is! that! there! could! be! multiple! deposition! sites! on!SbiQIIIQIV.! Therefore! an! accumulative! mutagenesis! strategy! (Fig.5.3.8)! was!utilized!to!eliminate!groups!of!potential!transacylation!targets!on!Sbi!domain!III!
Figure(5.3.8:(SbiEIIIEIV(single(and(multiple(mutants(used(during(the(adduct(
formation( site( screening.( (A)! Sequential! incorporation! of! domain! III! lysine!mutation.!(B)(Sequential!mutagenic!depletion!of!domain!III!hydroxyl!containing!residues.!(C)!Sbi!domain!IV!single!mutants!and!multiple!mutants.!
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and!IV,!aiming!to!pinpoint!the!locations!of!adduct!formation.!Firstly!a!quadruple!mutant! of! Sbi! domain! III! residues! (Fig.5.3.8.A)! was! made! by! the! sequential!substitution!of!D172,!K168,!K162!and!K159!to!alanine.!Secondly,!a!triple!mutant!(Fig.5.3.8.B)! of! Sbi! domain! III! hydroxyl! residues! was! made! by! the! sequential!substitution! of! S174,! S181! to! alanine! and! Y177! to! phenylalanine.! Finally,!according!to!the!C3d!convex!surface!binding!of!Sbi!domain!IV,!a!double!mutant!of!K212A!and!S213A!was!made,!based!on!which!S219A!and!K220A!mutations!were!then! incorporated! for! the! generation! of! a! K212AQS213AQS219AQK220A!quadruple!mutant!(Fig.5.3.8.C).!!
5.3.2.4(Mutagenic(PCR(reactions(




(After! the! successful! incorporation! of!multiple!mutations! into! the! pQE30SbiQIIIQIV!plasmid,! the!mutated! plasmids!were! extracted! and! transformed! into! the!E.coli&expression! cell! line! BL21! (DE3).! The! mutant! proteins! were! expressed! and!purified!using!the!same!protocol!as!the!WT!SbiQIIIQIV!(Section!3.2.1).!After!IPTG!induced!overQexpression,!E.coli! cells!were! lysed! and! solubilized! in!HisA!buffer.!The!soluble!fraction!of!the!cell!was!then!loaded!on!a!1ml!Histrap!FF!column.!The!purification!of! SbiQIIIQIV!multiple!mutants! is! shown!by!a! typical! chromatogram!
Figure( 5.3.9:( Agarose( gel( evaluation( of( the( PCR( amplification( of( mutations(
incorporated( into( the( pQE30SbiEIIIEIV( plasmid.! To! generate! accumulative!mutants,! for!every!cycle!of!PCR!reaction!a!new!PCR!template!was!used.!The!preQexisting!mutation!in!the!PCR!template!is!indicated!by!the!blue!colour,!mutation!intended!to!insert!is!indicated!by! the! red! colour.! Mutagenic! PCR! reactions! were! carried! out! at! five! extension!temperatures! (72°C,! 72.5°C,! 73.3°C,! 74.3°C! and! 75°C).! The! outcomes! of! mutation!insertion! and!PCR!amplification!were! represented!by! the! intensity! of! the!DNA!band!at!4.0!kb.!
! 170!
profile! (Fig.5.3.10.A);!with! the!SbiQIIIQIVS174A!S181A!Y177F!being! the!only!exception.!This! mutant! did! not! produce! a! significant! elution! peak! (Fig.5.3.10.B).! As!discussed! previously! the! mutation! of! the! only! UV! 280nm! absorptive! residue!(Y177)! renders! the! protein! undetectable.! Three! putative! peak! fractions! were!collected! for! each! SbiQIIIQIV! mutant.! The! final! and! purest! fraction! was! buffer!exchanged!to!PBS.!The!purity!of!all!the!purified!SbiQIIIQIV!multiple!mutants!was!then!assessed!by!SDSQPAGE!analysis!(Fig.5.3.11).!!
Figure( 5.3.10:( Ni2+( affinity(
purification( of( SbiEIIIEIV( multiple(
mutant.!(A)!A!typical!chromatogram!for!a!SbiQIIIQIV!multiple!mutant.!After!loading!and!intensive!washing,!every!mutant!protein!was!eluted!with!a!12!column! volume! gradient! of! HisB!buffer.! Peak! fractions! (1,2! and! 3! as!pointed! by! black! arrows)! of! every!Sbi!multiple!mutants!were!collected.!




(As! demonstrated! in! chapter! 4! (Section! 4.3.6.2),! various!mutations! in! SbiQIIIQIV!can!cause!different!degrees!of! impact!on!SbiQIIIQIV’s!activity.! In!addition,! it!was!also!shown!in!Chapter!4!that!the!SbiQC3b!adduct!is!subjected!to!factor!I!cleavage!immediately! after! formation,! and!different! SbiQIIIQIV!mutant:C3b!adducts! could!also! be! degraded! at! different! rates.! These! functional! variations! of! SbiQIIIQIV!mutants! inevitably! cause! fluctuations! in! the! quantity! of! SbiQC3b! adduct!formation! in! normal! serum.! Therefore,! instead! of! performing! quantitative!assessments! of! SbiQC3b! adduct! formation! in! normal! serum,! factor! I! depleted!serum!was!utilized! (Section!5.2.7).!By!depleting! factor! I! from!serum,! the!AP!of!complement!system!activates!spontaneously!in!the!presence!of!magnesium!ions,!and! the! resulting!C3b!molecules! remain!unprocessed.!Under! this! experimental!system,! different! SbiQIIIQIV! mutants! are! subjected! to! the! same! amount! of!complement!activation,!enabling!a!true!assessment!of!their!intrinsic!ability!to!be!deposited!on!by!C3b.! !




!Various!SbiQIIIQIV!mutants!(20!μM)!were!incubated!with!factor!I!depleted!serum!and! the! amount! of! SbiQC3b! adduct! formation!was! subsequently! assessed!using!polyclonal! antiQSbi! Western! blots.! Fig.5.3.12.A! demonstrates! that! with! an!increasing! number! of! Sbi! domain! III! lysine! mutations,! a! decreasing! trend! of!SbiQC3b! adduct! formation! was! observed.! At! the! same! time,! the! sequential!removal! of! Sbi! domain! III! hydroxylQcontaining! residues! shows! no! significant!impact!on!adduct!formation!level!(Fig.5.3.12.B).!We!also!found!that!the!residues!that! contribute! the!most! to! SbiQC3b! formation!were! located!within! domain! IV!(Fig.5.3.12.C).!Based!on!the!binding!model!of!SbiQIV!on!the!convex!surface!of!C3d!(Fig.5.3.7),! S199A,! D208,! K212A,! S213A,! S219A! and! K220! are! the! closest!residues!to!the!C3d!thioester!region.!However!substitutions!of!these!residues!do!not!produce!any!significant!reduction!in!adduct!formation!levels.!Conversely,!the!
Figure( 5.3.12:( AntiESbi(Western( blot( detection( of( SbiEC3b( adduct( formation( in( Factor( I(
depleted(serum.!(A)!Adduct!formation!of!SbiQIIIQIV!mutants!designed!to!study!potential!amine!deposition! sites! on! domain! III.! (B)! Adduct! formation! of! SbiQIIIQIV!mutants! designed! to! study!potential! hydroxyl!deposition! sites! on! domain! III.! (C)!Adduct! formation! of! SbiQIIIQIV!mutants!designed!to!study!potential!deposition!sites!on!domain!IV.!
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substitution! of! S226! by! an! alanine! residue! does! severely! impair! the! adduct!formation! process,! which! correlates! with! the! result! presented! in! Fig.4.3.12.!However,! the! analysis! here! suggests! that! S266A! is! able! to! form! a! minimal!amount! of! the! SbiQC3b! adduct.! Another! mutation! that! was! found! to! also!contribute! to! adduct! formation! is! R231A.! R231! is! an! essential! residue! for! the!interaction!between!the!C3!TED!domain!and!SbiQIIIQIV.!!
5.3.2.7(C3b(deposition(site(determination:(a(mass(spectrometry(approach(!Adduct!formation!assays!demonstrated!that!the!S226A!substitution!dramatically!reduces! C3b! deposition! on! SbiQIIIQIV.! But,! no! other! significant! deposition! sites!were! identified;! especially! neither! single! nor! multiple! lysine! mutants!demonstrate! significant! reduction! in! adduct! formation.! However,! the!hydroxylamine!sensitivity!assays!clearly!suggested!that!the!SbiQC3b!is!also!linked!through! an! amide! bond.! Therefore,! a! mass! spectrometry! approach! was!developed!and!utilized!to!reveal!the!full!repertoire!of!the!adduct!formation!sites!on!SbiQIIIQIV.! !
!It! is!known!that!after! the!hydrolysis!of! the! thioester! in!C3!(Fig.5.3.13.A),!a! free!thiol! group! (C1010)! emerges! in! hydrolyzed! C3b! and! is! available! for! labeling.!Previous! studies! (Shohet! et& al.! 1993;! Sarrias! et& al.! 2001)! demonstrated! that!various!functional!experiments!can!be!carried!out!based!on!the!reactivity!of!this!free!thiol!group.! ! !
Figure( 5.3.13:( (A)! Covalent!binding!reaction!of!C3.!The!free!thiol! group! available! after!reaction! is! highlighted! by! red!square.! ! Image! taken! from!(Law!&!Dodds!1997)!
(B)!IodoactylQPEG2QBiotin!label! (
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!In! this! study,! the! free! thiol! group! was! labeled! with! an! irreversible! biotin! tag!(Fig.5.3.13.B)! for! the! identification! of! C3b! deposition! sites! on! SbiQIIIQIV.! The!primary! sequence! of! the! biotinylated! SbiQC3b! adduct! (Fig.5.3.14.A)( shows! that!Q1013!in!the!C3b!α’!chain!is!linked!covalently!to!an!unknown!residue!in!SbiQIIIQIV.!Given! that! there! is! no! trypsin! digestion! site! between!C3! linkage! site!Q1013! and!biotinylation! site! C1010,! it!would! be! possible! to! purify! the! biotinylated! SbiQC3b!trypic! fragment! (Fig.5.3.14.B)! using! biotin! affinity! resin! and! subsequently!determine!its!molecular!weight!by!mass!spectrometry.!By!subtracting!the!mass!of! the! biotinylated! SbiQC3b! adduct! peptide! using! the!mass! of! the! C3b! peptide!(Fig.5.314.C),!the!mass!of!the!Sbi!peptide!(Fig.5.3.14.D)!can!be!calculated.!Finally,!by! referencing!with! the! in& silico! SbiQIIIQIV! trypsin!digestion!simulation! (Section!5.2.12),! the! mass! of! the! Sbi! peptide! could! then! be! interpreted! as! the! peptide!fragment!of!the!Sbi!primary!sequence.! !!!!
Figure( 5.3.14:! (A)!Primary! sequence!presentations! of!biotinylated! SbiQC3b!adduct,! (B)! Biotinylated!SbiQC3b!adduct!dipeptide,!
(C)! Biotinylated! C3b!peptide! and! (D)! Sbi!peptide.!!
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!A!flow!chart!detailing!the!experimental!design!of!the!adduct!peptide!purification!is! presented! in! Fig.5.3.15.! Firstly,! SbiQC3b! was! generated! with! the! previously!described! AP! in& vitro! reconstitution! method,! but! with! slight! modification!(Section! 5.2.2).! IodoacetylQPEG2QBiotin! label! was! added! during! incubation,! to!label!the!free!thiol!group!immediately!after!it!become!available.!After!Ni2+!affinity!purification,! the! purity! and! the! labeling! of! SbiQC3b! adduct! were! evaluated! by!SDSQPAGE! analysis! and! StrepQHRP! Western! blot.! Fig.5.3.16! shows! that! the!SbiQC3b!adduct!was!successfully!produced!and!purified,!at!the!same!time!the!C3b!α’chains! in! SbiQC3b! adduct! and! hydrolyzed! C3b! molecule! were! successfully!labeled!with!a!biotin!molecule.!As!an!internal!control,!the!C3!α!chain!and!β!chain!did! not! react! to! the! biotin! label,! which! suggested! the! labeling! process! was!specific!to!a!free!thiol!group!at!C1010.!The!biotinylated!SbiQC3b!adduct!was!then!concentrated,!reduced,!denatured!and!subjected!to!prolonged!inQsolution!trypsin!digest!(Section!5.2.8).!From!the!resulting!peptide!mixture,!neutravidin!resin!was!used!to!purify!the!biotinylated!peptide.!After!binding!and!intensive!washing,!the!
Figure(5.3.15:(Experimental(design(for(SbiEC3b(adduct(peptide(preparation!
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biotinylated!peptides!were!released!from!the!resin!using!6!M!guanidine!HCl!pH!1.2! (Section! 5.2.8).! C18! spin! columns! were! then! used! to! deQsalt! the! peptide!sample,!preparing!the!samples!for!mass!spectrometry!analysis!(Section!5.2.10).!!
!The! electrospray! ionization! time! of! flight! mass! spectrometry! (ESIQToFQMS)!analysis!of!purified!SbiQC3b!peptide!sample!yielded!a!variety!of!peptide!masses!from!4!kDa!to!20!kDa!(Fig.5.3.17!AQC).!When!compared!with!the!mass!spectrum!of! the! C3b! derived! peptide! (Fig.5.3.18),! a! similar! peak! of! putative! C3b!monomeric! peptide! was! also! observed! in! the! SbiQC3b! peptide! spectrum!(Fig.5.3.17.C).! This! suggested! that! a! fraction! of! the! covalent! linked! SbiQC3b!peptide!was!too!fragile!to!survive!the!peptide!preparation!and!the!MS!ionization!processes,! therefore! only! the! vestigial! C3b! peptide! peak! was! observed.! In!addition,!it!was!also!noticeable!that!there!were!a!considerable!number!of!peaks!overlapping! between! SbiQC3b! and! the! neutravidin! peptide! (Fig.5.3.19)! spectra.!This!is!likely!to!be!a!consequence!of!the!leaching!of!the!neutravidin!resin!during!the! peptide! elution! process.! However,! there! were! three! masses! (5309.30! Da,!6516.4! Da! and! 6584.12! Da)! that! were! unique! to! the! SbiQC3b! peptide! spectra!(Fig.5.3.17!AQB)!and!could!represent!the!possible!SbiQC3b!adduct!peptides.! (
Figure(5.3.16:(Producing,(purifying(and(labeling(of(the(SbiEC3b(adduct.!(A)!SDSQPAGE!analysis! of! SbiQC3b! adduct! purification.( (B)! StreptavidinQHRP!western! blot.! Lane! 1! After!SbiQC3b!adduct!formation,!2!FlowQthrough!fraction,!3!Wash!fraction,!4!Elution!fraction.!
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Figure( 5.3.17:( LC( coupled( ESIEToF( mass( spectra( of( SbiEC3b( adduct(
peptides.! (A)! Peptides! eluted! between! 5.099Q5.399!min! (B)! Peptides! eluted!between! 5.416Q5.649! min( (C)! Mass! spectra! between! 4200! Da! to! 4650! Da.!Peptide!masses!(indicated!by!arrow)!6516.40!Da,!6584.12!Da!and!5309.30!Da!were!selected!for!interpretation.! !
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Figure( 5.3.19:( LC( coupled( ESIETOF( mass( spectra( of( the( neutravidin(
peptide.! (A)! Peptides! eluted! between! 5.097Q5.297!min! (B)! Peptides! eluted!between!5.628Q5.712!min!
Figure( 5.3.18:( LC( coupled( ESIEToF( mass( spectrum( of( the( C3b( peptide.!Mass!spectrum!between!4200!Da!to!5000!Da.! !!
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!
In! order! to! interpret! the! putative! SbiQC3b! adduct! peptide! peaks,! it! was! a!prerequisite! to! establish! the!mass! of! the! biotinylated! C3b!monomeric! peptide.!Firstly,! the! theoretical!mass!of! the!C3! thioester! trypic! fragment!was! calculated!based! on! its! primary! sequence! (Fig.5.3.20.A).! Due! to! the! formation! of! the!thioester!bond!between!the!side!chains!of!C1010!and!Q1013,!the!masses!of!an!amine!
Figure(5.3.20:(C3(thioester(trypic(peptide(molecular(weight(variations.(
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group!and!a!hydrogen!atom!were!then!subtracted!(Fig.5.2.20.B).!However,!in!the!hydrolysed!C3b!molecule,!the!hydrolysis!of!the!thioester!results! in!the!addition!of! a! hydroxyl! group!and!biotin! label! (Fig.5.3.20.C).!But!when!C3b! is! covalently!deposited! on! Sbi,! the! additional! hydroxyl! group! is! then! replaced! by! the! Sbi!peptide!(Fig.5.3.20.D).! !!The!mass!spectrum!shown! in!Fig.5.3.18!demonstrates!a!major!peak!of!4343.03!Da,! which! is! less! than! 2! mass! units! heavier! than! the! theoretical! mass! of! the!hydrolysed! C3b! thioester! fragment! (Fig.5.3.20.C).! This! slight!mass! discrepancy!could! be! the! result! of! different! protonation! of! the! peptide! or! chemical!modifications! that! occurred! during! preparation! stage.! Given! that! the! C3b!monomeric!peptide!and!SbiQC3b!adduct!peptide!were!derived!from!the!same!C3!sample! and! prepared! using! the! same! protocol,! the! peak! of! 4343.03! Da! was!utilized! as! the! molecular! weight! of! the! hydrolysed! monomeric! C3b! peptide.!Based! on! this! mass,! the! molecular! weight! of! Sbi! deposited! C3b! monomeric!peptide!(Fig.5.3.20.D)!was!calculated.!The!resulting!mass!of!4326!Da!was!utilized!in!following!SbiQC3b!adduct!peptide!peak!interpretation!(Table!5.3.1).! !
!Calculations! involved! in! the! SbiQC3b! adduct! peptide! peak! interpretation! are!summarized!in!Table!5.3.1.!Briefly,!utilizing!the!observed!masses!of!the!putative!
Table(5.3.1:(SbiEC3b(adduct(peptide(peak(interpretation.(1Da!was!subtracted!from!all!Sbi!trypic! fragments,! due! to! the! loss! of! one! hydrogen! atom!during! amide! bond! formation.! Sbi!trypic!digestion!simulation!is!presented!in!appendix!Fig.9.8!
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SbiQC3b! adduct! peptide! (Fig.5.3.17.AQB)! and! subtracting! the! mass! of! the! C3b!monomeric! peptide,! the!masses! of! three! possible! Sbi! peptides!were! identified!with! molecular! weights:! 983.56,! 2191.2! and! 2260.16! Da.! Then,! by!crossQreferencing! with! the! SbiQIIIQIV! trypsin! digestion! simulation! (Appendix!Fig.9.8),!three!possible!Sbi!peptide!trypic!fragments!were!found.!Two!out!of!the!three! matches! show! less! than! 1! mass! unit! discrepancy! from! the! calculated!masses,! however! a! possible! peptide! fragment! larger! by! 2!mass! units!was! also!considered!as!a!match.! !
Peptide!mapping!shows!that!all!three!peptides!are!located!at!the!CQterminal!end!of! the!Sbi!domain! IV,!as!part!of!helix!3! (Fig.5.3.21.B).!The!primary!sequence!of!these!peptides!does!not!contain!any!hydroxylQcontaining!residues.!However!five!lysine!residues!(K245,!K250,!K259,!K263!and!K264)!are!distributed!over!the!25!residueQlong!segment!(Ala240!to!Lys264)!corresponding!to!the!identified!peptides.!Thus,!in!addition!to!the!previously!identified!hydroxyl!deposition!site!S226,!this!MS!analysis!suggested! that!multiple! lysine!deposition!sites!are!also! involved! in!the!formation!of!SbiQC3b!adduct.!
Figure( 5.3.21:( Amino( acid( and( peptide( mapping( of( Sbi( peptide.( (A)! Potential! lysine!deposition!sites!on!Sbi!domain!IV.!(B)!Mapping!of!Sbi!peptide!fragment!on!Sbi!domain!IV.!
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5.3.2.8(Lysine(deposition(sites(verification(via(accumulative(mutagenesis(!As!demonstrated!in!the!above!section,!the!MS!results!implicated!that!multiple!Sbi!domain! IV! lysine! residues! are! likely! to! be! involved! in! the! adduct! formation!process.! To! verify! this! finding,! all!five! lysine! residues!were!mutated!to! alanine! accumulatively.! The!effect! of! the! stepwise! mutations!was!then!examined!by!the!factor!I!depleted! serum! adduct! formation!assay.! Prior! to! the! mutagenesis!experiment,! the! newly! identified!lysine! deposition! sites! were!mapped!on!the!structure!of!SbiQIV!together! with! residues! previously!suspected! as! the! potential! adduct!formation! sites.! In! the! structure,!(Fig.5.3.22)! the! potential!deposition! sites! (K212! S213! S219!and!K220)!are!in!close!proximity!to!the! newly! discovered! lysine! deposition! sites! in! helix! 3,! although! as! previous!demonstrated!(Fig.5.3.12.C),!these!four!residues!are!not!significantly!involved!in!the!process!of!adduct!formation.!But!given!that!the!nascent!C3b!thioester!has!a!halfQlife!of!100!μs!and!reacts!nearly!nonQdiscriminately!with!hydroxyl!and!amine!groups,!it!is!possible!that!these!four!residues!take!on!the!role!of!targets!for!C3b!deposition! upon! the! mutagenic! removal! of! the! lysine! residues! in! helix! 3.!Therefore,! in! this! mutagenesis! experiment! the! accumulative! lysine! to! alanine!substitution! mutations! were! inserted! based! on! both! SbiQIIIQIVWT! and!SbiQIIIQIVK212A!S213A!S219A!K220A!(KSSK)!templates.!
Figure( 5.3.22:( Potential( C3b(
deposition( sites( on( Sbi( domain( IV(
helix(1(and(3.( (
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A! series! of! lysine! substitution! mutations! were! inserted! using! mutagenic! PCR!reaction! in!a! stepwise! fashion.!Based!on!pQE30SbiQIIIQIV!WT!and!KSSK! templates,!five!lysine!mutations!were!introduced!in!the!order!of!K259A,!K250A,!K245A!and!finally!K263A!K264A!(Fig.5.4.23).!Primers!(Table!5.2.2)!were!designed!based!on!the!mutated!DNA!sequence.!Special!primers!were!designed!to!mutate!K263!and!K264!at!the!same!time.!A!similar!extension!temperature!screen!was!also!carried!out.! For! every!mutation! five! PCR! reactions!were! conducted! using! five! distinct!extension!temperatures!and!the!results!of!each!PCR!reaction!was!then!analyzed!by!agarose!gel!electrophoresis.!Fig.5.3.23!shows!the!results!for!every!mutagenic!PCR! reaction.! Normally! at! least! two! PCR! conditions! demonstrate! a! significant!
Figure( 5.3.23:( Agarose( gel( evaluation( of( the( PCR( amplification( of( mutation(
incorporated(pQE30SbiEIIIEIV( plasmid.!To!generate!accumulative!mutants,! for! every!cycle!of!PCR!reaction!a!new!PCR!template!was!used.!The!preQexisting!mutation!in!the!PCR!template!is!indicated!by!blue! colour,!mutation! intended! to! insert! is! indicated!by! red! colour.!Mutagenic!PCR!reactions!were!carried!out!at! five!extension!temperatures!(72°C,!72.5°C,!73.3°C,!74.3°C!and!75°C),!the!outcomes!of!mutation!insertion!and!PCR!amplification!were!represented!as!the!intensity!of!the!DNA!band!at!4.0!kb.!!
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amount! of! PCR! amplification! products,! and! a! preference! of! lower! extension!temperature!was!observed.!But!despite!multiple!attempts,! the!K245A!mutation!failed! to! be! introduced! into! the! SbiQIIIQIVK259A!K250A! template,! thus! in! total! four!lysine! substitution! mutations! (K259A,! K250A,! K263A! and! K264A)! were!introduced! to!SbiQIIIQIV!WT! template.!Apart! from! this!mutation,! the! rest!of! the!mutagenesis! experiments! were! successful,! and! the! incorporation! of! multiple!mutations!was!confirmed!by!DNA!sequencing!(Appendix!9.1.2.2).!Expression!and!purification! of! SbiQIIIQIV! mutant! were! described! in! Section! 4.2.1.! Three! peak!fractions! were! collected! according! to! the! chromatograms! and! analyzed! by!SDSQPAGE! (Fig.5.3.24).( According! to! the! SDSQPAGE! analysis,! the! purest! peak!fraction!of!every!mutant!was!selected!and!buffer!exchanged!to!PBS!buffer.!
!
(
5.3.2.9( Factor( I( depleted( serum( deposition( assay( of( Sbi( domain( IV(
accumulative(mutants!All!accumulative! lysine!mutants!(20!μM)!were! incubated!with! factor! I!depleted!serum,! then! the! amount! of! adduct! formation! was! detected! by! Western! blot!
Figure( 5.3.24:( SDSEPAGE( gel( analysis( of( SbiEIIIEIV( mutant( purifications.( For! every! SbiQIIIQIV!mutant,! four! samples! were! analyzed,! soluble! fraction! (S)! and! three! peak! fractions! (1,! 2! and! 3).!Expressions!of!the!recombinant!SbiQIIIQIV!mutant!are!indicated!by!black!arrows.!The!majority!of!the!recombinant!protein!was!eluted!in!peak!fractions!2!and!3.!!
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analysis.!AntiQHis!tag!antibody!was!utilized!in!this!experiment,!because!the!large!number!of!mutations!in!the!SbiQIIIQIV!could!deform!its!epitope!and!affect!antiQSbi!antibody!recognition.!Fig.5.3.25!shows!that!with!the!increasing!number!of!lysine!substitution! mutations! introduced,! both! series! of! mutant! proteins! become!dramatically!less!likely!to!be!deposited!on!by!the!C3b!molecule.!According!to!the!gel!densitometry!quantification!of!the!bands,!on!substitution!of!lysine!259,!250,!263!and!264!with!alanine! residues,! a!70!percent!decrease! in!adduct! formation!was!observed! (Fig.5.3.25.C).! Even!more!dramatically,! based!on! the! template!of!SbiQIIIQIV!KSSK,!the!substitution!of!all!five!helix!3!lysine!produced!an!85!percent!drop! in! the! amount! of! adduct! formation! (Fig.5.3.25.D).! These! results! correlate!with!the!MS!data,!proving!that! lysine!residues!on!Sbi!domain!IV!helix!3!are!the!hydroxylamine!insensitive!covalent!attachment!sites!for!nascent!C3b!molecules.!!!!!!!!!!!!!
!
(
Figure( 5.3.25:( AntiEHis( tag(Western( blot( detection( of( SbiEC3b( adduct( formation( in(
Factor(I(depleted(serum.!(A)!Accumulative!lysine!mutants!based!on!SbiQIIIQIVWT!template!
(B)! Accumulative! lysine! mutants! based! on! SbiQIIIQIVKSSK! template! (C)! Gel! densitometry!quantification!of!A.!(D)!Gel!densitometry!quantification!of!B.!
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5.3.2.10(C3!binding(strength(of(SbiEIIIEIV(lysine(accumulative(mutants(!As! shown! by! the! C3b! deposition! assay! (Fig.5.3.25),! the! accumulation! of! lysine!substitution!mutations! in! the!CQterminal!of!Sbi!domain! IV!dramatically!reduces!the! amount! of! C3b! deposited! on! SbiQIIIQIV.! However,! it! was! also! known! that!SbiQIIIQIV! R231A! with! severely! impaired! C3! binding! strength! also! leads! to!reduced!adduct!formation!level!(Fig.5.3.12.C).!Given!that!Sbi!domain!IV!mediates!C3!binding,!therefore!the!insertion!of!a!considerable!amount!of!lysine!mutations!could! jeopardize! the! C3! binding! property,! thus! leading! to! an! artifact! of!adductQformation!reduction.!To!verify!the!C3!binding!property!of!Sbi!domain!IV!lysine!mutants,!ELISA!C3!binding!assays!were!performed.!!
Firstly,! doseQdependent! binding! of! C3!was!measured.! Fig.5.3.26! shows! that! all!lysine!mutants! require! increased! C3! concentration! to! reach! saturated! binding!compared! to! the!WT!protein.!Estimated! from! the!binding! curve,! the!Kd! for! the!SbiQIIIQIVWT:C3!interaction!is!around!12.47!nM.!In!comparison,!SbiQIIIQIVKSSK!K259A!K250A!K245A!K263A!K264A! shows! the!most! impaired!C3! binding!with!Kd! decreased! to!0.39!μM.!However,!despite! the!reduction! in!dissociation!constant,!all!Sbi! lysine!
Figure( 5.3.26:( C3(
binding( curves( of( Sbi(
domain( IV( lysine(
mutants.! SbiQIIIQIV!mutants! were!immobilized!and! for! each!type! of! Sbi! the!concentration! dependent!binding!of!C3!(0Q900!nM)!was! measured! by!polyclonal! antiQC3!antiserum.! The! Kd! of! C3!binding! was! determined!from! the! fitted! curve!using!GraphPad!Prism.! !
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(In! this! study,! it! was! demonstrated! that! SbiQC3b! adduct! formation! is! a! unique!feature!of!SbiQIIIQIV!triggered!C3!consumption.!Previously,!there!was!speculation!about! the!potential!complement!activation!assisting!role!of! the!SbiQC3b!adduct,!but! experimental! evidence! for! this! claim! was! scarce.! In! this! chapter,! two!SbiQIIIQIV!mutants!with!minimized! adduct! formation! property!were! presented.!Utilizing! their! unique! characteristics,! the! functional! role! of! SbiQC3b! adducts! in!the!mechanism!of!C3!futile!consumption!was!investigated.! !
Figure(4.3.27:(Consumption(of(C3(by(SbiEIIIEIV(adduct(formation(mutants.!(A)!Different!types!of!SbiQIIIQIV!were! incubated!with!HSS! for!30min!at!37°C,! then!the!consumption!of!C3!was!assessed!by!the!CP!complement!assay.!Data!shown!represents!means!and!standard!errors!from!two!experiments.!KSSK!5KA! is!an! abbreviation!of! “SbiQIIIQIV!KSSK!K245A!K250A!K259A!K263A!K264A”! (B)!AntiQC3a!Western!blot!analysis.!SbiQIIIQIV!induced!C3!consumption!was!marked!by!the!gradual!disappearance!of!the!C3!αQchain.!
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SbiQIIIQIV!WT!and!the!adduct!formation!mutants!(5!μM)!were!incubated!with!HSS!for! 1! hour,! treated! serum! samples! were! collected! every! 10! min! and! the! C3!activation! was! followed! by! antiQC3a! Western! blot.! As! shown! in! Fig.5.3.27.B,!although!both!mutants!demonstrated!minimal!adduct! formation! level,! they!still!function! as! an! activator! of! C3.! During! the! period! of! incubation,! bands! of! C3!αQchain! gradually! reduce! in! size.! However,! when! compared! with! the! C3!activation! profile! of! SbiQIIIQIVWT,! the! adduct! formation! mutants! require!prolonged!incubation!to!achieve!total!depletion!of!intact!C3!molecules.! !!A! previously! described! method! (Sections! 4.2.2! &! 4.2.3)! was! also! utilized! to!evaluate! the! SbiQIIIQIV! induced! consumption! of! complement.! Briefly,! HSS! was!treated! with! SbiQIIIQIV! proteins! (5! μM)! for! 30! min,! and! then! the! residual! CP!activity! was! determined! as! an! indicator! for! the! level! of! C3! consumption.!Fig.5.3.27.A!shows!that!within!the!halfQhour!preQincubation!period,!the!SbiQIIIQIV!multiple! lysine! mutant! consumed! 50%! of! complement! activity,! the! S226A!mutant! consumed! 80%! of! complement! activity,! but! the! SbiQIIIQIV! WT! protein!reduced! the! residual! CP! activity! by! 92%.! These!measurements! agree!with! the!results!of!the!C3!activation!Western!blot,!and!suggest!that!both!adduct!formation!mutants!of!SbiQIIIQIV!are!less!potent!C3!activators!than!the!SbiQIIIQIV!WT!protein.! !!!
5.3.3.2( Both( ternary( complexes( and( SbiEC3b( adduct( extends( serum( C3b(
halfElife!!In!chapter!4,!it!was!demonstrated!that!SbiQIIIQIV!mediated!ternary!complex!could!extend! C3b! in& vitro! halfQlife.! However,! whether! or! not! SbiQC3b! adducts! also!extend! C3b! halfQlife! remained! to! be! tested.! Using! the! methods! described! in!Section! 5.2.3,! free! SbiQIIIQIV! molecule! was! removed! from! the! SbiQC3b! adduct,!using!this!sample!the!complement!modulatory!function!of!SbiQC3b!adduct!alone!is!accessed.!
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Figure(5.3.28:(C3b(conformation(halfElife(is(extended(by(free(SbiEIIIEIVWT(and(the(formation(
of(SbiEC3b(adduct.(The!effect!of!free!SbiQIIIQIVWT!molecules!on!the!degradation!rate!of!SbiWTQC3b!adduct! and!C3b!molecule!was! conducted! in!C3!exhausted! factor! I!depleted! serum.!Two!sets!of!cleavage! experiment! were! constituted,! 6! μg! of! different! C3b! isoforms! was! incubated! in! the!presence!and!absence!of!3!μM!of!SbiQIIIQIVWT,!factor!I!was!added!to!4!ng/μl!to!initiate!the!cleavage!reaction.! (AEB)! Cleavage! of! SbiWTQC3b! in! the! presence! and! absence! of! free! SbiQIIIQIVWT! (CED)(Cleavage!of!C3b!in!the!presence!and!absence!of!free!SbiQIIIQIVWT.!Factor!I!addition!was!indicated!by!a!red!arrow.(
(To!study! if! the! free!SbiQIIIQIVWT!molecule! is!needed!for!the!extended!halfQlife!of!SbiQC3b!adduct,! factor! I!depleted!serum!based!cleavage!assays! (Section!5.2.17)!were! performed!with! the! addition! of! either! purified! SbiWTQC3b! adduct! or! C3b.!Free!SbiQWT!was!also!added!to!examine!the!effects!of!ternary!complex!formation.!Fig.5.3.28!shows!that!the!presence!of!free!SbiQIIIQIVWT!increases!the!C3b!α’!chain!halfQlife! of! the! SbiQC3b! adduct! and! C3b.! However! such! protective! effects!were!
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most!obvious! in! fluid!phase!C3b.! In! the! case!of! the!SbiWTQC3b!adduct,!with! the!presence! of! free! Sbi!molecule,! only! a! slight! protective! effect! was! observed.! In!contrast,! with! free! C3b,! the! SbiWTQC3b! adduct! alone! (Fig.5.3.28.A)! shows!exceptional!resistance!to!factor!I!mediated!cleavage.!Thus,!both!ternary!complex!formation! and! SbiQC3b! adduct! formation! contribute! to! the! extension! of! C3b!conformation! halfQlife! in! serum.! Additionally,! for! both! iC3b! species! further!cleavages!of!the!iC3b!α’!chain!were!observed.!This!further!proteolytic!processing!of! the! C3! fragment! indicates! the! presence! of! sCR1! in! the! serum.! As! shown! in!Fig.5.2.28,! SbiQIIIQIV! strongly! protects! SbiQiC3b! adduct! than! iC3b! from! sCR1!mediated!cleavage.!!!
5.3.3.3(SbiEC3b(adduct(facilitates(complement(consumption(!To! directly! assess! the! potential! role! of! SbiQC3b! as! a! facilitator! of! AP! pathway!activation,! the! ability! of! free! C3b! and! SbiQC3b! to!mediate! alternative! pathway!activation!in!serum!was!studied.!HSS!was!reconstituted!in!Mg2+QEGTAQwater,!and!two!types!of!C3b!were!added!in!various!concentrations.!After!a!1!hour!incubation!at! 37°C,! the! doseQdependent! consumption! of! C3! was! measured! by! the! AP!complement! assay.! At! the! same! time,! the! treated! serum! samples! were! also!analyzed!by!antiQSbi,!antiQFB!and!antiQC3a!Western!blot.!As!shown!in!Fig.5.3.29.A,!both! free! C3b! and! SbiQC3b! demonstrated! a! doseQdependent! consumption! of!serum! C3! activity.! However,! while! free! C3b! concentration! of! >2.5! μM! was!required! for! observable! consumption! of! C3,! SbiQC3b! yielded! significant!consumption!of!C3!at!concentration!higher!than!1!μM.!Without!either!type!of!C3b!added,!the!control!level!of!residual!AP!activity!was!91%.!With!the!addition!of!1.8!and! 2.6! μM! of! free! C3b,! the! residual! AP! activities! were! reduced! to! 89.9! and!81.3%.! In!contrast,!with!the!addition!of!1.8!and!2.6!μM!of!SbiQC3b,! the!residual!AP!activities!were!reduced!to!69.4!and!51.0%.!
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!Western! blot! analyses! of! AP! pathway! activation! markers! revealed! additional!differences! between! C3b! and! SbiQC3b! triggered! C3! consumption.! As! shown! in!Fig.5.3.29.D,! at! higher! concentrations! (2.6! and! 1.8! μM)! both! C3b! and! SbiQC3b!induced! similar! levels! of! factor!B! activation.!However,! at! lower! concentrations!(0.88!and!0.44!μM)!no!significant!C3b!induced!factor!B!activation!was!detected.!Although! both! C3b! and! SbiQC3b! can! trigger! factor! B! activation,! dramatic!differences! in! the! amount! of! C3a! production! were! observed! (Fig.5.3.29.C),!significantly!more!C3a!release!was!induced!by!SbiQC3b!than!C3b,!and!the!release!of! C3a! was! doseQdependent! on! SbiQC3b! concentration.! Finally,! the! antiQSbi!Western! blot! (Fig.5.3.29.B,! lane! 2Q5)! demonstrated! that! while! the! majority! of!
Figure(5.3.29:(Consumption(of(C3(by(C3b(and(SbiEC3b.( (A)!Various!amounts!of!C3b!or!SbiQC3b!were! added! to!Mg2+EGTAQHSS,! and! the! consumption! of! C3! was! assessed! after! 1!hour!by!the!AP!complement!assay.!Data!shown!represent!means!and!standard!errors!from!two!experiments.!(BED)!AntiQSbi,!antiQC3a!and!antiQfactor!B!Western!blot!analysis.!Each!gel!contains!the!following!samples:!1!SbiQC3b!alone,!2Q5!SbiQC3b!treated!HSS!samples!(2.6,!1.7,!0.88!and!0.44!μM!of!SbiQC3b),!6Q9!C3b!treated!HSS!samples!(2.6,!1.7,!0.88!and!0.44!μM!of!C3b),!10!Mg2+EGTAQHSS!incubation!alone.!Complement!assays!were!done!in!duplicate.!
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SbiQC3b!was! converted! to! SbiQiC3b,! a! small! amount!of! SbiQC3b! remained! intact!after!the!incubation.!More!importantly,!no!free!SbiQIIIQIV!was!detected!in!SbiQC3b!samples! (Fig.5.3.29.B,! lane!1),!which!proves! that! the!C3!consumption!observed!was!not!a!consequence!of!free!SbiQIIIQIV!contamination.!
5.4(Discussion:(!In! this! chapter,! the! freshly!developed!protocols! aiming! to! generate,! purify! and!label! SbiQC3b! adducts! are! presented.! The! covalent! deposition! sites! of! C3b! to!SbiQIIIQIV! have! been! determined! by! means! of! mutant! SbiQIIIQIV! and! mass!spectrometry.! It! was! established! that! C3b! could! deposit! covalently! on! both!hydroxyl!and!amine!containing!amino!acid!residues!predominantly!located!in!Sbi!domain! IV.! The! complement! modulatory! function! of! SbiQC3b! adduct! was! also!investigated;!it!was!shown!here!for!the!first!time!that!a!SbiQC3b!adduct!facilitates!consumption!of!C3!through!AP.!!
5.4.1,in,vitro,reconstitution(of(SbiEC3b(adduct(!As!introduced!in!result!Section!5.3.1,!previous!attempts!to!purify!SbiQC3b!adduct!from! serum! had! proved! futile,! both! the! quality! and! quantity! of! the! SbiQC3b!adduct! derived! in! these! ways! were! less! than! satisfactory.! It! has! been! shown!previously! that! the! reconstituted!AP!pathway! can! be! used! to! generate! various!types!of!C3b!adduct!(dextran,!polysaccharide,!insulin!and!IgG)!(Pangburn!1989b;!Shohet!et&al.!1991).!Inspired!by!these!early!studies,!protocols!for!the!production!of! the! SbiQC3b! adduct! using! the! reconstituted! AP! were! derived.! As! shown! in!Fig.5.3.4,! SbiQC3b! was! successfully! produced! by! incubating! SbiQIIIQIV! with!purified!AP!components.!This!method!is!relatively!easy!to!scaleQup,!as!the!main!consumables!in!this!procedure!are!purified!C3!and!factor!B!molecules.!Moreover,!the!reaction!conditions!of!this!procedure!can!be!subjected!to!small!adjustments!in! order! to! meet! special! experimental! conditions,! for! example! when! this!procedure! was! adapted! to! produce! the! biotin! labeled! SbiQC3b! adduct,! the!
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addition!of!iodoacetylQPEG2QBiotin!and!increased!pH!value!(pH!8.0)!were!found!compatible!with!AP!activation.!!
5.4.2(Determination(of(adduct(formation(sites( (!Prior!to!the!mutagenesis!and!mass!spectrometry!studies,!the!chemical!property!of! the! covalent! linkage! between! C3b! and! SbiQIIIQIV! was! probed! by! a!hydroxylamine! sensitivity! assay.! I125! radioisotope! labeled! adducts! are!traditionally! (Shohet! et& al.! 1991)! used! in! this! type! of! assay,! but! here!Western!blots!were!used!to!follow!the!hydrolysis!of!the!ester!bond!conjoined!C3b!adduct.!In! addition! to! the! changes! in! detection!methods,! the! 2D! gel! protocol!was! also!modified!to!suit!the!detection!of!dissociated!SbiQIIIQIV.!As!shown!in!Fig.5.3.5,!the!treated! serum! was! firstly! separated! on! 1st! dimensional! 8%! gel,! treated! with!hydroxylamine,! and! then! analyzed! by! the! 2nd! dimensional! gel.! Following! this!protocol,!no!dissociated!SbiQIIIQIV!was!detected.!The!potential!technical!problem!could!be!that!during!hydroxylamine!treatment!of!the!1st!dimensional!gel,!the!8%!gel! slice! remains! unfixed! and! will! be! soaked! for! 1! hour.! Thus! the! dissociated!SbiQIIIQIV! could! be! lost! significantly! through! diffusion! due! to! its! relative! small!molecular!weight.! Therefore! in! Section! 5.3.3,! an! updated! assay!was! utilized! to!minimize! the! loss! of! SbiQIIIQIV.! Together,! these! analyses! suggested! that! the!covalent! attachment! sites! on! SbiQIIIQIV! could! be! either! hydroxyl! or! amine!containing! residues,! which! leads! to! the! realization! that! there! are! multiple!deposition!sites!on!SbiQIIIQIV.!!In!the!next!step!of!the!study,!the!potential!covalent!attachment!sites!on!SbiQIIIQIV!were! proposed! and! investigated! via! siteQdirected! mutagenesis.! Having!established! that! Sbi! and! C3b! are! linked! by! both! ester! and! amide! bonds,! this!broadened!the!potential!covalent!attachment!sites!on!SbiQIIIQIV!to!almost!every!serine! and! lysine! residue.! Furthermore,! the! possible! existence! of! multiple!deposition! sites! complicated! the! problem! and! prompted! the! generation! of!
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accumulative! mutants! of! SbiQIIIQIV,! by! which! the! combined! effect! of! these!mutations!can!be!revealed.!The!mutagenesis!targets!were!decided!based!on!both!previous! hypotheses! and! new! discoveries.! (Burman! et& al.! 2008)! proposed! the!earliest!hypothesis!that!covalent!attachment!sites!are! located!in!SbiQIII,!and!the!crystal! structure! of! SbiQIV! binding! to! the! C3d! convex! surface! induced! the!emergence!of!another!theory.!But!direct!evidence!supporting!both!hypotheses!is!scarce.!Therefore!to!directly!probe!the!covalent!attachment!sites,!a!study!based!on! a! mass! spectrometry! method! was! described! here! (Section! 5.3.7),! which!provided!a!new!list!of!possible!covalent!attachment!residues.!! All!possible!covalent!attachment!residues!and!some! residue! combinations!were!mutated! to!alanine!residues,!and!the!resulting!changes!in!adduct! formation! level! were! examined.!Analyses! of! SbiQIIIQIV! mutant! adduct!formation!was! focused! on! selected! groups! of!residues! on! SbiQIII! and! three! putative!deposition! sites! on! SbiQIV! (Fig.5.4.1).! No!significant!reduction! in!adduct! formation!was!caused!by!mutations!in!domain!III.!In!contrast,!on! SbiQIV,! the! reduction! in! adduct! formation!level!caused!by!the!S226A!mutation!alone!(Site!1)!is!almost!the!same!as!the!total!substitution!of! lysine! residues! included! in! site! 2.! Site! 3! only! takes! on! the! role! as! the!deposition!target!when!other!sites!are!seriously!impaired.!Therefore,!three!sites!on! SbiQIV! are! responsible! for! C3b! attachment.! Ranked! by! their! tendency! to! be!deposited! on:! the! most! prominent! site! (Site! 1)! which! consists! of! only! the!solventQexposed! S226! located! in! the! loop! region! connecting! SbiQIV! helix! 1! to!helix!2,!Site!2!comprises!CQterminal!lysine!residues!that!are!implicated!by!the!MS!results! and! the! least! important! site! (Site! 3)! is! located! in! the!middle! of! SbiQIV!
Figure( 5.4.1:( Summary( of( C3b(
covalent( attachment( sites( on(
SbiEIV(
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helixQ1.!The! proposed! multiple! disposition! sites! on! SbiQIIIQIV! agree! with! previous!observations!from!hydroxylamine!sensitivity!assays!that!both!serine!and! lysine!residues! are! potential! deposition! residues.! The! miscellaneous! and! redundant!nature!of!covalent!attachment!residues!on!SbiQIV!reflects!firstly!the!semiQrandom!nature! of! C3b! deposition.! Secondly! the! deposition! process! is! probably! not!orchestrated! by! a! defined! proteinQprotein! interaction! but! the! formation! of!SbiQC3b!adduct!is!strongly!encouraged.!The!obvious!dominancy!of!Site!1!can!be!explained! by! the! human! C3! thioester! preference! for! hydroxylQcontaining!deposition! targets.! However! a! structural! transition! mechanism! might! be!involved!to!place!S226!in!close!proximity!to!the!metastable!C3b!thioester!motif.!!The! combination! of! siteQdirected!mutagenesis! and!C3b!deposition! assays!were!the!common!scheme!utilized!in!numerous!studies!(Vidarte!et&al.!2001)!to!verify!C3b!covalent!attachment!sites!on!a!protein.!However,!depending!on!the!specific!protein,! a! unique! strategy! is! normally! designed! and! executed! in! advance! to!narrow! down! the! list! of! potential! deposition! sites.! During! the! study! of! the!IgGQC3b! adduct,! multiple! strategies! were! shown! able! to! locate! the! potential!adduction! formation! sites.! For! example! to! roughly! locate! the! area! of! interest,!genetically!engineered!chimeric!IgG!molecules!were!used!by!which!specific!areas!of! the! protein! can! be! tested! (Vidarte! et& al.! 2001).! To! increase! the! detection!resolution! of! the! study,! (Shohet! et& al.! 1993)! demonstrated! that! MS! can! be!combined!with!radioisotope!labeling,!protease!digestion!and!peptide!purification!to!pinpoint!the!covalent!attachment!sites.!!Inspired! by! these! studies,! the! ESIQToF!MS! technique!was! used! in! combination!with! biotin! tag! labeling,! trypic! digestion! and! biotin! affinity! purification! to!elucidate!the!covalent!attachment!sites!on!SbiQIIIQIV.!The!results!clearly!indicated!that! five! lysine! residues! at! CQterminal! of! SbiQIV! are! C3b! deposition! targets.!However,!surprisingly!no!serine!residue!is! implicated!by!this!method!and!large!
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amounts! of! C3b! monomeric! peptide! was! detected! from! the! SbiQC3b! adduct!sample.!These!observations!could!reflect!the!technical!weakness!of!this!method!in!detection!of!ester!bond!conjoined!adduct.!As!described! in!Sections!5.2.9!and!5.2.10,!during!the!purification!and!preparation!of!SbiQC3b!adduct!peptides!for!MS!analysis,! the! peptide! sample! was! exposed! to! unavoidable! acidic! environment.!This!is!a!proven!condition!that!catalyzes!the!hydrolysis!of!ester!bonds,!therefore!making!this!method!unsuitable!for!detection!of!ester!bond!mediated!C3b!adduct.!Another! imperfection! of! the! current!method! is! the! leaching! of! the! neutravidin!peptide,! which! causes! contamination! of! resulting! peptide! spectra.! Although! in!this! study,! the! source! of! the! peptide! peaks! was! verified! by! comparing! with! a!neutravidin!resin!control.!The!existence!of!unnecessary!peptide!contaminations!could! still! interfere!with! the! ionization!of! the! targeting!peptides.!However! this!method!also!displays!advantages!such!as!high!efficiency,!high!detection!accuracy!and!theoretically!having!the!potential!to!reveal!the!entire!repertoire!of!covalent!attachment!sites.!Thus,!improvements!could!be!considered!to!make!this!method!applicable! to! various! types! of! C3b! adducts.! Firstly,! it!may! be! useful! to! use! an!affinity!resin!with!relatively!weaker!biotin!binding!strength,!by!which!the!bound!molecule! could!be!eluted!without!exposure! to!very!harsh!conditions.! Secondly,!although!the!use!of!ion!pair!reagents!(e.g.!formic!acid!and!TFA)!are!not!avoidable!during!the!MS!procedure,!during!preparation!and!storage!of!the!peptide!sample!the!exposure!to!these!reagents!should!be!minimized.! !!
5.4.3(Putative(mechanism(of(SbiEC3b(adduct(formation(! !So! far,! it! has! been! demonstrated! that! the! SbiQC3b! adduct! formation! process! is!virtually!synchronized!with!the!activation!of!C3.!A!simplified!explanation!for!this!phenomenon!is!based!on!the!binding!affinity!between!Sbi!and!C3,!which!means!the! majority! of! the! C3! is! presented! to! C3! convertase! in! the! Sbi! bound! form.!Therefore! after! the! conversion! to! C3b,! the! Sbi! in! close! proximity! becomes! a!prominent!deposition!target.!In!addition,!it!was!shown!that!the!intact!C3!binding!
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property!is!a!prerequisite!for!Sbi!molecule!to!become!covalently!deposited!on!by!C3b.! As! the! C3! binding! mutant! of! SbiQIIIQIV! (R231A)! demonstrates! minimal!adduct! formation,! it! seems! likely! that! the! same!Sbi!molecule! is! responsible! for!both! C3! binding! and! adduct! formation.! This! theory! fits! with! the! observations!that!C3b!preferentially!deposits!on!its!interaction!ligands!(e.g.!C3b!and!IgG).!!
However,!several!mechanistic!details!of!the!SbiQC3b!adduction!formation!remain!to! be! fully! explained.! Firstly,! as! shown! in! chapter! 4,! before! AP! activation,!SbiQIIIQIV! predominantly! exists! in! either! FH! or! FHRQ1! containing! ternary!complexes! in! combination! with! C3.! Therefore,! rather! than! the! Sbi:C3! binary!complex! being! presented! to! C3! convertase,! it! could! be! proposed! that! the!majority! of! the! C3! substrate! presented! is! in! the! form! of! ternary! complexes!(Fig.5.4.2.A).!This!updated!version!of! the!SbiQC3b!adduct! formation!mechanism!correlates!with!the!observation!that!SbiQIII!is!not!a!major!deposition!target,!since!SbiQIII! is! normally! interacting! with! FH! or! FHRQ1! in! the! context! of! ternary!complexes,!by!which!SbiQIII!is!shielded!from!C3b!deposition.!!
Figure(5.4.2:(Structural(transition(from(C3(to(C3b(bound(ternary(complexes.((A)(Putative!model! of! SbiQIV:C3:FH18Q20! ternary! complex.! C3:! Light! blue.! C3d:! Green.! FH! 18Q20:orange.!SbiQIV:!Purple.! (BEC)! Putative!model!of! SbiQIV:C3b:FH18Q20! ternary! complex.! C3b:!Light! blue.!C3d:! Green.! FH! 18Q20:orange.! SbiQIV:! Purple.! (D)( Steric! clash! between! C3b!MG1! domain! and!SbiQIV.!
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Secondly,! as! proposed! earlier! the! same! molecules! involved! in! Sbi:C3!nonQcovalent! interaction! are! highly! likely! to! be! converted! to! SbiQC3b! covalent!adducts! as! a! consequence! of! C3! activation.! In! this! chapter,! the!majority! of! the!covalent! attachment! sites! have! been! located! within! SbiQIV.! Together,! these!results! imply! that! the! C3! bound! SbiQIV! has! to! become! temporarily! dissociated!after!the!formation!of!C3b!and!undergoes!a!repositioning!process!by!which!S226!(Site!1)!on!SbiQIV!is!placed!in!close!proximity!to!the!metastable!thioester!motif.!The!structural!analysis!of!C3b!bound!SbiQIV!reveals!a!severe!steric!clash!between!the!MG1!domain!of!C3b!and!CQterminal!region!of!SbiQIV!(Fig.5.4.2.D).!Therefore!it!may! be! that! this! steric! clash! could! detach! the! SbiQIV! binding! on! the! concave!surface!of!C3d!and!trigger!the!repositioning!of!SbiQIV.!!
!
Figure(5.4.3:(Molecular(models(of(deposited(SbiEIIIEIV.!(A)!Two!SbiQIV!binding!modes!on!C3d.! (B)! Putative! structural! model! of! SbiQIV! reposition,! the! concave! surface! bound! SbiQIV!(purple)!repositions!to!the!new!location!(blue)!on!convex!surface.( (CED)(Putative!structural!model!of!SbiQIV!reposition!within!SbiQIIIQIV:C3d:FH18Q20!ternary!complex.!
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To! provide! further!molecular! details! for! this! repositioning! process,! the! crystal!structures! of! SbiQIV! binding! on! both! concave! (PDB:! 2WY8)! and! convex! (PDB:!2WY7)!surfaces!of!C3d!have!been!analyzed!(Fig.5.4.3.A).!Since!the!elucidation!of!SbiQIV:C3d!convex!surface!binding!mode,! this! structure! is!generally!believed! to!reveal! how! the! C3d! domain! covalently! attaches! onto! SbiQIV.! However! the!covalent! attachment! data! presented! in! this! chapter! contradict! with! this! view.!Furthermore,!in!respect!of!the!putative!SbiQIV!repositioning!process,!one!would!expect! that! the! SbiQIV! molecule! detached! from! the! concave! surface! would!maintain! the! same! general! orientation.! But! SbiQIV! was! found! binding! in! a!completely!opposite!direction! in! the!crystal!structure!2WY7.!Thus,! this!binding!mode!is!less!likely!to!be!involved!in!the!currently!proposed!SbiQIV!repositioning!mechanism.!
Figure(5.4.4:(Electrostatic(presentation(of(C3d(and(SbiEIV.((A)(Electrostatic!surfaces!of!C3d!at!pH!7.4.!(B)(Electrostatic!surfaces!of!SbiQIV!at!pH!7.4.!Thioester!region!of!C3d!is!indicated!by!red!dashed!box.!Deposition!sites!on!SbiQIV!are!indicated!by!black!dashed!box.!The!SbiQIV!region!responsible!for!C3d!concave!surface!binding!is!indicated!by!blue!dashed!box.!The!electrostatic!surfaces!were!calculated!by!the!APBS!sever!(Baker!et!al.!2001).!
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Although! the! crystal! structure! 2WY7! does! not! fit! within! the! current! SbiQIV!repositioning! hypothesis,! it! does! provide! structural! insight! into! the! SbiQIV!binding!interface!on!convex!surface!of!C3d.!The!2WY7!crystal!structure!(Fig.5.4.3)!reveals!that!the!acidic!surface!made!up!by!the!SbiQIV!helix!1Q3!(Fig.5.4.4.B!SbiQIV!helix! 1Q3)! contacts! with! the! largely! basic! C3d! convex! surface! (Fig.5.4.4.A! C3d!convex! surface).! Based! on! the! crystal! structure,! deposition! site! 3! (Fig.5.4.4.1)!should!be! the!most!prominent!deposition!site,!but!site!1!(S226)!was!proven!as!the!predominant!covalent!attachment!site! in!reality.!Therefore,! it! is! reasonable!to! hypothesize! that! the! acidity! of! SbiQIV! helix! 1Q3! surface! offers! the! general!electrostatic! attraction! to! the! convex! surface! of! C3d,! but! there! could! be! other!forms! of! constraints! that! increase! the! tendency! of! S226! to! be! the! covalent!attachment!residue.!!Considering! the! new! discoveries! such! as! the! ternary! complexes! and! covalent!attachment!sites!described!in!this!thesis,!a!putative!molecular!model!of!SbiQC3b!adduct!formation!was!shown!in!Fig.5.4.3.B.!In!this!model,!SbiQIV!repositions!from!the! concave! surface! of! C3d! to! the! convex! surface,! during! which! the! general!orientation! of! SbiQIV! remains! unchanged! and! the! verified! major! covalent!attachment!residue!S226!is!placed!in!close!proximity!to!the!C3d!thioester!region.!As! depicted! in! Fig.5.4.3.C,! ternary! complexes! could! also! play! a! role! during! the!repositioning!of!SbiQIV,!the!interaction!between!SbiQIII!and!FH!18Q20!may!act!as!a!pivot!point!that!restrains!the!general!orientation!of!the!moving!SbiQIV.!It!is!also!likely! that! after! SbiQIV! deposits,! the! ternary! complex! could! adapt! a! loosely!packed!alternative!configuration!(Fig.5.4.3.D).!This!is!supported!by!the!discovery!of!the!binary!binding!between!SbiQIIIQIV!and!FH!or!FHRQ1!(Section!4.3.10.3).!!!!!!
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6.1(Introduction(!In!chapter!4,!the!functional!significances!of!Sbi!NQterminal!domain!III!have!been!demonstrated! for! the! first! time.!This! domain! is! essential! for! Sbi! to! bind!FH!or!FHRQ1! in! combination! with! C3! isoforms.! The! resulting! ternary! complexes!demonstrate!unique!immuneQregulatory!characteristics!that!could!provide!fresh!molecular!insights!into!the!regulation!of!AP.!Although!numerous!Sbi!domain!III!amino!acid!residues!have!been!determined! that!are!crucial! for! the!assembly!of!these! complexes,! molecular! details! of! the! structure! of! the! ternary! complexes!remain!elusive.!!Structural! characterization!of! the!protein! complexes! comprising! staphylococcal!immune! evasion! proteins! and! complement! components! have! made! crucial!contributions!to!the!current!understanding!of!immune!evasion!and!complement!regulation! mechanisms! (Serruto! et& al.! 2010;! Garcia! et& al.! 2009).! The! BQcell!activation!inhibitory!functions!of!EfbQC!(Hammel!et&al.!2007b),!Ehp!(Hammel!et!
al.! 2007a)! and! Sbi! (Clark! et& al.! 2011)! have! been! elucidated! by! the! crystal!structures!of! these!proteins! in! complex!with!C3! fragment!C3d.! In! addition,! the!crystal! structure! of! SCIN! in! complex! with! C3b! and! a! factor! Bb! fragment!(Rooijakkers! et& al.! 2009)! not! only! resolved! the!mystery! of! the! SCIN! inhibitory!mechanism! but! also! offered! unprecedented! information! about! the! molecular!architecture!of!the!active!alternative!pathway!C3!convertase.!!Previously,! utilizing! conventional! structural! biology! methods! (XQray!crystallography,! SmallQangle! XQray! scattering! and! NMR! spectroscopy),! it! was!demonstrated! that! the! extracellular! region! of! Sbi! adopts! a! modular! domain!organization!to!form!an!elongated!structure!(Burman!et&al.!2008).!Among!those!four! NQterminal! domains,! only! the! structure! of! SbiQIV! was! solved,! and! this!threeQhelix!bundle!domain!was!later!shown!to!bind!both!the!concave!and!convex!
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(As!presented!in!previous!chapters,!various!analyses!were!performed!to!deepen!our! understanding! about! SbiQIIIQIV.! CD! spectroscopy! (Section! 4.3.8.1)! revealed!the! secondary! structure! composition,! SwitchSENSE! analysis! (Section! 4.3.8.2)!provided!information!regarding!to!the!hydrodynamic!diameter,!and!Sbi!mutant!ternary!complex!formation!assays!(Section!4.3.10)!pinpointed!crucial!interaction!residues.!On!their!own,!these!analyses!only!reflect!individual!aspects!of!SbiQIIIQIV,!however! if! these! data! can! be! considered! together! with! structural! models! of!SbiQIIIQIV,! this! would! make! an! inQdepth! structural! analysis! possible.! In! two!previous!publications!(Burman!et&al.,!2008;!Gorham,!Rodriguez!&!Morikis,!2014),!structural! models! for! the! entire! SbiQIQIV! were! presented,! but! no! inQdepth!structural! prediction! analysis! was! performed! on! SbiQIIIQIV.! Therefore! in! the!
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beginning!of!this!chapter,!structural!modeling!studies!of!SbiQIII!and!SbiQIIIQIV!are!presented.! !!Currently! the! computational!methods! for! predicting! threeQdimensional! protein!structures!have!been!classified!into!three!categories,!based!on!the!availability!of!template! structures! in! the! PDB! database.! Homology!modeling!method! is!most!suitable! for! those! sequences! that! have! structural! template! similarity! of! more!than! 80%.! Threading! methods! are! designed! to! match! the! query! sequence!directly! onto! the! 3D! structure! of! other! solved! proteins,! with! the! goal! of!identifying! and! exploiting! similar! folds! even! when! there! is! no! evolutionary!relationship! between! the! query! and! template! proteins.! Finally,! for! proteins!without! apparent! structurally! related! template! in! the! PDB! database,! ab& initio!modeling!method! can! be! attempted.! However,! the! sheer! computational! power!needed! limits! this!method! to! be! only! applied! on! small! proteins!with! less! than!120!amino!acids!(Zhang,!2008).! !
Figure(6.2.1:(Schematic(representation(of(the(IETASSER(protocol( for(protein(structure(and(function(
predication.!(AED)!Predication!step!1Q4.!Image!taken!from!(Roy,!Kucukural!&!Zhang,!2010).!!Previous! PDB! database! searches! demonstrated! that! Sbi! domain! III! does! not!share! significant! sequence! identity! to! any! proteins!with! known! 3D! structures.!However! the! structure!of! Sbi! domain! IV!has!been! solved!on! several! occasions.!Therefore! to! predict! the! 3D! structure! of! SbiQIII! and! SbiQIIIQIV,! an! iterative!
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threading! assembly! refinement! (IQTASSER)! method! (Roy,! Kucukural! &! Zhang,!2010)! was! utilized.! IQTASSER! is! a! composite! protein! structure! predication!approach,! which! combines! numerous! techniques! such! as! threading,! ab& initio!modeling!and!atomicQlevel!structure!refinement!approaches.!The!query!protein!sequence!is!submitted!through!the!IQTASSER!server,!the!program!then!performs!a!fourQstage!protocol!(Fig.6.2.1)!to!predict!the!3D!structure!of!a!protein.!The!first!stage! (Fig.6.2.1.A)! involves! matching! the! query! sequence! against! a!nonQredundant! protein! structure! database! through! positionQspecific! iterated!BLAST!(Altschul!et&al.,!1997)!to!find!template!proteins!with!similar!structures!or!motifs.!At!the!same!time,!using!the!query!sequence!and!its!predicted!secondary!structure!profile,!a!threading!procedure!is!also!performed!against!PDB!database!utilizing! LOMETS! (Wu! &! Zhang,! 2007),! which! is! a! locally! installed!metaQthreading! server! consisting! of! seven! high! performance! new! threading!programs.!At!the!end!of!stage!one,!all!templates!are!ranked!according!to!specific!score! criteria,! and! the! top! template!hits! are! selected! for! further! consideration.!The! second! stage! (Fig.6.2.1.B)! involves! extracting! threading! alignments! of!fragments! from! the! template! structure! in! order! to! assemble! regions! that! align!well! into! a! structural! conformation.! However,! for! these! unaligned! structural!fragments! (e.g.! loops),! structural! information! is! supplied!by! a! builtQin!ab& initio!modeling! program.! Once! all! the! fragments! are! assigned! with! structural!information,! assembly! is! performed!utilizing! the! replicaQexchange!Monte! Carlo!simulation! technique! (Zhang,! Kihara! &! Skolnick,! 2002).! From! the! newly!generated!structural!pool,! the!similar!3D!coordinates!are!clustered!by!SPICKER!(Zhang! &! Skolnick,! 2004),! which! averages! all! the! clustered! structures! by!superposition! to! produce! the! “Cluster! Centroids”.! At! this! stage,! the! cluster!centroids!generally!have!substantial!internal!steric!clash!and!can!be!structurally!distorted!(Wu,!Skolnick!&!Zhang,!2007).!Therefore!in!the!third!stage!(Fig.6.2.1.C),!starting!with!cluster!centroids,!fragment!assembly!simulation!is!performed!again.!But!this!time,!structural!constraints!are!introduced!to!remove!steric!clashes!and!to! refine! the! global! topology.!Therefore,! at! the! end!of! this! stage!only! a! limited!
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number! of! cluster! centroids! remain,! since! under! the! newly! introduced!constraints,!some!cluster!centroids!have!to!be!abandoned.!These!final!models!are!then! refined!by!REMO!(Li!&!Zhang,!2009),!which!decorates! the! crude!Cα! trace!models!(cluster!centroid)!with!an!optimized!hydrogen!bonding!network.! In!the!final! stage! (Fig.6.2.1.D),! functional! annotation! prediction! takes! place! by!comparing! the!predicted!model!with!proteins!of!known!structure!and! function!from!the!PDB!database.!!Every!stage! is!evaluated!by!multiple!categories!of!scores!that!propel! the!model!building!process:!energy!scores,!confidence!scores,!identity!scores!and!statistical!scores,! etc.! The! primary! scores! for! evaluating! the! final! 3D!model! outputs! are!CQscore!(Equation!6.2.1).! !!




(Apart! from! structure! predication! methods,! another! novel! structural! biology!approach!described!in!this!chapter!is!single!molecule!alternating!laser!excitation!(ALEX)!fluorescence!resonance!energy!transfer!(FRET)!(Doose,!Margeat!&!Weiss,!2004).! This! method! has! been! shown! to! be! particularly! powerful! in! capturing!different! conformational! states! of! biological! molecules! (Santoso! et& al.,! 2010).!Therefore,!by!utilizing! this! technique! the!conformational!dynamics!of!SbiQIIIQIV!in!response!to!ligand!binding!events!could!be!investigated.!!
(
Figure( 6.2.2:( Principles( of( fluorescence( and( fluorescence( resonance( energy( transfer(
(FRET).!(A)!External!light!source!(green)!directly!excites!an!orbital!electron!from!a!fluorescent!molecule!ground!state!(S0)!to!energy!level!S2.!The!highQenergy!electron!relaxes!from!S2!to!S1!level!vibrationally,! and! then! the! energy! is! released! (S1! to! S0)! in! the! form!of! a! photon.! (B)! After! the!excitation!of!the!fluorescent!donor,!two!processes!can!occur:!the!donor!electron!can!either!relax!to!ground!state!by!emitting!a!photon!or!the!energy!can!be!transferred!to!a!nearby!acceptor!where!the!energy! is! finally! released!as!a!photon! (red).!Figures! taken! from! (Hinterdorfer!&!Van!Oijen,!2009).!!!
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Fluorescence!was!first!described!and!studied!in!the!middle!of!the!19th!century!by!Sir! John! Frederic! William! Herschel.! It! is! a! special! form! of! luminescence! and!characterized!by!the!emission!of! light! from!a!substance!that!has!absorbed!light!or!electromagnetic!radiation.!The!physical!basis!of!this!process!is!summarized!by!a! Jablonski! diagram! (Fig.6.2.2.A),! which! involves! the! transition! of! an! electron!from! an! excited! higher! quantum! state! to! the! ground! state! by! emission! of! a!photon! or! energy.! It! was! later! discovered! that! the! energy! emitted! from! a!fluorophore! could! be! harvested! by! another! fluorophore! as! a! consequence! of!longQrange! dipoleQdipole! coupling.! This! phenomenon! was! defined! as!fluorescence! resonance! energy! transfer! (FRET)! or! FÖrster! resonance! energy!transfer! after! Theodor! FÖrster! who! developed! the! main! FRET! theory! in! the!middle!of! the!20th! century.! ! Fig.6.2.2.B! is! used! to! explain! the!physical! basis! of!this!phenomenon.!
Figure( 6.2.3( FRET( spectra:! (A)! Overlap! region! of! emission! spectrum! of! Alexa! 488! and!absorption!spectrum!of!Cy5!is!coloured!in!grey.!(B)!FRET!efficiency!is!dependent!on!the!distance!between!donor!and!acceptor!fluorophores.!(C)!FÖrster!radius!R0!is!the!distance!where!E=0.5.!!In! a! FRET! event! (Fig.6.2.3.B),! an! external! light! source! was! used! to! excite! a!highQenergy! fluorophore! (donor,! D),! the! energy! can! be! then! transferred! to! a!
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lowQenergy! fluorophore! (acceptor,! A).! However,! two! prerequisite! conditions!have!to!be!fulfilled:!first,!both!fluorophores!must!be!in!close!proximity!(<10!nm);!and! second! the! emission! spectrum! of! the! donor! must! overlap! with! the!adsorption!spectrum!of!the!acceptor!(Fig.6.2.3.A).!As!a!result!of!energy!transfer,!the!emission!intensity!of!the!donor!decreases,!and!the!emission!intensity!of!the!acceptor!increases.! !!As!stated!by!one!of!the!FRET!preconditions,!FRET!is!a!distance!dependent!energy!transfer!process.!According!to!Equation!6.2.2!stated!by!FÖrster,!FRET!efficiency!E!is! inversely! proportional! to! the! sixth! power! of! the! distance! R! between! two!fluorophores.! !!! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! !!!!!!!!!! = !!!(!/!!)! !!!!!!!!!!!!!!!!!!!!!!!!! Equation!6.2.2 !!!!! ! ! ! ! ! ! !! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! !The! FÖrster! radius! R0! (Fig.6.2.3.C),! which! describes! the! donorQtoQacceptor!distance!where!FRET!efficiency!equals!50%,!normally!varies!between!2!and!6!nm!(Selvin! 2000)! for! common! pairs! of! fluorophores.! It! can! be! calculated! using!Equation!6.2.3.! !! !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! = !"""(!" !")!!!!!!"#!!!!! !!!!!!!!!!!!!!!!!!!!!!!![Equation!6.2.3]!! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! !The! quantum! yield! of! the! fluorophore! donor! in! the! absence! of! acceptor!D,!Avogadro’!number!N,! refractive! index!of! the! sample!n.!The! relative!orientation!factor! k2! can! take! values! between! 0! (for! perpendicular! dipoles)! and! 4! (for!collinear!dipoles).!J&is!an!integral!that!described!the!overlap!between!the!donor!emission!and!acceptor!absorption!spectra,!it!is!calculated!by!Equation!6.2.4!as!a!function!of!the!wavelength!λ!using!εA!(λ)!as!the!molar!extinction!coefficient!of!the!acceptor!and&fD(λ)!as!the!normalized!emission!spectrum!of!the!donor.! !!
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!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! = !!(!)!!(!)!!!"!! !!!!!!!!!!!!!!!!!!![Equation!6.2.4](! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! !Given! the! relationship! between! FRET! efficiency! and! the! distance! between!fluorophores,! the! FRET! phenomenon! has! been! developed! intensively! to! be!applied! to! the! structural! studies! of! biological! molecules.! Using! polyQLQproline!(Stryer!&!Haugland!1967)!and!doubleQstranded!DNA!(Clegg!et&al.!1993)!as!model!molecules,! the! potential! of! FRET! as! a! type! of! “spectroscopic! ruler”! has! been!firmly!established.!However,!in!most!biological!applications,!FRET!measurement!has! been! found!more! appropriate! for! detecting! the! changes! in! distance! rather!than! reporting! the! absolute! distances! between! fluorophores.! As! shown! in!Equation! 6.2.3,! the! fluorophore! orientation! factor! k2! plays! a! key! role! in! the!determination!of!R0,!but!measuring!it!experimentally!is!often!error!prone!(Selvin!2000).!!FRET! technology! has! evolved! rapidly! in! the! past! two! decades;! today! it! has!become! an! invaluable! tool! for! characterization! of! conformational! dynamics!associated! with! biological! molecules.! In! the! traditional! FRET! experiment,! the!molecule!under!study!is!labeled!on!two!locations!with!a!pair!of!fluorophores,!and!then!the!energy!transfer!efficiency!is!determined.!Although!this!type!of!ensemble!FRET!measurements! provide! structural! insight! about! a!molecule,! this!method!only! reflects! the! mean! properties! of! populations! of! billions! of! molecules.!Therefore! the! internal! heterogeneity! of! the! sample! can! skew! the! mean! FRET!efficiency! to! a! degree! that! complicates! the! interpretation! of! experiments.! This!effect!is!particularly!worrying!when!large,!unstable!or!dynamic!biomolecules!are!analyzed!(Haas!et&al.!1975).!!!
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Figure(6.2.4:( Instrumentation( for(single(molecule(FRET.((A)!Simplified!confocal!microscopy!setQup! for! FRET! detection! of! single!molecules! diffusing! in! solution.! (B)! Single!molecule! FRET!confocal!microscopy!setQup.( (C)(Sample! loading!of!real!single!molecule!FRET.!Figure!A!adapted!from!(Hinterdorfer!&!Van!Oijen!2009).!!Some! of! these! drawbacks! of! ensemble! FRET! experiment! were! overcome! by!single!molecule!FRET!(smFRET),!which!is!principally!the!measurement!of!FRET!at!the!level!of!single!molecule.!The!concept!of!smFRET!was!firstly!demonstrated!in!1996!(Ha!et&al.!1996),!but!it!was!not!until!1999!(Ting!et&al.!1999)!that!it!was!developed! to! measure! biological! molecules! in! liquid! buffer.! Since! then! a!consensus!of!smFRET!experimental!conditions!has!been!established!(Fig.6.2.4.A).! !In! a! typical! smFRET! experiment,! the! sample! concentration! is! adjusted! to!between!50!and!100!pM,!and!a! laser!beam!is!utilized! to!excite! the!highQenergy!fluorophore.! However,! the! laser! beam! is! focused! by! a! microscope’s! objective,!thereby! an! extremely! small! excitation/detection! volume! (<1! femtoliter)! is!created.!The!smFRET!instrument!utilized!in!this!study!is!shown!in!Fig.6.2.4.BQC.!It!was!shown!that!given!the!extremely!low!sample!concentration!and!extremely!small!focus!volume,!the!probability!of!singleQmolecule!occupancy!is!roughly!1%!and!it! is!several!orders!of!magnitude!greater!than!the!chance!of!more!than!one!molecule! residing! simultaneously!within! the! focus! (Nie! et& al.! 1994).! To! derive!the!smFRET!energy!transfer!efficiency!E,!photons!emitted!are!counted!separately!using! donorQ! or! acceptorQemission! channel! detectors.! Upon! excitation! of! the!donor! fluorophore,! two! types! of! photon! emission! were! counted,! fDex,Dem! and&
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fDex,Aem!where!fXex,Yem!is!the!photon!count!for!XQexcitationQbased!YQemission.!The!resulting!smFRET!efficiency!E!is!then!expressed!as:!!
E=&fDex,Aem/(&fDex,Aem!+&fDex,Dem)! ! ! ! ! ! ! ! [Equation!6.2.5]!! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! !In! most! smFRET! studies,! the! conformational! dynamic! of! a! protein! is! usually!directly! reported! by! changes! in! the! smFRET! efficiency! E,! the! variation! in!absolute! distance! between! two! fluorophores! is! only! considered! as! an!approximation.! This! is! because! of! the! numerous! correction! steps! needed! to!determine! accurate! FRET! efficiencies!within! single!molecules.!Moreover!when!R>6Q8! nm! the! presence! of! chemically! or! photoQphysically! induced! species! also!would!obscure!FRET!measurements!(Doose!et&al.!2004).! !!During!the!last!decade,!the!latest!improvement!in!smFRET!measurement!was!the!development!of!alternative!laser!excitation!(ALEX)!smFRET!(Doose!et&al.!2004).!In!this!method!(Fig.6.2.5),!the!laser!rapidly!alternates!between!two!wavelengths!by! which! both! donor! and! acceptor! fluorophores! are! excited! regularly!(Fig.6.2.5.AQB).! In!combination!with!advanced!photon!detectors,!not!only!donor!excitation! associated! photon! emissions! (fDex,Dem! and& fDex,Aem)! are! recorded,! but!also! acceptor! excitation! associated! photon! emissions! (fAex,Dem! and! fAex,Aem,)!(Fig.6.2.5.CQD).! The! donor! excitation! provides! standard! information! about!smFRET!efficiency!E,!but!it!is!the!direct!excitation!of!the!acceptor!that!allows!the!relative!fluorophore!stoichiometry,!S,!to!be!measured!(Equation!6.2.6).!!
& & & S=&(fDex,Aem+&fDex,Dem)/(&fDex,Aem+&fDex,Dem+&fAex,Aem!+&fAex,Dem)! ! ! [Equation!6.2.6]!! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! !
S! can! be! considered! as! an! indicator! for! the! quality! of! fluorophore! labeling.! A!stoichiometry!reading!of!1!indicates!that!the!molecule!under!observation!is!only!donor!fluorophore!labeled,!which!will!display!an!E!value!of!0.!On!the!other!hand,!when!the!stoichiometry!reading!of!a!molecule!biases!toward!0,!this!indicates!that!
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the!molecule!is!only!acceptor!labeled,!which!would!give!an!E!reading!of!1.When!the!molecule! is! labeled!with! both! donor! and! acceptor! fluorophores,! a! S! value!close!to!0.5!is!expected.!Only!under!this!circumstance!can!the!variation!in!E!value!be!interpreted!as!changes!in!donor!to!acceptor!distance!(RDQA).!!
!
Figure( 6.2.5:( Alternative( laser( excitation( (ALEX)( ( smFRET.( (A)( Simplified! presentation! of!ALEX!microscopy!setQup.!APD,!avalanche!photodiode;!DM,!dichroic!mirror;!EOM,!electroQoptical!modulator;! P,! polarizer.!When! the! EOM! and! polarizer! are! used! in! combination,! lasers! rapidly!alternate! between! two! excitation! wavelengths! (Dex=495! nm! and! Aex=645! nm)! with! period!defined!as!τAlt.!The!resulting!fluorescence!emission!(orange)!is!collected!in!Dem!and!Aem!channels.!
(B)(Excitation!of!a!single!diffusing!molecule!across!the!microscopic!focus!point.!The!travel!time!is!defined! as! a! single! “burst”! (C)! When! excited! at! 495! nm,! donorQexcitation! based! DQ! and!AQemissions!(green!and!red!columns,!respectively).!When!excited!at!645!nm,!acceptorQexcitation!based!emissions!are!collected.((D)!The!integration!of!the!four!excitation/emission!streams!yields!four! emissions! for! a! single! burst! from!which! transfer! efficiency! (E)! and! stoichiometry& (S)! are!calculated.!Figure!adapted!from!(Doose!et&al.!2004)! !!!!!
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6.2.3(SAXS(analysis(of(macroEmolecular(assembly(!Small!angle!XQray!scattering!(SAXS)!is!an!established!structural!biology!method!for! lowQresolution! characterization! of! biological! molecules.! It! utilizes! the!isotropic! scattering! pattern! of! a! molecule.! By! applying! mathematical!transformations! on! the! scattering! data,! lowQresolution! (1Q2! nm)! molecular!models!can!be!constructed!for!various!types!of!biological!molecules.!This!method!has! been! intensively! exploited! in! the! studies! of! protein! structural! properties!such! as! overall! topology,! oligomeric! state,! flexibility! and! even! folding! status.!Nowadays,! taking! advantages! of! modern! highQbrilliance! synchrotron! XQray!sources,!polypeptides!in!the!range!of!1Q10!kDa,!macroQmolecular!complexes!and!large! virus! particles! up! to! several! hundred! MDa! can! all! be! analyzed! by! this!method! (Mertens! &! Svergun! 2010).! Normally,! for! a! complete! set! of!measurements,!1Q2!mg!of!protein!sample!is!needed,!and!the!experiments!can!be!performed!in!most!common!biological!buffer!systems.!!In!this!thesis,!exploratory!SAXS!experiments!were!carried!out,!aiming!to!pave!the!way! for! the! detailed! characterization! of! the! Sbi:C3d:FHRQ1! ternary! complex! in!the! future.! By! combining! the! results! of! in& silico! structural! modeling,! ALEX!smFRET! and! SAXS! analysis,! we! hope! the! molecular! organization! of! the!Sbi:C3d:FHRQ1! ternary! complex! can! be! revealed! for! the! first! time.! In! the!following!sections,! the!methodology!of!SAXS!and! its!data!analysis!methods!will!be!described.!
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!
Figure( 6.2.6:( Schematic( presentation( of( a( typical( SAXS( experiment( and( subsequent( data(
processing( steps.! (A)! Scattering! data! acquisition( (B)! Scattering! curve,! I(s),! of! a! hypothetical!protein!(B)!Pair!distance!distribution!function.!!During!SAXS!measurements!(Fig.6.2.6.A),! the!sample! is!exposed!to!a!collimated!monochromatic! XQray! beam.! The! incipient! beam! is! scattered! by! the! tumbling!sample!molecules,!the!resulting!angle!between!incipient!and!scattering!beams!is!defined!as!2θ.!The!scattering!of!macromolecules!such!as!protein!or!nucleic!acid!in!the!aqueous!solution!normally!gives!rise!to!an!isotropic!intensity!(Mertens!&!Svergun! 2010),! which! depends! on! the! modulus! of! the! momentum! transfer! s.!Therefore!mathematically,!the!scattering!pattern!is!described!by!the!intensity!(I)!as!a!function!of!s.!Based!on!this!mathematical!relationship,!the!scattering!pattern!is! transformed! to! an! radially! averaged! one! dimensional! scattering! curve!(Fig.6.2.6.B).! Although! this! curve! could! provide! several! important! indications!related! to! the! size,! shape! and! oligomeric! state! of! the!molecule,! the! reciprocal!relationship! between! I(s)! and! s! prevents! it! from! being! used! in! quantitative!
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descriptions! of! molecular! structures.! Thus,! to! interpret! a! scattering! profile! in!terms! of! a! structure,! it! is! useful! to! Fourier! transform! the! scattering! curve! to!obtain!a!pair!distance!distribution!function!(P(r))!(Glatter!1977),!which!is!a!real!space!representation!of!the!scattering!profile!(Fig.6.2.6.C).!The!shape!of!the!P(r)!function! gives! strong! indications! about! the! symmetry! and!domain! structure! of!the! sample! molecule,! but! more! informatively,! several! quantitative! structural!parameters! can! also! be! derived! from! the! P(r)! function.! These! include! Dmax!(maximum!particle!diameter),!Rg!(radius!of!gyration)!and!Vp!(hydrated!particle!volume)(Porod!1982).!Through! these!parameters,! a!basic!understanding!about!the! shape! and! weight! of! the! scattering! particle! can! be! established,! which! is!invaluable! information! for! downstream! sophisticated! 3D! model! building!processes.!!Although!all! biological! samples! in! solution!would! scatter!XQray!beam,! for!SAXS!analysis! several! stringent! sample! requirements! have! to! be! satisfied.! Firstly,!sample!buffer!has!to!be!coherent,!when!a!sample!solution!is!illuminated!by!XQray!beam,!not!only!the!sample!molecules!causes!scattering!of!the!incipient!beam!but!also!the!solvent!molecules.!Therefore,!experimentally!the!scattering!intensities!of!both!sample!solution!and!buffer!solution!are!measured;!the!scattering!intensity!for! sample! molecules! alone! is! then! derived! by! subtraction.! As! a! result,! a!consistent!buffer!environment!is!essential!for!the!generation!of!a!credible!sample!scattering!curve.!! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! I(s)=F(s)×S(s)! ! ! ! ! ! ! ! ! ! ! ! ! ! ! [Equation!6.2.7]! !!After! subtraction! of! the! buffer! contribution! from! the! total! scattering! intensity,!the! scattering! intensity! of! the! sample! is! derived.! However,! the! Equation! 6.2.7!that! defines! the! composition! of! the! sample! intensity! elicits! an! additional!requirement! for! SAXS! sample,! monodispersity.! Equation! 6.2.7! shows! that! the!sample!scattering!intensity!comprises!the!form!factor!(F(s)),!which!describes!the!
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structure! of! the!molecule! and! the! structural! factor! (S(s)),! which! describes! the!interQmolecular!interactions!(e.g.!attractions!and!repulsions).!In!a!monodisperse!sample,! where! molecules! are! subject! to! minimal! levels! of! interQmolecular!interactions,! the! S(s)! should! be! approximately! equal! to! 1.! Only! under! this!condition! can! the! sample! scattering! intensity! (I(s))! be! considered! the! same! as!the!form!factor!(F(s))!and!can!be!used!for!accurate!structural!modeling!process.!!In! other! structural! biology! techniques! (e.g.! Crystallography! and! NMR!spectroscopy),! solvable! data! are! usually! only! obtained! when! the! sample! is!appropriately! prepared.! But! smallQangle! scattering! pattern! can! always! be!produced! from! samples! of! any! quality! (Jacques! &! Trewhella! 2010);! therefore!verification!of!scattering!particles’!purity!and!monodispersity!is!essential!before!structural! modeling! can! proceed.! Numerous! complementary! analyses! are!recommended! to! verify! the! sample! quality! independently! such! as! SDSQPAGE,!dynamic! light! scattering! and! size! exclusion! chromatography! multiQangle! laser!light! scattering! (Mertens! &! Svergun! 2010).! However,! for! preliminary! sample!quality! inspection,! the!scattering! intensity! function! I(s)! can!be!reQarranged!and!plotted!again!using!Guinier!analysis!(Guinier!1939).!Based!on!the!linearity!of!the!bestQfit! line,! the! presence! of! aggregation! in! the! scattering! sample! could! be!detected.!A!nonQlinear!Guinier!plot! is!a!strong!indicator!of!poor!sample!quality.!Apart! from! its! use! in! data! evaluation,! using! the! scattering! profile! in! the! very!small! angle! region! (s<!1.3/Rg),!Guinier! analysis! could!also! function!as! a!useful!means!for!estimating!values!for!Rg.!!Nowadays,! ab& initio& reconstruction! of! lowQresolution! 3D! models! strictly! from!SAXS! data! is! a! common!procedure.!Most!modeling! programs! are! based! on! the!concept! of! “spherical! harmonics! representation”(Stuhrmann! 1970),! which!defines! the! model! structure! as! a! sum! of! independent! contributions! from! the!substructures! corresponding! to! different! spherical! harmonics.! This! allows! the!calculation!of!scattering!patterns!of!the!model,!which!then!can!be!compared!with!
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experimental! scattering! patterns.! ! By! applying! algorithms! (Equation! 6.2.8)! to!minimize! the! discrepancy! between! the! calculated! and! experimented! data,! 3D!SAXS!models! can! be! generated!with! some! confidence! (Fig.6.2.7).! In! this! study,!the!modeling!program!DAMMIF!(Franke!&!Svergun!2009)!was!used,!which!is!the!latest!addition!to!the!automated!beadQmodeling!program!family.!!
!DAMMIF!represents!the!particle!as!a!collection!of!densely!packed!beads!inside!an!adaptable! and! loosely! constrained! search! volume! (Fig.6.2.7.B)! defined! by!experimentally! determined& Rg.! The! latest! version! of! the! DAMMIF! program!utilizes!an!unrestricted!search!volume!that!can!expand!and!reduce!in!size!during!simulated! annealing! processes,! avoiding! undesired! boundary! effects! that! may!occur! in! the!case!of!asymmetrical!particles.!Each!bead! is! randomly!assigned! to!solvent! (assigned! “0”)! or! solute! (assigned! “1”),! and! the! particle! structure! in!solution! is! described!by! a! binary! string! of! length!M.!Only! connected! strings! of!beads! are! considered! as! a! possible! model,! and! the! scattering! amplitudes! are!
Figure( 6.2.7:( Principal( of( ab, initio(
reconstruction.( (A)! Starting! from! a!bead! filled! spherical! search!volume,! a!fitting! process! is! performed! until! a!model! is!produced!that! correlates!not!only!to!the!experimental!data!but!also!has! been! shaped! into! a! compact! and!connected! model! of! beads! (B)! The!spherical! search! volume! with! beads!that! represent! particle! (yellow)! and!solvent! (blue).! Images! taken! from!(Mertens!&!Svergun!2010).!.1!
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A! single! substitution! mutation! of! R14C! was! introduced! using! the! method!described! in! Section! 2.2.2,! slight! modifications! were! made! including! the! PCR!template! (pQE30SbiQIIIQIVQcys)! and! mutagenic! primers! (Forward! 5’Q3’: atcaccatcacggatccgaatgtcaaaatattgaaaatgcg;!Reverse!5’Q3’:!cgcattttcaatattttgacatt!cggatccgtgatggtgat).! The!mutated!plasmids!were!verified!with!DNA! sequencing!service.!!
6.3.4(Protein(expression(&(purification(of(SbiEIIIEIVdualEcys(




(Labeling!of!the!SbiQIIIQIVdualQcys!with!sulfhydryl!specific!fluorophores!was!carried!out! according! to! the!manufacturer’s! instructions.! Prior! to! the! labeling!process,!after! a!30!min! room! temperature! incubation,!βQmercaptoethanol!was! removed!using! a! proteinQdesalting! spinQcolumn! (Section! 2.3.5).! The! protein! sample!was!buffer!exchanged!into!phosphateQTCEP!buffer!(10!mM!sodium!phosphate!pH!7.0,!5!mM!TCEP).! To! label! SbiQIIIQIVdualQcys!with! the! fluorescent! donor! and! acceptor!simultaneously,!the!protein!concentration!was!adjusted!to!150!μM!(final!volume!of!200!μl),!and!then!2Qfold!molar!excess!of!both!maleimide!derivative!of!Cy5!(GE!healthcare)!and!Alexa!Fluor!488! (Invitrogen)!was!added.!The! labeling! reaction!was!flushed!with!nitrogen!gas!and!maintained!at!room!temperature!for!2!hours!shielded!from!light.!Assuming!that!both!maleimide!fluorescent!derivatives!have!similar!reactivity!to!the!reduced!Cys!sideQchain!on!both!ends!of!SbiQIIIQIVdualQcys,!this! way! a! single! protein!molecule! became! double! labeled! by! both! donor! and!acceptor.! After! the! labeling! reaction,! the! unincorporated! fluorophores! were!removed! by! PD10! desalting! column.! The! labeled! proteins! were! concentrated!(100!μM)!and!stored!at!Q80°C!in!PBS!buffer.!!
6.3.6(Fluorescence(labeling(verification(using(mass(spectrometry(!The! molecular! weights! of! unlabeled! SbiQIIIQIVdualQcys! and! fluorescent!doubleQlabeled! SbiQIIIQIVdualQcys! were! determined! by! ESIQMS.! Before! mass!spectrometry!analysis,!both!proteins!were!buffer!exchanged!into!water,!the!mass!determination!procedure!was!as!described!in!Section!3.2.13.!
(
6.3.7(Single(molecule(confocal(experiment(!SingleQmolecule! fluorescence! analyses! were! performed! at! the! Central! Laser!Facility!(CLF),!Rutherford!Appleton!laboratory.!For!each!measurement,!100!pM!of! doubleQlabeled! SbiQIIIQIVdualQcys! was! prepared! in! combination! with! various!protein! ligands!(Appendix!Table!9.8)!and!PBS!buffer! to!a! final!volume!of!25!μl.!
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Single! molecule! FRET! was! measured! at! room! temperature! using! a! confocal!microscope! with! alternatingQlaser! excitation! at! 495! nm! and! 645! nm.! Photon!arrival!times!were!recorded!and!processed!using!customized!software!written!in!MATLAB! (MathWorks,! Natick)! and! Python! (Python! Software! Foundation).!Alternating! laser! excitation! (ALEX)! experiments! produce! four! photon! streams:!
fDex,Dem,& fDex,Aem,& fAex,Dem! and! fAex,Aem,! where! fXex,Yem! is! the! photon! count! for!XQexcitationQbased!YQemission.!To!calculate!the!fluorescence!transfer!efficiency!E!of!a!single!molecule,!a!data!acquisition!period!is!defined!as!a!fluorescence!burst,!which! putatively! corresponds! to! the! time! of! a! single!molecule! diffusing! across!the! force! point! of! the! confocal! microscope.! Within! this! period,! the! photon!numbers! based! on! the! donorQexcitation! were! counted! to! generate& fDex,Dem!and!
fDex,Aem.! Using! these! data! that! report! the! relative! distance! between! D! and! A,!calculation!of!transfer!efficiency!E!is!based!on!Equation!6.2.5.!!A! unique! feature! of! single! molecule! ALEX! FRET! is! that! during! a! fluorescence!burst,!not!only!the!total!emission!due!to!donor!excitation!is!recorded!but!also!the!total!emission!results!from!the!excitation!of!the!fluorescent!acceptor.!Using!this!feature!two!emission!parameters!(fAex,Aem!and!fAex,Dem)!are!derived!and!report!on!the! DQA! stoichiometry.! Using! the! Equation! 6.2.6! the! stoichiometry! of! the! each!burst! was! calculated.! For! the! data! presentation,! stoichiometry,! S,! and! FRET!efficiency,! E,! were! calculated! for! each! fluorescence! burst,! resulting! in!2Qdimensional!EQS!histograms.!
6.3.8(Analysis(of(E(histograms(!The! peak! positions! of! various! SbiQIIIQIV! ligand! complexes! were! obtained! by!iteratively! fitting! the!E! histograms! to! a! singleQGaussian! function.! Fitting! the! E&histogram!yielded!the!mean!E! for!each!SbiQIIIQIV!conformation,!which!was!then!used!for!the!calculation!of!interQfluorophore!(interQterminal)!distances.!!
RDQA!calculation!was!based!on!Equation!6.2.2.!A!FÖrster!radius!(R0)!of!5.2nm!was!
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(SAXS! data! of! the! complex! comprising! the! three! proteins:! SbiQIIIQIV,! C3d! and!FHRQ1! were& collected! at! I711! beamline! in! MaxQlab! in! Lund,! Sweden.! The!wavelength! of! 0.9! Å! was! used! and! a! sampleQtoQdetector! distance! of! around!1996mm.!The!range!of!momentum!transfer!0.01!<!s!<!0.55!ÅQ1!was!covered!(s!=!4π!sinθ/λ,!where!2θ!is!the!scattering!angle).!A!cell!with!mica!windows!was!used.!The! acquisition! time!was! 2!minutes.! The! volume! between! the! sample! and! the!detector! was! kept! under! vacuum! during! data! collection! to! minimize! the!
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background!scattering.!The!automated!sample!changer!was!employed!to!load!the!samples! and! oscillate! the! sample! through! the! observation! capillary! during! the!exposure! period! to! constantly! remove! the! irradiated! sample.! 4! successive!exposures! of! 30! second! exposure! time!were! collected! and! compared! to! detect!and!discard!radiation!damage!effects.!Only!one!sample!concentration!(2!mg/ml)!was!measured!at!10°C!in!PBS!buffer.!These!primary!data!processing!steps!were!performed!using!appropriate!programs!for!the!ATSAS!2.6!package!((Petoukhov!
et& al.! 2012);! http://www.emblQhamburg.de/biosaxs/download.html).! The!forward! scattering! I(0)! and! the! radius! of! gyration!Rg!were! extracted! from! the!Guinier! approximation! calculated! with! the! AutoRG! function! within! PRIMUS!(Konarev! et& al.! 2003;! Petoukhov! et& al.! 2007).! These! parameters! were! also!computed! from! the! entire! scattering! patterns! using! the! indirect! transform!package! GNOM! (Svergun! 1992),! providing! the! pair! distribution! function,! p(r),!and!the!maximum!size!Dmax!of!the!particle!as!well.!To!evaluate!the!flexibility!of!the!two!dimer!species,!dimensionless!Kratky!plots!were!generated!(Kratky!1964;!Durand!et&al.!2010).!The!molecular!weight!(MW)!of!the!solute!was!evaluated!by!comparison! of! the! forward! scattering! with! that! from! a! reference! solution! of!bovine! serum! albumin.! The! MW! estimations! were! crossQvalidated! using! the!particle! excluded! (Porod)! volumes! as! previously! described! (Petoukhov! et& al.!2012).!!
6.3.12,Ab,initio(shape(determination(and(molecular(modeling(
(The!ab&initio!reconstructions!were!generated!with!the!program!DAMMIF!(Franke!&! Svergun! 2009).! To! check! the! stability! of! the! solution! the! ten! independent!DAMMIF!runs!performed!for!each!dimer!were!superimposed!onto!each!other!by!SUPCOMB!(Kozin!&!Svergun!2001).!Using!DAMAVER!(Volkov!&!Svergun!2003)! !common! structural! features! were! determined! and! an! averaged! model! was!generated! for! the! complex! with! the! most! persistent! features! of! all!reconstructions.!! !
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6.4(Results:(!!
6.4.1(IETASSER(structural(prediction(of(SbiEIII(!In! chapter! 3,! based! on! comparative! CD! analyses! (Section! 4.3.8.1)! and!hydrodynamic!diameter!measurements!(Section!4.3.8.2),!we!demonstrated!that!SbiQIIIQIVK173A! could! be! more! structurally! ordered! and! compacted! than!SbiQIIIQIVWT.!Therefore!in!this!chapter,!the!IQTASSER!structural!prediction!server!was!used!to!predict!the!structure!of!SbiQIII!and!SbiQIIIQIV!of!both!WT!and!K173A!proteins!(Section!6.3.2).! !
!According! to! the! IQTASSER! confidence! score! (CQscore)! the! best!models! for!WT!and! K173A! SbiQIII! are! shown! in! Fig.6.4.1.! The! CQscores! for! both! models! are!around!Q1,!which!is!in!the!middle!between!two!extremes!of!modeling!quality.!The!tertiary! structure! organization! of! these! models! (Fig.6.4.1.A! and! B)! is! nearly!identical,! it!was! predicted! that! Sbi! domain! III! could! start!with! two!NQterminal!αQHelices! and! then! finished! with! a! CQterminal! loop.! Together,! these! three!
Figure( 6.4.1:( IETASSER( predictions( of( SbiEIIIWT( and( SbiEIIIK173A.( (A)! The! best!model! for!SbiQIIIWT!(Cyan).! (B)!The! best!model! for! SbiQIIIK173A! (Orange).! (C)! Superposition!of! SbiQIIIWT!and!SbiQIIIK173A!models.!CQscore!varies! from!2! to!Q5,!where!a!higher!value! indicates!a!model!with!a!higher!confidence.! !
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secondary! structure! segments! organize! to! a! compact! bundleQlike! tertiary!structure.!The!only!noticeable!difference!between!WT!and!K173A!models!is!the!secondary! structure! of! the! CQterminal! predicted! loop! region,! as! the!superimposed!presentation!(Fig.6.4.1.C)!indicated!that!this!region!is!replaced!by!a!partial!helical!structure!in!K173A!mutant.! !!A! slight! difference! in! secondary! structure! was! also! detected,! when!Ramachandran!analyses!were!used!to!validate!both!models.!The!resulting!plots!(Appendix!Fig.9.9!A!&!B)!demonstrate!that!some!residues!adopt!different!φ!and!ψ! angles! in!WT! or! K173A!models,! but! the!majority! of! the! residues! from! both!SbiQIII!models!are! located! in! the! favorable! region.!Although! the!Ramachandran!analyses! support! the! viability! of! both! models,! since! Sbi! domain! III! lacks! a!homologous! protein! as! modeling! template,! the! modeling! process! uses! the!structural! information! that! is!mainly!extracted! from!aligned!peptide! fragments!and! ab& initio! modeling! processes.! Therefore,! fluctuations! in! local! modeling!accuracy! are! expected.! Fig.6.4.2! shows! that! the! mean! estimated! accuracy! for!both! SbiQIII! models! is! about! 3! Å,! the! helical! segments! demonstrate! highest!accuracy! (less! than! 3! Å),! the! loop! regions! between! helices! have! slightly! lower!accuracy,! and! the! accuracy! decreases! dramatically! for! the! last! seven! residues!approaching!the!CQterminus!of!the!molecule.!!
Figure( 5.4.2:( Local(modeling( accuracy( of( SbiEIII.(ResidueQlevel!distance!error!estimation!for!SbiQIII.!The!solid!lines!are!predicted!error.!The!dashed!line!represents!the!predicted!error!level!of!3!Å.!The!α!helical!secondary!structural!segments!are!indicated!by!red!dots,!the!loops!are!indicated!by!black!dots.(
! 227!
6.4.2(IETASSER(structural(prediction(of(SbiEIIIEIV( (!Under! the! assumption! that! the! folding! of! SbiQIII! could! be! influenced! by! the!presence! of! SbiQIV,! the! primary! sequences! of! WT! and! K173A! SbiQIIIQIV! were!submitted! to! the! IQTASSER! structural! prediction! server.! The! best! models! are!presented!according!to!the!CQscore!(Fig.6.4.4.A!&!B).!These!models!demonstrate!that!the!insertion!of!K173A!mutation!has!no!significant!structural!impact!on!the!predicted!overall!topology!of!SbiQIIIQIV,!and!both!models!are!mainly!composed!of!αQhelix!secondary!structure.! !!However,! unlike! the! previously! presented! models! of! SbiQIII,! the! predicted!structure! of! Sbi! domain! III! in! SbiQIIIQIV! appears! as! a! loosely! packed! helical!domain.!In!SbiQIIIQIVWT!model,!starting!from!the!NQterminus!of!the!molecule,!two!αQHelix! segments!and!a! loop!segment!are!connected! to!SbiQIV! through! two!90°!turns.!Also!in!this!model,!rather!than!modeling!SbiQIIIQIV!as!an!elongated!protein!consisting! of! two! domains,! SbiQIII! is! folded! toward! SbiQIV! resulting! an! overall!arrangement!similar!to!a!globular!protein.!
!!
Figure(6.4.3:(Local(modeling(accuracy(of(SbiEIIIEIV.(ResidueQlevel!distance!error!estimation!for!SbiQIIIQIV.!The!solid!lines!are!predicted!error.!The!dashed!line!represents!the!predicted!error!level!of! 7! Å.! The! α! helical! secondary! structural! segments! are! indicated! by! red! dots,! the! loops! are!indicated!by!black!dots.!
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Figure(6.4.4:(IETASSER(predictions(of(SbiEIIIEIVWT(and(SbiEIIIEIVK173A.((A)!The!best!model!for!SbiQIIIQIVWT! (SbiQIII:! Cyan,! SbiQIV:! Blue).! (B)( The! best! model! for! SbiQIIIQIVK173A! (SbiQIII:! Gold,!SbiQIV:!Orange).!(C)!Superimposed!models!of!SbiQIIIQIVWT!and!SbiQIIIQIVK173A.!(D)!Superimposed!models!of!SbiQIIIQIVWT,!SbiQIIIQIVK173A!and!SbiQIV!NMR!structure!(PDB:!2JVG,!Pink).!CQscore!varies!from!Q5!to!2,!where!a!higher!value!indicates!a!model!with!a!higher!confidence.! !
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Prior!to!the!smFRET!experiment,!SbiQIIIQIV!has!to!be!labeled!by!both!donor!and!acceptor! fluorophores! on! both! ends! of! the! protein.! Therefore! based! on!pQE30SbiQIIIQIVQCys! construct,! one! additional! cysteine! was! introduced! to! the!NQterminus!of!the!SbiQIIIQIV!by!substituting!arginine!at!location!14!to!a!cysteine,!and!the!resulting!protein! is!named!SbiQIIIQIVdualQcys.!The!mutagenic!PCR!reaction!was!carried!out!as!described!in!Section!6.3.3.!Essentially!five!PCR!reactions!were!conducted! using! five! distinct! extension! temperatures,! and! the! results! of! each!PCR! condition! were! then! analyzed! by! agarose! gel! electrophoresis.! After! PCR!amplification!was!detected,!the!mutated!plasmids!were!processed!and!purified.!The! incorporation! of! the! correct!mutation! was! confirmed! by! DNA! sequencing!(Appendix! 9.1.1.7).! The! expression! and! purification! of! SbiQIIIQIVdualQcys! were!described!in!Section!3.2.1.!The!purity!of!the!protein!sample!was!analyzed!using!SDSQPAGE!(Fig.6.4.5.B).!
Figure( 6.4.5:( Preparation( of( SbiEIIIEIVdualEcys.! (A)! Agarose! gel! evaluation! of! the! PCR!amplification! of! mutation! incorporated! pQE30SbiQIIIQIV! dualQcys! plasmid.! The! mutagenic! PCR!reactions!were!carried!out!5!extention!temperatures.!The!outcomes!of!mutation!insertion!and!PCR! amplification! were! represented! as! the! intensity! of! the! DNA! band! at! 4.0kb.! ! (B)!SDSQPAGE!profile!of!Ni2+!affinity!purified!SbiQIIIQIVdualQcys!(black!arrow).! !!
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Labeling&verification&via&ESIBToF&mass&spectrometry& &
!The!protocol!for!labeling!of!SbiQIIIQIVdualQcys!with!both!Alexa!488!(donor)!and!Cy5!(acceptor)!was!described!in!Section!6.3.5.!To!confirm!the!simultaneous!labeling!of!SbiQIIIQIVdualQcys!with!both!donor!and!acceptor! fluorophore!molecules,!protein!mass! changes! before! and! after! the! labeling! process!were! detected! by! ESIQToF!mass!spectrometry.! !
Figure( 6.4.6:(MS( analysis( of( fluorophore( double( labeled( SbiEIIIEIV.!(A)(ESIQToF!mass!spectrum!of!unlabeled!SbiQIIIQIVdualQcys.!The!theoretical!mass!based!on!primary!sequence!is!indicated.( (B)!ESIQToF!mass!spectrum!of!doubleQlabeled!SbiQIIIQIVdualQcys.!“DA”!indicates!the!peaks!resulted!from!the!labeling!of!SbiQIIIQIV!by!both!donor!and!acceptor!fluorophore.!“DD”!indicates! the! peaks! resulted! from! the! labeling! of! SbiQIIIQIV! by! two! donor! fluorophores.!Donor:!Alexe!488;!Acceptor:!Cy5! ! !!
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Fig.6.4.6.A! shows! the!MS! spectrum! of! SbiQIIIQIVdualQcys! before! labeling,! the!mass!14478.57!Da!was!detected!and!presented!as!a!major!peak!in!the!spectrum,!this!mass! is!nearly! identical! to! the! calculated!mass!of! SbiQIIIQIVdualQcys!(14778.06!Da,!reducing! condition).! Therefore,! this! result! demonstrates! that! firstly!SbiQIIIQIVdualQcys!was!correctly!engineered!via!mutagenesis;!secondly!the!majority!of! the! SbiQIIIQIVdualQcys!molecule!was! in! its! reduced! state.! Along!with! this! peak,!several! other! peaks! were! also! detected! that! could! be! derivatives! of!SbiQIIIQIVdualQcys! molecule! as! the! consequences! of! a! range! of! chemical!modifications.! !Analysis! of! doubleQlabeled! SbiQIIIQIVdualQcys! (Fig.6.4.6.B)! demonstrates! several!peaks!that!could!be!the!results!of!fluorophore!labeling.!To!interpret!these!peaks,!mass!modifications! caused! by!DA! (1476!Da)!DD! (1554!Da)! and!AA! (1394!Da)!labeling! were! subtracted! from! these! peaks! and! then! compared! with! the!unlabeled! SbiQIIIQIVdualQcys! spectrum.! The! interpretable! peaks!were! indicated! in!Fig.6.4.6.B!and!listed!in!Table!6.4.1!A&B.!It!was!found!that!majority!of!the!peaks!are!the!result!of!double!labeling!of!DA.!However,!there!are!a!couple!of!peaks!that!could!be! the! result! of! labeling!with! two!donors.!No!peaks! representing!double!labeling! of! the! acceptor! were! detected.! There! were! two! masses! (16176.85!and16286.84! Da)! from! Fig.6.4.6.B! that! were! not! directly! interpretable.! The!16176.85!Da!peak!represents!the!most!abundant!double!labeled!SbiQIIIQIVdualQcys!species! in! the! sample,! it! was! 15! Da! lighter! than! the! DA! doubleQlabel!SbiQIIIQIVdualQcys!(16191.87!Da),!this!could!suggest!that!the!16176.85!Da!peak!also!represents!DA!labeled!SbiQIIIQIVdualQcys,!the!15!Da!mass!discrepancy!was!the!result!of!deQamidation.!
Table( 6.4.1:( Interpretation( of( MS( spectra.( LQDA! and! LQDD! masses! match! with! one! of! the!SbiQIIIQIVdualQcys!masses.!
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6.4.3.2( Unliganded( SbiEIIIEIV( demonstrates( a( single( conformation( in(
solution(!
Single! molecule! FRET! study! of! unliganded! SbiQIIIQIV! was! performed! on! free!diffusing! molecules! through! a! femtoliter! observation! volume! defined! by! the!focused! laser! beam! and! confocal! microscope.! In! combination! with! alternating!laser!excitation! (ALEX),! the! status!of!both!donor!and!acceptor! fluorophores!on!the! diffusing!molecule! were! reported,! using! the!methods! described! in! Section!6.3.8.! Two!parameters!were!derived,! relative!donor:acceptor! stoichiometry! (S)!and!FRET!efficiency!(E).! !!The! distribution! of! E& (Fig.6.4.7)! obtained! for! SbiQIIIQIV! reveals! an! unbiased!distribution!that!fits!into!a!single!Gaussian!function!with!the!mean&E&=!0.27.!This!indicates! that! unliganded! SbiQIIIQIV! molecule! largely! exists! in! one! major!conformation.! The! internal! flexibility! of! the! molecule! is! reflected! by! the!
Figure( 6.4.7:( FRET( related( histograms( for( SbiEIIIEIV.! The! sample! is! described! by! two!histograms:! a! histogram! of! transfer! efficiency! (E)! versus! a! histogram! of! stoichiometry! (S).!Individual!burst!are!plotted!in!an!E!vs!S!graph,!which!is!colour!coded!to!describe!overlapping!in!the! data! population,! the! high! density! region! is! coloured! red,! low! density! region! is! coloured!blue.! Both! E! and! S! distributions! were! fitted! into! a! singleQGaussian! distribution! (black! solid!line),! the!mean! values! derived! from! the! fitting! were! provided! on! the! graph.! The! number! of!bursts!measured!was!also!indicated!on!the!graph.!!
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broadness! of! the! E! distribution.! Using! Equation! 6.2.2! and! a! previously!determined! R0! of! 52! Å! (Kalinin! et& al.! 2012),! the! estimated! RDQA! between! two!fluorophores! is!calculated!as!61.3!Å.!Because! the! fluorophore! labeling!sites!are!designed!on!either!end!of!the!SbiQIIIQIV,!therefore!the!distance!RDQA!is!utilized!to!represent! the! interQterminus! distance! of! the! SbiQIIIQIV! molecule.! The! single!Gaussian! fitting! of! S! distribution! yields! the!mean! S! of! 0.5,! suggesting! that! the!majority! of! the! single! molecules! analyzed! are! double! labeled! by! donor! and!acceptor!fluorophores.! !!!
6.4.3.3(Ligand(induced(conformational(changes(in(SbiEIIIEIV(
(SbiQIIIQIV!was! shown! to!be!able! to!bind!various!C3d! containing! fragments,! and!the! main! binding! site! was! located! in! Sbi! domain! IV.! In! Chapter! 3,! it! was!demonstrated!that!C3d!fragment!binding!is!a!prerequisite!condition!for!the!high!affinity!ternary!complex!assembly!mediated!by!Sbi!domain!III.!A!hypothesis!that!could!account!for!this!phenomenon!is!that!SbiQIIIQIV!undergoes!binding!induced!conformation!changes,!through!which!a!new!Sbi!domain!III!conformation!forms!which! is! favorable! for! FH/FHRQ1! binding.! In! the! following! sections,! single!molecule! FRET! measurements! of! ligand! bound! SbiQIIIQIV! are! presented! to!provide! new! molecular! insights! into! ligand! binding! triggered! SbiQIIIQIV!conformation! changes.! During! each! experiment,! an! excess! amount! of! ligand!molecule! was! added! to! ensure! the! binding! status! of! SbiQIIIQIV! (Section! 6.3.7).!Only!smFRET!measurements!with&S!≈0.5!were!presented!in!following!sections.! !!Firstly,! the!FRET!efficiency!changes! induced!by!binding!of!various!TED!domain!containing!C3!fragments!were!determined.!In!Fig.6.4.8!a!single!Gaussian!function!was!fitted!in!the!E!distribution!of!C3d,!C3(H2O),!C3b!and!C3!bound!SbiQIIIQIV,!the!mean!E! determined!are!0.30,! 0.34,! 0.27! and!0.31! respectively.!Therefore! apart!from! binding! of! C3b,! all! other! C3! fragments! trigger! an! increase! in! transfer!efficiency,!hence!a!decrease!in!RDQA.!Disparate!E!values!also!indicate!that!although!
! 235!
SbiQIIIQIV! binds! to! the! same! TED! domain! interaction! interface,! the! average!conformation!of!bound!SbiQIIIQIV!is!also!sensitive!to!the!overall!shape!of!the!C3!fragments.!
!Secondly,! in! addition! to! prominent! TED! domain! interactions,! previously!SbiQIIIQIV! was! also! shown! to! bind! C3! activation! fragment! C3a! (Burman! et& al.!2008).!This!interaction!with!a!Kd!of!19.8!μM!was!shown!to!be!much!weaker!then!
Figure( 6.4.8:! Single( molecule( FRET( experiments( reveal( conformational( flexibility( of(
ligand( bound( SbiEIIIEIV.! (aEf)! E! histograms! for! ligand! bound! SbiQIIIQIV.! SingleQGaussian! fit!(black! solid! line),! the!mean! values! derived! from! the! fitting!were! provided! on! the! graph.!The!number! of! bursts!measured!was!also! indicated!on! the!graph.!(g)(Table! summarizing!mean!E!values!for!various!bound!SbiQIIIQIV.!Based!on!the!mean!E!value,!RDQA!was!derived.!The!changing!in! interprobe! distance! ΔRDQA! was! calculated! as! RDQA! liganded! Q! RDQA! unliganded.! (h)! A! bar! chart!presentation! of! ligand! induced! interprobe! distance! changes.! The! negative! values! indicate!relative!shortening!of!SbiQIIIQIV!molecule.!
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!As! shown! in! previous! sections,! the! SbiQIIIQIV! binding! to! C3! fragments! induces!subtle!shortening!of!the!interQterminus!distance.!Although!the!changes!in!RDQA!are!modest,!this!could!still!imply!the!existence!of!a!new!domain!III!conformation!that!is!ready!to!recruit!FH/FHRQ1!as!the!third!component!of!a!ternary!complex.!Based!on!the! flexible!and!elongated!domain!structure!of!FH!and!FHRQ1,!by!binding!to!these! proteins,! the! Sbi! domain! III! could! be! subjected! to! more! conformational!influences.! Therefore! with! the! recruitment! of! FH! or! FHRQ1! further! FRET!efficiency!changes!would!be!expected.!
Figure( 5.4.9:( Single( molecule( FRET( measurements( of( ternary( complex( embedded(
SbiEIIIEIV.((aEb)!E!histograms!for!secondary!ligand!bound!SbiQIIIQIV.!(cEd)!E!histograms!for!ternary!complex!embedded!SbiQIIIQIV.!Red!dashed!line:!Before!FH!recruitment,!Blue!dashed!line:! After! FH! recruitment.! Using! a! singleQGaussian! fit! (black! solid! line),! the!mean! values!derived!from!the!fitting!were!provided!on!the!graph!as!well!as!the!total!number!of!bursts.!
(e)! A! table! summarizing! the! detected! E! and! the! resulting! RDQA! values.! (f)! A! bar! chart!presentation!of!changes! in! interprobe!distance,!calculated!as!RDQA!ternary!complex!Q!RDQA!unliganded.(
(g)!A!bar!chart!presentation!of!changes!in!interprobe!distance,!calculated!as!RDQA!ternary!complex!Q! RDQA! dimeric! complex.! For! ΔRDQA,! positive! values! indicate! relaxation! of! SbiQIIIQIV! molecule,!negative!values!indicate!relative!shortening!of!SbiQIIIQIV!molecule.!!
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The!single!molecule!FRET!measurements!demonstrated!that!in!combination!with!different! C3! fragments,! SbiQIIIQIV! could! bind! to! FH! in! distinct! conformations.!Fig.6.4.9.aQd! shows! two! comparisons! of! E! distributions,! before! and! after! the!recruitment! of! FH.! Using! C3(H2O)! as! the! secondary! ligand,! the! binding! of! FH!induces! a! decrease! in& E! from! EC3(H20)=! 0.34! to! EC3(H20)+FH=! 0.30.! However,! the!separate! measurement! using! C3! as! the! secondary! ligand! shows! that! the! FH!recruitment!increases!E! from!EC3=!0.31!to!EC3+FH=!0.34.!After!conversion!of!E!to!
RDQA,! the! interQterminus! distances! of! the! ternary! complex! embedded! SbiQIIIQIV!were! compared! with! the! unliganded! SbiQIIIQIV! and! secondary! ligand! bound!SbiQIIIQIV.! As! shown! in! Fig.6.4.9.f,! compared! to! unliganded! SbiQIIIQIV,! the!assembly!of!ternary!complexes!shortens!the!interQterminus!distance!of!SbiQIIIQIV!in!both!cases.!However,!the!FH!induced!distance!changes!are!dependent!on!the!type!of!C3!isoform.!Based!on!the!C3(H2O):Sbi!complex!a!subsequent!relaxation!was!observed,! but! based! on! the! C3:Sbi! complex! a! further! shortening! process! was!detected.!These!observations!suggest!that!in!order!to!recruit!FH,!SbiQIIIQIV!has!to!adopt! different! conformations! to! accommodate! the! requirements! of! using!structurally! different! C3! isoforms! as! the! secondary! component! of! the! ternary!complex.!!!!!!
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!FH! or! FHRQ1! have! been! shown! to! be! able! to! form! ternary! complexes! with!SbiQIIIQIV! in! combination! with! multiple! types! of! C3! isoform.! However,! when!using!the!same!type!of!C3!isoform,!SbiQIIIQIV!mediates!a!much!stronger!binding!to! FHRQ1! than! FH! (Section! 4.3.10.2).! This! observation! is! especially! hard! to!comprehend,! as! the! putative! binding! regions! of! FHRQ1! and! FH! are! almost!identical! in! primary! sequence.! Using! single!molecule! FRET,! the! FH! and! FHRQ1!binding! modes! of! SbiQIIIQIV! were! studied.! To! perform! the! experiment,! an! E!distribution! of! SbiQIIIQIV! incubated! with! C3d! and! C3a! was! firstly! acquired!(Fig.6.4.10.a).! As! previously! established,! EC3d! is! almost! the! same! as! EC3a+C3d,!therefore! in! this! series! of! measurement! an! excess! amount! of! C3a! was! also!supplemented,! firstly! as! a! negative! control! molecule! and! secondly! to! help!
Figure( 5.4.10:( Single( molecule( FRET( measurements( of( ternary( complex( embedded(
SbiEIIIEIV.( (a)!E! histograms! for! secondary! ligands! (C3a! and! C3b)!bound!SbiQIIIQIV.!(bEc)!E!histograms! for! ternary! complex! embedded! SbiQIIIQIV.! Red! dashed! line:! Before! FH/FHRQ1,!Green!dashed!line:!After!FH!recruitment,!Blue!dashed!line:!After!FHRQ1!recruitment.!Using!a!singleQGaussian!fit!(Black!solid!line),!the!mean!values!derived!from!the!fitting!were!provided!on!the!graph!as!well!as!the!total!number!of!bursts.((d)!Table!summarizing!the!detected!E!and!the! resulting!RDQA! values.( (e)! A! bar! chart! presentation! of! changes! in! interQprobe! distance,!calculated! as! RDQA! ternary! complex! Q! RDQA! unliganded.! (f)! A! bar! chart! presentation! of! changes! in!interprobe! distance,! calculated! as! RDQA! ternary! complex!Q! RDQA! C3a! +C3d.! For! ΔRDQA,! negative! values!indicate!relative!shortening!of!SbiQIIIQIV!molecule.!!
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et& al.! 2011),! FHRQ11Q2! (Goicoechea! de! Jorge! et& al.! 2013)! and! FHRQ14Q5!(Bhattacharjee!et&al.!2015),!but!little!information!is!available!on!the!arrangement!of! these! components! in! the! ternary! complex.! Although! a! putative! molecular!model!of!the!ternary!complex!is!proposed!in!Section!4.4.3,!further!experimental!validations!are!needed.!Therefore!smallQangle!XQray!scattering!(SAXS)!was!used!to!determine!the!structural!contours!of!the!SbiQIIIQIV:C3d:FHRQ1!ternary!complex.!Ternary!complex!components!were!mixed!as!described!in!Section!6.3.10,!until!a!final!molar!ratio!of!1:1:1!was!achieved.!The!scattering!profile!was!acquired!at!a!protein!concentration!of!2.0!mg/ml!(SDSQPAGE!analysis!is!presented!in!Appendix!Fig.9.10.A).!
Figure( 6.4.11:( SmallEangle( XEray( scattering( (SAXS)( of( SbiEIIIEIV:C3d:FHRE1( ternary(
complex.!(A)!Buffer!subtracted!scattering!curve!of!the!ternary!complex.!(I&is!a!relative!unit,!s!is!expressed!in!nmQ1).!(B)!Pair!distance!distribution!function!P(r).!(C)!Guinier!approximation.!
(D)! An! average!model!of!10! independent! calculated!models.!(E)! Single!model!with!highest!score.!B!and!C!were! calculated!using!PRIMUS!program!package.!Ab& initio! scattering!models!were! generated!with!DAMMIF! and!averaged! in!DAMAVER.! The! surface! presentations!were!prepared!by!Chimera.!
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During! the! SAXS! experiment,! the! scattering!profiles! of! protein!with!buffer! and!buffer!alone!were!collected!(Appendix!Fig.9.10.B),!after!subtraction!of!the!buffer!signal,!the!differential!scattering!profile!of!the!protein!sample!alone!was!derived!(Fig.6.4.11.A).! The! scattering! profile! was! subsequently! converted! to! a! P(r)!function! and!Guiner!plot! (Fig.6.4.11.BQC),! through!which! structural! parameters!were!calculated.!As!a!preliminary!indication!of!the!sample!quality,!the!linear!fit!at!the!low!s!region!of!the!Guiner!plot!suggests!that!the!protein!scattering!profile!is!eligible!for!downstream!structural!modeling!processes.!As!shown!in!Table!6.4.2,!the! SAXS! parameters! of! the! FHRQ1! ternary! complex! are! compared! with!previously! published! data! of! the! SbiQIIIQIV:C3d! complex! (Clark! et& al.! 2011).!According!to!the!volume,!the!ternary!complex!is!about!4Q5!times!larger!than!the!SbiQIIIQIV:C3d!binary!complex,!which!demonstrates!an!unexpected!large!size!for!the!monomeric! ternary! complex.! At! the! same! time,! significant! increases! in!Rg!and!Dmax!are!also!observed.!Therefore,! these!data! indicate! that,! in!solution,! the!FHRQ1! ternary! complex! probably! exists! as! a! dimer! with! an! elongated!conformation.!!
Table( 6.4.2:( Overall( parameters( of( SAXS( data.! SbiQIIIQIV:C3d! SAXS! data!was! retrieved! from!(Clark!et&al.!2011).!Rg,!Dmax,!Vp!and!Vex!are!radius!of!gyration,!maximum!size,!Porod!volumn!and!excluded!volume!derived!by!experimental!SAXS!data.!
! Rg(Guinier)! Rg(P(r))! Dmax! Vp! Vex!SbiQIIIQIV:C3d! 3!nm! 3.3!nm! 12!nm! 90!nm³! 104!nm³!
SbiQIIIQIV:C3d:FHRQ1! 7.8!nm! 8.2!nm! 27nm! 400!nm³! 490!nm³!!The!lowQresolution!ab&initio&models!of!the!ternary!complex!reconstructed!using!the! beadQfitting! program! DAMMIF.! An! “average! model”! of! 10! independently!calculated!models!is!presented!in!Fig.6.4.11.D,!and!the!“best!model”!with!lowest!χ2=1.34!is!shown!in!Fig.6.4.11.E.!Both!average!and!best!models!are!very!similar!in! shape! and! size,! and! adopt! an! asymmetrical! “L”! shape,! which! comprises! 5!
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distinct!globular!domains!(Fig.6.4.11.DQE).!The!first!density!domain!is!related!to!the! other! four! densityQdomains! through! an! angle! of! 120°.! The! “best! model”!shows!clear!domain!boundaries!and!decreased!densities!in!the!connecting!region,!which! indicates! that! the! protein! domains! are! likely! to! be! connected! through!flexible!loops.! !
Using! the! determined! lowQresolution! structural! envelopes,! semiQautomatic!fitting! processes!were! performed! to! generate! the! putative!molecular!model! of!FHRQ1!containing! ternary!complexes.!Using! the!program!Chimera! (Pettersen!et&
al.! 2004),! individual! structural! components!of! the! ternary! complex!were! fitted!into! the! “Best! model”,! under! the! principal! of! maximal! occupancy.! Then! small!
Figure(6.4.12:(Model(fitting(of(Ternary(complex.!(A)!Fitting!of!the!FHRQ11Q2!dimer.!(B)!Fitting!of!fullQlength!FHRQ1!dimer.!(C)!Fitting!of!the!SbiQIV:C3d!binary!complex.!(D)!An!overview!of!fitted!SbiQIIIQIV:C3d:FHRQ1! 1:1:2! dimer.! Inside! percentage! indicates! the! percentage! of! the! structural!model!that!is!included!in!the!SAXS!envelope.!PDB!files!used!were!indicated!on!the! figure.!Model!fitting!and!graphic!presentation!were!performed!with!Chimera!program.!
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manual!adjustments!were!made!based!on!established!structural!characteristics!of!FHRQ1!and!the!SbiQIV:C3d!complex.!As!introduced!in!Section!1.4.3,!FHRQ1!was!shown!to!dimerize!in!serum,!therefore!it!could!be!that!the!elongated!SAXS!model!contains! a! pair! of! dimerized! FHRQ1! proteins,! with! the! dimerization! region!located!in!middle!of!the!model,!and!Sbi:C3d!complex!bound!on!either!end!of!the!model.! !!Using!the!“best!model”!generated!by!DAMMIF!as!the!search!density,!the!highest!occupancy!was! achieved!by! fitting! the! crystal! structure! of! FHRQ11Q2! dimer! into!the!density!domain!3!(Fig.6.4.12.A).!Based!on!the!location!and!orientation!of!the!fitted! FHRQ11Q2! dimer,! two! FH18Q20! (FH18Q20≈FHRQ13Q5)! domains! were! manually!fitted! into! the! SAXS! envelope,! flanking! the! dimerization! region.! The! resulting!putative!model! of! the! FHRQ1! dimer! occupies! density! domains! 2Q5! of! the! SAXS!envelope!(Fig.6.4.12.B).!Finally,!a!space!fitting!search!was!performed!again!using!SbiQIV:C3d! crystal! structure.! It!was! found! that! density! domain! 1! provides! best!occupancy!to!this!binary!complex!(Fig.6.4.12.C).! !!Thus,! this! putative! ternary! complex! model! suggests! that! although! the! FHRQ1!dimer! provides! two! Sbi:C3d! binding! sites,! but! only! one! site! is! bound! in! the!current! model.! Another! surprising! discovery! is! that! unlike! the! previously!proposed! idea! that! SbiQIV:C3d:FH18Q20! is! a! tightly! packed! globular! complex!(Section! 4.4.3),! the! new! SAXS! based! model! suggests! that! the! C3d! is! not!necessarily! interacting! with! FHRQ14Q5! in! the! ternary! complex.! Instead! the!connection! between! C3d! and! FHRQ1! could! be! solely! maintained! by! SbiQIIIQIV,!which!is!strongly!supported!by!the!newly!discovered!binary!binding!between!Sbi!and! FH/FHRQ1! (Section! 4.3.10.3).! As! shown! by! Fig.6.4.12.D,! using! current!structural!information,!a!considerable!amount!of!space!(Fig.6.4.12.D,!white!dash!line!circle)!in!densityQdomain!2!was!unable!to!be!explained,!but!given!the!close!proximity! of! this! space! to! the! NQterminus! of! SbiQIV,! it! is! possible! that! SbiQIII!occupies!this!space!and!makes!contact!with!FH18Q20/FHRQ13Q5.!
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6.5(Discussion(
(In! this! chapter,! the! structural! aspects! of! SbiQIIIQIV! and! its! ligand! binding!properties! were! investigated.! Firstly,! the! protein! structure! prediction! server!IQTASSER! was! used! to! construct! putative! models! of! SbiQIIIWT! and! SbiQIIIK173A.!Comparisons!of!these!models!indicate!a!slight!secondary!structure!difference!in!the!CQterminal!of!SbiQIII!could!cause!a!decrease!in!SbiQIII’s!activity.!In!the!second!part! of! this! chapter,! the! conformational! flexibility! of! SbiQIIIQIV!was! studied! by!ALEX! smFRET.! These! results! suggest! that! unQliganded! SbiQIIIQIV! adopts! one!major! conformation,! but! sequential! changes! in! conformation! are! inducible! by!binding! with! various! ligands.! The! FHRQ1! binding! of! SbiQIIIQIV:C3d! complex!causes! a! reduction! of! 9%! in! SbiQIIIQIV’s! interQterminal! distance! indicating! a!significant! structural! compaction.! The! final! results! section! of! this! chapter,!Section! 6.4.4,! provides! the! first! structural! insight! into! the! SbiQIIIQIV:C3d:FHRQ1!ternary!complex.!The!molecular!model!derived!from!SAXS!analysis!confirms!the!dimerization! state! of! FHRQ1! in! solution,! suggesting! that! the!molar! ratio! of! the!ternary! complex! in! the! current! model! is! 1:1:2,! and! supports! an! alternative!packing!mechanism! of! the! ternary! complex! that! is! different! from! the! putative!model!proposed!in!Section!4.4.3.! !!
6.5.1( Evaluation( of( current( structural( data( against( SbiEIIIEIV:C3d( SAXS(
analysis(
(Like!most!structure!prediction!studies,!despite! the!sophisticated!algorisms!and!selfQevaluating! scores,! discrepancies! from! the! real! structure! are! unavoidable;!therefore!experimental!verification!is!essential!before!further!exploitation!of!the!model.!To! evaluate! the! SbiQIIIWT!model!presented! in! this! chapter,! the!model! of!SbiQIIIWT!(Fig.6.4.1.A)!and!the!crystal!structure!of!SbiQIV:C3d!were!fitted!manually!into! the! SAXS! envelope! of! SbiQIIIQIV:C3d! binary! complex! that! had! been!determined!previously.!By! comparing! the! theoretical! scattering! intensity! curve!
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of! the! model! against! the! experimental! scattering! curve,! the! accuracy! of! the!current!SbiQIIIWT!model!can!be!tested.! !
!As!shown!by!Fig.6.5.1,!guided!by!the!SbiQIIIQIV:C3d!SAXS!envelope,!the!model!of!SbiQIIIWT!fits!neatly!into!SAXS!ab&initio!density.!The!theoretical!scattering!curve!of!the!model!was!then!calculated!and!compared!with!experimental!scattering!curve!using!CRYSOL!(Svergun!et&al.!1995).!Fig.6.5.2!shows!that!the!overall!discrepancy!between!two!set!of!data!is!χ2=4.7.!At!the!low!s!region!of!the!plot,!the!scattering!curve! of! the! SbiQIIIQIV:C3d! theoretical! model! nearly! superimposes! with! the!experimental!data,!but!large!discrepancies!were!detected!at!the!high!s!region!of!the!plot!(Fig.6.5.2,!blue!dash!box).!The!high!correlation!at!low!s!suggests!that!the!model! genuinely! reflects! the! size! and! shape! properties! of! the! real! structure!(Svergun!&!Koch!2002).!However!in!terms!of!internal!structure!(reflected!by!the!
Figure(6.5.1:( Reconstruction( of( the(SbiEIIIEIV:C3d(complex( based(on( the( SbiEIIIEIV:C3d(
SAXS(envelope(using(the(SbiEIIIWT(model(and(the(SbiEIV:C3d(crystal(structure.!(A)!Before!SbiQIII! fitting!and!(B)!after! fitting.!The! identity!of! the!structural! components! is! indicated!by!colour! key.! The!SAXS! envelope! is! depicted! in! translucent! Cyan!colour.! Guided! by! the! SAXS!envelope,! SbiQIIIWT!was!manually! fitted,! and! the!distance!between! the!NQterminus!of! SbiQIII!and! the! CQterminus! of! SbiQIV! was! determined! by! Chimera.! The! SbiQIV:C3d! complex! (PDB:!2WY8)!was!used!to!construct!this!model.!
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high!s!region)!this!model!still!can!be!improved,!which!indicates!the!difficulty!of!accurately! predicting! the! 3D! structure! of! SbiQIII! using! structural! prediction!methods.!The!distance!between!the!SbiQIIIQIV’s!termini,!based!on!the!SAXS!model!is! 63.7! Å! (Fig.6.5.1.B).! This! is! similar! to! the! distance! determined! by! smFRET!(59.8!Å,!Fig6.4.8.g).!Although!no!large!discrepancy!is!revealed,!a!difference!of!3.9!Å! is! observed! which! could! be! the! result! of! the! modeling! error! of! SbiQIIIWT! or!smFRET’s!inherent!technical!shortcoming!in!measuring!absolute!distance.!Thus,! here! we! provided! a!SbiQIIIQIV:C3d! model! with! reliable!size!and!shape!characteristics,!which!could! be! exploited! further! for! the!modeling!of!SbiQIIIQIV!ligand!induced!conformation!changes.!!
6.5.2( Hypothesis( of( SbiEIIIEIV(
ternary(complex(binding(mode( (
(It! was! demonstrated! in! Section!6.4.3.3! that! SbiQIIIQIV! changes! in!interQterminus! distance! upon! binding! of! various! protein! ligands.! The!conformational! flexibility! seems! highly! related! to! the! complement!modulatory!function!of!SbiQIIIQIV,!as!the!CD!studies!(Section!4.3.8.1)!demonstrated!that!both!K173A! and! S199A! mutants! contain! increased! αQhelix! content.! The! modeling!study!(Section!6.4.1)!indicates!that!CQterminal!segment!of!SbiQIII!that!connects!to!SbiQIV! could!be! responsible! for! the! flexibility!of! SbiQIIIQIV.!The! flexibility!of! the!peptide!segment!connecting!SbiQIV!to!SbiQIII!was!also!previously!illustrated!by!a!NMR! study! of! SbiQIV! (Upadhyay! et& al.! 2008).! As! shown! in! Fig.6.5.3.A,! the!NQterminal!loop!region!of!the!20!solution!NMR!structures!of!SbiQIV!demonstrates!three! general! orientations.! The! majority! of! the! loop! adopts! the! orientation!coloured! in!blue! in!Fig.6.5.3.A,! the!purple!and!yellow! loop!orientations!are! less!
Figure( 6.5.2:( Experimental( vs( theoretical(
scattering( curve.! SbiQIIIQIV:C3d! model! was!used! for! theoretical! scattering! curve!calculation!and!compared!to!experimental!data!using! CRYSOL.! Large! discrepancy! is!highlighted!by!blue!dashed!box.!
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common.!Based!on!this!previously!unexploited!information,!we!propose!that!the!three!observed!SbiQIV!NQterminal!loop!orientations!could!be!translated!into!three!SbiQIII! orientations,! depicted! in! Fig.6.5.3.B! as! O1,! O2! and! O3.! The! orientation!changes!of!SbiQIII!from!O1!to!O2!and!O3!involve!two!isoQplanar!rotations!of!90°,!due! to! the! rotations! being! centred! around! the! NQterminus! of! SbiQIV,! therefore!only!slight!interQterminus!distance!changes!are!produced!(Fig.6.5.3.C).!Changing!from!O1!(61.5!Å)!to!O2!(60.4!Å)!produces!an!interQterminus!distance!change!of!1!Å,! and! from!O1! to!O3! (55.6!Å)!a! larger!decrease! in!distance! (5!Å)! is!observed.!Among! these! three! SbiQIII! orientations,! the! O1! orientation! is! found! able! to! fit!neatly!in!the!SbiQIIIQIV:C3d!SAXS!envelope!shown!in!Fig.6.5.1.A.! !
!
Figure(6.5.3.(SbiEIII’s(orientation(flexibility:!(A)!20!solution!NMR!structures!of!SbiQIV.PDB:2JVG!
(B)!Three!extrapolated!SbiQIII!orientations!based!on!the!NMR!structures.!(C)!The!interQterminus!distances! of! SbiQIIIQIV.! Distances! are! determined! using! Chimera! (D)! Putative! structural!relationship! between! SbiQIII’s! orientations! and! ternary! complex! formation.! (EEF)! Putative!structural!relationship!between!SbiQIII!O3!orientation!and!FH18Q19≈CFHR13Q4.!The!proposed!SbiQIII!binding! region! is! indicated! in! a! red! dashed! oval.! Structural! analysis! and! presentation! were!performed!using!Chimera.! !
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The!subtle!decreasing!trend!in!interQterminus!distances!(O1>O2>O3,!Fig.6.5.3.C),!fits! with! our! smFRET! results! (Section! 6.4.3.3! &! 6.4.3.4),! which! shows! that!SbiQIIIQIV! decreases! in! interQterminus! distances! upon! stepQwise! ligandQbinding!events.!Therefore,!we!propose!that!the!changing!of!SbiQIII!orientations!could!be!the!underlying!molecular!requirement!for!SbiQIIIQIV!ligand!binding!events.! ! This!theory!is!evaluated!in!the!context!of!ternary!complex!formation,!which!has!been!proven!to!be!predominantly!a!SbiQIII!mediated!event.!Using!SbiQIV!as!a!reference,!three! SbiQIII! orientations! were! modelled! into! the! previously! proposed!SbiQIV:C3d:FH18Q20!complex!(Fig.4.4.2.B).!It! is!shown!(Fig.6.5.3.D)!that!the!SbiQIII!O1!and!O2!orientation!is!not!in!a!favourable!location!to!make!contact!with!FH18Q19.!By!adopting!the!O3!orientation,!however!SbiQIII!is!hypothetically!placed!in!close!contact!with!FH18Q19!(Fig.6.5.3.EQF).!!
6.5.3(“Loose”(and(“Tight”(binding(model(of(ternary(complex(!In! this! study,! based! on! the! SAXS! analysis,! a! putative! model! for! the!SbiQIIIQIV:C3d:FHRQ1! ternary! complex! was! generated! (Fig.6.4.12.D),! based! on!which! the! previous! report! regarding! the! dimerization! state! of! FHRQ1! was!confirmed.!The!model!also!suggests!a!previously!unexpected!molar! ratio!and!a!novel! loosely! packed! ternary! complex! binding! mode.! These! observations! not!only!prompt!new!hypotheses!about!ternary!complex!formation,!but!also!pave!the!way!for!further!inQdepth!structural!studies.!!Sbi!and!Ecb!are!two!Staphylococcal& immune!evasion!proteins!that!form!ternary!complexes.! In! this! thesis,! it! was! found! that! although! similar! complement!constituents! are! used,! the! assembly!mechanisms! of! the! ternary! complexes! are!totally! different.! The! previous! bioinformatic! analysis! (Hammel! et& al.! 2007a)!shows! that! Ecb! has! no! SbiQIIIQlike! domain,! the! author! (Amdahl! et& al.! 2013)!proposes! a! model! for! the! Ecb! ternary! complex! (Fig.6.5.4.A)! by! matching! the!Ecb:C3d! crystal! structure! (Hammel! et& al.! 2007a)! with! the! C3d:FH19Q20! crystal!
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structure! (Kajander! et& al.! 2011).! Using! C3d! as! the! reference! structure,! their!model!suggests!that!the!Ecb!binds!FH19,!which!increases!the!affinity!between!FH!and! C3b.! Notably,! the! proposed! Ecb! residues! interacting! with! FH19! are! not!conserved!in!SbiQIV!structure.!
!Inspired! by! their! methodology,! in! Section! 4.4.3! a! putative! SbiQIV:C3d:! FH18Q20!model! was! generated,! based! on! which! SbiQIII! O3! was! added! to! generate! a!SbiQIIIQIV:C3d:!FH18Q20!model! (Fig.6.5.3.EQF)!and! the!putative!SbiQIII!binding!site!was!proposed.!The!updated!model!shows!that!the!SbiQIIIQIV:C3d:!FH18Q20!ternary!complex!is!extremely!tightly!packed!(Fig.6.5.4.B),!therefore!raising!concern!over!steric!hindrance!and!accessibility!to!the!binding!site.!A!possible!answer!for!this!issue! is! provided! in! Section! 6.4.4,! in! which! a! loosely! packed! ternary! complex!configuration!(Fig.6.4.12.D!and!Fig.6.5.4.D)!is!implicated!by!the!SAXS!study.!!This! new! discovery! triggers! a! rethink! of! the! mechanistic! detail! about! ternary!complex!formation.!It!has!been!shown!in!this!study!that!C3!isoform!binding!is!a!
Figure( 6.5.4:( “Loose”(
and( ”Tight”(packing(models(
of( ternary( complex.!(A)!The!surface! representation! of!Ecb:C3d:FH19Q20! ternary!complex.! (B)! The! surface!representation! of!SbiQIIIO3QIV:C3d:FH18Q20.! (C)!Hypothesized! structural!model! of!SbiQIIIO3QIV:C3d:FH18Q20,!“Tightly! packed! model”.! (D)!SAXS! model! of!SbiQIIIQIV:C3d:FH18Q20,! the!“Loosely! packed! model”.!Figure!A! taken! from! (Amdahl!et!al.!2013).!
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!In!chapter!4!(Section!4.3.10.2),!it!was!demonstrated!that!SbiQIIIQIV!preferentially!binds! FHRQ1! over! FH! in! combination! with! various! C3! isoforms.! Although! this!binding! preference! is! one! of! the! theoretical! foundations! for! Sbi! triggered! C3!consumption,! given! the! extremely! high! sequence! identity! between! FH18Q20! and!FHRQ13B5,! how! this! selectivity! is! achieved! remains! elusive.! In! this! section,! an!explanation!for!this!question!is!discussed!based!on!the!differential!glycosylation!status! of! FH! and! FHRQ1.! Despite! the! sequence! identity! between! FH18Q19! and!FHRQ13Q4,!biochemical!differences!could!still!be!introduced!via!postQtranslational!modifications.!The!NQlinked!glycosylation!site!in!FH18!(N1095)!has!been!shown!to!always! have! a! carbohydrate! chain! attached! (Fenaille! et& al.! 2007),! but! the!postQtranslational! modification! on! the! equivalent! glycosylation! site! in! FHRQ13!(N194)! is! less! strict.! Two! glycosylated! forms! of! FHRQ1! were! found! in! human!serum!(Skerka!et&al.!1991),!FHRQ1β!has!two!and!FHRQ1α!has!one!carbohydrate!chain! attached! (Skerka! &! Zipfel! 2008).! FHRQ1α! could! represent! the! FHRQ1!protein! with! no! glycosylation! on! N194.! As! shown! in! Fig.6.5.5,! this! potentially!
Figure( 6.5.5:( Impact( of(
glycosylation( on( ternary(
complex( formation.( The!putative!SbiQIII!binding!site!(red!dashed! circle)! is! in! close!proximity! to! the! differential!glycosylated!site!on!both!FH!and!FHRQ1.! Complex! NQlinked!carbohydrate! glycosylated!FH18Q20! is! modelled! using!GlyProt! (BohneQLang! &! Lieth!2005).! !
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decisive! glycosylation! site! is! located! in! close! proximity! to! the! putative! SbiQIII!binding!site,!in!the!presence!of!a!complex!carbohydrate!chain!the!accessibility!of!the! surrounding! protein! surface! could! be! significantly! hampered.! Therefore,!SbiQIIIQIV! could! bind! FHRQ1α!with! a! distinct! binding! kinetic! profile,! leading! to!preference!for!FHRQ1!over!FH.!Although,!as!shown!in!Fig.4.3.19.B,!it!appears!that!SbiQIIIQIV! binds! FHRQ1β! better! than! FHRQ1α,! but! this! result!may! be! an! artifact!caused!by!recognition!bias!of!the!polyclonal!FH!antibody!(Skerka!et&al.!2013).! !!
6.5.5(ALEX(smFRET(as(a(tool(to(study(protein(conformation(flexibility(!In!this!study,!using!ALEX!smFRET!the!conformational!flexibility!of!SbiQIIIQIV!has!been! demonstrated! in! great! detail.! Although! the! E& histogram! (Fig.6.4.7)! only!suggests!one!major!interQterminal!distance!of!unliganded!SbiQIIIQIV,!based!on!the!model! proposed! in! Fig.6.5.3.C,! changes! in! SbiQIII! orientation! could! still! occur!without! significant! impact! on! the! interQterminal! distance.! The! smFRET! data!indicated! stepQwise! changes! in! SbiQIIIQIV’s! interQterminal! distance! during! the!assembly!of!ternary!complex.!The!binding!of!secondary!ligand!(e.g.!C3!isoforms)!generally!induces!relatively!small!decreases!in!interQterminal!distance,!followed!by!big!distance!decreases!induced!by!binding!of!tertiary!ligand!(e.g.!FH/FHRQ1).!This! fits! with! the! previous! arguments! that! SbiQIII! undergoes! orientational!changes!and!then!binds!to!FH/FHRQ1.!Corresponding!to!the!differential!binding!affinity,!it!is!also!revealed!that!SbiQIIIQIV!binds!to!FH/FHRQ1!in!slightly!different!manners!(Section!6.4.3.4).!This!could!reflect!differences!in!the!overall!structure!between!FH18Q20!and!FHRQ13Q5! in!solution.!But!at! the!same!time,! the!differential!glycosylation!status!could!also!cause!this!difference.!!
6.5.6(Further(experiments(
(Based! on! current! structural! data,! a! putative! model! for! the! ternary! complex!formation! is! constructed! in! this! chapter.!This! leads! to!multiple! lines!of! further!
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7.1(Immune(evasion(mechanism(of(Sbi(!!Within! the! arsenal! of! S.& aureus! immune! evasion! proteins,! there! are! numerous!small! and! secreted! proteins! that! interfere! with! the! function! of! the! central!complement! component,! C3.! Although! these! Staphylococcal& proteins! have!different!modes! of! action,! the! goals! of! the! previously! determined!mechanisms!are! the! same:! to! block! complement! activation,! to! prevent! opsonization,! and! to!neutralize!the!complement!effector!molecules!(e.g.!C3a!and!C5a).!The!discovery!that!Sbi!triggers!C3!consumption!fits!with!the!longQterm!objections!of!these!goals,!but! also! demonstrates! the! unique! mechanistic! signatures! of! Sbi.! Rather! than!direct!inhibition,!Sbi!exploits!the!host’s!AP!activation!and!regulation!mechanisms!to!achieve!immune!evasion.! !!At!first!it!may!seem!counterQintuitive!that!an!immune!evasion!protein!such!as!Sbi!promotes! C3! activation,! but! detailed! scrutiny! of! the! mechanism! suggests!otherwise.! The! significance! of! a! distal! C3! activation! resembles! an! antiQmissile!flare!that!consumes!active!C3!before!it!can!reach!the!bacterium.!The!metastable!C3b! only! has! a! finite! lifetime,! therefore! only! the! microbial! surfaces! in! close!proximity! are! under! threat! of! opsonization.! Furthermore,! if! the! complement!activation!is!not!well!orchestrated,!the!metastable!C3b!will!more!likely!react!with!water!and!subsequently!be!degraded!by!complement!regulators.!Clearly,!Sbi!has!evolved! to! minimize! selfQinflicted! opsonization! on! the! bacteria,! doing! so! by!directing! the! metastable! C3b! molecules! to! host! targets! such! as! IgG.! Sbi!expression! correlates! with! the! presence! of! IgG! (Zhang! et& al.! 2000),! and! it!deliberately!attracts!IgG!to!the!site!of!C3!consumption.!The!IgG!molecule!may!be!exploited!as!a!molecular!mop!for!metastable!C3b.!The!SbiQIQII:IgG!interaction!was!shown! to! form! large! insoluble! immune! complexes! (Atkins! et& al.! 2008),! which!
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potentially! offer! enough! C3b! deposition! sites! to! neutralize! the! amount! of! C3b!generated!from!a!C3!convertase.!Under!physiological!circumstances,!a!single!C3!convertase!has!a!halfQlife!of!90!s,!and!is!able!to!turn!160!C3!molecules!into!C3b!(Pangburn!1986).!In!addition,!(Smith!et&al.!2012)!demonstrated!that!SbiQIIIQIV!is!only!active!after!becoming!secreted! ,which! is!another!protective!mechanism!to!tackle!the!C3!consumption!“backQfiring”.!!Given! that! Sbi! triggered! C3! consumption! is! distanced! from! the! location! of! the!bacteria,! the! resulting! release! of! C3a! probably! would! not! cause! harm! to! the!bacteria,!but!could!direct!the!leukocytes!to!irrelevant!sites.!On!the!contrary,!the!release!of!the!much!more!potent!chemoattractant!C5a!is!strongly!suppressed!by!Sbi.!!Through!the!means!of!ternary!complexation,!Sbi!achieves!the!goal!of!destroying!active!C3!before!they!can!reach!the!bacteria.!Although!the!mechanistic!detail!of!Sbi! is! surprising,! proteolytic! degradation!of! C3! as! an! immune!evasion! strategy!has! been! described! before.! Streptococcal! cysteine! protease! SpeB! (Terao! et& al.!2008)!degrades!C3!to!inhibit!bacterial!clearance.!Both!Gelatinase!E!(GelE)!(Park!
et& al.! 2008)! from! Enterococcus& faecalis! and! Staphylococcal! metalloprotease!aureolysin!(Laarman!et&al.!2011)!cleave!the!C3!αQchain!at!a!site!close!to!the!C3!convertase! cleavage! site,! exposing! the! resulting! C3b! molecule! to! the! host!complement! proteases.! Sbi! shares! a! very! similar! immune! evasion! philosophy!with! GelE! and! aureolysin,! converting! C3! to! its! activated! conformation! C3b! in!distal! fluid! phase,! where! C3b! can! be! disposed! of! by! host! protease! factor! I.!However,!Sbi! is! clearly!designed! to!deal!with! the!explosive!C3!activation!event!resulting! from! C3! convertase,! as! discussed! earlier,! the! use! of! IgG! could! be! a!guarantee! that! the! activated! C3b! will! not! harm! the! bacteria.! The! proteolytic!reactions! catalyzed! by!GelE! and! aureolysin! are! generally! slower,! therefore! the!factor!I!mediated!C3b!inactivation!is!unlikely!to!be!overwhelmed.!!
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A! more! prevalent! immune! evasion! strategy! involves! recruiting! FH! onto!microbial! surfaces.! This! strategy! is! used! by! several! bacteria,! some! yeasts! and!even! some! viruses! (Lambris! et& al.! 2008).! The! surface! acquisition! of! FH! is!beneficial!for!the!survival!of!the!pathogens,!and!the!surface!associated!FH!makes!the! microbial! surfaces! like! the! nonQactivator! surface,! which! is! hostile! for!complement! AP! amplification.! Various! microbial! proteins! have! evolved!convergently!to!target!two!binding!sites!on!FH,!which!suggests!that!the!FH!needs!to!be!maintained!in!a!specific!orientation!in!order!to!be!functionally!active!(Meri!
et&al.!2013).! !!Recently,! this! traditional! view! of! FH’s! role! in! immune! evasion! is! being!reinvestigated,! as! an! increasing! number! of! secreted! immune! evasion! proteins!have! been! shown! able! to! recruit! FH! as! well.! Sbi! is! the! first! secreted!
Staphylococcal! immune! evasion! protein! discovered! that! sequesters! FH! family!proteins! in! combination! with! C3! isoforms! (Burman! et& al.! 2008;! Haupt! et& al.!2008).!Similar!activity!was!later!associated!with!another!two!Staphylococcal!C3!binding!proteins!EcbQC!(EcbQC,!C3d!binding!domain!of!Ecb)(Amdahl!et&al.!2013)!and! EfbQC! (EfbQC,! C3d! binding! domain! of! Efb)(Chen! et& al.! 2010;! Amdahl! et& al.!2013).!Although!all!three!proteins!(SbiQIV,!EcbQC!and!EfbQC)!share!a!high!level!of!structural! similarity! and! are! able! to! form! similar! FH! ternary! complexes,! the!mechanisms! of! ternary! complex! formation! and! the! immunological! outcomes!differ!significantly!from!each!other.!An!inQdepth!discussion!of!the!similarities!and!differences! of! these! three& staphylococcal! proteins! was! presented! in! Sections!3.4.6.2.! These! three! proteins! present! a! perfect! example! of! the! functional!significances!of!the!C3!binding!and!ternary!complex!formation.!The!inhibition!of!C3! convertase! is! positively! related! to! the! avidity! to! C3b,! the! inhibition! of! C5!convertase! is! positively! related! to! the! ability! to! form! ternary! complexes.! We!propose! that! Sbi! organizes! more! stable! ternary! complexes! than! the! ones!mediated!by!EcbQC!and!EfbQC,!because!Sbi!dedicates!a!separate!domain!(Domain!III)! to! FH/FRH1! binding,! while! the! other! two! proteins! only! provide! a! limited!
! 258!













S.&pyogenes& Scl1.6!and!Scl1.55! No! No! (Reuter!et&al.!2010)!
S.aureus& Sbi! Yes! Yes! (Burman!et&al.!2008;!Haupt!et&al.!2008)!
B.&burgdorferi&
CRASPQ3,!CRASPQ4,!CRASPQ5,! No! No! (Haupt!et&al.!2007)!
P.&aeruginosa& Tuf,!Lpd! No! No! (Kunert!et&al.!2007)!(Hallstrom!et&al.!2012)!
E.&coli& Stx2! No! Yes! (Orth!et&al.!2009)!(Poolpol!et&al.!2014)!!!The! simultaneous! binding! of! FHRQ1! and! FH! is! not! an! exclusive! feature! of! Sbi.!Numerous!bacterial!proteins! (Table!7.1)!have!been! identified! that! can!bind!FH!and!FHRQ1!at!the!same!time.!Similar!to!Sbi,!FH!and!FHRQ1!compete!for!binding!to!these! proteins,! among! which! Scl! and! CRASP! have! been! shown! able! to! reduce!fluid! phase! C3b! degradation.! This! C3b! protective! property! is! attributed! to! the!FHRQ1!binding,!as!FHRQ1!does!not!possess!factor!I!cofactor!activity.!The!majority!of!these!proteins!are!not!able!to!trigger!C3!activation.!But,!Stx2!is!the!only!other!protein!that!shares!the!C3!activation!outcome!with!Sbi.!This!protein!is!unique!in!its!ability!to!bind!both!FH6Q8!and!FH18Q20!regions!of!FH,!unlike!the!majority!of!the!proteins! described! here! that! only! target! the! FH18Q20! region.! The! AP! pathway!activation!process!triggered!by!Stx2!is!able!to!proceed!until!the!formation!of!the!membrane! attack! complex,! which! releases! anaphylotoxins! C3a! and! C5a.!Therefore,!Stx2!is!proposed!as!a!bacterial!toxin,!which!could!be!a!major!cause!of!hemaolytic!uremic!syndrome!(HUS).!The!molecular!mechanism!of!Stx2!induced!AP!activation!remains!to!be!elucidated.!!In!many!aspects,!these!FH!family!binding!proteins!behave!in!a!strikingly!similar!
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fashion! to! Sbi,! however! Sbi! is! the! only! protein! that! binds! FH! and! FHRQ1! in!combination!with!C3! isoforms.!C3,!C3b!and!C3d!are!all!eligible!constituents! for!Sbi! ternary! complex! assembly.! This! suggests! that! Sbi! recruits! FHRQ1! before,!during!and!after!the!C3!activation.!Sbi!decreases!the!physical!distance!between!C3b! and! FHRQ1,! and! this! could! be! another! reason! for! the! enhanced! C3b!protection.! It! was! also! demonstrated! that! Sbi! prefers! to! bind! FHRQ1! over! FH!during! ternary! complex! assembly.! Under! physiological! conditions,! where! the!FHRQ1:FH! ratio! is! 0.5:1,! only! 40%!of! C3b! is! FH!bound.! Together,! these! unique!features!make! Sbi! a! better!protector! of! fluid!phase!C3b! than! any!other! known!bacterial!complement!modulator!(Table!7.1).! !!Another!truely!unique!feature!of!Sbi! is! its!ability!to! form!the!SbiQC3b!adduct.! It!has! been! demonstrated! that! this! is! a! deliberate!mechanism! of! Sbi! in! order! to!extend!the!serum!halfQlife!of!the!C3b!conformation!(Section!5.3.3.2).!By!covalent!deposition! on! polysaccharides! or! proteins,! a! 10Qfold! reduction! (S.! Meri! &!Pangburn! 1990)! in! FH! affinity! for! C3b! can! be! achieved.! This! phenomenon! is!normally!exploited!by!the!host!immune!system.!To!assist!AP!signal!amplification,!IgG!molecules!have!evolved!to!behave!as!a!prominent!deposition!target!for!C3b.!The! resulting! IgGQC3b! adduct! demonstrates! a! long! serum! halfQlife! (Fries! et& al.!1984)!and!has!been!accredited!as!the!most!potent!C3!convertase!precursor!in!the!blood!(Lutz!&!Jelezarova!2006).!A!mutation!at!the!major!IgG!C3b!deposition!site!(S132A)!abolishes!the!ability!of!the!Fab!region!to!bind!C3b!and!to!activate!the!AP!of! complement! (Vidarte! et& al.! 2001).! These! observations! correlate! with! the!results! here! that! adductQformation! defective! SbiQIIIQIV! mutants! are! poor!initiators!of!C3!consumption.! !!The!SbiQC3b!adduct!alone!can!consume!AP!activity!in!a!doseQdependent!manner.!In! Section! 5.3.3.3,! it! was! proposed! that! the! SbiQIIIQIV! in! Sbi:C3:FHRQ1! ternary!complex! embedded!mode! is! convertible! to! C3b! deposited!mode,! during!which!the! domain! III! interaction! with! FHRQ1! could! be! maintained.! The! resulting!
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SbiQC3b:FHRQ1! complex! could! be! another! explanation! for! the! exceptional!resilience!of!the!SbiQC3b!adduct!against!factor!I!mediated!inactivation.!All!these!observations! taken! together!could!suggest! that!an!orchestrated!C3b!deposition!process! is! another! secret! of! the! success! of! Sbi! as! a! C3! activator.! After! the!conversion! of! C3! to! C3b,! the! nascent! C3b! molecule! needs! to! be! stabilized!immediately! by! forming! a! covalent! adduct.! Instead! of! allowing! C3b! to! become!deposited! in! a! semiQrandom! and! inefficient! natural! process,! Sbi! deliberately!offers! itself!as!the!deposition!target.!By!this!route,!the!resulting!SbiQC3b!adduct!stands!a!better!chance!of!eventually!developing!into!a!functional!C3!convertase.!!
7.2(Structural(aspects(of(the(ternary(complexes(!In! this! study,! the! smFRET! study! of! SbiQIIIQIV! and! its! ligand! binding! properties!indicates:! 1)! Free! SbiQIIIQIV!demonstrates!one!major! interQterminal!distance!2)!SbiQIIIQIV! only! demonstrates! limited! interQterminal! distance! flexibility,! 3)!SbiQIIIQIV! undergoes! a! stepQwise! structural! change! process! to! assemble! the!ternary! complex.! In! addition,! using! the! predicted! SbiQIII!model,! previous!NMR!data,! the! SbiQIIIQIV:C3d! and! the! SbiQIIIQIV:C3d:FHRQ1! SAXS! envelopes,! two! Sbi!ternary!complex!models!were!constructed.!The!“tight”!packed!model!is!believed!to! represent! the! “capturing”! phase! of! ternary! complex! formation,! the! “loose”!packed!model!could!represent!the!“captured”!ternary!complex.!!!
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So! far!multiple!attempts!have!been!made! to!construct! structural!models!of! the!ternary!complexes.!A!detailed!discussion!of!the!modelling!process!is!presented!in!Sections!4.4.3!and!6.5.2.!The!putative!models!of!SbiQIV,!EcbQC!and!EfbQC!ternary!complexes! are! shown! in! Fig.7.1.! According! to! these! models,! the! C3d! binding!EcbQC! and! EfbQC! could! form! ternary! complex! with! C3d! and! FH! with! minimal!steric!clashes.!However,!if!the!NQterminal!regions!of!these!C3d!binding!proteins!were!taken!into!account,!an!alternative!conclusion!would!be!more!reasonable.!As!shown!in!Fig.7.1.A,!there!are!considerable!lengths!of!extra!polypeptide!chains!in!the!NQterminal! segments!of!EcbQC!and!EfbQC,!which!are!not!associated!with!FH!binding! activity.! The! NQterminal! region! of! EfbQC! is! responsible! for! fibrinogen!binding(Bodén! &! Flock! 1994),! and! the! function! of! the! NQterminal! domain! of!EcbQC! is! unknown.! Therefore,! under! physiological! circumstances,! whether! the!fullQlength!Ecb!and!Efb!will!achieve!the!same!level!of!ternary!complex!formation!as!their!recombinant!truncated!counterparts!remains!in!doubt.!As!pointed!out!in!Section!5.5.3,! if! the!NQterminal! region!of!a!C3d!binding!domain! is!not!correctly!positioned,! the! ternary! complex! formation! will! be! significantly! jeopardized.!
Figure(7.1:(Putative(models(of(Staphylococcal(immune(evasion(protein(mediated(ternary(
complex.((A)!Sequence!and!structural!alignments!of!Sbi,!Ecb!and!Efb.!In!Section!4.4.3!details!of!putative! ternary! complex! modeling! are! provided.! SbiQIV,! EcbQC! and! EfbQC! present! the! C3d!binding!region!shown!in!the!structural!model.!(B)!Proposed!bacterial!protein!binding!sites!on!FH18Q20.!
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However,!Sbi!does!not!pose!the!same!problem,!since!SbiQIII! is!designed!to!bind!FH! or! FHRQ1.! More! interestingly,! in! this! study! a! loosely! packed! Sbi! ternary!complex!model!was!proposed!based!on!the!SAXS!analysis.!This!result!offers!us!an!answer!of!how!Sbi!solves!the!problem!of!potential!steric!clash!once!the!ternary!complex!has!formed.! !!
7.3(Therapeutic(potential(of(Sbi(!The!complement! system! is!often!considered!as!a!doubleQedge!sword.!An! intact!complement!cascade! is!essential! for!protection!against! invading!pathogens!and!for!developing!longQterm!adaptive!immunity!of!the!host.!Whereas,!an!imbalanced,!excessive! or! deregulated! complement! activation! is! hugely! problematic! to! the!host.! As! described! in! this! thesis,! Sbi! demonstrates! duplicitous! complement!modulatory! functions,! activating! C3! with! great! efficiency! and! at! same! time!potently!suppressing!C5!activation.!These!features!could!be!delicately!exploited,!thereby!unleashing!the!therapeutic!potential!of!Sbi.!!
7.3.1(Vaccine(adjuvant(!Firstly,! this! immune!evasion!protein& from!S.aureus&could!be!exploited!as!a!new!type! of! vaccine! adjuvant.! Vaccination! has! been! proven! as! the!most! successful!method! of! eradicating! infectious! diseases.! Traditionally,! attenuated! or!inactivated! pathogens!were! used! as! antigens.! Despite! their! success! in!modern!day!disease!control,!their!inherent!safety!flaws!undermine!the!potential!of!these!relatively! simple! and! robust! methods! to! be! exploited! further.! Nowadays,! the!therapeutic! industry! is! increasingly! interested! in! the! development! of! subunit!vaccines,! which! are! based! on! a! purified! antigenic! subunit.! This! pinpointed!antigen!presentation!scheme!allows!vaccination!to!be!utilized!not!only!as!a!way!to!fight!infectious!pathogens,!but!also!deadly!human!diseases!that!are!associated!with!aberrant!biochemical!epitopes.!However,!not!all!purified!antigenic!subunits!
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are! sufficiently! immunogenic! (Coffman! et& al.! 2010);! therefore! adjuvants!generally!need!to!be!added!to!subunit!vaccines!to!enhance!the!immune!response.!In! recent! years,! the! attention! of! new! adjuvant! research! is! shifting! from! the!activators!of!TollQlike!receptors!(TLRs)! to!activators!of! the!complement!system!(Reddy! et& al.! 2007;! Liu! et& al.! 2013).! Although! the! complement! system! was!conventionally!considered!as!a!defense!mechanism,!there!is!mounting!evidence!suggesting!that!complement!also!plays!a!role!in!promoting!B!cell!(Dempsey!et&al.!1996)! and! T! cell! (Kemper! &! Atkinson! 2006;! Kopf! et& al.! 2002)! immunities.!(Dempsey! et& al.! 1996)! has! demonstrated! that! by! conjugating! up! to! three! C3d!molecules!per!antigen,! the!threshold!of!antigen!specific!BQcell!activation!can!be!dramatically!reduced!by!1000!times.! !!As! a! C3! activator,! Sbi! fits! with! the! general! goal! of! vaccine! adjuvant.! By!coQinjection!or!conjugated!with!an!antigen,!the!Sbi!induced!local!activation!of!C3!could!increase!the!efficiency!of!C3b!opsonization!of!antigen,!thereby!decreasing!the! antigen! specific!BQcell! activation! threshold.!At! the! same! time,! the! resulting!C3a! production! could! simulate! the! leukocytes! chemotaxis! toward! the! site! of!complement!activation,! facilitating!the!antigen!presentation.!New!evidence!also!suggests! that! the! activation! of! C3a! receptor! upQregulates! the! inflammatory!cytokine!production!(Zhang!et&al.!2007).!Despite!the!theoretical!possibility!of!Sbi!as!an!adjuvant,! there!are!a! several!problems! that!are!worth!considering.!1)!To!achieve! the! best! C3b! opsonization! efficiency,! whether! to! coQinject! or!preQconjugate! Sbi!with! antigen! remains! to! be! tested.! 2)! Potential! complement!receptor! 2! (CR2)! inhibition! of! Sbi,! as! illustrated! by! crystal! structures! of!SbiQIV:C3d! (Clark! et& al.! 2011)! and! CR2:C3d! (van! den! Elsen! &! Isenman! 2011),!SbiQIV! is!an! inhibitor!of! the!C3d:CR2!interaction!(Burman!et&al.!2008),!which! is!the! molecular! basis! of! BQcell! activation.! SbiQIIIQIV! mutant! with! decreased! C3d!binding!avidity!could!be!used!to!avoid!this!problem.!As!demonstrated!in!Section!4.3.9.4,!the!R231A!mutant!of!SbiQIIIQIV!has!a!very!low!affinity!for!C3,!but!it!is!still!a! potent! activator! of! C3,! although! increased! Sbi! concentration! and! prolonged!
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incubation!are!needed.!3)!It!is!optimistic!to!assume!that!Sbi!is!directly!usable!as!a!molecular! adjuvant.! Since! Sbi! is! derived! from! a! commensal! human! pathogen,!preQexisting!antibodies!might!further!complicate!this!approach.!!
7.3.2(AntiEcancer(drug(!In! addition! to! vaccine! adjuvants,! Sbi! could! also! contribute! to! the! effort! of!conquering! cancer.! ImmuneQtargeted! treatment! is! a! contemporary! trend! of!cancer!treatment.!Antibodies!are!raised!against!aberrant!cancerous!cell!surface!epitopes.!The!binding!of!antibody!to!these!epitopes!would!trigger!the!activation!of! the! complement! classical! pathway,!which! links! antibodyQdependent! cellular!cytotoxicity! (ADCC)! (Perlmann! 1981)! to! complementQdependent! cellular!cytotoxicity! (CDCC)!(Bara!&!Lint!1987).!However,!a!high!density!of! the!surface!epitope! are! required! for! the! efficient! initiation! of! CP,! and! the! cancer! cells!normally!overexpress!complement!regulators!on!the!cell!surface!(Fishelson!et&al.!2003),!therefore!the!antibody!mediated!killing!can!hardly!achieve!its!ideal!level.!As! Sbi! is! a! strong! activator! of! complement! AP,! it! would! be! reasonable! to!speculate! that! by! conjugating! the! Sbi! together! with! an! antibody,! the! antibody!mediated! killing! of! cancerous! cell! could! be! significantly! enhanced.! The!conjugated!antibody!could!simultaneously!trigger!the!activation!of!both!CP!and!AP,! so! the! resulting! complement! activation! would! be! significantly! harder! to!contain.!Since!Sbi! is!a!bacterial!protein,!modifications!may!be!necessary!before!this!protein!totally!complies!with!the!designated!function.!Some!of!the!concerns!mentioned!in!the!above!paragraph!still!apply!here.!In!addition,!another!potential!obstacle!for!this!particular!application!is!the!C5!activation!suppressive!activity!of!Sbi.!C5!activation!leads!to!the!formation!of!the!membrane!attack!complex,!which!is!the!direct!killing!mechanism!for!cancer!cells.!This!study!demonstrated!that!the!formation! of! ternary! complexes! is! vital! for! both! the! activation! of! AP! and!inhibition! of! C5! activation.! Thus,! potentially,! the! SbiQIIIQIV! mutants! could! be!screened! for!mutants!and!concentrations! that!are!able! to! trigger!AP!activation,!
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but! with! low! C5! inhibitory! activity.! Alternatively,! E.coli& toxin! Stx2! could! be! a!more!suitable!candidate!for!this!purpose,!as!Stx2!is!an!activator!of!entire!AP.!!
7.3.3(AntiEinflammatory(drug(!So! far,! the! potential! applications! of! Sbi! have! been! suggested! based! on! its! C3!activating! function.! However,! in! this! study! it! was! also! shown! that! Sbi! is! an!inhibitor! of! C5.! Given! these! multifaceted! complement! modulatory! activities,!native! Sbi! might! not! be! a! suitable! candidate! for! potential! antiQinflammatory!therapeutics.! But,! with! slight! genetic! manipulation! SbiQIIIQIV! could! be!transformed! into! a! protein! that! strongly! inhibits! both!C3! and!C5! activation.! In!Section! 4.4.6.2,! it! was! elucidated! that! two! positive! relationships! exist,! one! is!between!C3!binding!strength!and!C3!convertase!inhibitory!activity,!and!another!one!is!between!ternary!complex!formation!and!C5!convertase!inhibitory!activity.!The! native! SbiQIIIQIV! demonstrates! relatively! loosened! C3b! binding! strength,!therefore! only! causing! limited! inhibition! of! C3! convertase.! Thus,! it! would! be!reasonable! to! speculate! that! by! swapping! the! C3d! binding! region! of! SbiQIIIQIV!with! the! similar! region! of! Efb,! the! resulting! fusion! protein! of! SbiQIII! and!EfbQC!could!be!an!extremely!potent!inhibitor!of!the!entire!complement!cascade.!!ImproperlyQregulated! complement! activation! is! a! major! cause! of! numerous!human! diseases! (Ricklin! &! Lambris! 2007),! such! as! AMD,! aHUS,! rheumatoid!arthritis,! and! systemic! lupus! erythematosus.! But! given! the! complexity! of! the!complement! cascade! and! the! sheer! amount! of! complement! components! in! the!blood,!the!development!of!drugs!targeting!complement!seems!very!frustrated.!To!date,! there! are! only! a! handful! of! clinicallyQapproved! complement! inhibitors! on!the! market.! The! most! successful! one! is! the! antiQC5! monoclonal! antibody!eculizumab!(Alexion,!Cheshire,!CT,!USA),!which!inhibits!the!terminal!pathway!by!binding! to! C5.! Reflected! by! the! success! of! eculizumab,! antibodyQbased!therapeutics!appear! to!be! the!general! trend! in! the!pharmaceutical! industry! for!
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complement! related! diseases.! Despite! the! demonstration! of! the! inhibitory!potency!of!staphylococcal! immune!modulatory!proteins!(e.g.!SCIN,!Efb,!Ecb!and!Sbi),!so!far!only!their! inhibitory!mechanisms!(Rooijakkers!et&al.!2007;!Laarman!
et&al.!2010;!Jongerius!et&al.!2007;!Chen!et&al.!2010)!are!inspirational!for!potential!new!therapeutics.!Thus,!in!the!light!of!this!inQdepth!study!of!Sbi!mediated!ternary!complex! formation,! a! biQspecific! antibody! that! binds! to! C3d! and! FHRQ14Q5!simultaneously!could!be!a!potential!Sbi!inspired!C5!inhibition!solution.!!
7.4(Conclusion!!This!study!shows!that!Sbi!binds!directly!to!FH!and!FHRQ1,!and!in!complex!with!isoforms! of! complement! component! C3,! the! resulting! FH! and! FHRQ1! ternary!complexes! are! significantly! stronger! in! avidity.! Specifically,! Sbi! domain! III!was!identified!as!the!domain!responsible!for!the!binding!of!FH!and!FHRQ1.!Systematic!mutagenesis!studies!pinpointed!K173!as!the!key!residue!for!the!activity!of!SbiQIII.!Comparative! assays! using! SbiQIIIQIV!WT! and! K173A!mutants! lead! to! following!conclusions:! 1)! The! formation! of! the! FHRQ1! containing! ternary! complex! is!essential! for!the!Sbi!triggered!C3!consumption!mechanism,!2)!The!formation!of!the!FHRQ1!ternary!complex!protects!C3b!from!FH!mediated!inactivation,!and!3)!The!C3!consumption!is!controlled!to!avoid!activation!of!C5.!Despite!the!sequence!identity!of!FH18Q20!and!FHRQ13Q5,!Sbi!prefers!FHRQ1!over!FH!during!the!assembly!of! the! ternary! complex.! This! binding! preference! could! further! increase! the!stability!of!C3b!species!(e.g.!C3b,!C3H20!and!SbiQC3b)!in!the!serum,!and!as!a!result,!disrupting!the!regulation!of!AP,!which!leads!to!the!local!consumption!of!C3.!!Ternary! complex! formation! is! only! one! of! the! factors! contributing! to! the!increased!C3b!stability.!It!is!also!shown!in!this!study!that!by!covalently!attaching!C3b!to!SbiQIIIQIV,!the!resulting!SbiQC3b!adduct!demonstrates!a!prolonged!halfQlife!in! the! serum! compared! with! free! C3b! molecule.! Moreover,! a! stronger!doseQdependent! relationship! was! observed! between! the! SbiQC3b! adduct!
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Table(9.1:!Recipes!for!8%,!10%,!12%,!15%!acrylamide!resolving!gel!for!SDSQPAGE!(4!gels).(! 8%!gel! 10%!gel! 12%!gel! 15%!gel!Tris!1.5M!pH8.8!(ml)! 6.25! 6.25! 6.25! 6.25!H20!(ml)! 13.6! 12.36! 11.11! 9.25!40%!v/v!29:1!Acrylamide/bisQacrylamide!(ml)! 5! 6.25! 7.5! 9.35!10%!APS!(μl)! 125! 125! 125! 125!TEMED!(μl)! 11.25! 11.25! 11.25! 11.25!
(
(
Table(9.2:!Recipe!for!4%!acrylamide!stacking!gel!for!SDSQPAGE!(4!gels)(! 4%!gel!Tris!0.5M!pH6.8!(ml)! 3.125!H20!(ml)! 8!40%!v/v!29:1!Acrylamide/bisQacrylamide!(ml)! 1.25!10%!APS!(μl)! 62.5!TEMED!(μl)! 12.5!! ! ! ! !
Table(9.3:!4%,!20%!acrylamide!gel!for!gradient!SDSQPAGE!(3!gels)(! 4%!gel! 20%!gel!Tris!1.5M!pH8.8!(ml)! 3.125! 3.125!H2O!(ml)! 8.054! 3.055!40%!v/v!29:1!Acrylamide/bisQacrylamide!(ml)! 1.25! 6.25!10%!APS!(μl)! 114! 114!TEMED!(μl)! 12! 12!! ! !
Table(9.4:!2×SDSQPAGE!reducing!sample!buffer!! Reducing! NonQreducing!H2O! 2.25!ml! 2.75!ml!0.5M!Tris!pH6.8! 1.25!ml! 1.25!ml!10%!(w/v)!SDS! 3!ml! 3!ml!50%!(v/v)!glycerol! 2!ml! 2!ml!2Qmercaptoethanol! 0.5!ml! 0!ml!0.18%!bromophenol!blue! 1!ml! 1!ml!
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Table( 9.5:! 10×Glycine! running! buffer! for! SDSQPAGE.! MakeQup! to! 1! L! with!distilled!H2O.!Do!not!need!to!adjust!pH.!Tris!Base! 30.3g!Glycine! 143.75g!SDS! 10g!!
Table(9.6:!Coomassie!Blue!stain!for!acrylamide!gel(40%!Methanol!0.1%!(w/v)!Brilliant!blue!R250!10%!Acetic!acid!50%!H2O!! ! ! ! ! ! ! ! ! ! ! ! ! ! !














































Figure( 9.7:( Gel( of( factor( H(












Figure( 9.9:( Ramachandran( analysis( of( SbiEIII( and( SbiEIIIEIV( predicted(



















Ligand Concentration(SbiQIIIQIV! 100!pM!C3a! 28!μM!C3d! 24!μM!C3! 20!μM!C3(H20)! 10!μM!C3b! 2.8!μM!FH! 3.3!μM!FHRQ1! 4!μM!
Figure( 9.10:( SAXS( sample( preparation( and( raw( scattering( profiles! (A)!SDSQPAGE!profile!of!SbiQIIIQIV:C3d:FHRQ1!complex.!Molar!ratio:!1:1:1.!(B)!Raw!scattering!curves!of!SbiQIIIQIV:C3d:FHRQ1!
